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ABSTRACT 
The prenatal use of medicines and recreational substances is of significant 
importance because there is insufficient information on the effects of 
medicines and recreational substances on pregnancy outcomes. In addition, 
literatures on health beliefs of pregnant women about medicine and 
recreational substance use are lacking. 
The aim of this thesis was to investigate medicine and recreational 
substance use during pregnancy in an antenatal population of London. The 
study was approved by the ethics committee. 
The first part of the thesis was a prospective cohort study of medicine and 
substance use across all trimesters (using survey methods), and the 
pregnancy outcomes (using the medical records); the second part was a 
qualitative study of the health beliefs of pregnant women which employed 
semi-structured telephone interviews and the Health Belief Model as a 
framework for data collection and analysis. 
The results of the prospective study demonstrated that the prevalence of use 
of prescription, over-the-counter and complementary and alternative 
medicines during at least one trimester were 32.5%, 50.2% and 57.1% 
respectively. The prevalence of exposure to alcohol, cigarette and illicit 
substances were 16.0%, 3.5% and 0.9% respectively. However, due to 
limited sample size, the study could not demonstrate an association between 
the medicines and substances used and increased risk of congenital 
anomalies in the baby. The qualitative study indicated that pregnant women’s 
adherence to medicines could be explained by women’s perception of the 
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severity of a medical condition, risks of non-adherence to the medicine as 
well as anxiety about the risks of the medicine on the foetus. In the case of 
substance use, a low risk perception could be used to explain women’s 
behaviour. 
Healthcare professionals have a responsibility to counsel pregnant women 
about the benefits or risks of medicines and substances, informed by the 
best evidence, and guided by the women’s perceptions. 
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OVERVIEW OF THE THESIS CHAPTERS 
Medicine and recreational substance use in the antenatal period presents a 
special interest due to the paucity of information on the safety of these 
agents in pregnancy. In addition, women’s perceptions or beliefs about the 
risks or benefits of exposure have implications on their subsequent health-
related behaviour. 
This thesis presents the research conducted to investigate medicine and 
recreational substance use in pregnancy and is reported in five chapters. 
Chapter 1 provides a general introduction to the research field, describing 
the physiologic and pharmacokinetic changes in pregnancy and presents a 
literature review on the epidemiology of medicine and recreational substance 
use in pregnancy. 
Chapter 2 describes the prospective cohort study which was carried out in an 
antenatal population of London to estimate the prevalence of medicine and 
recreational substance use during pregnancy as well as examine the 
pregnancy outcomes and safety knowledge of the mothers. 
Chapter 3 presents another literature review on the health beliefs, attitudes 
and knowledge of expectant mothers regarding medicine and recreational 
substance use during pregnancy. 
Chapter 4 focuses on a semi-structured qualitative study of the health beliefs 
of pregnant women. 
10 
 
The last chapter (chapter 5) provides a discussion of the main findings in the 
thesis, implications of the findings, and identifies areas for further work. It 
ends with the main conclusions of the research.      
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1.1 General Introduction 
The use of medicines and recreational substances during pregnancy calls for 
special attention because in addition to the mother, the health and life of her 
unborn child is also at stake. For many years, the general opinion was that 
the placenta served as a barrier that protects the foetus from harmful agents. 
However, the thalidomide catastrophe in the 1960s, with the birth of several 
thousands of severely malformed babies clearly showed that medicines used 
by the mother can cross the placenta and may have untoward effects on the 
foetus (Irl and Hasford, 2000; Sanz et al., 2001; Baggley, 2004). The 
consequence of the thalidomide disaster was an increased awareness of the 
potential for medicines or substances to cause congenital malformations and 
other developmental disorders and the necessity to investigate this (Irl and 
Hasford, 2000). Furthermore, the changes in maternal physiology which 
occur normally during pregnancy have far-reaching implications on medicine 
or recreational substance disposition in the woman’s body. 
1.1.1 The physiology of pregnancy 
The process of pregnancy begins when a sperm penetrates an ovum. This is 
called fertilisation and usually takes place in the woman’s fallopian tube. 
Between 5-7 days after fertilisation, the fertilised ovum implants into the wall 
of the uterus and starts forming the placenta. The placenta maintains and 
nourishes the baby by enabling the transfer of oxygen, carbon dioxide, amino 
acids, fats, vitamins and minerals from the mother’s blood. It also allows 
transfer of waste substances from the growing foetus to maternal circulation. 
From the time of implantation into the wall of uterus until approximately 
eighth week of life, the baby is known as embryo. Development is rapid 
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during this stage as the specialized cells begin to form the vital organs, 
nervous system, bones, muscles and blood. After the eighth week of 
pregnancy, the developing baby is called a foetus (Sachdeva et al., 2009). 
The trimester of pregnancy is often very important. Some medicines can be 
dangerous to take in the first three months but safe in the second or third, or 
vice versa. It is even suggested that women who are likely to conceive 
should withdraw all unnecessary medicines 3-6 months before conception 
(Sorensan et al., 2004). The first trimester is the period of greatest risk for 
the baby. This is because during this stage, the baby’s organs are 
developing. Certain medicines taken early in pregnancy (15-21 days after 
fertilisation)- during the period of blastogenesis- may act in all or nothing 
fashion; killing the embryo or not affecting it at all. During this early stage, the 
developing baby is highly resistant to birth defects. However, it becomes 
vulnerable to birth defects between the 3rd and 8th week after fertilisation; 
which is the period of organogenesis. All major organs start developing 
during this period and medicines or recreational substances reaching the 
foetus at this stage may cause a miscarriage, an obvious birth defect, or a 
permanent but subtle defect that is noticed later in life (Porter, 2004). During 
the second trimester, recreational substances e.g. alcohol and tobacco, can 
interfere with the development of the baby’s nervous system, or with the 
growth of the baby, resulting in a low birth weight. Development during this 
time is primarily maturation and growth. Exposure to medicines or 
recreational substances during this period is believed not to be associated 
with major congenital malformations but they may alter the growth and 
function of normally formed organs and tissues (Porter, 2004). Some 
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medicines or recreational substances taken in the final three months of 
pregnancy may cause complications for the baby after birth. For example, 
maternal intake of ibuprofen in the third trimester increases the risk of 
premature closure of the ductus arteriosus, which may lead to persistent 
pulmonary hypertension in the newborn (Glover et al., 2003). Medicines 
taken by the mother can also indirectly affect the baby by interfering with the 
environment within the uterus. Some medicines, for example 
pseudoephedrine, can alter the function of the placenta usually by 
constricting blood vessels and reducing the blood supply of oxygen and 
nutrients from the mother to the baby. Furthermore, they can cause the 
muscles of the uterus to contract forcefully, thereby injuring the foetus. Other 
medicines or recreational substances may cause early, delayed or even 
prolonged labour, all of which pose a threat to the baby (Briggs et al., 2008). 
1.1.2 Pharmacokinetics in pregnancy 
The physiologic changes of pregnancy affect the pharmacokinetics of 
medicines or recreational substances used by pregnant women. During 
pregnancy, a woman’s plasma volume increases by 30-50% and cardiac 
output and glomerular filtration rate also increase in similar proportion. These 
factors contribute to lower circulating concentration of some medicines 
(especially those excreted by the kidneys) in a pregnant woman and possibly 
to sub-therapeutic medicine levels. Also there is increase in body fat during 
pregnancy which increases the volume of distribution of fat-soluble 
medicines. A decrease in plasma albumin concentration during pregnancy 
increases the volume of distribution for highly protein bound medicines or 
recreational substances. But the unbound medicines or substances are 
                                                                                                                                   Chapter 1 
 
28 
 
excreted out more rapidly by the kidney and liver; and this offsets the effect 
of increased volume of distribution. Due to the effect of progesterone on 
smooth muscle activity, gastric emptying time is prolonged particularly in the 
third trimester thus delaying the onset of effect of some medicines 
(Frederiksen, 2001; Yankowitz and Niebyl, 2001). 
Intramuscular absorption of medicines is generally more rapid due to 
increased blood flow; which enhances the rate of onset of action of 
medicines (Yankowitz and Niebyl, 2001). Lastly, oestrogen and progesterone 
alter hepatic enzyme activity and this can increase the accumulation or 
decrease elimination of some medicines or recreational substances 
(Frederiksen, 2001; Hansen and Yankowitz, 2002). 
1.1.3 Placental transfer of medicines and recreational substances 
The placenta is the functional unit between foetal blood and maternal blood. 
The functions of the placenta include nutrition, respiration, metabolism, 
excretion and endocrine activity to maintain foetal and maternal well-being. 
In order for a medicine or recreational substance to cause a teratogenic or 
pharmacological effect on the foetus, it must cross from maternal circulation 
to foetal circulation through the placenta by diffusion (Sorensan et al., 2004). 
The rate of transfer depends on the chemical properties of the medicine or 
recreational substance such as protein binding, pH difference, lipid solubility 
and molecular weight (Kraemer, 1997). Only free unbound medicine or 
substance crosses the placenta. During pregnancy, maternal plasma 
albumin decreases while foetal albumin increases. As a result, the 
concentration of free medicine or recreational substance increases which 
crosses the placenta to reach the foetus. Foetal pH is slightly more acidic 
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than maternal pH and so weak bases are more likely to cross the placenta 
(Loebstein et al., 1997). Moderately lipid soluble medicines or recreational 
substances can easily diffuse across the placental membrane. Medicines or 
recreational substances with low molecular weight (< 500 g/mol) diffuse 
freely across the placenta, those with moderate molecular weights (between 
500-1000 g/mol) cross the placenta less easily, while a few others with high 
molecular weights (> 1000 g/mol) do not usually cross the placental 
membrane (Kraemer, 1997). Transplacental transfer of a medicine or 
recreational substance increases in the third trimester due to increased 
maternal and placental blood flow, decreased thickness and increased 
surface area of the placenta (Yankowitz and Niebyl, 2001). 
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Figure 1 Simplified diagrammatic representation of circulatory systems between 
placenta, mother and foetus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Key to the diagram: 
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Transfer the foetal 
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CO2 to the placenta and 
transfer to the mother 
via umbilical 
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maternal blood via the 
placenta. Absorption of 
nutrients and O2  
 
  
Maternal 
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Supplies 
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and O2 to 
the foetus 
via the 
placenta 
Maternal 
Vein: 
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waste 
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and CO2 
from the 
foetus via 
the 
placenta 
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Filled with 
maternal blood 
Umbilical vein: 
Transfer the nutrients 
and O2 to the foetus. 
Direction of blood flow 
Movement 
of wastes 
and CO2  
Movement of 
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1.1.4 Medicine and recreational substance use in pregnancy – An 
overview of risks and benefits 
Medicine and recreational substance use during pregnancy has potential 
risks that may threaten both foetal and maternal health (Koren et al., 1998; 
De Santis et al., 2004; Lagoy et al., 2005). However, many pregnant women 
take prescription medicines or are exposed to other agents that may have 
adverse effects on foetus such as over-the-counter medicines, 
complementary and alternative medicines as well as recreational substances 
(Shehata and Nelson-Piercy, 2001; Conover, 2003; Andrade et al., 2004; 
Schempf, 2007). 
Nonetheless, pregnant women can have health problems that require the 
use of pharmacologic agents, hence prescription medicine exposure in 
pregnancy is inevitable. When this need is combined with the many 
physiologic changes of pregnancy, prescribers must make critical decisions 
regarding the risks of teratogenicity versus the well-being of the mother 
(Hansen et al., 2002; Vickers and Brackley, 2002; Suresh and Radfar, 2004; 
Weiner et al., 2005). Although some medicines, such as thalidomide, 
isotretinoin and diethylstilbestrol have clearly been shown to be teratogenic, 
data about foetal effects of most medicines is unsatisfactory (Mehta and 
Larson, 2011). 
Exposure to over-the-counter medicines is frequent in pregnant women 
(Black and Hill, 2003; Conover, 2003; Tillet et al., 2003; Das et al., 2006). 
Limited information exists on the effects of many of these agents during 
pregnancy; it is not safe to assume that because these products are 
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available without medical prescription that they are without danger to the 
pregnant woman and her foetus (Conover, 2003; Tillet et al., 2003). 
Prenatal use of complementary and alternative medicine (CAM) is an area 
where more research is especially needed. This is because very little is 
known about the potential adverse effects of herbals in widespread use as 
dietary supplements or natural health products in industrialised societies. 
Moreover, the use of CAM to support health in pregnancy is on the increase 
worldwide (Westfall, 2001; Dugoua, 2010). Some researchers posit that this 
rise in the popularity of CAM is related to increased ethnic influences 
resulting from migration and globalisation (Coulter and Willis, 2004). CAM is 
defined as a group of diverse medical and health care systems, practices, 
and products that are not generally considered part of conventional 
medicine. These practices are often grouped into the broad categories below 
(some practices may fit into more than one category). 
1. Natural Products such as herbal medicines or botanicals many of 
which are sold over the counter as dietary supplements; 
2. Mind-Body Medicine such as meditation, yoga, acupuncture, deep-
breathing exercises, guided imagery, hypnotherapy, progressive 
relaxation, qi gong and tai chi; 
3. Manipulative and Body-based Practices such as spinal manipulation 
and massage therapy; 
4. Other CAM practices e.g. movement therapies, use of energy fields 
and whole medical systems (such as ayurvedic medicine, traditional 
Chinese medicine, homeopathy and naturopathy). (National Centre for 
Complementary and Alternative Medicine, 2013) 
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Recreational substances can be grouped into Licit and Illicit substances. The 
licit substances are alcohol and tobacco while the illicit include cocaine, 
marijuana, opioids and non-medical use of barbiturates and other 
tranquilizers. Although the maternal and neonatal consequences of tobacco 
and alcohol exposure are well established, the evidence related to prenatal 
illicit substance use is less consistent, necessitating the need for further 
research in this area (Schempf, 2007). 
1.1.5 Summary 
Pregnancy is usually viewed in the context of a woman and her unborn 
baby’s overall health. The physiological changes in pregnancy, beginning 
from the first trimester affects the disposition of medicines and recreational 
substances in the mother’s body.  Medicine and recreational substance use 
during this period therefore presents a special interest due to the paucity of 
information on the safety of these agents in pregnancy. 
 
1.2 The epidemiology of medicine and recreational substance use in 
pregnancy – A narrative literature review 
1.2.1 Background 
Epidemiology is the study of the distribution and determinants of health-
related states or events (including diseases), and the application of this study 
to the control of diseases and other health problems. Various methods can 
be used to carry out epidemiological investigations: surveillance and 
descriptive studies can be used to study distribution while analytical studies 
are used to study determinants (World Health Organisation, 2011).  
                                                                                                                                   Chapter 1 
 
34 
 
Pregnancy is a time of particular vulnerability and it is concerning that 
despite the dearth of information on the safety of medicines in pregnancy, 
the available statistics indicate that the use of medicines in pregnancy is 
widespread (Das et al., 2006; Briggs et al., 2008; Davis, 2010). Many 
pregnant women are exposed to prescription or over-the-counter medicines 
which are used to treat chronic and pregnancy-induced conditions, such as 
hypertension, nausea and vomiting, heartburn and backache, which can start 
afresh during pregnancy or can be exacerbated by pregnancy (Davis, 2010). 
Furthermore, some medications like vitamins and minerals are essential for 
the health of the pregnant woman and the foetus. It has been discovered that 
folic acid administration prevents neural tube defects in the developing baby, 
leading to the conclusion that the deficiency of this vitamin may be 
teratogenic (Nelson and Forfar, 1971). 
However, ethical concerns about possible harm generally have led to the 
appropriate exclusion of pregnant women from premarketing clinical trials of 
medicine safety and efficacy (Koren et al., 1998; Mitchell, 2000; Ward, 2001; 
Black and Hill, 2003; Webster and Freeman, 2003; Hardy et al., 2006; Gagne 
et al., 2008). In the post-marketing setting, case series and small cohorts of 
exposed pregnant women such as the pregnancy registries for newly 
marketed medicines, can only detect major human teratogens such as 
thalidomide or isotretinoin. Fortunately, while major teratogens appear to be 
few, less serious teratogens may be more numerous and more widely used 
and could therefore lead to a greater number of birth defects than major 
teratogens (Mitchell, 2003). It is also important to recognise that patterns of 
medicine use in pregnancy change over time, for some reasons: new 
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prescription medicines are continually introduced, older ones are increasingly 
available over-the-counter and concerns may change regarding their safety 
(Hernandez-Diaz, 2006). 
In contrast to prescription and over-the-counter medicines, herbal products 
and other complementary medicines are usually marketed without the benefit 
of clinical trials to demonstrate their safety. Thus, safety concerns related to 
the use of these therapies have emerged (Broussard, 2010). The remarkably 
limited knowledge regarding the effects of these therapies on the developing 
foetus requires that special attention should be focused on the study of their 
risks and relative safety in pregnancy (Broussard, 2010).   
Prenatal use of alcohol, tobacco, or illicit substances is also common. 
Alcohol exposure during pregnancy is a well-recognised public health 
problem and is one of the few modifiable risk factors for poor pregnancy and 
child outcomes (Burd, 2003; Peadon, 2010). Even before conception, the 
toxic effects of alcohol may harm both the ovum and the sperm (Coles, 
1994). Maternal factors such as smoking, which is often associated with 
alcohol use, may also increase the teratogenic effects of alcohol (Young, 
1997). The evidence related to the outcomes of prenatal illicit substance use 
is not consistent and this underscores the need for further research in this 
area (Schempf, 2007). 
In the light of the above, it is critical that the prevalence and adverse effects 
of medicine and recreational substance use in pregnancy be evaluated and 
the information made accessible to women and healthcare providers. 
Knowledge of such data could help to strengthen supposed correlations 
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between a specific agent and the occurrence of a specific malformation. 
Therefore, current and coherent epidemiological studies that ascertain the 
medicines and recreational substances most commonly used in pregnancy 
are important for establishing priorities in birth defects research with major 
clinical and public health implications (Gagne et al., 2008). 
1.2.2 Aim 
To conduct a narrative literature review on the epidemiology of medicine and 
recreational substance (licit and illicit) use in pregnancy. 
1.2.3 Objectives 
1. To investigate the prevalence of medicine and recreational substance 
use during in pregnancy. 
2. To determine the medicines and recreational substances reportedly 
used in pregnancy and adverse pregnancy outcomes. 
1.2.4 Methods 
1.2.4.1 Literature Search 
Three databases – PubMed, EMBASE and International Pharmaceutical 
Abstracts – were searched for articles which focus on the subject of interest 
in December 2010 and these yielded 101 articles. The search was then 
updated in August 2013 with 4 databases – PubMed (1950 to August 2013), 
EMBASE (1980 to 2013 Week 31), International Pharmaceutical Abstracts 
(1970 to August 2013), and CINAHL Plus (1937 to August 2013). In addition, 
reference lists of the relevant articles were searched for other relevant 
publications. 
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1.2.4.2 Search strategy and terms 
Drug OR Drugs OR Medicine OR Medicines OR Medication OR Medications 
AND 
Pregnant OR Pregnancy OR Pregnant woman OR Pregnant women OR 
Gestation OR Gestational OR Prenatal OR Antenatal OR Maternal 
AND 
Epidemiology OR Survey OR Interview OR Questionnaire OR Database OR 
Record 
1.2.4.3 Inclusion criteria 
Articles included were the cohort and cross-sectional studies that were 
written in English language and focus on the use of medicines and 
recreational substances in pregnancy. The medicines and recreational 
substances of interest in this review are prescription medicines, over-the-
counter medicines, complementary and alternative medicines and 
recreational substances (licit and illicit substances). 
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                             Figure 2 Narrative review flow chart 
 
 
 
Duplicates removed (n = 4,817) 
Irrelevant articles excluded      
(n = 2,982) 
Article titles and abstracts 
screened (n = 3,245) 
154 articles excluded                     
• Reviews (n = 33)                            
• Case control studies (n = 46)       
• Non-English articles (n = 35)        
• Others e.g. case reports, 
case series, research letters, 
correspondences (n = 40)      
Full text articles assessed for 
eligibility (n= 263) 
Articles included in the 
narrative review (n = 109) 
Reference lists of included 
articles reviewed (n = 23) 
Total number of articles included in the narrative 
review (n = 132) 
Articles retrieved and imported into EndNote             
(n = 8,062) 
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1.2.5 Results 
The electronic search produced 8062 articles – 3687 from PubMed, 21 from 
EMBASE, 39 from International Pharmaceutical Abstracts and 4315 from 
CINAHL Plus. The PubMed search was limited to TITLE/ABSTRACT 
because a large number of articles were obtained without activating the limit. 
As shown in the narrative review flow chart (Figure 2), 132 studies which 
were carried out between 1973 and 2013 were included in the narrative 
review. The summary of the main findings are presented in Table 1 while 
Figure 3 illustrates the trend in the number of published studies within that 
time frame. 
 
 
   Figure 3 Trend in the number of published studies between 1973 and 2013 
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Table 1 Articles included in the narrative literature review 
 
Author
Year of 
study Country Objectives of the study
Type of medicine or 
substance studied
Study design Data collection Sample size Study participants
Prescription 
medicines
Over-the-
counter 
medications
Recreational 
drugs or 
substances
Complementary & 
alternative 
medicines Overall
Forfar and 
Nelson 1973
United 
Kingdom
Investigate the drugs taken by 
pregnant women and those that 
may affect the fetus adversely Cross-sectional 
Structured interview 
and medical record 
review n  = 911
Postpartum women 
(shortly after 
delivery)
Prescription medications; 
Recreational drug- cigarette 82% N/A 57% N/A N/A
Golden et al 1984
United 
States of 
America
Determine the extent of 
phencyclidine use during 
pregnancy
Prospective 
cohort study
Interview with 
questionnaire and 
urine analysis n  = 2327
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Recreational drug- 
phencyclidine N/A N/A 0.80% N/A 0.80%
Rubin et al 1986
United 
Kingdom
Investigate the use of therapeutic 
drugs, alcohol and cigarettes 
during pregnancy
Prospective 
cohort study
Self-administered 
questionnaire n  = 2765
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Therapeutic drugs, alcohol 
and cigarettes N/A N/A N/A N/A 34.80%
Frank et al 1988
United 
States of 
America
Assess cocaine use during 
pregnancy
Prospective 
cohort study
Interview, urine 
toxicology and 
medical record review n  = 679 Pregnant women Recreational drug- cocaine N/A N/A 17% N/A 17%
Chasnoff et al 1990
United 
States of 
America
Estimate the prevalence of 
substance abuse by pregnant 
women
Cross-
sectional 
Urine toxicology and 
medical record review n  = 715 Pregnant women
Recreational drugs- alcohol, 
cannabis, cocaine and 
opiates N/A N/A 14.80% N/A 14.80%
Buitendijk 
and Bracken 1991
United 
States of 
America
Assess medication use in a 
population of pregnant women Cross-sectional Interview n  = 4186
Pregnant women 
(1st trimester)
Prescription and over-the-
counter medications 27.30% 54.90% N/A N/A 66%
Correy et al 1991 Australia
Investigate the use of prescription 
drugs in the first trimester and 
congenital malformations
Prospective 
cohort study
Medical form (filled by 
doctors) n  = 56 037
Pregnant women 
(1st trimester) Prescription medicines 30.90% N/A N/A N/A 30.90%
C.G.D.U.P. 
(Collaborative 
Group on 
Drug Use in 
Pregnancy) 1992 Italy
Assess the pattern of drug use in 
pregnancy
Cross-
sectional 
Interview using 
structured 
questionnaire n  = 14 778
Postpartum women 
(within 1st week of 
delivery)
Prescription and over-the-
counter medications N/A N/A N/A N/A 86%
Kokotailo et 
al 1992
United 
States of 
America
Determine the prevalence and 
associated risk factors of cigarette, 
alcohol and other drug use among 
school-age pregnant adolescents 
Prospective 
cohort study
Self-administered 
questionnaire, urine 
and breathe sample 
analyses and medical 
record review n  = 212
Pregnant 
adolescents
Cigarette, Alcohol and Other 
drugs (marijuana, heroin, 
cocaine, cannabis, opiates, 
benzodiazepines and 
prescription pain killers) N/A N/A 17% N/A 17%
Methods Population characteristics Prevalence of use
                                                                                                                                   Chapter 1 
 
41 
 
Table 1 Articles included in the narrative literature review (continued) 
 
Ostrea et al 1992
United 
States of 
America
Determine the prevalence and 
epidemiologic characteristics of 
drug use in a high-risk, urban 
obstetric population
Cross-
sectional 
Meconium analysis 
and medical record 
review n  = 3010
Postpartum women 
and neonates
Recreational drugs- 
cocaine, morphine and 
cannabis N/A N/A 44% N/A 44%
Aviv et al 1993
South 
Africa
Record the prevalence of 
medication use in the antenatal 
period
Cross-
sectional Interview n  = 236
Pregnant women 
(3rd trimester)
Prescription and over-the-
counter medications 59% 28.80% N/A N/A 71.20%
Berthier et al 1993 France
Determine the drugs prescribed 
during pregnancy Cross-sectional 
Interview with 
questionnaire n  = 225
Postpartum women 
(3 days after 
delivery)
Prescription and over-the-
counter medications 88.10% 17.90% N/A N/A 99.50%
Buchi et al 1993
United 
States of 
America
Determine the prevalence of 
substance abuse among pregnant 
women Cross-sectional Urine analysis n  = 792
Pregnant women 
(3rd trimester)
Recreational drugs- 
marijuana, cocaine, 
amphetamines and alcohol N/A N/A 7.80% N/A 7.80%
Vega et al 1993
United 
States of 
America
Identify the prevalence and 
demographic profiles associated 
with substance use during 
pregnancy
Cross-
sectional Urine analysis n  = 29 494 Postpartum women
Recreational drugs- 
amphetamines, 
barbiturates, 
benzodiazepines, cannabis, 
cocaine, methadone, 
opiates, phencyclidine and 
alcohol N/A N/A 11.35% N/A 11.35%
Bonassi et al 1994 Italy
Investigate drug intake during 
pregnancy
Cross-
sectional 
Interview with 
questionnaire n  = 3112
Postpartum women 
(within 5 days of 
delivery)
Prescription and over-the-
counter medications N/A N/A N/A N/A 82.7%
Heikkila et al 1994 Finland
Record the use of medications and 
the policy of prescribing during the 
course of pregnancy
Prospective 
cohort study
Questionnaire (filled 
by physician or nurse) n  = 5851
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription and over-the-
counter medications 8% 15% N/A N/A N/A
Kokotailo et 
al 1994
United 
States of 
America
Determine the prevalence of 
cigarette, alcohol and other drug 
use among small-city pregnant 
adolescents 
Prospective 
cohort study
Self-administered 
questionnaire, urine 
toxicology and 
medical record review n  = 117
Pregnant 
adolescents
Recreational drugs- 
cigarette, alcohol and illicit 
drugs (amphetamines, 
benzodiazepines, cannabis, 
cocaine, opiates, 
phencyclidine and lysergic 
acid diethylamide N/A N/A 35% N/A 35%
Martinez-
Crespo et al 1994 Spain
Determine the prevalence of 
cocaine abuse during pregnancy
Cross-
sectional 
Self-completed 
structured 
questionnaire and 
urine toxicology n  = 1773
Postpartum women 
(immediately after 
delivery) Recreational drug- cocaine N/A N/A 18.20% N/A 18.20%
Stewart and 
Streiner 1994 Canada
Determine the prevalence of 
regular alcohol drinking during the 
second half of pregnancy Cross-sectional 
Self-completed 
questionnaire n  = 466
Pregnant women 
(2nd trimester) Recreational drug- alcohol N/A N/A 22.70% N/A 22.70%
Stewart and 
Streiner 1995 Canada
Determine the prevalence of 
regular smoking in the latter half of 
pregnancy Cross-sectional 
Self-completed 
questionnaire n  = 545
Pregnant women 
(2nd trimester) Recreational drug- cigarette N/A N/A 16.30% N/A 16.30%
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Table 1 Articles included in the narrative literature review (continued) 
 
Gilchrist et al 1996
United 
States of 
America
Investigate the substance use 
patterns of adolescent mothers
Prospective 
cohort study
Face-to-face interview 
and urine analysis n  = 229
Pregnant 
adolescents
Recreational drugs- 
cigarette, alcohol, 
marijuana, crack, cocaine, 
psychedelics, heroin, opium, 
amphetamines, 
barbiturates, tranquilizers 
and inhalants (such as 
sniffing glue, gasoline, etc) N/A N/A 16% N/A 16%
Larivaara et 
al 1996 Finland
Investigate the use of psychotropic 
drugs and pregnancy outcome
Prospective 
cohort study
Self-administered 
questionnaire n  = 7933
Pregnant women 
(2nd and 3rd 
trimesters)
Prescription drugs- 
tranquilizers, hypnotics, 
antidepressants and lithium 1.50% N/A N/A N/A 1.50%
Irl et al 1997 Germany
Evaluate the recorded information 
on drug exposure during pregnancy 
with regard to teratogenic 
properties and to contribute to the 
quality assurance of medical 
treatment in pregnancy
Prospective 
cohort study Medication form n  = 921
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter and alternative 
medicines N/A N/A N/A N/A 83.60%
Mabina et al 1997 South Africa
Determine the prevalence of herbal 
medicine use during pregnancy Cross-sectional 
Interview with 
questionnaire n  = 577
Pregnant women 
(3rd trimester) Herbal medicines N/A N/A N/A 43.70% 43.70%
Massele et al 1997 Tanzania
Determine the use of antimalarial 
drugs during pregnancy
Prospective 
cohort study
Interview with 
structured 
questionnaire and 
antenatal card review n  = 200
Pregnant women 
(2nd trimester)
Prescription medications- 
antimalarials 75% N/A N/A N/A 75%
Perham-
Hester and 
Gessner 1997
United 
States of 
America
Examine the characteristics related 
to drinking during pregnancy Cross-sectional 
Self-completed postal 
questionnaire n  = 6973
Postpartum women 
(2 to 8 months after 
delivery) Recreational drug- alcohol N/A N/A 9.20% N/A 9.20%
Splinter et al 1997
United 
States of 
America
Determine overall medication use 
by prenatal patients Cross-sectional 
Personal interview and 
medical record review n  = 100
Postpartum women 
(within 4 days of 
delivery)
Prescription and over-the-
counter medications 93% 94% N/A N/A N/A
Jimenez et al 1998 Spain
Determine drug use before 
pregnancy and in the early period 
of pregnancy
Cross-
sectional 
Interview with 
structured 
questionnaire n  = 272
Pregnant women 
(1st trimester)
Prescription and over-the-
counter medications N/A N/A N/A N/A 62%
Opaneye 1998 Nigeria
Determine the prevalence of use of 
traditional medicines in pregnancy 
and the asociation between the use 
of traditional medicines and 
obstetric outcomes Cross-sectional 
Interview with 
structured 
questionnaire and 
case note review n  = 300
Postpartum women 
(within 2 days of 
delivery) Traditional medicines N/A N/A N/A 53.30% 53.30%
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Table 1 Articles included in the narrative literature review (continued) 
 
 
Teagle and 
Brindis 1998
United 
States of 
America
Investigate substance use among 
pregnant adolescents and to 
compare self-reported use and 
provider perception Cross-sectional 
In-person interview 
and self-administered 
questionnaire n  = 248
Pregnant 
adolescents (1st 
trimester)
Substance use- cigarette, 
alcohol, marijuana, cocaine 
and crack N/A N/A 49% N/A 49%
Olesen et al 1999 Denmark
Examine the drug prescription 
pattern from 12 weeks prior to 
conception until 12 weeks post-
partum
Retrospective 
cohort study
Prescription database 
and Medical birth 
registry n  = 16 001
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 44.20% N/A N/A N/A 44.20%
Donati et al 2000 Italy
Describe the use of drugs during 
pregnancy
Cross-
sectional 
Interview with 
questionnaire n = 9004
Postpartum women 
(within 2 months of 
delivery) Prescription medications 75% N/A N/A N/A 75%
Gharoro and 
Igbafe 2000 Nigeria
Determine the pattern and extent of 
drug consumption amongst 
pregnant women
Cross-
sectional 
Interview with 
structured 
questionnaire n  = 1200
Pregnant women 
(any trimester)
Prescription, herbal and 
recreational drugs 
(cigarette) 19.75% N/A 0.42% 12.08% N/A
Henry and 
Crowther 2000 Australia
Provide information on the patterns 
of medication use during and in the 
3 months prior to pregnancy
Cross-
sectional 
Structured interview 
and medical record 
review n  = 140
Pregnant women 
(any trimester)
Prescription and over-the-
counter medications N/A N/A N/A N/A 96.50%
Lester et al 2001
United 
States of 
America
Describe drug use by pregnant 
women Cross-sectional 
Structured interview 
and meconium 
toxicology n  = 11 811
Postpartum women 
and neonates 
(shortly after 
delivery)
Recreational drugs- cocaine 
and opiate N/A N/A 10.70% N/A 10.70%
Nordeng et al 2001 Norway
Estimate the impact of maternal 
illness and prior pregnancy 
outcome on the use of drugs in 
early pregnancy Cross-sectional Structured interview n  = 1945
Pregnant women 
(early 2nd 
trimester) Prescription medications 29% N/A N/A N/A 29%
Bauer et al 2002
United 
States of 
America
Determine the effects of exposure 
to illicit drugs during pregnancy on 
the mother, fetus and infant
Cross-
sectional 
Interview with 
questionnaire and 
meconium analysis n  = 1185
Postpartum women 
and neonates 
(within 7 days of 
delivery)
Recreational drugs- 
cocaine, opiate, alcohol, 
tobacco and marijuana N/A N/A 13% N/A 13%
Fergusson et 
al 2002
United 
Kingdom
Determine the prevalence of 
cannabis use in pregnancy, the 
association between its use and 
lifestyle factors and assessment of 
its effects on pregnancy outcome
Prospective 
cohort study
Self-completed postal 
questionnaire n  = 12 129 
Pregnant women 
(2nd trimester) Cannabis N/A N/A 2.30% N/A 2.30%
Hayes et al 2002
United 
States of 
America
Examine prenatal alcohol intake in 
a rural, caucasian clinic Cross-sectional Medical record review n  = 212
Pregnant women 
(1st trimester) Recreational drug- alcohol N/A N/A 30% N/A 30%
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Table 1 Articles included in the narrative literature review (continued) 
 
Hepner et al 2002
United 
States of 
America
Determine the prevalence and 
pattern of use of herbal and over-
the-counter medicines in pregnancy 
Cross-
sectional 
Self-completed postal 
questionnaire n  = 734
Pregnant women 
(2nd trimester)
Herbal remedies 
(echinacea, St. John's wort 
and ephedra) and over-the-
counter medications (cold 
remedies, pain relievers 
and heartburn medications) N/A 75.60% N/A 7.10% N/A
Hollyer et al 2002 Canada
Examine the prevalence and 
supervision of the use of 
complementary and alternative 
medicine in treating nausea and 
vomiting Cross-sectional 
Telephone survey 
using structured 
questionnaire n  = 70 Pregnant women
Complementary and 
alternative therapies: ginger, 
vitamin B6 and acupressure N/A N/A N/A 61% 61%
Maats and 
Crowther 2002 Australia
Assess medicines used 
preconceptionally and during 
pregnancy
Cross-
sectional 
Semi-structured 
interview n  = 211
Pregnant women 
(3rd trimester)
Over-the-counter and herbal 
medicines N/A N/A N/A N/A 62%
Pinn and 
Pallett 2002 Australia
Determine the use of alternative 
medical therapy in an antenatal 
population Cross-sectional 
Self-completed 
questionnaire n  = 305
Pregnant women 
(2nd trimester)
Herbal medicines, vitamin 
supplements, homeopathy, 
aromatherapy, iridology and 
acupuncture N/A N/A N/A 40% 40%
Ebrahim and 
Gfroerer 2003
United 
States of 
America
Estimate the national prevalence of 
pregnancy-related illicit drug use 
and abstinence rates
Cross-
sectional Interview n  = 1249
Pregnant women 
(any trimester)
Marijuana/hashish, 
cocaine/crack, inhalants, 
hallucinogens and heroin N/A N/A 2.80% N/A 2.80%
Glover et al 2003
United 
States of 
America
Identify the medications that are 
used by a rural obstetric population
Prospective 
cohort study Interview n  = 578
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter and herbal 
medicines 95.80% 92.60% N/A 45.20% N/A
Li et al 2003
United 
States of 
America
Evaluate prenatal use of non-
steroidal anti-inflammatory drugs 
(NSAIDS), aspirin and paracetamol 
and its association with increased 
risk of miscarriage
Prospective 
cohort study In-person interview n  = 1055
Pregnant women 
(1st trimester)
Over-the-counter 
medications- NSAIDS, 
aspirin and paracetamol N/A 5% N/A N/A 5%
Andrade et al 2004
United 
States of 
America
Provide information on the 
prevalence of use of prescription 
drugs among pregnant women
Retrospective 
cohort study Databases n  = 152 531
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 64% N/A N/A N/A 64%
Durisova and 
Magulova 2004 Slovakia
Determine the consumption of 
drugs and compliance with therapy 
in pregnancy Cross-sectional 
Self-administered 
structured 
questionnaire n  = 331 Postpartum women
Prescription and over-the-
counter medications N/A N/A N/A N/A 75%
Egen-Lappe 
and Hasford 2004 Germany
Examine the prescription of drugs 
prior to, during and after pregnancy
Retrospective 
cohort study Prescription database n  = 41 293
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 96.40% N/A N/A N/A 96.40%
Gilchrist et al 2004 Australia
Determine smoking practices 
during pregnancy and 
breastfeeding
Cross-
sectional 
Interview using 
Questionnaire n  = 425 Postpartum women Recreational drug- cigarette N/A N/A 66.90% N/A 66.90%
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Headley et al 2004
United 
Kingdom
Investigate the prevalence of use of 
all types of medicinal products in 
pregnancy
Prospective 
cohort study
Self-completed postal 
questionnaire n  = 11 545
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter, herbal and 
homeopathic products and 
other supplements N/A N/A N/A N/A 92.40%
Nordeng and 
Havnen 2004 Norway
Investigate the use of herbal drugs 
by pregnant women Cross-sectional 
Interview with 
structured 
questionnaire n  = 400
Postpartum women 
(within 3 days of 
delivery)
Herbal drugs- echinacea, 
iron-rich herbs, ginger, 
chamomile and cranberry N/A N/A N/A 36% 36%
Zolnierczuk-
Kieliszek et al 2004 Poland
Determine the frequency and 
intensity of tobacco smoking by 
pregnant women Cross-sectional 
Self-completed 
questionnaire n  = 100 Pregnant women Recreational drug- cigarette N/A N/A 18% N/A 18%
Chasnoff et al 2005
United 
States of 
America
Determine the prevalence of 
substance use among pregnant 
women Cross-sectional 
Questionnaire and 
structured clinical 
interview n  = 4865 Pregnant women
Illicit drugs- marijuana, 
heroin,cocaine and 
methamphetamines N/A N/A 9% N/A 9%
Checa et al 2005 Spain
Assess the drug intake behaviour 
of immigrants during pregnancy
Cross-
sectional 
Interview with 
structured 
questionnaire and 
medical record review n  = 1103 Postpartum women
Prescription and over-the-
counter medicines N/A N/A N/A N/A 74.60%
Pichini et al 2005 Spain
Estimate the prevalence of drug 
use by pregnant women and the 
effects on the mother, fetus and 
infant
Prospective 
cohort study 
Structured interview 
and meconium 
analysis n  = 1151 
Pregnant women 
(any trimester) and 
neonates
Recreational drugs- opiates, 
cocaine, MDMA and 
arecoline N/A N/A 7.90% N/A 7.90%
Refuerzo et al 2005
United 
States of 
America
Determine the frequency of 
prescription, over-the-counter and 
herbal medicines use by pregnant 
women Cross-sectional 
Self-completed 
questionnaire n  = 418 Postpartum women
Prescription, over-the-
counter and herbal 
medicines 76.50% 62.80% N/A 4.10% 96.90%
Riley et al 2005
United 
States of 
America
Determine the correlates of 
prescription drug use during 
pregnancy
Prospective 
cohort study
Telephone survey and 
medical record review n  = 1626 Pregnant women
Prescription drugs- 
antibiotics, analgesics, 
asthma medications and 
antiemetics 56% N/A N/A N/A 56%
Uncu et al 2005 Turkey
Evaluate maternal and paternal 
smoking habits during pregnancy 
and their correlation with pregnancy 
complications and newborn status Cross-sectional 
Face-to-face interview 
using questionnaire n  = 499 Postpartum women Recreational drug- cigarette N/A N/A 9.80% N/A 9.80%
Bakker et al 2006
The 
Netherland
s
Investigate presription of drugs in 
women before, during and after 
pregnancy
Retrospective 
cohort study Pharmacy database n = 5412
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications N/A N/A N/A N/A 79.10%
Chuang et al 2006 Taiwan
Investigate herbal medicine use 
during pregnancy and major 
congenital malformations
Prospective 
cohort study
Interview using 
structured 
questionnaire n  = 14 551
Pregnant women 
(3rd trimester)
Herbal medicines- An-Tai-
Yin, huanglian and ginseng N/A N/A N/A 16.90% 16.90%
                                                                                                                                   Chapter 1 
 
46 
 
Table 1 Articles included in the narrative literature review (continued) 
 
Forster et al 2006 Australia
Determine the prevalence and 
attitude towards herbal medicine 
use in pregnant women Cross-sectional 
Self-administered 
questionnaire n  = 588
Pregnant women 
(3rd trimester)
Herbal supplements: 
raspberry leaf, ginger and 
chamomile N/A N/A N/A 36% 36%
Olesen et al 2006 Denmark
Examine the association between 
socio-economic factors and use of 
prescription medication during 
pregnancy
Retrospective 
cohort study
Birth registry and 
Prescription database n  = 19 874 
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 46.80% N/A N/A N/A 46.80%
Ververs et al 2006
The 
Netherland
s
Determine the extent and patterns 
of antidepressant use before, 
during and after pregnancy
Retrospective 
cohort study
Health care records 
and prescription 
database n  = 29 005
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription medications- 
antidepressants 1.90% N/A N/A N/A 1.90%
Chuang et al 2007 Taiwan
Investigate the prevalence of 
Chinese herbal medicines use by 
pregnant women 
Cross-
sectional 
Interview with 
structured 
questionnaire n  = 1783 
Postpartum women 
(6 months after 
delivery)
Chinese herbal medicines- 
An-Tai-Yin, pearl powder, 
huanglian, szu-wu-tang and 
ginseng N/A N/A N/A 24.10% 24.10%
Garcia-
Bournissen et 
al 2007 Canada
Identify and quantify 
methamphetamine and other drugs 
of abuse in maternal and neonatal 
hair Cross-sectional Hair analysis n  = 8270
Postpartum women 
and neonates
Recreational drugs- 
methamphetamine, cocaine, 
cannabis and opiates N/A N/A 60% N/A 60%
Lozano et al 2007 Spain
Investigate the prevalence of in 
utero exposure of neonates to 
cannabis
Cross-
sectional 
Structured interview 
and meconium 
analysis n  = 974
Postpartum women 
and neonates Recreational drug- cannabis N/A N/A 5.30% N/A 5.30%
Andrade et al 2008
United 
States of 
America
Provide information on the 
prevalence of use of cardiovascular 
drugs among pregnant women
Retrospective 
cohort study Databases n  = 118 935
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription medicines- 
antihypertensives and 
antihyperlipidemics 3.20% N/A N/A N/A 3.20%
Dal Pizzol et 
al 2008 Brazil
Evaluate the association between 
the use of misoprostol and other 
drugs to induce menstruation and 
congenital anomalies
Prospective 
cohort study
Structured interview 
and medical chart 
review n  = 4856
Pregnant women 
(late 2nd or early 
3rd trimester)
Prescription drug- 
misoprostol; 
Complementary therapy- 
herbal teas (senna, marcela 
and quinine) 17% N/A N/A 34.40% 14.60%
Engeland et 
al 2008 Norway
Determine the use of prescription 
drugs before and during pregnancy
Retrospective 
cohort study
Birth registry and 
Prescription database n  = 106 329
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 57% N/A N/A N/A 57%
Gagne et al 2008 Italy
Estimate the prevalence of 
prescription drug use among 
pregnant women
Retrospective 
cohort study Healthcare database n  = 33 343
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 70% N/A N/A N/A 70%
Garcia-Algar 
et al 2008 Spain
Assess the prevalence of 
gestational ethanol exposure in 
neonates
Cross-
sectional 
Meconium analysis 
and medical record 
review n  = 353
Postpartum women 
and neonates Recreational drug- alcohol N/A N/A 45% N/A 45%
Holst et al 2008 Sweden
Study the characteristics of women 
using herbal drugs and impact of 
use in early pregnancy on 
pregnancy outcome
Retrospective 
cohort study Medical birth registry n  = 860 215
Pregnant women 
(1st trimester)
Herbal drugs- Floradix, 
ginseng and valerian N/A N/A N/A 0.90% 0.90%
                                                                                                                                   Chapter 1 
 
47 
 
Table 1 Articles included in the narrative literature review (continued) 
 
Lapi et al 2008 Italy
Explore pregnant women's use, 
attitudes, knowledge and beliefs of 
complementary and alternative 
drugs
Cross-
sectional 
Face-to-face interview 
using semi-structured 
questionnaire n  = 150
Pregnant women 
(3rd trimester)
Complementary and 
alternative drugs- almond 
oil, propolis, fennel, arnica, 
St. John's wort, vegetable 
carbon, lemon balm, 
chamomile and mauve N/A N/A N/A 48% 48%
Marcus and 
Flynn 2008
United 
States of 
America
Describe the prenatal patterns of 
antidepressant use and their 
relationship to depression in 
pregnancy Cross-sectional 
Structured clinical 
interview n  = 276
High risk pregnant 
women (2nd or 3rd 
trimester)
Prescription medications- 
antidepressants 13% N/A N/A N/A 13%
Schempf and 
Strobino 2008
United 
States of 
America
Examine the association between 
adverse birth outcomes and drug 
use in pregnancy Cross-sectional 
Interview with 
questionnaire, medical 
record review and 
urine toxicology n  = 808 Postpartum women
Recreational drugs- 
cocaine, opiates, marijuana, 
cigarette and alcohol N/A N/A 25% N/A 25%
Skouteris et 
al 2008 Australia
Explore the use of complementary 
and alternative medicines during 
pregnancy and women's 
perceptions of the safety of the 
medicines Cross-sectional 
Self-report postal 
questionnaire n  = 321
Pregnant women 
(late 2nd or early 
3rd trimester)
Complementary and 
alternative medicines N/A N/A N/A 73% 73%
Chuang et al 2009 Taiwan
Investigate the use of Chinese 
herbal medicines during pregnancy 
and the postpartum period
Cross-
sectional 
Interview using 
structured 
questionnaire n  = 21 248
Postpartum women 
(6 months after 
delivery)
Chinese herbal medicines- 
An-Tai-Yin, pearl powder, 
huanglian, szu-wu-tang and 
ginseng N/A N/A N/A 33.60% 33.60%
Dal Pizzol et 
al 2009 Brazil
Evaluate the risk of adverse 
perinatal events among newborns 
exposed to dipyrone during 
gestation
Prospective 
cohort study
Interview with 
structured 
questionnaire and 
medical record review n  = 5564
Pregnant women 
(late 2nd or early 
3rd trimester)
Over-the-counter medicine- 
dipyrone N/A 11.50% N/A N/A 11.50%
Fakeye et al 2009 Nigeria
Determine the attitude and use of 
herbal medicines among pregnant 
women Cross-sectional 
Self-administered 
structured 
questionnaire n  = 595 Pregnant women Herbal medicines N/A N/A N/A 67.50% 67.50%
Gray et al 2009
United 
States of 
America
Determine prenatal amphetamine, 
methamphetamine and ecstasy use
Cross-
sectional 
Interview and 
meconium analysis n  = 3705
Postpartum women 
and neonates 
(shortly after 
delivery)
Amphetamine, 
methamphetamine and 
ecstasy N/A N/A 5.50% N/A 5.50%
Harrison and 
Sidebottom 2009
United 
States of 
America
Examine alcohol and drug use 
before and during pregnancy and to 
identify the predictors of use 
cessation
Prospective 
cohort study
Structured clinical 
interview n  = 1492
Pregnant women 
(1st trimester) Recreational drug- alcohol N/A N/A 5.60% N/A 5.60%
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Havens et al 2009
United 
States of 
America
Examine the prevalence and 
correlates of substance use during 
pregnancy
Cross-
sectional 
Computer-assisted 
self-interview n  = 1800
Pregnant women 
(any trimester)
Recreational drugs- alcohol, 
cigarettes, marijuana, 
prescription analgesics, 
tranquilizers, sedatives and 
stimulants, cocaine, crack, 
heroin and 
methamphetamine N/A N/A 25.80% N/A 25.80%
Holst et al 2009
United 
Kingdom
Describe the use and user of 
herbal remedies during pregnancy 
and to study sources of information 
about herbs used Cross-sectional 
Self-administered 
questionnaire n  = 578
Pregnant women 
(2nd or 3rd 
trimester)
Herbal remedies- ginger, 
cranberry, raspberry leaf, 
chamomile, echinacea, 
peppermint, lavender, 
fennel, nettle and Floradix® 
(iron-rich herbs) N/A N/A N/A 57.80% 57.80%
Kebede et al 2009 Ethiopia
Assess drug use among pregnant 
women
Cross-
sectional 
Interview with semi-
structured 
questionnaire and 
antenatal card review n  = 1268
Pregnant women 
(any trimester) Prescription medications 71.30% N/A N/A N/A 71.30%
Kulaga et al 2009 Canada
Assess prescriptions filled by 
pregnant women for drugs with fetal 
harm and document the pregnancy 
outcomes
Retrospective 
cohort study Pregnancy registry n  = 109 344
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 56% N/A N/A N/A 56%
Lacroix et al 2009 France
Investigate the drugs prescribed 
and dispensed during pregnancy 
and the outcome of the 
pregnancies
Retrospective 
cohort study Databases n  = 10 174 Pregnant women Prescription drugs 93% N/A N/A N/A 93%
Mashayekhi 
et al 2009 Iran
Examine the awareness of 
pregnant women about the effects 
of drugs in pregnancy
Cross-
sectional 
Self-completed 
questionnaire n  = 400
Pregnant and 
Postpartum women
Prescription and over-the-
counter medications N/A N/A N/A N/A 18.80%
Moussally et 
al 2009 Canada
Determine the prevalence and 
predictors of herbal products use 
during pregnancy
Cross-
sectional 
Self-completed postal 
questionnaire n  = 3354
Postpartum women 
(3 to 8 years after 
delivery)
Herbal products: 
chamomile, green tea, 
peppermint and flax N/A N/A N/A 9% 9%
Senn et al 2009
Papua New 
Guinea
Investigate the habit of betel nut 
chewing and its impact on 
pregnancy Cross-sectional 
Interview with semi-
structured 
questionnaire n  = 310
Postpartum women 
(3 days after 
delivery) Recreational drug- betel nut N/A N/A 94% N/A 94%
Viktil et al 2009 Norway
Explore the use of antirheumatic 
drugs in pregnant women
Retrospective 
cohort study
Prescription database 
and Medical birth 
registry n  = 1411 Pregnant women
Antirheumatic drugs- 
Prednisolone, NSAIDs, 
sulfazalazine, 
hydroxychloroquine, 
azathioprine, methotrexate, 
leflunomide, etanercept and 
adalimumab 28% N/A N/A N/A 28%
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Yeh et al 2009 Taiwan
Investigate the patterns of 
traditional Chinese medicine use 
among pregnant women
Retrospective 
cohort study
Health Insurance 
database n  = 196 350
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Traditional Chinese 
medicine N/A N/A N/A 20.90% 20.90%
Bercaw et al 2010
United 
States of 
America
Investigate the prevalence, reasons 
for use and physician-patient level 
of communication about the use of 
herbs, vitamins, over-the-counter 
and prescription medications in 
pregnancy
Cross-
sectional 
Self-administered 
questionnaire n  = 485
Postpartum women 
(immediately after 
delivery)
Herbs, vitamin supplements, 
over-the-counter 
medications and 
prescription medicines
29% 23% N/A 19% N/A
Bessa et al 2010 Brazil
Compare the self-report of drug 
use by pregnant adolescents with 
their hair analysis Cross-sectional 
Interview with 
structured 
questionnaire and hair 
analysis n  = 1000
Postpartum 
adolescents (within 
2 days of delivery)
Recreational drugs- cocaine 
and marijuana N/A N/A 0.30% N/A 0.30%
Cleary et al 2010
Republic of 
Ireland
Examine the extent, nature and 
determinants of medication use in 
early pregnancy
Cross-
sectional Face-to-face interview n  = 61 252
Pregnant women 
(1st trimester)
Prescription, over-the-
counter, herbal and illicit 
drugs 39.20% 19.50% 0.90% 0.58% N/A
Cuzzolin et al 2010 Italy
Explore the use of herbal products 
in pregnancy and possible effects 
of its use on pregnancy outcome 
Cross-
sectional 
Face-to-face interview 
using prestructured 
questionnaire n  = 392
Postpartum women 
(within 3 days of 
delivery)
Herbal products- 
chamomile, licorice, fennel, 
aloe, valerian, echinacea, 
almond oil, propolis and 
cranberry N/A N/A N/A 27.80% 27.80%
Falcon et al 2010 Spain
Investigate the prevalence of drug 
use in pregnancy and the 
relationship between drug 
exposure and induced abortions
Cross-
sectional 
Self-administered 
structured 
questionnaire and 
serum and hair testing n  = 142
Pregnant women 
(1st trimester)
Recreational drugs- 
cannabis, cocaine, opiates 
and MDMA (ecstasy) N/A N/A 30% N/A 30%
Irvine et al 2010
United 
Kingdom
Investigate the patterns of 
prescribing of drugs to women who 
gave birth in Scotland
Retrospective 
cohort study
Maternity records and 
Prescription database n  = 3937
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription drugs 85.20% N/A N/A N/A 85.20%
Kalder et al 2010 Germany
Assess the use of complementary 
and alternative medicines in 
pregnancy and reasons for use
Cross-
sectional 
Self-report 
questionnaire n  = 205 Postpartum women
Homeopathy, acupuncture 
and phytotherapy N/A N/A N/A 50.70% 50.70%
van Gelder et 
al 2010
United 
States of 
America
Determine the prevalence of self-
reported illicit drug use during 
pregnancy and its association with 
demographic and social factors
Cross-
sectional Telephone interview n  = 5871
Postpartum women 
(between 6 weeks 
and 24 months 
after delivery)
Recreational drugs- 
cannabis, cocaine and 
stimulants N/A N/A 3.60% N/A 3.60%
Zhu et al 2010 China
Describe the pattern of drug use 
during the first trimester and to 
examine the impact of maternal 
diseases on choice of drugs Cross-sectional 
Self-completed 
questionnaire and 
maternal handbook 
review n  = 4290
Pregnant women 
(1st trimester)
Prescription, over-the-
counter and traditional 
medicines N/A N/A N/A 10.10% 75.90%
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Al-Riyami et 
al 2011 Oman
Evaluate medication use pattern in 
pregnant women
Prospective 
cohort study
Interview with 
structured 
questionnaire and 
electronic patient 
record n  = 139
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter and herbal 
medicines N/A N/A N/A 23.80% 48.50%
Bello et al 2011 Nigeria
Assess the drug use profile of an 
antenatal population
Cross-
sectional 
Self-administered 
questionnaire n  = 410
Pregnant women 
(any trimester)
Over-the-counter and herbal 
medicines N/A 19.20% N/A 46.30% N/A
Bishop et al 2011
United 
Kingdom
Report the frequency of 
complementary and alternative 
medicine use by a population of 
pregnant women
Prospective 
cohort study
Self-completed postal 
questionnaire n  = 14 115
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Complementary and 
alternative medicines N/A N/A N/A 26.70% 26.70%
Chang et al 2011
United 
States of 
America
Describe the prevalence and 
factors associated with self-
reported substance use in young 
pregnant women
Cross-
sectional 
Mail survey and 
diagnostic interview n  = 30
Pregnant young 
adults (2nd 
trimester) Alcohol and marijuana N/A N/A 33.30% N/A 33.30%
Crespin et al 2011 France
Describe the prescribing of drugs 
to pregnant women before and 
during pregnancy
Retrospective 
cohort study
Pharmacy records of 
the health insurance 
service n  = 23 898
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 95.60% N/A N/A N/A 95.60%
Malan and 
Neuba 2011
Cote 
d'Ivoire
Determine medicinal plants used, 
the associated practices and 
reasons for such practices by 
pregnant women
Cross-
sectional 
Interview with 
questionnaire n  = 55 
Pregnant women 
(any trimester) Herbal medicines N/A N/A N/A 90.30% 90.30%
Nordeng et al 2011 Norway
Investigate the use of herbal drugs 
by pregnant women in relation to 
concurrent use of conventional 
drugs, delivery, and pregnancy 
outcome
Cross-
sectional 
Interview with 
structured 
questionnaire and 
medical birth charts n  = 600
Postpartum women 
(within 5 days of 
delivery) Herbal medicines N/A N/A N/A 39.70% 39.70%
Sawicki et al 2011 Australia
Study the extent and nature of the 
use of prescribed medications 
during pregnancy and factors 
associated with medication 
nonadherence
Cross-
sectional 
Self-completed 
questionnaire n  = 819
Pregnant women 
(3rd trimester) Prescription medicines 26.50% N/A N/A N/A 26.50%
Stephansson 
et al 2011 Sweden
Study drug use during pregnancy 
and agreement between antenatal 
records and dispensed drugs from 
pharmacy database
Retrospective 
cohort study
Medical birth register 
and Prescribed drug 
register n  = 102 995
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 57.60% N/A N/A N/A 57.60%
Yusuff and 
Omarusehe 2011 Nigeria
Assess the frequency and evaluate 
the factors underlining self-
medication with orthodox and 
herbal medicines among pregnant 
women
Cross-
sectional 
Interview with 
questionnaire n  = 1594
Pregnant women 
(any trimester)
Prescription, over-the-
counter and herbal 
medicines N/A N/A N/A 31.20% 63.80%
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Abasiubong 
et al 2012 Nigeria
Assess the level of self-medication 
among pregnant women
Cross-
sectional 
Self-report 
questionnaire n  = 518 Pregnant women
Prescription, over-the-
counter, herbal medicines, 
and alcohol 27.60% 41.90% 3.50% 9.10% 72.40%
Bertoldi et al 2012 Brazil
Estimate the exposure to 
medicines with unknown foetal risk 
during pregnancy
Cross-
sectional 
Interview with 
questionnaire n  = 4189
Postpartum women 
(within 24 hours of 
delivery)
Prescription and over-the-
counter medications N/A N/A N/A N/A 92.70%
Daw et al 2012 Canada
Measure the frequency, timing and 
type of medicines used before, 
during and after pregnancy 
Retrospective 
cohort study
Health care records 
and prescription drug 
claims n  = 163 082
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 63.50% N/A N/A N/A 63.50%
Friguls et al 2012 Spain
Estimate the prevalence of drug 
use by pregnant women 
Cross-
sectional 
Structured 
questionnaire and 
maternal hair analysis n  = 107
Postpartum women 
(1 day after 
delivery)
Cannabis, cocaine and 
MDMA N/A N/A 16% N/A 16%
Hayatbakhsh 
et al 2012 Australia
Examine association between 
cannabis use before and during 
pregnancy and birth outcomes
Prospective 
cohort study
Interview with 
questionnaire and 
medical records n  = 24 874
Pregnant women 
(2nd trimester) Recreational drug- cannabis N/A N/A 2.60% N/A 2.60%
Joya et al 2012 Spain
Estimate the prevalence of illicit 
drug use among pregnant women
Cross-
sectional 
Structured 
questionnaire and 
maternal hair analysis n  = 347
Postpartum women 
(1 day after 
delivery) Cocaine N/A N/A 2.60% N/A 2.60%
Khadivzadeh 
and Ghabel 2012 Iran
Assess the use of 
traditional/complementary and 
alternative medicine during 
pregnancy
Cross-
sectional 
Self-report 
questionnaire n  = 919
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Complementary and 
alternative medicines N/A N/A N/A 83.70% 83.70%
Kratz and 
Vaughan 2012
United 
States of 
America
Examine the predictors of cigarette 
use in pregnant women
Cross-
sectional 
Computer-assisted in-
home interview n  = 1782
Pregnant women 
(2nd or 3rd 
trimester) Cigarette N/A N/A 18.90% N/A 18.90%
Mureyi et al 2012 Zimbabwe
Determine the prevalence of 
prenatal use of traditional medicine 
within a sample of women
Cross-
sectional 
Interview with 
questionnaire n  = 248
Postpartum women 
(6 weeks after 
delivery) Traditional medicines N/A N/A N/A 52% 52%
Nordeng et al 2012 Norway
Study the associations between 
medication use, fear of childbirth, 
and maternal mental health
Prospective 
cohort study
Self-completed 
questionnaire n  = 1984
Pregnant women 
(2nd and 3rd 
trimesters)
Prescription and over-the-
counter medications N/A N/A N/A N/A 57.70%
Odalovic et al 2012 Serbia
Investigate prescription and over-
the-counter drug use before and 
during pregnancy
Cross-
sectional 
Self-report 
questionnaire n  = 311  
Pregnant women 
(2nd trimester)
Prescription and over-the-
counter medications 27.30% 8.70% N/A N/A 34.70%
Passey et al 2012 Australia
Describe women's self-reported 
antenatal smoking behaviour
Cross-
sectional 
Self-completed 
questionnaire n  = 264
Pregnant women 
(3rd trimester) Recreational drug- cigarette N/A N/A 46% N/A 46%
Vythilingum et 
al 2012
South 
Africa
Study the prevalence of substance 
use in an antenatal population
Cross-
sectional 
Self-report 
questionnaire n  = 323
Pregnant women 
(any trimester) Recreational substances N/A N/A 4% N/A 4%
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Table 1 Articles included in the narrative literature review (continued) 
 
 
 
Ystrom et al 2012 Norway
Examine the role of personality in a 
pregnant woman's consumption of 
medications and alcohol
Cross-
sectional Internet questionnaire n  = 835
Pregnant women 
(any trimester)
Prescription, over-the-
counter, herbal medicines 
and alcohol 1.90% 58.80% 7.40% 8.90% N/A
Baraka et al 2013 Belgium
Investigate the differences in 
exposure to medications in a 
cohort of multi-ethnic pregnant 
women
Cross-
sectional 
Self-completed 
questionnaire n  = 641
Pregnant women 
(2nd or 3rd 
trimester)
Prescription and over-the-
counter medications N/A N/A N/A N/A 83.80%
Gardiner et al 2013
United 
States of 
America
Determine the prevalence of herb 
and vitamin use in a population of 
underserved postpartum women 
and types of herbs used
Cross-
sectional 
Interview with 
questionnaire and 
medical chart review n  = 160 Postpartum women
Herbal medicines and 
vitamins N/A 65% N/A 39% N/A
Hall and Jolly 2013
United 
Kingdom
Determine the prevalence of 
women's use of complementary 
and alternative medicines during 
pregnancy and reasons for use
Cross-
sectional 
Interview with 
questionnaire n  = 315 Postpartum women
Complementary and 
alternative medicines N/A N/A N/A 57.10% 57.10%
Lendoiro et al 2013 Spain
Compare maternal interview and 
hair analysis to determine drug 
consumption throughout pregnancy 
and study relations among maternal 
interview, hair results, and neonatal 
outcomes 
Cross-
sectional 
Interview with 
questionnaire and 
maternal hair analysis n  = 209 Postpartum women 
Illicit drugs- cocaine, 
cannabis, opiates, 
methadone, and ketamine N/A N/A 15.40% N/A 15.40%
Mallard et al 2013
New 
Zealand
Describe the prevalence and 
patterns of alcohol intake among 
pregnant women
Cross-
sectional 
Self-administered 
questionnaire n  = 723 Postpartum women Alcohol  N/A N/A 34% N/A 34%
Rachidi et al 2013 Lebanon
Assess risky exposure of pregnant 
women to drugs, tobacco and 
caffeine and determine their effect 
on postnatal outcomes
Cross-
sectional 
Interview with 
questionnaire and 
medical files n  = 350
Postpartum women 
(1 day after 
delivery)
Prescription, over-the-
counter medicines, and 
cigarette 34.90% 66% 6.30% N/A N/A
Santiago et al 2013
United 
States of 
America
Describe maternal intake of food, 
drink, and medication during 
pregnancy
Cross-
sectional 
Self-completed 
questionnaire n  = 200
Pregnant women 
(3rd trimester) and 
Postpartum women 
(8 weeks after 
delivery)
Over-the-counter medicines 
and alcohol N/A 28.90% 5.80% N/A N/A
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1.2.5.1 Geographical distribution of the articles 
The studies were from different parts of the world - United States (n = 36), 
South Africa (n = 3), The Netherlands (n = 2), France (n = 3), Brazil (n = 4), 
Italy (n = 6), Spain (n = 10), Taiwan (n = 4), Republic of Ireland (n = 1), 
Australia (n = 10), Slovakia (n = 1), Germany (n = 3), Norway (n = 7), Nigeria 
(n = 6), United Kingdom (n = 8), Canada (n = 7), Finland (n = 2), Sweden (n 
= 2), Belgium (n = 1), Lebanon (n = 1), New Zealand (n = 1), Zimbabwe (n = 
1), Serbia (n = 1), Cote d’Ivoire (n = 1), Ethiopia (n = 1), Iran (n = 2), 
Tanzania (n = 1), Denmark (n = 2), Papua New Guinea (n = 1), Turkey (n = 
1), China (n = 1), Poland (n = 1) and Oman (n = 1). The articles reported a 
wide variation in the prevalence of medicine and recreational substance use 
in pregnancy. Differences in study objectives, population characteristics, 
study design, data collection methods, sample sizes and focus on different 
time frames of pregnancy and the postpartum period are factors that may 
have contributed to the disparities. It is also apparent from the reports that 
use of medicines vary between countries, making comparison between 
studies and interpretation of results difficult (Table 2). For example, a WHO 
sponsored study carried out in 1987 in 22 countries reported that there was a 
marked variation in medicine use in the countries that participated in the 
study. The differences reflect the broad spectrum of medical care, public 
health problems, and cultural differences between countries (C.G.D.U.P., 
1992). Even with such differences, most of the research concluded that the 
consumption of medicines is common among pregnant women. 
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Table 2 Geographical distribution of the articles 
 
Author
Year of 
study Country Objectives of the study
Type of medicine or 
substance studied
Study design Data collection Sample size Study participants
Prescription 
medicines
Over-the-
counter 
medications
Recreational 
drugs or 
substances
Complementary & 
alternative 
medicines Overall
Correy et al 1991 Australia
Investigate the use of prescription 
drugs in the first trimester and 
congenital malformations
Prospective 
cohort study
Medical form (filled by 
doctors) n  = 56 037
Pregnant women 
(1st trimester) Prescription medicines 30.90% N/A N/A N/A 30.90%
Forster et al 2006 Australia
Determine the prevalence and 
attitude towards herbal medicine 
use in pregnant women Cross-sectional 
Self-administered 
questionnaire n  = 588
Pregnant women 
(3rd trimester)
Herbal supplements: 
raspberry leaf, ginger and 
chamomile N/A N/A N/A 36% 36%
Gilchrist et al 2004 Australia
Determine smoking practices 
during pregnancy and 
breastfeeding
Cross-
sectional 
Interview using 
Questionnaire n  = 425 Postpartum women Recreational drug- cigarette N/A N/A 66.90% N/A 66.90%
Hayatbakhsh 
et al 2012 Australia
Examine association between 
cannabis use before and during 
pregnancy and birth outcomes
Prospective 
cohort study
Interview with 
questionnaire and 
medical records n  = 24 874
Pregnant women 
(2nd trimester) Recreational drug- cannabis N/A N/A 2.60% N/A 2.60%
Henry and 
Crowther 2000 Australia
Provide information on the patterns 
of medication use during and in the 
3 months prior to pregnancy
Cross-
sectional 
Structured interview 
and medical record 
review n  = 140
Pregnant women 
(any trimester)
Prescription and over-the-
counter medications N/A N/A N/A N/A 96.50%
Maats and 
Crowther 2002 Australia
Assess medicines used 
preconceptionally and during 
pregnancy
Cross-
sectional 
Semi-structured 
interview n  = 211
Pregnant women 
(3rd trimester)
Over-the-counter and herbal 
medicines N/A N/A N/A N/A 62%
Passey et al 2012 Australia
Describe women's self-reported 
antenatal smoking behaviour
Cross-
sectional 
Self-completed 
questionnaire n  = 264
Pregnant women 
(3rd trimester) Recreational drug- cigarette N/A N/A 46% N/A 46%
Pinn and 
Pallett 2002 Australia
Determine the use of alternative 
medical therapy in an antenatal 
population Cross-sectional 
Self-completed 
questionnaire n  = 305
Pregnant women 
(2nd trimester)
Herbal medicines, vitamin 
supplements, homeopathy, 
aromatherapy, iridology and 
acupuncture N/A N/A N/A 40% 40%
Sawicki et al 2011 Australia
Study the extent and nature of the 
use of prescribed medications 
during pregnancy and factors 
associated with medication 
nonadherence
Cross-
sectional 
Self-completed 
questionnaire n  = 819
Pregnant women 
(3rd trimester) Prescription medicines 26.50% N/A N/A N/A 26.50%
Skouteris et 
al 2008 Australia
Explore the use of complementary 
and alternative medicines during 
pregnancy and women's 
perceptions of the safety of the 
medicines Cross-sectional 
Self-report postal 
questionnaire n  = 321
Pregnant women 
(late 2nd or early 
3rd trimester)
Complementary and 
alternative medicines N/A N/A N/A 73% 73%
Methods Population characteristics Prevalence of use
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Table 2 Geographical distribution of the articles (continued) 
 
Baraka et al 2013 Belgium
Investigate the differences in 
exposure to medications in a 
cohort of multi-ethnic pregnant 
women
Cross-
sectional 
Self-completed 
questionnaire n  = 641
Pregnant women 
(2nd or 3rd 
trimester)
Prescription and over-the-
counter medications N/A N/A N/A N/A 83.80%
Bertoldi et al 2012 Brazil
Estimate the exposure to 
medicines with unknown foetal risk 
during pregnancy
Cross-
sectional 
Interview with 
questionnaire n  = 4189
Postpartum women 
(within 24 hours of 
delivery)
Prescription and over-the-
counter medications N/A N/A N/A N/A 92.70%
Bessa et al 2010 Brazil
Compare the self-report of drug 
use by pregnant adolescents with 
their hair analysis Cross-sectional 
Interview with 
structured 
questionnaire and hair 
analysis n  = 1000
Postpartum 
adolescents (within 
2 days of delivery)
Recreational drugs- cocaine 
and marijuana N/A N/A 0.30% N/A 0.30%
Dal Pizzol et 
al 2009 Brazil
Evaluate the risk of adverse 
perinatal events among newborns 
exposed to dipyrone during 
gestation
Prospective 
cohort study
Interview with 
structured 
questionnaire and 
medical record review n  = 5564
Pregnant women 
(late 2nd or early 
3rd trimester)
Over-the-counter medicine- 
dipyrone N/A 11.50% N/A N/A 11.50%
Dal Pizzol et 
al 2008 Brazil
Evaluate the association between 
the use of misoprostol and other 
drugs to induce menstruation and 
congenital anomalies
Prospective 
cohort study
Structured interview 
and medical chart 
review n  = 4856
Pregnant women 
(late 2nd or early 
3rd trimester)
Prescription drug- 
misoprostol; 
Complementary therapy- 
herbal teas (senna, marcela 
and quinine) 17% N/A N/A 34.40% 14.60%
Daw et al 2012 Canada
Measure the frequency, timing and 
type of medicines used before, 
during and after pregnancy 
Retrospective 
cohort study
Health care records 
and prescription drug 
claims n  = 163 082
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 63.50% N/A N/A N/A 63.50%
Garcia-
Bournissen et 
al 2007 Canada
Identify and quantify 
methamphetamine and other drugs 
of abuse in maternal and neonatal 
hair Cross-sectional Hair analysis n  = 8270
Postpartum women 
and neonates
Recreational drugs- 
methamphetamine, cocaine, 
cannabis and opiates N/A N/A 60% N/A 60%
Hollyer et al 2002 Canada
Examine the prevalence and 
supervision of the use of 
complementary and alternative 
medicine in treating nausea and 
vomiting Cross-sectional 
Telephone survey 
using structured 
questionnaire n  = 70 Pregnant women
Complementary and 
alternative therapies: ginger, 
vitamin B6 and acupressure N/A N/A N/A 61% 61%
Kulaga et al 2009 Canada
Assess prescriptions filled by 
pregnant women for drugs with fetal 
harm and document the pregnancy 
outcomes
Retrospective 
cohort study Pregnancy registry n  = 109 344
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 56% N/A N/A N/A 56%
Moussally et 
al 2009 Canada
Determine the prevalence and 
predictors of herbal products use 
during pregnancy
Cross-
sectional 
Self-completed postal 
questionnaire n  = 3354
Postpartum women 
(3 to 8 years after 
delivery)
Herbal products: 
chamomile, green tea, 
peppermint and flax N/A N/A N/A 9% 9%
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Table 2 Geographical distribution of the articles (continued) 
 
Stewart and 
Streiner 1994 Canada
Determine the prevalence of 
regular alcohol drinking during the 
second half of pregnancy Cross-sectional 
Self-completed 
questionnaire n  = 466
Pregnant women 
(2nd trimester) Recreational drug- alcohol N/A N/A 22.70% N/A 22.70%
Stewart and 
Streiner 1995 Canada
Determine the prevalence of 
regular smoking in the latter half of 
pregnancy Cross-sectional 
Self-completed 
questionnaire n  = 545
Pregnant women 
(2nd trimester) Recreational drug- cigarette N/A N/A 16.30% N/A 16.30%
Zhu et al 2010 China
Describe the pattern of drug use 
during the first trimester and to 
examine the impact of maternal 
diseases on choice of drugs Cross-sectional 
Self-completed 
questionnaire and 
maternal handbook 
review n  = 4290
Pregnant women 
(1st trimester)
Prescription, over-the-
counter and traditional 
medicines N/A N/A N/A 10.10% 75.90%
Malan and 
Neuba 2011
Cote 
d'Ivoire
Determine medicinal plants used, 
the associated practices and 
reasons for such practices by 
pregnant women
Cross-
sectional 
Interview with 
questionnaire n  = 55 
Pregnant women 
(any trimester) Herbal medicines N/A N/A N/A 90.30% 90.30%
Olesen et al 2006 Denmark
Examine the association between 
socio-economic factors and use of 
prescription medication during 
pregnancy
Retrospective 
cohort study
Birth registry and 
Prescription database n  = 19 874 
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 46.80% N/A N/A N/A 46.80%
Olesen et al 1999 Denmark
Examine the drug prescription 
pattern from 12 weeks prior to 
conception until 12 weeks post-
partum
Retrospective 
cohort study
Prescription database 
and Medical birth 
registry n  = 16 001
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 44.20% N/A N/A N/A 44.20%
Kebede et al 2009 Ethiopia
Assess drug use among pregnant 
women
Cross-
sectional 
Interview with semi-
structured 
questionnaire and 
antenatal card review n  = 1268
Pregnant women 
(any trimester) Prescription medications 71.30% N/A N/A N/A 71.30%
Heikkila et al 1994 Finland
Record the use of medications and 
the policy of prescribing during the 
course of pregnancy
Prospective 
cohort study
Questionnaire (filled 
by physician or nurse) n  = 5851
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription and over-the-
counter medications 8% 15% N/A N/A N/A
Larivaara et 
al 1996 Finland
Investigate the use of psychotropic 
drugs and pregnancy outcome
Prospective 
cohort study
Self-administered 
questionnaire n  = 7933
Pregnant women 
(2nd and 3rd 
trimesters)
Prescription drugs- 
tranquilizers, hypnotics, 
antidepressants and lithium 1.50% N/A N/A N/A 1.50%
Berthier et al 1993 France
Determine the drugs prescribed 
during pregnancy Cross-sectional 
Interview with 
questionnaire n  = 225
Postpartum women 
(3 days after 
delivery)
Prescription and over-the-
counter medications 88.10% 17.90% N/A N/A 99.50%
Crespin et al 2011 France
Describe the prescribing of drugs 
to pregnant women before and 
during pregnancy
Retrospective 
cohort study
Pharmacy records of 
the health insurance 
service n  = 23 898
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 95.60% N/A N/A N/A 95.60%
Lacroix et al 2009 France
Investigate the drugs prescribed 
and dispensed during pregnancy 
and the outcome of the 
pregnancies
Retrospective 
cohort study Databases n  = 10 174 Pregnant women Prescription drugs 93% N/A N/A N/A 93%
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Table 2 Geographical distribution of the articles (continued) 
 
Egen-Lappe 
and Hasford 2004 Germany
Examine the prescription of drugs 
prior to, during and after pregnancy
Retrospective 
cohort study Prescription database n  = 41 293
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 96.40% N/A N/A N/A 96.40%
Irl et al 1997 Germany
Evaluate the recorded information 
on drug exposure during pregnancy 
with regard to teratogenic 
properties and to contribute to the 
quality assurance of medical 
treatment in pregnancy
Prospective 
cohort study Medication form n  = 921
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter and alternative 
medicines N/A N/A N/A N/A 83.60%
Kalder et al 2010 Germany
Assess the use of complementary 
and alternative medicines in 
pregnancy and reasons for use
Cross-
sectional 
Self-report 
questionnaire n  = 205 Postpartum women
Homeopathy, acupuncture 
and phytotherapy N/A N/A N/A 50.70% 50.70%
Khadivzadeh 
and Ghabel 2012 Iran
Assess the use of 
traditional/complementary and 
alternative medicine during 
pregnancy
Cross-
sectional 
Self-report 
questionnaire n  = 919
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Complementary and 
alternative medicines N/A N/A N/A 83.70% 83.70%
Mashayekhi 
et al 2009 Iran
Examine the awareness of 
pregnant women about the effects 
of drugs in pregnancy
Cross-
sectional 
Self-completed 
questionnaire n  = 400
Pregnant and 
Postpartum women
Prescription and over-the-
counter medications N/A N/A N/A N/A 18.80%
Bonassi et al 1994 Italy
Investigate drug intake during 
pregnancy
Cross-
sectional 
Interview with 
questionnaire n  = 3112
Postpartum women 
(within 5 days of 
delivery)
Prescription and over-the-
counter medications N/A N/A N/A N/A 82.7%
C.G.D.U.P. 
(Collaborative 
Group on 
Drug Use in 
Pregnancy) 1992 Italy
Assess the pattern of drug use in 
pregnancy
Cross-
sectional 
Interview using 
structured 
questionnaire n  = 14 778
Postpartum women 
(within 1st week of 
delivery)
Prescription and over-the-
counter medications N/A N/A N/A N/A 86%
Cuzzolin et al 2010 Italy
Explore the use of herbal products 
in pregnancy and possible effects 
of its use on pregnancy outcome 
Cross-
sectional 
Face-to-face interview 
using prestructured 
questionnaire n  = 392
Postpartum women 
(within 3 days of 
delivery)
Herbal products- 
chamomile, licorice, fennel, 
aloe, valerian, echinacea, 
almond oil, propolis and 
cranberry N/A N/A N/A 27.80% 27.80%
Donati et al 2000 Italy
Describe the use of drugs during 
pregnancy
Cross-
sectional 
Interview with 
questionnaire n = 9004
Postpartum women 
(within 2 months of 
delivery) Prescription medications 75% N/A N/A N/A 75%
Gagne et al 2008 Italy
Estimate the prevalence of 
prescription drug use among 
pregnant women
Retrospective 
cohort study Healthcare database n  = 33 343
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 70% N/A N/A N/A 70%
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Table 2 Geographical distribution of the articles (continued) 
 
Lapi et al 2008 Italy
Explore pregnant women's use, 
attitudes, knowledge and beliefs of 
complementary and alternative 
drugs
Cross-
sectional 
Face-to-face interview 
using semi-structured 
questionnaire n  = 150
Pregnant women 
(3rd trimester)
Complementary and 
alternative drugs- almond 
oil, propolis, fennel, arnica, 
St. John's wort, vegetable 
carbon, lemon balm, 
chamomile and mauve N/A N/A N/A 48% 48%
Rachidi et al 2013 Lebanon
Assess risky exposure of pregnant 
women to drugs, tobacco and 
caffeine and determine their effect 
on postnatal outcomes
Cross-
sectional 
Interview with 
questionnaire and 
medical files n  = 350
Postpartum women 
(1 day after 
delivery)
Prescription, over-the-
counter medicines, and 
cigarette 34.90% 66% 6.30% N/A N/A
Mallard et al 2013
New 
Zealand
Describe the prevalence and 
patterns of alcohol intake among 
pregnant women
Cross-
sectional 
Self-administered 
questionnaire n  = 723 Postpartum women Alcohol  N/A N/A 34% N/A 34%
Abasiubong 
et al 2012 Nigeria
Assess the level of self-medication 
among pregnant women
Cross-
sectional 
Self-report 
questionnaire n  = 518 Pregnant women
Prescription, over-the-
counter, herbal medicines, 
and alcohol 27.60% 41.90% 3.50% 9.10% 72.40%
Bello et al 2011 Nigeria
Assess the drug use profile of an 
antenatal population
Cross-
sectional 
Self-administered 
questionnaire n  = 410
Pregnant women 
(any trimester)
Over-the-counter and herbal 
medicines N/A 19.20% N/A 46.30% N/A
Fakeye et al 2009 Nigeria
Determine the attitude and use of 
herbal medicines among pregnant 
women Cross-sectional 
Self-administered 
structured 
questionnaire n  = 595 Pregnant women Herbal medicines N/A N/A N/A 67.50% 67.50%
Gharoro and 
Igbafe 2000 Nigeria
Determine the pattern and extent of 
drug consumption amongst 
pregnant women
Cross-
sectional 
Interview with 
structured 
questionnaire n  = 1200
Pregnant women 
(any trimester)
Prescription, herbal and 
recreational drugs 
(cigarette) 19.75% N/A 0.42% 12.08% N/A
Opaneye 1998 Nigeria
Determine the prevalence of use of 
traditional medicines in pregnancy 
and the asociation between the use 
of traditional medicines and 
obstetric outcomes Cross-sectional 
Interview with 
structured 
questionnaire and 
case note review n  = 300
Postpartum women 
(within 2 days of 
delivery) Traditional medicines N/A N/A N/A 53.30% 53.30%
Yusuff and 
Omarusehe 2011 Nigeria
Assess the frequency and evaluate 
the factors underlining self-
medication with orthodox and 
herbal medicines among pregnant 
women
Cross-
sectional 
Interview with 
questionnaire n  = 1594
Pregnant women 
(any trimester)
Prescription, over-the-
counter and herbal 
medicines N/A N/A N/A 31.20% 63.80%
Engeland et 
al 2008 Norway
Determine the use of prescription 
drugs before and during pregnancy
Retrospective 
cohort study
Birth registry and 
Prescription database n  = 106 329
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications 57% N/A N/A N/A 57%
Nordeng and 
Havnen 2004 Norway
Investigate the use of herbal drugs 
by pregnant women Cross-sectional 
Interview with 
structured 
questionnaire n  = 400
Postpartum women 
(within 3 days of 
delivery)
Herbal drugs- echinacea, 
iron-rich herbs, ginger, 
chamomile and cranberry N/A N/A N/A 36% 36%
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Table 2 Geographical distribution of the articles (continued) 
 
Nordeng et al 2001 Norway
Estimate the impact of maternal 
illness and prior pregnancy 
outcome on the use of drugs in 
early pregnancy Cross-sectional Structured interview n  = 1945
Pregnant women 
(early 2nd 
trimester) Prescription medications 29% N/A N/A N/A 29%
Nordeng et al 2011 Norway
Investigate the use of herbal drugs 
by pregnant women in relation to 
concurrent use of conventional 
drugs, delivery, and pregnancy 
outcome
Cross-
sectional 
Interview with 
structured 
questionnaire and 
medical birth charts n  = 600
Postpartum women 
(within 5 days of 
delivery) Herbal medicines N/A N/A N/A 39.70% 39.70%
Nordeng et al 2012 Norway
Study the associations between 
medication use, fear of childbirth, 
and maternal mental health
Prospective 
cohort study
Self-completed 
questionnaire n  = 1984
Pregnant women 
(2nd and 3rd 
trimesters)
Prescription and over-the-
counter medications N/A N/A N/A N/A 57.70%
Viktil et al 2009 Norway
Explore the use of antirheumatic 
drugs in pregnant women
Retrospective 
cohort study
Prescription database 
and Medical birth 
registry n  = 1411 Pregnant women
Antirheumatic drugs- 
Prednisolone, NSAIDs, 
sulfazalazine, 
hydroxychloroquine, 
azathioprine, methotrexate, 
leflunomide, etanercept and 
adalimumab 28% N/A N/A N/A 28%
Ystrom et al 2012 Norway
Examine the role of personality in a 
pregnant woman's consumption of 
medications and alcohol
Cross-
sectional Internet questionnaire n  = 835
Pregnant women 
(any trimester)
Prescription, over-the-
counter, herbal medicines 
and alcohol 1.90% 58.80% 7.40% 8.90% N/A
Al-Riyami et 
al 2011 Oman
Evaluate medication use pattern in 
pregnant women
Prospective 
cohort study
Interview with 
structured 
questionnaire and 
electronic patient 
record n  = 139
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter and herbal 
medicines N/A N/A N/A 23.80% 48.50%
Senn et al 2009
Papua New 
Guinea
Investigate the habit of betel nut 
chewing and its impact on 
pregnancy Cross-sectional 
Interview with semi-
structured 
questionnaire n  = 310
Postpartum women 
(3 days after 
delivery) Recreational drug- betel nut N/A N/A 94% N/A 94%
Zolnierczuk-
Kieliszek et al 2004 Poland
Determine the frequency and 
intensity of tobacco smoking by 
pregnant women Cross-sectional 
Self-completed 
questionnaire n  = 100 Pregnant women Recreational drug- cigarette N/A N/A 18% N/A 18%
Cleary et al 2010
Republic of 
Ireland
Examine the extent, nature and 
determinants of medication use in 
early pregnancy
Cross-
sectional Face-to-face interview n  = 61 252
Pregnant women 
(1st trimester)
Prescription, over-the-
counter, herbal and illicit 
drugs 39.20% 19.50% 0.90% 0.58% N/A
Odalovic et al 2012 Serbia
Investigate prescription and over-
the-counter drug use before and 
during pregnancy
Cross-
sectional 
Self-report 
questionnaire n  = 311  
Pregnant women 
(2nd trimester)
Prescription and over-the-
counter medications 27.30% 8.70% N/A N/A 34.70%
Durisova and 
Magulova 2004 Slovakia
Determine the consumption of 
drugs and compliance with therapy 
in pregnancy Cross-sectional 
Self-administered 
structured 
questionnaire n  = 331 Postpartum women
Prescription and over-the-
counter medications N/A N/A N/A N/A 75%
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Aviv et al 1993
South 
Africa
Record the prevalence of 
medication use in the antenatal 
period
Cross-
sectional Interview n  = 236
Pregnant women 
(3rd trimester)
Prescription and over-the-
counter medications 59% 28.80% N/A N/A 71.20%
Mabina et al 1997 South Africa
Determine the prevalence of herbal 
medicine use during pregnancy Cross-sectional 
Interview with 
questionnaire n  = 577
Pregnant women 
(3rd trimester) Herbal medicines N/A N/A N/A 43.70% 43.70%
Vythilingum et 
al 2012
South 
Africa
Study the prevalence of substance 
use in an antenatal population
Cross-
sectional 
Self-report 
questionnaire n  = 323
Pregnant women 
(any trimester) Recreational substances N/A N/A 4% N/A 4%
Checa et al 2005 Spain
Assess the drug intake behaviour 
of immigrants during pregnancy
Cross-
sectional 
Interview with 
structured 
questionnaire and 
medical record review n  = 1103 Postpartum women
Prescription and over-the-
counter medicines N/A N/A N/A N/A 74.60%
Falcon et al 2010 Spain
Investigate the prevalence of drug 
use in pregnancy and the 
relationship between drug 
exposure and induced abortions
Cross-
sectional 
Self-administered 
structured 
questionnaire and 
serum and hair testing n  = 142
Pregnant women 
(1st trimester)
Recreational drugs- 
cannabis, cocaine, opiates 
and MDMA (ecstasy) N/A N/A 30% N/A 30%
Friguls et al 2012 Spain
Estimate the prevalence of drug 
use by pregnant women 
Cross-
sectional 
Structured 
questionnaire and 
maternal hair analysis n  = 107
Postpartum women 
(1 day after 
delivery)
Cannabis, cocaine and 
MDMA N/A N/A 16% N/A 16%
Garcia-Algar 
et al 2008 Spain
Assess the prevalence of 
gestational ethanol exposure in 
neonates
Cross-
sectional 
Meconium analysis 
and medical record 
review n  = 353
Postpartum women 
and neonates Recreational drug- alcohol N/A N/A 45% N/A 45%
Jimenez et al 1998 Spain
Determine drug use before 
pregnancy and in the early period 
of pregnancy
Cross-
sectional 
Interview with 
structured 
questionnaire n  = 272
Pregnant women 
(1st trimester)
Prescription and over-the-
counter medications N/A N/A N/A N/A 62%
Joya et al 2012 Spain
Estimate the prevalence of illicit 
drug use among pregnant women
Cross-
sectional 
Structured 
questionnaire and 
maternal hair analysis n  = 347
Postpartum women 
(1 day after 
delivery) Cocaine N/A N/A 2.60% N/A 2.60%
Lendoiro et al 2013 Spain
Compare maternal interview and 
hair analysis to determine drug 
consumption throughout pregnancy 
and study relations among maternal 
interview, hair results, and neonatal 
outcomes 
Cross-
sectional 
Interview with 
questionnaire and 
maternal hair analysis n  = 209 Postpartum women 
Illicit drugs- cocaine, 
cannabis, opiates, 
methadone, and ketamine N/A N/A 15.40% N/A 15.40%
Lozano et al 2007 Spain
Investigate the prevalence of in 
utero exposure of neonates to 
cannabis
Cross-
sectional 
Structured interview 
and meconium 
analysis n  = 974
Postpartum women 
and neonates Recreational drug- cannabis N/A N/A 5.30% N/A 5.30%
Martinez-
Crespo et al 1994 Spain
Determine the prevalence of 
cocaine abuse during pregnancy
Cross-
sectional 
Self-completed 
structured 
questionnaire and 
urine toxicology n  = 1773
Postpartum women 
(immediately after 
delivery) Recreational drug- cocaine N/A N/A 18.20% N/A 18.20%
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Table 2 Geographical distribution of the articles (continued) 
 
Pichini et al 2005 Spain
Estimate the prevalence of drug 
use by pregnant women and the 
effects on the mother, fetus and 
infant
Prospective 
cohort study 
Structured interview 
and meconium 
analysis n  = 1151 
Pregnant women 
(any trimester) and 
neonates
Recreational drugs- opiates, 
cocaine, MDMA and 
arecoline N/A N/A 7.90% N/A 7.90%
Holst et al 2008 Sweden
Study the characteristics of women 
using herbal drugs and impact of 
use in early pregnancy on 
pregnancy outcome
Retrospective 
cohort study Medical birth registry n  = 860 215
Pregnant women 
(1st trimester)
Herbal drugs- Floradix, 
ginseng and valerian N/A N/A N/A 0.90% 0.90%
Stephansson 
et al 2011 Sweden
Study drug use during pregnancy 
and agreement between antenatal 
records and dispensed drugs from 
pharmacy database
Retrospective 
cohort study
Medical birth register 
and Prescribed drug 
register n  = 102 995
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 57.60% N/A N/A N/A 57.60%
Chuang et al 2007 Taiwan
Investigate the prevalence of 
Chinese herbal medicines use by 
pregnant women 
Cross-
sectional 
Interview with 
structured 
questionnaire n  = 1783 
Postpartum women 
(6 months after 
delivery)
Chinese herbal medicines- 
An-Tai-Yin, pearl powder, 
huanglian, szu-wu-tang and 
ginseng N/A N/A N/A 24.10% 24.10%
Chuang et al 2009 Taiwan
Investigate the use of Chinese 
herbal medicines during pregnancy 
and the postpartum period
Cross-
sectional 
Interview using 
structured 
questionnaire n  = 21 248
Postpartum women 
(6 months after 
delivery)
Chinese herbal medicines- 
An-Tai-Yin, pearl powder, 
huanglian, szu-wu-tang and 
ginseng N/A N/A N/A 33.60% 33.60%
Chuang et al 2006 Taiwan
Investigate herbal medicine use 
during pregnancy and major 
congenital malformations
Prospective 
cohort study
Interview using 
structured 
questionnaire n  = 14 551
Pregnant women 
(3rd trimester)
Herbal medicines- An-Tai-
Yin, huanglian and ginseng N/A N/A N/A 16.90% 16.90%
Yeh et al 2009 Taiwan
Investigate the patterns of 
traditional Chinese medicine use 
among pregnant women
Retrospective 
cohort study
Health Insurance 
database n  = 196 350
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Traditional Chinese 
medicine N/A N/A N/A 20.90% 20.90%
Massele et al 1997 Tanzania
Determine the use of antimalarial 
drugs during pregnancy
Prospective 
cohort study
Interview with 
structured 
questionnaire and 
antenatal card review n  = 200
Pregnant women 
(2nd trimester)
Prescription medications- 
antimalarials 75% N/A N/A N/A 75%
Bakker et al 2006
The 
Netherland
s
Investigate presription of drugs in 
women before, during and after 
pregnancy
Retrospective 
cohort study Pharmacy database n = 5412
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medications N/A N/A N/A N/A 79.10%
Ververs et al 2006
The 
Netherland
s
Determine the extent and patterns 
of antidepressant use before, 
during and after pregnancy
Retrospective 
cohort study
Health care records 
and prescription 
database n  = 29 005
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription medications- 
antidepressants 1.90% N/A N/A N/A 1.90%
Uncu et al 2005 Turkey
Evaluate maternal and paternal 
smoking habits during pregnancy 
and their correlation with pregnancy 
complications and newborn status Cross-sectional 
Face-to-face interview 
using questionnaire n  = 499 Postpartum women Recreational drug- cigarette N/A N/A 9.80% N/A 9.80%
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Table 2 Geographical distribution of the articles (continued) 
 
Bishop et al 2011
United 
Kingdom
Report the frequency of 
complementary and alternative 
medicine use by a population of 
pregnant women
Prospective 
cohort study
Self-completed postal 
questionnaire n  = 14 115
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Complementary and 
alternative medicines N/A N/A N/A 26.70% 26.70%
Fergusson et 
al 2002
United 
Kingdom
Determine the prevalence of 
cannabis use in pregnancy, the 
association between its use and 
lifestyle factors and assessment of 
its effects on pregnancy outcome
Prospective 
cohort study
Self-completed postal 
questionnaire n  = 12 129 
Pregnant women 
(2nd trimester) Cannabis N/A N/A 2.30% N/A 2.30%
Forfar and 
Nelson 1973
United 
Kingdom
Investigate the drugs taken by 
pregnant women and those that 
may affect the fetus adversely Cross-sectional 
Structured interview 
and medical record 
review n  = 911
Postpartum women 
(shortly after 
delivery)
Prescription medications; 
Recreational drug- cigarette 82% N/A 57% N/A N/A
Hall and Jolly 2013
United 
Kingdom
Determine the prevalence of 
women's use of complementary 
and alternative medicines during 
pregnancy and reasons for use
Cross-
sectional 
Interview with 
questionnaire n  = 315 Postpartum women
Complementary and 
alternative medicines N/A N/A N/A 57.10% 57.10%
Headley et al 2004
United 
Kingdom
Investigate the prevalence of use of 
all types of medicinal products in 
pregnancy
Prospective 
cohort study
Self-completed postal 
questionnaire n  = 11 545
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter, herbal and 
homeopathic products and 
other supplements N/A N/A N/A N/A 92.40%
Holst et al 2009
United 
Kingdom
Describe the use and user of 
herbal remedies during pregnancy 
and to study sources of information 
about herbs used Cross-sectional 
Self-administered 
questionnaire n  = 578
Pregnant women 
(2nd or 3rd 
trimester)
Herbal remedies- ginger, 
cranberry, raspberry leaf, 
chamomile, echinacea, 
peppermint, lavender, 
fennel, nettle and Floradix® 
(iron-rich herbs) N/A N/A N/A 57.80% 57.80%
Irvine et al 2010
United 
Kingdom
Investigate the patterns of 
prescribing of drugs to women who 
gave birth in Scotland
Retrospective 
cohort study
Maternity records and 
Prescription database n  = 3937
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription drugs 85.20% N/A N/A N/A 85.20%
Rubin et al 1986
United 
Kingdom
Investigate the use of therapeutic 
drugs, alcohol and cigarettes 
during pregnancy
Prospective 
cohort study
Self-administered 
questionnaire n  = 2765
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Therapeutic drugs, alcohol 
and cigarettes N/A N/A N/A N/A 34.80%
Andrade et al 2008
United 
States of 
America
Provide information on the 
prevalence of use of cardiovascular 
drugs among pregnant women
Retrospective 
cohort study Databases n  = 118 935
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription medicines- 
antihypertensives and 
antihyperlipidemics 3.20% N/A N/A N/A 3.20%
Andrade et al 2004
United 
States of 
America
Provide information on the 
prevalence of use of prescription 
drugs among pregnant women
Retrospective 
cohort study Databases n  = 152 531
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription medicines 64% N/A N/A N/A 64%
Bauer et al 2002
United 
States of 
America
Determine the effects of exposure 
to illicit drugs during pregnancy on 
the mother, fetus and infant
Cross-
sectional 
Interview with 
questionnaire and 
meconium analysis n  = 1185
Postpartum women 
and neonates 
(within 7 days of 
delivery)
Recreational drugs- 
cocaine, opiate, alcohol, 
tobacco and marijuana N/A N/A 13% N/A 13%
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Table 2 Geographical distribution of the articles (continued) 
 
Bercaw et al 2010
United 
States of 
America
Investigate the prevalence, reasons 
for use and physician-patient level 
of communication about the use of 
herbs, vitamins, over-the-counter 
and prescription medications in 
pregnancy
Cross-
sectional 
Self-administered 
questionnaire n  = 485
Postpartum women 
(immediately after 
delivery)
Herbs, vitamin supplements, 
over-the-counter 
medications and 
prescription medicines
29% 23% N/A 19% N/A
Buchi et al 1993
United 
States of 
America
Determine the prevalence of 
substance abuse among pregnant 
women Cross-sectional Urine analysis n  = 792
Pregnant women 
(3rd trimester)
Recreational drugs- 
marijuana, cocaine, 
amphetamines and alcohol N/A N/A 7.80% N/A 7.80%
Buitendijk 
and Bracken 1991
United 
States of 
America
Assess medication use in a 
population of pregnant women Cross-sectional Interview n  = 4186
Pregnant women 
(1st trimester)
Prescription and over-the-
counter medications 27.30% 54.90% N/A N/A 66%
Chang et al 2011
United 
States of 
America
Describe the prevalence and 
factors associated with self-
reported substance use in young 
pregnant women
Cross-
sectional 
Mail survey and 
diagnostic interview n  = 30
Pregnant young 
adults (2nd 
trimester) Alcohol and marijuana N/A N/A 33.30% N/A 33.30%
Chasnoff et al 2005
United 
States of 
America
Determine the prevalence of 
substance use among pregnant 
women Cross-sectional 
Questionnaire and 
structured clinical 
interview n  = 4865 Pregnant women
Illicit drugs- marijuana, 
heroin,cocaine and 
methamphetamines N/A N/A 9% N/A 9%
Chasnoff et al 1990
United 
States of 
America
Estimate the prevalence of 
substance abuse by pregnant 
women
Cross-
sectional 
Urine toxicology and 
medical record review n  = 715 Pregnant women
Recreational drugs- alcohol, 
cannabis, cocaine and 
opiates N/A N/A 14.80% N/A 14.80%
Ebrahim and 
Gfroerer 2003
United 
States of 
America
Estimate the national prevalence of 
pregnancy-related illicit drug use 
and abstinence rates
Cross-
sectional Interview n  = 1249
Pregnant women 
(any trimester)
Marijuana/hashish, 
cocaine/crack, inhalants, 
hallucinogens and heroin N/A N/A 2.80% N/A 2.80%
Frank et al 1988
United 
States of 
America
Assess cocaine use during 
pregnancy
Prospective 
cohort study
Interview, urine 
toxicology and 
medical record review n  = 679 Pregnant women Recreational drug- cocaine N/A N/A 17% N/A 17%
Gardiner et al 2013
United 
States of 
America
Determine the prevalence of herb 
and vitamin use in a population of 
underserved postpartum women 
and types of herbs used
Cross-
sectional 
Interview with 
questionnaire and 
medical chart review n  = 160 Postpartum women
Herbal medicines and 
vitamins N/A 65% N/A 39% N/A
Gilchrist et al 1996
United 
States of 
America
Investigate the substance use 
patterns of adolescent mothers
Prospective 
cohort study
Face-to-face interview 
and urine analysis n  = 229
Pregnant 
adolescents
Recreational drugs- 
cigarette, alcohol, 
marijuana, crack, cocaine, 
psychedelics, heroin, opium, 
amphetamines, 
barbiturates, tranquilizers 
and inhalants (such as 
sniffing glue, gasoline, etc) N/A N/A 16% N/A 16%
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Table 2 Geographical distribution of the articles (continued) 
 
 
Glover et al 2003
United 
States of 
America
Identify the medications that are 
used by a rural obstetric population
Prospective 
cohort study Interview n  = 578
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter and herbal 
medicines 95.80% 92.60% N/A 45.20% N/A
Golden et al 1984
United 
States of 
America
Determine the extent of 
phencyclidine use during 
pregnancy
Prospective 
cohort study
Interview with 
questionnaire and 
urine analysis n  = 2327
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Recreational drug- 
phencyclidine N/A N/A 0.80% N/A 0.80%
Gray et al 2009
United 
States of 
America
Determine prenatal amphetamine, 
methamphetamine and ecstasy use
Cross-
sectional 
Interview and 
meconium analysis n  = 3705
Postpartum women 
and neonates 
(shortly after 
delivery)
Amphetamine, 
methamphetamine and 
ecstasy N/A N/A 5.50% N/A 5.50%
Harrison and 
Sidebottom 2009
United 
States of 
America
Examine alcohol and drug use 
before and during pregnancy and to 
identify the predictors of use 
cessation
Prospective 
cohort study
Structured clinical 
interview n  = 1492
Pregnant women 
(1st trimester) Recreational drug- alcohol N/A N/A 5.60% N/A 5.60%
Havens et al 2009
United 
States of 
America
Examine the prevalence and 
correlates of substance use during 
pregnancy
Cross-
sectional 
Computer-assisted 
self-interview n  = 1800
Pregnant women 
(any trimester)
Recreational drugs- alcohol, 
cigarettes, marijuana, 
prescription analgesics, 
tranquilizers, sedatives and 
stimulants, cocaine, crack, 
heroin and 
methamphetamine N/A N/A 25.80% N/A 25.80%
Hayes et al 2002
United 
States of 
America
Examine prenatal alcohol intake in 
a rural, caucasian clinic Cross-sectional Medical record review n  = 212
Pregnant women 
(1st trimester) Recreational drug- alcohol N/A N/A 30% N/A 30%
Hepner et al 2002
United 
States of 
America
Determine the prevalence and 
pattern of use of herbal and over-
the-counter medicines in pregnancy 
Cross-
sectional 
Self-completed postal 
questionnaire n  = 734
Pregnant women 
(2nd trimester)
Herbal remedies 
(echinacea, St. John's wort 
and ephedra) and over-the-
counter medications (cold 
remedies, pain relievers 
and heartburn medications) N/A 75.60% N/A 7.10% N/A
Kokotailo et 
al 1992
United 
States of 
America
Determine the prevalence and 
associated risk factors of cigarette, 
alcohol and other drug use among 
school-age pregnant adolescents 
Prospective 
cohort study
Self-administered 
questionnaire, urine 
and breathe sample 
analyses and medical 
record review n  = 212
Pregnant 
adolescents
Cigarette, Alcohol and Other 
drugs (marijuana, heroin, 
cocaine, cannabis, opiates, 
benzodiazepines and 
prescription pain killers) N/A N/A 17% N/A 17%
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Table 2 Geographical distribution of the articles (continued) 
 
Kokotailo et 
al 1994
United 
States of 
America
Determine the prevalence of 
cigarette, alcohol and other drug 
use among small-city pregnant 
adolescents 
Prospective 
cohort study
Self-administered 
questionnaire, urine 
toxicology and 
medical record review n  = 117
Pregnant 
adolescents
Recreational drugs- 
cigarette, alcohol and illicit 
drugs (amphetamines, 
benzodiazepines, cannabis, 
cocaine, opiates, 
phencyclidine and lysergic 
acid diethylamide N/A N/A 35% N/A 35%
Kratz and 
Vaughan 2012
United 
States of 
America
Examine the predictors of cigarette 
use in pregnant women
Cross-
sectional 
Computer-assisted in-
home interview n  = 1782
Pregnant women 
(2nd or 3rd 
trimester) Cigarette N/A N/A 18.90% N/A 18.90%
Lester et al 2001
United 
States of 
America
Describe drug use by pregnant 
women Cross-sectional 
Structured interview 
and meconium 
toxicology n  = 11 811
Postpartum women 
and neonates 
(shortly after 
delivery)
Recreational drugs- cocaine 
and opiate N/A N/A 10.70% N/A 10.70%
Li et al 2003
United 
States of 
America
Evaluate prenatal use of non-
steroidal anti-inflammatory drugs 
(NSAIDS), aspirin and paracetamol 
and its association with increased 
risk of miscarriage
Prospective 
cohort study In-person interview n  = 1055
Pregnant women 
(1st trimester)
Over-the-counter 
medications- NSAIDS, 
aspirin and paracetamol N/A 5% N/A N/A 5%
Marcus and 
Flynn 2008
United 
States of 
America
Describe the prenatal patterns of 
antidepressant use and their 
relationship to depression in 
pregnancy Cross-sectional 
Structured clinical 
interview n  = 276
High risk pregnant 
women (2nd or 3rd 
trimester)
Prescription medications- 
antidepressants 13% N/A N/A N/A 13%
Ostrea et al 1992
United 
States of 
America
Determine the prevalence and 
epidemiologic characteristics of 
drug use in a high-risk, urban 
obstetric population
Cross-
sectional 
Meconium analysis 
and medical record 
review n  = 3010
Postpartum women 
and neonates
Recreational drugs- 
cocaine, morphine and 
cannabis N/A N/A 44% N/A 44%
Perham-
Hester and 
Gessner 1997
United 
States of 
America
Examine the characteristics related 
to drinking during pregnancy Cross-sectional 
Self-completed postal 
questionnaire n  = 6973
Postpartum women 
(2 to 8 months after 
delivery) Recreational drug- alcohol N/A N/A 9.20% N/A 9.20%
Refuerzo et al 2005
United 
States of 
America
Determine the frequency of 
prescription, over-the-counter and 
herbal medicines use by pregnant 
women Cross-sectional 
Self-completed 
questionnaire n  = 418 Postpartum women
Prescription, over-the-
counter and herbal 
medicines 76.50% 62.80% N/A 4.10% 96.90%
Riley et al 2005
United 
States of 
America
Determine the correlates of 
prescription drug use during 
pregnancy
Prospective 
cohort study
Telephone survey and 
medical record review n  = 1626 Pregnant women
Prescription drugs- 
antibiotics, analgesics, 
asthma medications and 
antiemetics 56% N/A N/A N/A 56%
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Table 2 Geographical distribution of the articles (continued) 
 
 
 
Santiago et al 2013
United 
States of 
America
Describe maternal intake of food, 
drink, and medication during 
pregnancy
Cross-
sectional 
Self-completed 
questionnaire n  = 200
Pregnant women 
(3rd trimester) and 
Postpartum women 
(8 weeks after 
delivery)
Over-the-counter medicines 
and alcohol N/A 28.90% 5.80% N/A N/A
Schempf and 
Strobino 2008
United 
States of 
America
Examine the association between 
adverse birth outcomes and drug 
use in pregnancy Cross-sectional 
Interview with 
questionnaire, medical 
record review and 
urine toxicology n  = 808 Postpartum women
Recreational drugs- 
cocaine, opiates, marijuana, 
cigarette and alcohol N/A N/A 25% N/A 25%
Splinter et al 1997
United 
States of 
America
Determine overall medication use 
by prenatal patients Cross-sectional 
Personal interview and 
medical record review n  = 100
Postpartum women 
(within 4 days of 
delivery)
Prescription and over-the-
counter medications 93% 94% N/A N/A N/A
Teagle and 
Brindis 1998
United 
States of 
America
Investigate substance use among 
pregnant adolescents and to 
compare self-reported use and 
provider perception Cross-sectional 
In-person interview 
and self-administered 
questionnaire n  = 248
Pregnant 
adolescents (1st 
trimester)
Substance use- cigarette, 
alcohol, marijuana, cocaine 
and crack N/A N/A 49% N/A 49%
van Gelder et 
al 2010
United 
States of 
America
Determine the prevalence of self-
reported illicit drug use during 
pregnancy and its association with 
demographic and social factors
Cross-
sectional Telephone interview n  = 5871
Postpartum women 
(between 6 weeks 
and 24 months 
after delivery)
Recreational drugs- 
cannabis, cocaine and 
stimulants N/A N/A 3.60% N/A 3.60%
Vega et al 1993
United 
States of 
America
Identify the prevalence and 
demographic profiles associated 
with substance use during 
pregnancy
Cross-
sectional Urine analysis n  = 29 494 Postpartum women
Recreational drugs- 
amphetamines, 
barbiturates, 
benzodiazepines, cannabis, 
cocaine, methadone, 
opiates, phencyclidine and 
alcohol N/A N/A 11.35% N/A 11.35%
Mureyi et al 2012 Zimbabwe
Determine the prevalence of 
prenatal use of traditional medicine 
within a sample of women
Cross-
sectional 
Interview with 
questionnaire n  = 248
Postpartum women 
(6 weeks after 
delivery) Traditional medicines N/A N/A N/A 52% 52%
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1.2.5.2 Prevalence of medicine and recreational substance use 
The papers reviewed reported between 1.5% (Larivaara et al., 1996) and 
96.4% (Egen-Lappe and Hasford 2004) for the prevalence of use of 
prescription medicines in pregnancy. Over-the-counter medicines had the 
prevalence which ranged between 5% (Li et al., 2003) and 94% (Splinter et 
al., 1997). The prevalence of recreational substance use in pregnancy as 
reported varied from 0.3% (Bessa et al., 2010) to 94% (Senn et al., 2009). 
Complementary and alternative medicines use had a prevalence which 
ranged from 0.58% (Cleary et al., 2010) to 90.3% (Malan and Neuba 2011). 
The overall prevalence of medicine and recreational substance use in 
pregnancy as reported by all the studies ranged from 0.3% (Bessa et al., 
2010) to 99.5% (Berthier et al., 1993). Table 3 shows the range of values 
reported in the articles. 
 
Table 3 Prevalence of medicine and substance use in pregnancy 
Medicine/Substance   Prevalence % (range of values) 
Prescription medicines     1.5 – 96.4 
Over-the-counter medicines    5 – 94 
Recreational substances     0.3 – 94 
Complementary and alternative medicines  0.58 – 90.3 
Overall prevalence       0.3 – 99.5 
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1.2.6 Discussion 
1.2.6.1 Methodological issues 
Research focusing on the use of medicines and recreational substances 
during pregnancy has been reported from different parts of the world. 
However, it is difficult to compare the prevalence of use of these agents in 
different populations based on the relevant literature for several reasons: the 
articles studied different categories of medicine or recreational substance 
exposures while focusing on different time periods of pregnancy or 
postpartum; patterns of medicine or recreational substance use differ 
according to countries and the social and cultural characteristics of their 
pregnant women; and the differences in research methodology led to great 
variations in the completeness of antenatal medicine and substance 
exposure data. 
In terms of the study designs, 89 of the papers employed the cross-sectional 
study designs, 25 carried out prospective studies while 18 of the studies 
were done retrospectively. 
The sample sizes of the studies reviewed varied from 30 (Chang et al., 2011) 
to 860,215 (Holst et al., 2008) which also makes the comparison of results 
difficult. 
The participants involved in the studies included pregnant women at different 
stages of gestation, postpartum women at different times after delivery as 
well as neonates. Eighty-seven of the papers recruited pregnant women, one 
study (Pichini et al., 2005) involved pregnant women and subsequently their 
neonates, 36 papers recruited postpartum women, 7 papers involved 
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postpartum women and neonates while Mashayekhi et al. (2009) and 
Santiago et al. (2013) were the two studies which recruited both pregnant 
and postpartum women as participants. 
The data collection methods used by the studies varied from questionnaires 
(which could be self-administered, postal, internet, structured or semi-
structured) clinical interviews, birth registries, health care records, 
prescription databases, computer-assisted self-interviews and telephone 
surveys to urine, hair, meconium, serum and breathe analyses. Hence, a 
significant challenge when interpreting the literature results from variation in 
data collection methods. Most studies employed self-administered 
questionnaires (e.g. Forster et al., 2006); interviews using various tools (e.g. 
Chuang et al., 2009) or information from databases (e.g. Andrade et al., 
2004) while a few others carried out analyses of urine, meconium, hair, 
serum or breathe samples (e.g. Martinez-Crespo et al., 1994). Two studies 
(Havens et al., 2009; Kratz and Vaughan 2012) employed the computer-
assisted self-interview method. Each data collection method has strengths 
and limitations which need to be considered when interpreting the results of 
the studies. 
Self-administered questionnaires are a relatively quick method of collecting 
information from a large group in a standardised way. However, there is no 
capacity to clarify confusion and they are limited by the participants’ 
knowledge of the subject matter and their willingness to recall and report 
use. 
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Interviewing allows the researcher to adapt questions as necessary and to 
ensure that they are properly understood. Although this method requires 
significant resources, it was reported by Kelsey et al., (1996) that data from 
interviewer-administered questionnaires provide more reliable and complete 
information than self-administered questionnaires, the latter methodology 
being often associated with a lower adhesion by potential participants and 
inappropriate compilation and misinterpretation of the answers. 
The use of the internet questionnaire as an efficient way of collecting 
population-based data is limited by the fact that not all potential participants 
have access to the internet. 
The analysis of prescription data is a cost-effective way to collect information 
on medicine use in pregnancy and has an added advantage of providing a 
large population-based sample for analysis. All prescriptions redeemed by 
the women are available and the relevant details on the prescribed 
medicines are given. These survey instruments also avoid the potential for 
maternal underreporting of medicine exposures due to recall bias but they 
have limitations. One of the major limitations of administrative pharmacy data 
is that they serve only as a proxy for exposure as they cannot ensure that 
medicines are actually consumed. They do not take into account non-
compliance and therefore may not reflect what was actually used or 
ingested. For example, the EUROMAP Group noted that only 43% of 
dispensed prescription medicines were reported as being used by the 
pregnant women in their study (Olesen et al., 2001). Furthermore, it is 
possible that a dispensing during pregnancy might be meant for maternal 
use after delivery (e.g. contraceptive hormones dispensed during the third 
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trimester of pregnancy), leading to a possible overestimation of the burden of 
medicine use during pregnancy (Donati et al., 2000). Also, non-prescription 
medicines such as over-the-counter analgesics, herbal products and 
recreational substances are not captured in the database which contributes 
to a possible underestimate of risk exposure (Gagne et al., 2008).  Another 
limitation of using databases is lack of data on the length of gestation; a 270-
day gestational period is assumed. Therefore, it does not adequately 
address the timing of medicine exposure among women with preterm birth, 
considering the ambiguity in length of gestation for these women (Andrade et 
al., 2004). 
All biological screening tests are expensive and some of them could be 
complicated to carry out. For example, the use of maternal or neonatal hair 
for assessment of recreational substance use is limited by the fact that 
coarse black hair incorporates more of the substance than brown or blonde 
hair, necessitating the need for differential scaling by hair colour (Ebrahim 
and Gfroerer, 2003). 
Urine toxicology screens provide conservative estimates because they can 
detect only very recent substance use. Thus, the sensitivity of urine testing is 
constrained by the limited detection period for each substance. For example, 
alcohol can be detected in urine only if it had been consumed in the 
preceding 8-12 hours because of its rapid metabolism and excretion in the 
urine. This implies that the actual prevalence of use over the course of a 
pregnancy is likely to be underestimated (Frank et al., 1988; Chasnoff et al., 
1990; Kokotailo et al., 1992; Buchi et al., 1993; Vega et al., 1993; Ebrahim 
and Gfroerer, 2003). Another limitation of using urine for drug testing is that it 
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does not provide information on the amount and frequency of substance use 
(Chasnoff et al., 1990; Bibb et al., 1995). 
Blood or serum analysis can only detect acute use and must be repeated 
very often. Also, its sampling procedure is invasive and it is more difficult 
than urine to analyse because it contains proteins and other cellular 
constituents (Bibb et al., 1995; Lozano et al., 2007). 
The efforts involved in collecting and conducting meconium analyses is high 
(Lozano et al., 2007). The timing of recreational substance exposure may 
also influence meconium toxicology results. Some women discontinue use 
before the third trimester and the results obtained from the meconium 
analysis of their neonates can be misleading. In the first trimester, meconium 
has not yet formed therefore substance use in early pregnancy may be 
poorly reflected in meconium (Gray et al., 2009). It was suggested by 
Ebrahim and Gfroerer (2003) and Gray et al. (2009) that maternal self-report 
is more rational and sensitive than meconium testing for identifying 
substance-exposed neonates. 
The breathe sample test for expired carbon monoxide is a qualitative method 
of assessing cigarette smoking and is dependent on time of use. It is not 
highly sensitive and sporadic use of cigarettes can make it more difficult to 
use this objective screening method effectively (Kokotailo et al., 1992). 
In the case of the computer-assisted self-interview, it has been discovered 
that some participants are more comfortable using this method. However, 
this only seemed to be feasible with middle class participants; it is very 
challenging to recruit where subjects are less familiar with computers. 
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Participants’ refusal in the latter case are not usually linked to the topic of the 
research, but to the inability to use computers which could make them look 
naive (Boynton, 2004). 
1.2.6.2 Medicines and recreational substances reported by the articles 
The articles reported a wide range of medicines and recreational substances 
which are presented in Table 4 (some articles reported more than one 
medicine or recreational substance). Fifty-seven articles studied prescription 
medicines, 35 papers reported on over-the-counter medicines, 41 
researched on complementary and alternative medicines while 52 articles 
studied recreational substances. The prescription medicines presented in the 
table have been grouped according to the World Health Organisation ATC 
(Anatomical Therapeutic Chemical) classification system. 
The number of medicines or recreational substances (Prescription, Over-the-
counter, Complementary and alternative medicines or Recreational 
substances) studied also varied across the articles reviewed. Most of the 
papers (69%) studied only one type of medicine or recreational substance 
(e.g. Hollyer et al., 2002; Chasnoff et al., 2005), some two types of medicines 
(e.g. Hepner et al., 2002), others studied three medicine types (e.g. Zhu et 
al., 2010) while only 3 articles (Cleary et al., 2010; Abasiubong et al., 2012; 
Ystrom et al., 2012) studied all the medicine types as well as recreational 
substances. 
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Table 4 Medicines and recreational substances reported by the articles 
Prescription medicines Over-the-counter medicines Complementary and 
alternative medicines 
Recreational substances 
 
(A) Alimentary tract and 
metabolism 
Antacids, drugs for peptic ulcer 
and flatulence e.g. ranitidine. 
Antispasmodics, 
anticholinergics and 
propulsives e.g. dicyclomine + 
pyridoxine. 
Antiemetics and Antinauseants 
e.g. metoclopramide, 
doxylamine + pyridoxine, 
domperidone. 
Laxatives. 
Antidiarrhoeals, intestinal anti-
inflammatory/anti-infectives. 
 
Vitamins e.g. folic acid 
Mineral supplements 
Anti-anaemic preparations 
 
Analgesics/Antipyretics e.g. 
paracetamol 
 
Cough and cold preparations 
 
Antihistamines for systemic 
use 
 
Nasal preparations 
Antacids and drugs for 
flatulence. 
 
Acupressure/seabands, 
acupuncture, alfalfa, almond 
oil, aloe, an-tai-yin, arnica, 
aromatherapy, autogenic 
training. 
 
Bach flowers, ban lan gen, bao 
tai ling, barley, bioresonance 
therapy, black elderberry, 
black powder, black soap, 
breathing exercises, burdock. 
 
CAM diets (e.g. vegetable 
carbon), chamomile, cocoa 
butter, cod liver oil, cranberry. 
 
Licit substances 
Alcohol 
Tobacco 
Betel (Areca) nut (contains 
arecoline) 
 
Illicit drugs 
Amphetamine (AMP) 
 
Cannabis (also known as 
marijuana, hashish grass, 
ganja or Indian hemp) 
 
Cocaine/Crack 
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Table 4 Medicines and recreational substances reported by the articles (continued) 
Drugs used in diabetes e.g. 
insulin. 
Vitamins 
Mineral supplements 
 
(B) Blood and blood forming 
organs 
Anti-anaemic preparations 
 
(C) Cardiovascular system 
Vasoprotectives (anti-
haemorrhoidals) 
Beta-blocking agents 
Calcium channel blockers 
 
(D) Dermatologicals 
Antifungals 
Antipruritics 
 Damascisa, devil’s claw, 
digestive bitters. 
 
Echinacea, ephedra, essential 
oils. 
 
Fennel, flax, floradix (iron-rich 
herbs), fringed rue. 
 
Garden cress, garlic, ginger, 
ginkgo biloba, ginseng, golden 
seal, green tea. 
 
Herbal brew, herbal soup, 
herbal teas, homeopathy, 
horsetail, huang lien, 
huanglian. 
Codeine 
 
Drugs used without medical 
prescription e.g. barbiturates 
and benzodiazepines. 
 
Heroin 
 
Inhalants e.g. sniffing glue, 
gasoline. 
 
Lysergic acid diethyl amide 
(LSD) 
 
Methylene 
dioxymethamphetamine 
(MDMA or ecstasy) 
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Table 4 Medicines and recreational substances reported by the articles (continued) 
Topical antibiotics. 
Corticosteroids, topical. 
Antiseptics and disinfectants. 
 
(G) Genito-urinary system 
and sex hormones 
Gynaecological anti-infectives 
and antiseptics. 
Sex hormones, modulators of 
genital system e.g. oestrogen, 
progestogen, 
medroxyprogesterone. 
 
(H) Systemic hormones 
excluding sex hormones 
Corticosteroids for systemic 
use. 
Thyroid therapy e.g. thyroxine. 
 Incantations, inoculations, 
iridology, isihlambezo. 
 
Kava kava 
 
Lavender, lemon, licorice. 
 
Marcela, massage, mauve, 
melatonin, metabolife, miso 
paste. 
 
Naturopathy, nettle, niu huang 
jie du pian, noni juice. 
 
Orthomolecular medicine 
 
Parsley, pearl powder, 
peppermint, phytotherapy, 
Mescaline 
 
Methamphetamine (MAMP) 
 
Morphine 
 
Phencyclidine (PCP or angel 
dust) 
 
Buprenorphine 
 
Methadone 
                                                                                                                                   Chapter 1 
 
77 
 
Table 4 Medicines and recreational substances reported by the articles (continued) 
(J) Anti-infectives for 
systemic use 
Antibacterials e.g. amoxicillin, 
ampicillin, macrolides. 
 
(M) Musculo-skeletal system 
Anti-inflammatory and 
antirheumatic products e.g. 
sulfasalazine, prednisolone. 
 
(N) Nervous system 
Analgesics 
Antiepileptics 
Psycholeptics – 
benzodiazepines, 
antipsychotics. 
Psychoanaleptics – 
antidepressants 
 propolis, pumpkin. 
 
Raspberry leaf, revulsive 
balsam, rye ergot 
 
Senna, shang ching pian, 
slippery elm, sobe herbal drink, 
St. John’s wort, szu-wu-tang. 
 
Valerian, vitamin B6 
 
Waistbands rings & safety 
pins, wheat germ oil, witch 
hazel. 
 
Xenadrine, xiao chai hu tang. 
 
Yinqiao, yoga. 
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Table 4 Medicines and recreational substances reported by the articles (continued) 
(P) Anti-parasitics, 
insecticides and repellents 
Antiprotozoals e.g. chloroquine 
 
(R) Respiratory system 
Nasal preparations 
Throat preparations 
Anti-asthmatics 
Cough and cold preparations 
Antihistamines for systemic 
use 
 
(S) Sensory organs 
Ophthalmologicals 
Otological products 
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1.2.6.3 Pregnancy Outcomes 
Twenty-eight of the 132 papers reviewed gave information about the 
outcomes of the pregnancies but 19 of those found correlation between the 
medicines or recreational substances used and the pregnancy outcomes 
(Table 5). However of the 19 articles, 9 were prospective cohort studies 
(Correy et al., 1991; Larivaara et al., 1996; Fergusson et al., 2002; Li et al., 
2003; Headley et al., 2004; Pichini et al., 2005; Chuang et al., 2006; Dal 
Pizzol et al., 2008; Hayatbakhsh et al., 2012) while others were cross-
sectional studies. 
With regard to the articles which found correlations, 4 reported on 
prescription medicines (Correy et al., 1991; Larivaara et al., 1996; Dal Pizzol 
et al., 2008; Rachidi et al., 2013), 3 articles studied over-the-counter 
medicines (Li et al., 2003; Headley et al., 2004; Rachidi et al., 2013), 4 
articles provided information about complementary and alternative medicines 
(Opaneye, 1998; Chuang et al., 2006; Cuzzolin et al., 2010; Nordeng et al., 
2011), 1 article was on alcohol (Schempf and Strobino, 2008), 5 articles 
reported on cigarette and arecoline (Pichini et al., 2005; Uncu et al., 2005; 
Schempf and Strobino, 2008; Senn et al., 2009; Rachidi et al., 2013), and 6 
articles were about illicit substances (Ostrea et al., 1992; Bauer et al., 2002; 
Fergusson et al., 2002; Pichini et al., 2005; Hayatbakhsh et al., 2012; 
Lendoiro et al., 2013). 
As documented in the articles, prescription medicine use during pregnancy 
was associated with hypospadias, phocomelia, pes cavus, syndactyly, 
clubfoot, meningomyelocele, microcephaly, fingernail defects, low birth 
weight, decreased apgar scores and medical complications of babies. Over-
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the-counter medicine use was found to be associated with wheezing in early 
childhood (a long-term outcome of paracetamol use), increased risk of 
miscarriage, decreased apgar scores, increased risk of underweight babies 
and medical complications of babies. Complementary and alternative 
medicine use was associated with increased risk of congenital malformations 
of the nervous system, musculoskeletal, connective tissues and the eye, 
threatening miscarriages, preterm labour, cardiac malformation, enlarged 
kidney, uterine hyper-contractility, placenta previa, intrauterine growth 
restriction, small-for-gestational age babies, high birth weight, antepartum 
and postpartum haemorrhages, ruptured uterus and stillbirths. 
Deceased apgar scores, low birth weight, medical complications of babies, 
preterm delivery, intrauterine growth retardation, prenatal death and 
hyporeflexia were found to be associated with alcohol, cigarette and 
arecoline (from areca nut) use. In the case of illicit substances, placental 
abruption, low birth weight, preterm labour, small-for-gestational age babies, 
admission to the neonatal intensive care unit, neonatal abstinence 
syndrome, smaller length and smaller head circumference were found to be 
associated with use. 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used 
Author/Year Medicines/Substances Pregnancy outcomes Correlation with 
medicines/substances used 
 
Bauer et al., 2002 
 
 
 
 
 
 
 
Berthier et al., 1993 
 
Cocaine and opiates 
 
 
 
 
 
 
 
Prescription and over-the-
counter medications 
 
Maternal complications such 
as increased risk of syphilis, 
gonorrhoea, hepatitis and HIV 
infections as well as 
psychiatric, nervous and 
emotional disorders and 
placental abruption. 
 
Premature birth, stillbirth, 
lombo-sacral meningocele, 
sacral fistula, atrial and 
ventricular septal defects, 
bilateral cleft lip, preauricular 
fistula and polydactylia. 
 
 
Yes 
 
 
 
 
 
 
 
No 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used (continued) 
Chuang et al., 2006 
 
 
 
 
 
 
 
Chuang et al., 2007 
 
 
 
Correy et al., 1991 
Huanglian 
 
 
An-Tai-Yin 
 
 
 
 
Chinese herbal medicines 
 
 
 
Aspirin 
Dicyclomine 
Oral contraceptive 
Increased risk of congenital 
malformation of the nervous 
system 
Increased risk of congenital 
malformations of the 
musculoskeletal and 
connective tissues and the eye 
 
Low birth weight, preterm 
delivery and congenital 
malformations 
 
Hypospadias 
Phocomelia 
Pes cavus 
(significance level of these 
associations was considered 
marginal) 
Yes 
 
 
 
 
 
 
 
No 
 
 
 
Yes 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used (continued) 
Cuzzolin et al., 2010 
 
 
 
 
 
 
 
 
 
Dal Pizzol et al., 2008 
 
 
 
 
Dal Pizzol et al., 2009 
Chamomile and Licorice 
 
Chamomile 
 
Ginger 
 
Echinacea 
 
 
 
Misoprostol 
 
 
 
 
Dipyrone 
Threatening miscarriages and 
preterm labour. 
Cardiac malformation and 
enlarged kidney. 
Uterine hyper-contractility and 
placenta previa. 
Intrauterine growth restriction. 
All the herbals caused small-
for-gestational age babies. 
 
Syndactyly, clubfoot, 
meningomyelocele, 
microcephaly and fingernail 
defects. 
 
Clubfoot, syndactyly, 
polydactyly, choanal atresia, 
anencephaly, macrocephaly, 
Yes 
 
 
 
 
 
 
 
 
 
Yes 
 
 
 
 
No 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used (continued) 
 
 
 
 
 
Durisova and Magulova 2004 
 
 
 
 
Fergusson et al., 2002 
 
Friguls et al., 2012 
 
 
Hayatbakhsh et al., 2012 
 
 
 
 
 
Prescription and over-the-
counter medications 
 
 
 
Cannabis 
 
Cannabis, cocaine and MDMA 
 
 
Cannabis 
meningomyelocele, abducted 
fourth and fifth left foot fingers, 
intrauterine death, preterm 
birth and low birth weight. 
 
Premature birth, neonatal 
sepsis, 
cheilognatopalatoschisis, 
vitium cordis congenitum. 
 
Low birth weight 
 
Foetal acid-base status, Apgar 
scores, hypoglycaemia events. 
 
Low birth weight, preterm 
labour, small-for-gestational 
age, admission to the neonatal 
 
 
 
 
 
No 
 
 
 
 
Yes 
 
No 
 
 
Yes 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used (continued) 
 
 
Headley et al., 2004 
 
 
Joya et al., 2012 
 
 
 
Kulaga et al., 2009 
 
 
Lacroix et al., 2009 
 
 
Paracetamol 
 
 
Cocaine 
 
 
 
Prescription medicines 
 
 
Prescription medicines 
intensive care unit. 
 
Wheezing in early childhood  
(a long-term outcome) 
 
Low birth weight, low crown-
heel length, low cranial 
perimeter. 
 
Miscarriage and major 
congenital malformations 
 
Malformations of the central 
nervous system, 
cardiovascular system, urinary 
tract, musculo-skeletal system, 
intrauterine growth retardation 
and genetic abnormality. 
 
 
Yes 
 
 
No 
 
 
 
No 
 
 
No 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used (continued) 
Larivaara et al., 1996 
 
 
 
Lendoiro et al., 2013 
 
Li et al., 2003 
 
Nordeng et al., 2011 
 
Opaneye, 1998 
Psychotropic drugs 
(tranquilisers, hypnotics and 
antidepressants) 
 
Methadone and cocaine 
 
NSAIDs and Aspirin 
 
Iron-rich herbs 
 
Traditional medicines 
Low birth weight 
 
 
 
Neonatal abstinence syndrome 
 
Increased risk of miscarriage 
 
High birth weight 
 
Maternal morbidity and 
mortality- hypertensive 
diseases, antepartum and 
postpartum haemorrhages, 
ruptured uterus, cervical tear 
and maternal death; Stillbirths. 
Yes 
 
 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used (continued) 
Ostrea et al., 1992 
 
 
 
 
 
 
 
 
 
 
Pichini et al., 2005 
Cocaine 
 
 
 
Morphine 
 
 
Cannabis 
 
 
 
Opiates and Cocaine 
 
Arecoline (from areca nut) 
Premature neonates, small-for-
gestational age, low birth 
weight, smaller length and 
smaller head circumference. 
Low birth weight, smaller 
length and smaller head 
circumference. 
Low birth weight, smaller 
length and smaller head 
circumference. 
 
Low birth weight and crown-
heel length. 
Low birth weight, low 
intrauterine growth, 
hyporeflexia, hypotonia and 
neonatal abstinence 
syndrome. 
Yes 
 
 
 
 
 
 
 
 
 
 
Yes 
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Table 5 Pregnancy outcomes and correlation with medicines or recreational substances used (continued) 
Rachidi et al., 2013 
 
 
 
 
Schempf and Strobino 2008 
 
 
Senn et al., 2009 
 
Uncu et al., 2005 
 
 
 
Van Gelder et al., 2010 
Prescription, over-the-counter 
medicines and cigarettes 
 
 
 
Cigarette and alcohol 
(heavy smoking and drinking) 
 
Betel (areca) nut 
 
Cigarette 
 
 
 
Illicit drugs- cannabis, cocaine 
and stimulants 
Decreased Apgar scores, 
increased risk of underweight 
babies and medical 
complications of babies. 
 
Low birth weight 
 
 
Low birth weight 
 
Low birth weight, preterm 
delivery, intrauterine growth 
retardation and prenatal death. 
 
Low birth weight and preterm 
birth. 
Yes 
 
 
 
 
Yes 
 
 
Yes 
 
Yes 
 
 
 
No 
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1.2.6.4 Implications for this thesis 
The differences in contexts, times and methods, and different variables taken 
into account in each study suggest the need for further research. Eighty-six 
of the 132 articles covered in this narrative review were published in the last 
10 years, and this trend is in line with a growing interest in the use of 
medicines and recreational substances in general. Nevertheless, the 
narrative review has identified some gaps in the scientific literature. 
First, most of the studies (n = 89) were cross-sectional while others were 
cohort studies. Although both cross-sectional and cohort studies give the 
prevalence of medicine and recreational substance use, it is also important 
to recognise the medicines and recreational substances used during each of 
the three trimesters of pregnancy and the pregnancy outcomes. 
Furthermore, because the first trimester has been noted to be the period of 
greatest risk to the foetus if medicines or substances are taken (Porter, 
2004), it is crucial to examine the association between medicine or 
recreational substance use during this period and the pregnancy outcomes. 
Hence cohort studies are necessary in these contexts. However, of the 19 
articles which reported associations between the medicines or recreational 
substances used and the pregnancy outcomes, 9 were prospective cohort 
studies (section 1.2.6.3) and only Headley et al. (2004) recruited pregnant 
women in the first trimester and did a follow up in the second and third 
trimesters up to the pregnancy outcomes. In addition, only 2 of the 9 
prospective cohort studies (Correy et al., 1991; Li et al., 2003) considered 
first trimester use of medicines and pregnancy outcomes.  
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Therefore, in addition to learning about the prevalence of use of medicines 
and recreational substances in pregnancy, researchers also need to 
understand the changes in types of product or therapy used during the three 
trimesters of pregnancy and how the products relate to pregnancy outcomes. 
The effects of multiple medicines or substances on pregnancy outcomes 
would also be informative to healthcare professionals. Chuang et al. (2006) 
therefore concluded that prospective exposure data collection during 
pregnancy, before the outcome of pregnancy, remains the best method of 
gathering reliable data on medicine and recreational substance use during 
pregnancy. 
A second issue relate to when the information was collected during the 
study, which could be either during the gestational or postpartum period. One 
hundred and nineteen of the 132 studies involved data collection in the mid- 
or late pregnancy or postpartum period. This could have led to under-
reporting of medicine or recreational substance use due to the unreliability of 
recall. For example, Moussally et al. (2009) relied on women’s memories of 
herbal medicine use three to eight years after the pregnancy of interest. 
Therefore, recall bias may be a significant limitation in the survey and this 
might have affected the results obtained. 
Third, while 69% of the articles studied one type of medicine or substance 
(section 1.2.6.2), only 3 articles (Cleary et al., 2010; Abasiubong et al., 2012; 
Ystrom et al., 2012) reported on all the medicines and recreational 
substances of interest (prescription, over-the-counter, complementary and 
alternative medicines and recreational substances). These studies were 
cross-sectional; hence, there is a need for research of this type to be carried 
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out longitudinally in order to identify those medicines and substances which 
are most commonly used and to highlight where further research into safety 
might appropriately be pursued. 
Another important point is that further research is still needed to develop the 
evidence base for the use of complementary and alternative therapies 
especially because of the safety issues related to their use in gestation. 
Lastly, although the 132 studies reviewed examined the use of medicines 
and recreational substances in a wide range of countries, it is necessary to 
investigate medicine and recreational substance use during pregnancy within 
a large ethnically diverse metropolitan city such as London, United Kingdom. 
This narrative review has identified 6 published studies on medicine and 
recreational substance use in pregnancy in the UK in the last 15 years (Table 
6). Irvine et al. (2010) reported the prevalence of prescription medicines 
using the prescription database and maternity records. As discussed earlier 
(section 1.2.6.1), the use of databases and records have several limitations 
which might have affected the results of the study. Two studies (Holst et al., 
2009a; Hall and Jolly, 2013) investigated the use of complementary and 
alternative remedies in pregnancy. They were cross-sectional studies carried 
out with questionnaires and the participants were not followed up to the 
pregnancy outcomes. Three other studies - Fergusson et al., 2002; Headley 
et al., 2004; Bishop et al., 2011- presented data on self-reported use of 
medicines and recreational substances in pregnancy in the UK. These 
studies were carried out in 1991-1992; they relate to pregnancies over 20 
years ago and may have little relevance to the current situation of pregnant 
women in the UK. Therefore, it is important to update the existing knowledge 
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of medicine and recreational substance use during pregnancy in the United 
Kingdom.  
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Table 6 Studies carried out within the United Kingdom in the last fifteen years 
 
 
Author
Year of 
study Country Objectives of the study
Type of medicine or 
substance studied
Study design Data collection Sample size Study participants
Prescription 
medicines
Over-the-
counter 
medications
Recreational 
drugs or 
substances
Complementary & 
alternative 
medicines Overall
Fergusson et 
al 2002
United 
Kingdom
Determine the prevalence of 
cannabis use in pregnancy, the 
association between its use and 
lifestyle factors and assessment 
of its effects on pregnancy 
outcome
Prospective 
cohort study
Self-completed 
postal 
questionnaire n  = 12 129 
Pregnant women 
(2nd trimester) Cannabis N/A N/A 2.30% N/A 2.30%
Headley et al 2004
United 
Kingdom
Investigate the prevalence of use 
of all types of medicinal products 
in pregnancy
Prospective 
cohort study
Self-completed 
postal 
questionnaire n  = 11 545
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Prescription, over-the-
counter, herbal and 
homeopathic products 
and other supplements N/A N/A N/A N/A 92.40%
Holst et al 2009
United 
Kingdom
Describe the use and user of 
herbal remedies during 
pregnancy and to study sources of 
information about herbs used Cross-sectional 
Self-
administered 
questionnaire n  = 578
Pregnant women 
(2nd or 3rd 
trimester)
Herbal remedies- 
ginger, cranberry, 
raspberry leaf, 
chamomile, echinacea, 
peppermint, lavender, 
fennel, nettle and 
Floradix® (iron-rich 
herbs) N/A N/A N/A 57.80% 57.80%
Irvine et al 2010
United 
Kingdom
Investigate the patterns of 
prescribing of drugs to women 
who gave birth in Scotland
Retrospective 
cohort study
Maternity 
records and 
Prescription 
database n  = 3937
Pregnant women 
(1st, 2nd and 3rd 
trimesters) Prescription drugs 85.20% N/A N/A N/A 85.20%
Bishop et al 2011
United 
Kingdom
Report the frequency of 
complementary and alternative 
medicine use by a population of 
pregnant women
Prospective 
cohort study
Self-completed 
postal 
questionnaire n  = 14 115
Pregnant women 
(1st, 2nd and 3rd 
trimesters)
Complementary and 
alternative medicines N/A N/A N/A 26.70% 26.70%
Hall and Jolly 2013
United 
Kingdom
Determine the prevalence of 
women's use of complementary 
and alternative medicines during 
pregnancy and reasons for use Cross-sectional 
Interview with 
questionnaire n  = 315 Postpartum women
Complementary and 
alternative medicines N/A N/A N/A 57.10% 57.10%
Methods Population characteristics Prevalence of use
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1.2.7 Summary 
Pregnant women are typically considered a special group and frequently 
excluded from pre-approval medicine studies. Consequently, the safety of 
medicines in this population is largely unknown prior to experience gained 
through widespread use. There are few data available on the full extent of 
medicine use during pregnancy including prescription, over-the-counter and 
complementary and alternative medicines as well as recreational substances 
and their effects on pregnancy outcomes. There is therefore, the need for 
further research on the subject matter. Cohort studies, with their prospective 
exposure assessment and the ability to monitor both adverse and beneficial 
foetal outcomes, seem to be the most promising study type from a 
methodological viewpoint. This will be explored in the next chapter which is a 
prospective cohort study of the epidemiology of medicine and recreational 
substance use amongst pregnant women in London. 
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CHAPTER 2 - PRENATAL USE OF MEDICINES AND RECREATIONAL 
SUBSTANCES: PREVALENCE, PREGNANCY OUTCOMES AND 
MOTHERS’ SAFETY KNOWLEDGE 
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2.1 Introduction 
Prescription medicine use in pregnancy is common (Hardy et al., 2006; 
Mehta and Larson, 2011). In addition to prescribed medicines, many women 
also take over-the-counter, complementary and alternative medicines and 
recreational substances during their pregnancy which could pose a risk to 
the developing baby (Shehata and Nelson-Piercy, 2001; Conover, 2003; 
Andrade et al., 2004; Schempf, 2007). The investigation of the effects of 
medicines and recreational substances on foetal development can take the 
form of case reports or epidemiologically based cohort and case-control 
studies. The most common are cohort studies and if there is no increase in 
the incidence of birth defects associated with a particular medicine, 
researchers will often conclude that the medicine is ‘safe’ in pregnancy 
(Webster and Freeman, 2003). 
There is limited information available on the use of medicines and 
recreational substances during pregnancy within the UK in the last fifteen 
years. A survey of 256 women attending the EPAU (Emergency Pregnancy 
Assessment Unit) at Guy’s and St. Thomas’ Hospital carried out in 1998 
found that 26% of the women had taken prescription medicines, 56% had 
taken over-the-counter medicines, 26% had used a recreational substance, 
most frequently cannabis while 5% had used complementary therapies 
during their pregnancy (Dines et al., 2005). 
Some studies have revealed associations between the use of medicines or 
recreational substances during pregnancy and adverse pregnancy outcomes 
(Ostrea et al., 1992; Chuang et al., 2006); this issue is complicated by the 
fact that the safety profile of a given medicine often changes during the 
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course of a normal pregnancy (Black and Hill, 2003). Thus Koren (2002) 
pointed out that the best way to achieve better knowledge of possible 
teratogenic effects of medicines and recreational substances during 
pregnancy is the collection and follow-up of observational data. It is therefore 
important to monitor medicine and recreational substance use regularly 
among pregnant women in order to improve the evidence base on the safety 
of these agents. 
2.2 Aim 
To investigate the use of medicines (prescription, over-the-counter and 
complementary and alternative medicines) and recreational substances (licit 
and illicit substances) in an ethnically diverse antenatal population of 
London. 
2.3 Objectives 
1. To estimate the prevalence of medicine and recreational substance use 
before and during pregnancy. 
2. To investigate the associations between participants’ characteristics and 
medicine or recreational substance use in pregnancy. 
3. To assess the knowledge of mothers about the safety of medicines and 
recreational substances in pregnancy. 
4. To examine the mothers’ medicines preferences for treating a new 
medical condition. 
5. To determine pregnant women’s potential sources of information on 
medicine and recreational substance use. 
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6. To explore the outcomes of the pregnancies and the relationship between 
use of medicines and recreational substances and adverse pregnancy 
outcomes. 
2.4 Research Ethics 
An ethics application for this study was submitted to the South East London 
REC 3 (Research Ethics Committee 3) for a multi-site study and approval 
was obtained. The R and D (Research and Development) approval was also 
sought from the sites before participants were recruited for the study. 
2.5 Methods 
2.5.1 Study Design 
The design was both cross-sectional (at 2 sites) and prospective cohort 
study (at 1 site). This is because R and D authorisation for the cross-
sectional study was granted at 2 sites while prospective cohort study 
authorisation was granted only at 1 site. A cross-sectional study design was 
used for objectives 1 to 5 (section 2.3) while a prospective cohort study 
design was used for objectives 1 and 6. 
A prospective cohort study is one in which a group of subjects, selected to 
represent the population of interest, is studied over time. The study is carried 
out from the present time into the future and information is collected at 
distinct points in time about the exposure to risk factors and outcome of 
interest. Prospective cohort studies may be either fixed, where the study 
subjects do not vary over time and dropouts are not replaced, or dynamic, 
where new subjects enter the study in accordance with eligibility criteria. This 
type of study is observational and used to examine causal factors (Levin, 
Chapter 2 
 
99 
 
2003). Unlike cross-sectional studies where information is collected about 
the exposure to risk factors and outcomes simultaneously at a specific point 
in time, the longitudinal nature of prospective cohort studies enables the 
assessment of causal hypotheses since exposure is seen to occur before the 
outcome (Hennekens and Buring, 1987; Levin, 2003). 
The prospective cohort study is therefore a valuable tool with important 
applications in epidemiological studies. The design is more commonly used 
because accurate and complete data are readily available and it can be used 
to study more than one outcome. It also offers researchers the advantage of 
measuring outcomes in the real world without the ethical and logistical 
constraints faced by randomized controlled trials. However, prospective 
cohort studies have the disadvantages of being costly, time consuming, 
prone to dropouts, as well as concerns with internal validity due to the 
presence of selection bias and confounding variables (Bookwala et al., 
2011). 
2.5.2 Setting 
This study was carried out at the antenatal outpatient units of 2 London 
teaching hospitals – University College London and St. Thomas’ Hospitals. 
These central London hospitals provide antenatal services to 6,200 and 
6,800 women respectively per year. 
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Figure 4 Recruitment flow chart 
 
2.5.3 Data collection    
2.5.3.1 A Cross-sectional study at University College London (UCLH) 
and St. Thomas’ Hospitals (STH) 
Potential participants were identified from appointment lists for routine 
antenatal ultrasound scans at each site and had information leaflets posted 
to them with their appointment letter by the maternity outpatient’s staff. 
Women attending for their 11-13 week scan were recruited consecutively on 
alternate days of the week from the 2 hospitals. This recruitment pattern was 
also alternated every week at the 2 hospitals to reduce bias. Before their 
Total number of participants 
recruited for the study                                 
N = 610 
Pilot 
Study      
N = 50 
Main 
Study       
N = 560 
Cross-sectional 
study (at 2 sites) 
UCLH (n = 455) 
STH (n = 105) 
Prospective 
cohort study (at 
1 site)        
UCLH (n = 455) 
University 
College London 
Hospital (UCLH) 
n = 20 
St. Thomas’ 
Hospital (STH)  
n = 30 
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scan, the purpose of the study was verbally explained and consent was 
obtained for carrying out a short interview after their ultrasound scan. 
Consenting participants were interviewed with a structured questionnaire 
about prescription, over-the-counter, complementary and alternative 
medicines and recreational substance (licit and illicit) use in the 3 months 
prior to and during their first trimester (Appendix 2). The interview lasted 
about 15 minutes. The questionnaire was developed by Prof. Alastair 
Sutcliffe of the Institute of Child Health, UCL. A pilot study was carried out in 
March 2011 with 50 patients (20 from UCLH and 30 from STH) to assess the 
feasibility of the project. The study protocol was then revised and submitted 
to the ethics committee for approval before commencing the main study. 
Hence, the results of the pilot study were reported separately from the main 
study. The main study was carried out from September 2011 to June 2012. 
2.5.3.2 A prospective cohort study at University College London 
Hospital (UCLH) 
As stated in sections 1.2.6.4 and 2.5.1 that prospective cohort study is the 
best method, a follow-up of participants recruited only at UCLH above was 
further carried out by telephoning women to obtain information about the 
second and third trimesters’ medicine and recreational substance use. They 
were telephoned in the 23rd-25th week of their gestation for second trimester 
information, and 35-39th week for third trimester information. Consent for this 
was obtained during the first trimester interview. Women were classified as 
lost to follow up if they were telephoned and did not pick up on at least three 
occasions or if their numbers were not reachable. If a woman was lost to 
follow-up in the second trimester, she was not contacted again in the third 
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trimester. The follow-ups were carried out from December 2011 to January 
2013. 
The pregnancy outcomes for this cohort were obtained from the electronic 
medical records at UCLH in February 2013. The pregnancy outcomes of 
interest were preterm birth, congenital anomaly, low birth weight and 
admission to neonatal unit (NNU). The outcomes were retrieved and 
analysed as documented in the records. Twins were excluded from the 
analyses in order to avoid bias since they are usually preterm with low birth 
weight (Jobe, 2010; Bladh et al., 2013). 
2.5.4 Ethical issues 
Pregnant women are a vulnerable group of participants. Hence, the 
interviews were carried out at convenient times for the participants and in a 
private area where other people would not hear the conversations but within 
the hospital. If participants requested for information or advice about 
medicines, they were referred to the clinical team. Informed verbal and 
written consent were obtained from participants who were also assured of 
confidentiality and anonymity before the interviews were carried out. All 
questionnaires and medical records information were anonymised with a 
unique study subject number. The subject numbers and identities of the 
participants were stored separately with a password. 
2.5.5 Inclusion criteria 
Pregnant women over the age of 16 years who could communicate in 
English language and gave their consent. 
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2.5.6 Sample size 
The sample size needed to estimate the prevalence of medicine and 
recreational substance use was calculated at 95% confidence level to be 400 
pregnant women using the formula N = Z2 x p (100 – p)    where 
                                         e2 
Z = Z value at 95% confidence level which is approximately 2 
p = expected prevalence which is 50% 
e = precision ± 5% 
2.5.7 Statistical Analyses 
Descriptive statistics were performed to obtain the frequencies and 
percentages of participants’ characteristics. Univariate analyses were carried 
out using chi-square tests and variables with p < 0.1 were then analysed 
using logistic regression where p < 0.05 was considered significant. Analyses 
were carried out with Statistical Package for Social Sciences (SPSS) version 
21. 
2.6 Results 
2.6.1 Pilot Study (N = 50) 
2.6.1.1 Sample Characteristics 
The pilot study was carried out in March 2011. Fifty out of the 68 pregnant 
women that were approached participated in the study (8 women could not 
communicate in English language while 10 women did not give their 
consent), giving a response rate of 73.5%. The age of the participants was 
30.8 ± 4.9 years (mean ± SD). As shown in Table 7 below, most of the 
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women (56.0%) were between 31 and 40 years old. They were mainly 
Whites (46.0%) as reported by the participants and multigravidas (56.0%). 
Thirty-two percent (16/50) reported previous obstetric problems, the most 
frequent of which was miscarriage (n = 11) followed by termination (n = 4). 
Half of the participants (n = 25) have previously given birth to one or more 
children and 22 of them mentioned having healthy children.     
 
 
Table 7 Sample characteristics of the pilot study 
Characteristic n (%) 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic origin 
White 
Black origin 
Asian 
Other 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric problems 
Yes 
No 
Not Applicable 
 
Parity 
   0 
≥ 1 
 
Previous healthy child(ren) 
Yes 
No 
Not Applicable 
 
 
 
1 (2.0) 
20 (40.0) 
28 (56.0) 
1 (2.0) 
 
 
23 (46.0) 
11 (22.0) 
8 (16.0) 
8 (16.0) 
 
 
22 (44.0) 
28 (56.0) 
 
 
16 (32.0) 
12 (24.0) 
22 (44.0) 
 
 
25 (50.0) 
25 (50.0) 
 
 
22 (44.0) 
3 (6.0) 
25 (50.0) 
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Lifestyle variables (early 
pregnancy) 
Coffee 
Yes 
No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
 
Lifestyle variables (before 
pregnancy) 
Coffee 
Yes 
No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
 
 
 
14 (28.0) 
36 (72.0) 
 
 
24 (48.0) 
26 (52.0) 
 
 
1 (2.0) 
49 (98.0) 
 
 
 
 
21 (42.0) 
29 (58.0) 
 
 
28 (56.0) 
22 (44.0) 
 
 
8 (16.0) 
42 (84.0) 
 
 
 
 
2.6.1.2 Prevalence of medicine and recreational substance use 
Ninety-eight percent (49/50) of the participants had used at least one 
medicine or recreational substance in the first trimester. Folate 
supplementation was found in 90% of the women. Except for over-the-
counter and complementary and alternative medicines, there were 
reductions in the use of prescription medicines, alcohol and cigarette in the 
first trimester when compared to the use before pregnancy. Cannabis 
consumption before pregnancy was reported by 3 of the women but none of 
Chapter 2 
 
106 
 
them declared using it in early pregnancy (Table 8). The list of medicines and 
recreational substances used before and in the first trimester are displayed in 
Table 9. The prescription medicines have been grouped according to the 
World Health Organisation ATC (Anatomical Therapeutic Chemical) 
classification system. 
 
Table 8 Self-reported use of medicines and recreational substances 3 
months before pregnancy and in early pregnancy 
Medicine/Substance Before pregnancy Early pregnancy 
 n (%) n (%) 
Prescription medicines 
 
Over-the-counter 
medicines 
12 (24.0) 
 
 
28 (56.0) 
5 (10.0) 
 
 
44 (88.0) 
   
Complementary and 
alternative medicines 
5 (10.0) 6 (12.0) 
   
Alcohol 
 
Cigarette 
 
Illicit substances 
26 (52.0) 
 
7 (14.0) 
 
3 (6.0) 
5 (10.0) 
 
1 (2.0) 
 
0 (0.0) 
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Table 9 List of medicines and recreational substances used before and 
in early pregnancy 
Before pregnancy Early pregnancy 
Prescription medicines 
(B) Blood and blood forming organs – 
Warfarin. 
 
(C) Cardiovascular system – 
Amlodipine, losartan. 
 
(G) Genitourinary system and sex 
hormones – desogestrel, 
levonorgestrel, ethinylestradiol + 
drospirenone, ethinylestradiol + 
levonorgestrel, ethinylestradiol + 
gestodene. 
 
(M) Musculoskeletal system – 
Diclofenac 
 
(R) Respiratory system – Loratadine 
 
Over-the-counter medicines 
Multivitamins (including folic acid) 
 
Mineral supplements – Calcium and 
iron 
 
Analgesics – Paracetamol, aspirin, 
ibuprofen, aspirin + caffeine 
 
Antihistamine – Diphenhydramine, 
loratadine 
 
Antispasmodic – Hyoscine 
butylbromide 
 
Antacids 
 
Complementary and alternative 
medicines 
Camomile, peppermint, green tea, 
Chinese herbal tea, acupuncture. 
 
Recreational substances  
Alcohol, cigarette and cannabis 
Prescription medicines 
(A) Alimentary tract and metabolism 
– Mesalazine 
 
(B) Blood and blood forming organs – 
Folic acid, 75mg aspirin. 
 
(C) Cardiovascular system – 
Aldomet, amlodipine, losartan. 
 
(J) Anti-infectives for systemic use – 
Penicillin 
 
(L) Antineoplastic and 
immunomodulating agents – 
Azathioprine 
 
(P) Antiparasitic products – 
Atovaquone + proguanil 
hydrochloride 
 
(R) Respiratory system – Salbutamol 
inhaler 
 
Over-the-counter medicines 
Multivitamins (including folic acid) 
 
Mineral supplements – Calcium and 
iron 
 
Analgesic – Paracetamol 
 
Antihistamine – Loratadine 
 
Antispasmodic – Colpermin 
 
Complementary and alternative 
medicines 
Camomile, peppermint, green tea, 
ginger, lemon grass, massage. 
 
Recreational substances 
Alcohol and cigarette 
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2.6.1.3 Sources of information on medicine and recreational substance 
use in pregnancy 
When the women were asked where they would go if they needed more 
information on medicine or recreational substance use, the most frequently 
cited source was the General Practitioner (GP). This is displayed in Figure 5. 
 
 
Figure 5 Sources of information about medicines and substances in pregnancy 
 
2.6.1.4 Summary 
The aim of the pilot study was to assess the feasibility of the project. During 
the pilot study, it was not difficult to approach and explain the study to 
potential participants and to use the questionnaire. It was also observed that 
the questions were not ambiguous although majority of the participants 
needed more explanation about complementary and alternative medicines. 
The range of time taken to complete the questionnaire was between 13 – 15 
minutes.  
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The high response rate of 73.5% indicated that the participants considered 
the study to be important. Hence, the pilot study showed that the study is 
feasible and that the required sample size can be reached within a 
reasonable time frame. However in order to enrich the outcome measures of 
the study, the educational status, safety knowledge and medicines 
preferences of the participants were included in the questionnaire. These 
amendments were submitted to and approved by the ethics committee 
before commencement of the main study. 
 
2.6.2 Main Cross-sectional Study (N = 560) 
The updated questionnaire which included the educational status of the 
subjects, the safety knowledge about medicines and recreational substances 
as well as the medicine preferences was used in data collection in this main 
study. The study was carried out from September 2011 to June 2012.  
2.6.2.1 Participants’ Characteristics 
Six hundred and seven women were approached out of which 21 could not 
communicate in English language and 26 did not provide their consent. This 
left a total of 560 participants in the study – a response rate of 92.3%. Their 
age was 31.9 ± 5.1 years (mean ± SD). 
As presented in Table 10, more than 58% of the participants were in the age 
range of 31-40 years, 66.8% were Whites and 74.1% were university degree 
holders. About 62% of the women had one or more prior pregnancies while 
31.8% (178/560) had experienced problems in previous pregnancies. These 
obstetric problems were mainly miscarriages (n = 124) and termination (n = 
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57). There were few other obstetric problems such as ectopic pregnancies, 
heterotopic pregnancies and preterm labour due to infection (n = 15). About 
53% of the participants were nulliparous and 44.6% had previously given 
birth to healthy children. 
Table 10 Participants’ characteristics 
Characteristic n (%)  
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
Yes 
No 
Not Applicable 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
Yes 
No 
Not Applicable 
 
 
 
12 (2.1) 
194 (34.6) 
329 (58.8) 
25 (4.5) 
 
 
374 (66.8) 
68 (12.1) 
51 (9.1) 
67 (12.0) 
 
 
145 (25.9) 
 
415 (74.1) 
 
 
211 (37.7) 
349 (62.3) 
 
 
 
178 (31.8) 
171 (30.5) 
211 (37.7) 
 
 
299 (53.4) 
261 (46.6) 
 
 
 
250 (44.6) 
11 (2.0) 
299 (53.4) 
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Table 10 Participants’ characteristics (continued) 
Characteristic n (%)  
 
Lifestyle variables 
Coffee 
Yes 
No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
 
Before pregnancy 
 
266 (47.5) 
294 (52.5) 
 
 
298 (53.2) 
262 (46.8) 
 
 
82 (14.6) 
478 (85.4) 
 
Early pregnancy 
 
172 (30.7) 
388 (69.3) 
 
 
248 (44.3) 
312 (55.7) 
 
 
66 (11.8) 
494 (88.2) 
 
 
 
2.6.2.2 Prevalence of medicine and recreational substance use 
In all, 30.5%, 49.5% and 30.2% of the study participants were exposed to 
prescription, over-the-counter, and complementary and alternative medicines 
respectively in the 3 months prior to pregnancy. These figures rose to 37.9%, 
86.6% and 40.5% in the first trimester. However, after excluding 
multivitamins and mineral supplements, the prevalence of use of prescription 
and over-the-counter medicines was 27.7% and 25.5% respectively (Table 
11). 15.4% (22/143) of the over-the-counter medicine users reported using 2 
or more of such medicines, 38.1% (59/155) of those exposed to prescription 
medicines reported using 2 or more, while more than half of complementary 
and alternative medicine users (130/227) reported using 2 or more 
modalities.  
The prevalence of alcohol, cigarette and illicit substance consumption before 
pregnancy was 64.3%, 13.2% and 2.3% respectively. In the first trimester, 
Chapter 2 
 
112 
 
the proportions of women who reported the consumption of these 
substances were 11.4% for alcohol, 3.0% for cigarette and 0.4% for illicit 
substance. The only illicit substance that was reportedly taken prenatally was 
cannabis. Before pregnancy, 10 women reported the use of cannabis, 5 
reported cocaine use and 1 reported MDMA (Methylene 
dioxymethamphetamine) use. 
Table 11 Prevalence of medicine and recreational substance use 
Medicine/Substance Before pregnancy  
n (%) 
Early pregnancy 
n (%) 
 
Prescription medicines 
 
Over-the-counter 
medicines 
 
Complementary and 
alternative medicines 
 
Alcohol 
 
Cigarette 
 
Illicit substances 
 
 
171 (30.5) 
 
277 (49.5) 
 
 
169 (30.2) 
 
 
360 (64.3) 
 
74 (13.2) 
 
13 (2.3) 
 
155 (27.7) 
 
143 (25.5) 
 
 
227 (40.5) 
 
 
64 (11.4) 
 
17 (3.0) 
 
2 (0.4) 
 
 
The frequencies of use of prescription and over-the-counter medicines are 
presented in Tables 12 and 13. The medicines have been grouped according 
to the Anatomical Therapeutic Chemical (ATC) classification. 
In the case of prescription medicines, the number of women with prescribed 
medicines in the ATC group A (Alimentary tract and metabolism) increased 
by over 150% from the period prior to pregnancy to the first trimester due 
mainly to the use of metoclopramide (for pregnancy-induced nausea and 
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vomiting), vitamin D + calcium, antacids and ranitidine. The Blood and blood 
forming products (ATC group B) had the highest frequency of use in early 
pregnancy (n = 128). This is because of the increase in prescriptions for folic 
acid (either singly or in combination with other vitamins) and antithrombotic 
agents. In the 3 months before pregnancy, the number of times that the 
medicines in this group were used was 23. In the Dermatologicals (group D), 
retinol cream was prescribed three times before pregnancy but not in the first 
trimester. Prescriptions for Genitourinary system and sex hormones (group 
G) before pregnancy were almost two and a half times the ones in the first 
trimester because of the reported use of oral contraceptives.  
The increase in the use of group H medicines – Systemic hormonal 
preparations from the period before pregnancy to the first trimester was due 
to increases in the prescriptions for levothyroxine. There was also an 
increase in the use of ATC group J (Anti-infectives) in early pregnancy 
compared to before pregnancy which was as a result of the rise in the use of 
amoxicillin for indications such as urinary tract and respiratory infections. A 
reduction in the number of prescriptions for Nervous system medications 
(group N) from the period before pregnancy (n = 38) to early pregnancy (n = 
24) was observed. There were decreases in the use of analgesics and 
antidepressants in early pregnancy compared to the 3 months prior 
pregnancy. There was an increase in the reported frequency of use of ATC 
group R medications - Respiratory System – in pregnancy due to 
prescriptions received for promethazine and cyclizine, both of which were 
used in treating pregnancy-induced nausea and vomiting.      
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Exposures to Cardiovascular medicines (group C), Antineoplastic and 
immunomodulating agents (group L), Musculoskeletal products (group M), 
Antiparasitic products (group P) and Sensory organ medicines (group S) 
before and during early pregnancy were low.   
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Table 12 Frequency of use of prescription medicines before and in early pregnancy, by ATC group 
Before pregnancy n Early pregnancy n 
(A) Alimentary tract and 
metabolism  
Omeprazole  
Vitamin D + calcium  
Insulin  
Mesalazine 
 
 
 
 
 
 
 
 
(B) Blood and blood forming 
organs   
Folic acid 
Iron preparations  
Aspirin 75mg 
 
 
 
(C) Cardiovascular system 
Propranolol  
Methyldopa   
 
14 
 
3 
7 
2 
2 
 
 
 
 
 
 
 
 
23 
 
12 
7 
4 
 
 
 
2 
1 
1 
 
(A) Alimentary tract and 
metabolism  
Antacids  
Vitamin D + calcium 
Metoclopramide  
Ondansetron  
Ranitidine,  
Omeprazole  
Lactulose solution 
Lubiprostone  
Domperidone  
Mesalazine  
Insulin 
 
(B) Blood and blood forming 
organs 
Folic acid  
Iron preparations 
Aspirin 75mg  
Enoxaparin  
Dalteparin  
 
(C) Cardiovascular system 
Propranolol, bisoprolol and 
labetalol.  
Methyldopa 
37 
 
3 
12 
8 
1 
4 
1 
1 
1 
2 
2 
2 
 
128 
 
77 
13 
23 
11 
4 
 
5 
3 
 
2 
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Table 12 Frequency of use of prescription medicines before and in early pregnancy, by ATC group (continued) 
Before pregnancy n Early pregnancy n 
 
(D) Dermatologicals 
Erythromycin + zinc acetate 
Retinol  
clobetasol propionate 
clobetasol butyrate   
 
(G) Genitourinary system 
and sex hormones 
Ethinylestradiol + 
levonorgestrel  
Ethinylestradiol + drospirenone  
Desogestrel  
Clomiphene  
Bromocriptine 
 
(H) Systemic hormonal 
preparations (excluding sex 
hormones and insulins) 
Levothyroxine  
Prednisolone 
 
 
 
7 
1 
3 
2 
1 
 
74 
 
31 
24 
16 
1 
2 
 
 
18 
 
 
15 
3 
 
 
 
(D) Dermatologicals 
Erythromycin + zinc acetate 
Betamethasone  
Clobetasol propionate 
Clobetasol butyrate   
 
(G) Genitourinary system 
and sex hormones 
Progestogen  
Estradiol  
Bromocriptine  
 
 
 
 
(H) Systemic hormonal 
preparations (excluding sex 
hormones and insulins) 
Levothyroxine  
Carbimazole  
Prednisolone  
Dexamethasone 
  
 
6 
1 
1 
2 
2 
 
30 
 
24 
5 
1 
 
 
 
 
28 
 
 
21 
1 
5 
1 
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Table 12 Frequency of use of prescription medicines before and in early pregnancy, by ATC group (continued) 
Before pregnancy n Early pregnancy n 
 
(J) Anti-infectives for 
systemic use  
Penicillin  
Amoxicillin  
Doxycycline  
Pivmecillinam  
Trimethoprim  
Acyclovir  
Emtricitabine + tenofovir 
Darunavir  
Zidovudine 
 
 
 
(L) Antineoplastic and 
immunomodulating agents 
Hydroxycarbamide 
Azathioprine 
 
(M) Musculoskeletal system 
Alendronic acid  
Diclofenac 
 
16 
 
4 
4 
2 
1 
1 
1 
1 
1 
1 
 
 
 
3 
 
1 
2 
 
5 
1 
4 
 
 
(J) Anti-infectives for 
systemic use  
Penicillin  
Pivmecillinam 
Flucloxacillin and cloxacillin 
Amoxicillin  
Cephalexin  
Erythromycin  
Nitrofurantoin 
Emtricitabine + tenofovir 
Darunavir  
Zidovudine  
Anti-D (rh) immunoglobulin 
 
(L) Antineoplastic and 
immunomodulating agents 
Azathioprine  
 
 
(M) Musculoskeletal system 
Diclofenac  
 
39 
 
3 
1 
2 
20 
6 
2 
1 
1 
1 
1 
1 
 
2 
 
 
 
 
1 
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Table 12 Frequency of use of prescription medicines before and in early pregnancy, by ATC group (continued) 
Before pregnancy n Early pregnancy n 
 
(N) Nervous system 
Sumatriptan, zolmitriptan, 
almotriptan and rizatriptan. 
Naproxen, ibuprofen, codeine,  
dihydrocodeine + paracetamol, 
and codeine + paracetamol. 
Amitriptyline, fluoxetine, 
sertraline, bupropion, 
alprazolam and citalopram. 
Lamotrigine 
 
(P) Antiparasitic products 
Hydroxychloroquine 
Mefloquine 
 
 
38 
7 
 
9 
 
 
20 
 
 
2 
 
2 
1 
1 
 
 
 
(N) Nervous system 
Paracetamol  
Codeine  
Paracetamol + codeine 
Sertraline, citalopram and 
fluoxetine.  
Prochlorperazine  
Lamotrigine 
 
 
 
(P) Antiparasitic products 
Hydroxychloroquine 
 
 
 
24 
6 
2 
3 
8 
 
3 
2 
 
 
 
1 
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Table 12 Frequency of use of prescription medicines before and in early pregnancy, by ATC group (continued) 
Before pregnancy n Early pregnancy n 
 
(R) Respiratory system  
Xylometazoline nasal spray 
Loratadine, cetirizine, and 
chlorphenamine.  
Salbutamol, salmeterol, 
terbutaline, beclometasone, 
fluticasone, fluticasone + 
salmeterol, budesonide and 
budesonide + formoterol. 
Montelukast 
 
 
 
(S) Sensory organs  
Dexamethasone eye drops 
 
 
36 
4 
4 
 
27 
 
 
 
 
1 
 
 
 
3 
 
 
(R) Respiratory system  
Xylometazoline nasal spray 
Beclometasone nasal spray 
Promethazine  
Cyclizine 
Salbutamol, salmeterol, 
fluticasone, budesonide, 
terbutaline, beclometasone, 
fluticasone + salmeterol, 
budesonide + formoterol. 
Doxylamine + pyridoxine      
Cough and cold preparations 
 
(S) Sensory organs 
Dexamethasone eye drops 
 
 
47 
3 
1 
2 
10 
27 
 
 
 
 
1 
3 
 
2 
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Regarding over-the-counter medicines, there was an increase in the use of 
Alimentary tract medicines from the 3 months before pregnancy to early 
pregnancy period due to increased exposure to antacids (for the treatment of 
heartburn and flatulence) and vitamin D + calcium supplement. Blood and 
blood forming products had the highest frequency of use in early pregnancy 
due to maternal intake of folic acid to prevent neural tube defects. This 
increase in use in early pregnancy compared to before pregnancy was more 
than 100%.  
The use of clotrimazole pessaries for vaginal thrush which was not reported 
before pregnancy had a frequency of 7 in early pregnancy. It was interesting 
to observe that before pregnancy, use of analgesics (Nervous system 
medicines) was much higher than in the first trimester. The most common 
analgesics were paracetamol (n = 115) and ibuprofen (n = 78) before 
pregnancy. These figures decreased to 105 and 6 for paracetamol and 
ibuprofen respectively in the first trimester. There was also a marked 
reduction in the use of respiratory medicines in early pregnancy when 
compared to prior pregnancy. This was because antihistamines were not 
reportedly used over-the-counter in the first trimester as compared to before 
pregnancy. There was also a reduction in the use of cough and cold 
preparations from 16 before pregnancy to 6 during pregnancy. Exposure to 
Dermatologicals and Musculoskeletal system products was low both before 
and during pregnancy. 
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Table 13 Frequency of use of over-the-counter medicines before and in 
early pregnancy, by ATC group 
Before 
pregnancy 
n Early  
Pregnancy 
n 
 
(A) Alimentary 
tract and 
metabolism 
Antacids  
Vitamin D + 
calcium 
Simethicone 
Omeprazole 
Ranitidine 
Ispaghula 
Docusate sodium 
Domperidone 
Hyoscine 
butylbromide 
 
(B) Blood and 
blood forming 
organs 
Folic acid 
Iron preparations 
 
 
(D) 
Dermatologicals  
Hydrocortisone 
Clotrimazole 
 
 
 
 
(G) 
Genitourinary 
system and sex 
hormones 
 
 
 
(M) 
Musculoskeletal 
system 
Glucosamine 
sulphate 
 
27 
 
 
5 
13 
 
1 
2 
1 
1 
2 
1 
1 
 
 
141 
 
 
138 
3 
 
 
 
3 
1 
2 
 
 
 
 
 
0 
 
 
 
 
 
 
2 
 
 
(A) Alimentary 
tract and 
metabolism 
Antacids  
Vitamin D + 
calcium 
Simethicone  
Omeprazole 
Ispaghula 
 
 
 
 
 
 
(B) Blood and 
blood forming 
organs 
Folic acid 
Iron preparations 
Aspirin 75mg 
 
(D) 
Dermatologicals   
Hydrocortisone 
Hydrocortisone + 
clotrimazole 
Hydrocortisone + 
miconazole 
 
(G) 
Genitourinary 
system and sex 
hormones 
Clotrimazole 
pessaries 
 
(M) 
Musculoskeletal 
system 
Glucosamine 
sulphate 
 
53 
 
 
19 
29 
 
1 
1 
3 
 
 
 
 
 
 
327 
 
 
316 
7 
4 
 
 
3 
1 
1 
 
1 
 
 
 
7 
 
 
 
 
 
 
1 
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Table 13 Frequency of use of over-the-counter medicines before and in 
early pregnancy, by ATC group (continued) 
Before 
pregnancy 
n Early  
Pregnancy 
n 
 
(N) Nervous 
system 
Paracetamol 
Ibuprofen  
Aspirin  
Mefenamic acid 
Paracetamol + 
codeine + 
doxylamine + 
caffeine  
Naproxen  
Codeine 
 
(R) Respiratory 
system 
Loratadine 
Diphenhydramine 
Cetirizine  
Beclometasone 
nasal spray 
Xylometazoline 
nasal spray 
Cough and cold 
preparations  
 
 
204 
 
115 
78 
6 
1 
2 
 
 
 
1 
1 
 
34 
 
7 
2 
4 
3 
 
2 
 
16 
 
 
(N) Nervous 
system 
Paracetamol 
Ibuprofen 
 
 
 
 
 
 
 
 
 
(R) Respiratory 
system 
Beclometasone 
nasal spray 
Xylometazoline 
nasal spray 
Isotonic solution 
nasal spray 
Cough and cold 
preparations  
 
 
111 
 
105 
6 
 
 
 
 
 
 
 
 
 
15 
 
1 
 
7 
 
1 
 
6 
 
 
 
The categories of complementary and alternative medicines which were 
used as well as the frequency of use are presented in Table 14. There was 
over 50% increase in the use of Natural products in early pregnancy (n = 
356) in comparison to the 3 months prior to pregnancy (n = 229). The most 
commonly used natural products were ginger, peppermint and camomile 
which were used to treat pregnancy-related conditions such as nausea and 
vomiting and indigestion. The most common Mind-body medicines were 
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yoga and acupuncture but these found reduction in use during pregnancy 
compared to before pregnancy. Yoga was used for exercise and relaxation 
while acupuncture was used for vomiting due to pregnancy. The 
Manipulative and body-based practices that were used are massage, 
osteopathy and chiropractic therapy which were used for differing indications 
like back ache and stress. Massage was the most common and its use 
decreased in the first trimester compared to before pregnancy. In the “Other 
CAM practices” category, the use of homeopathic remedies and 
aromatherapy increased during early pregnancy compared to before 
pregnancy. 
Table 14 Frequency of use of complementary and alternative medicines 
(CAM) before and in early pregnancy 
Before 
pregnancy 
n Early  
Pregnancy 
n 
 
Natural 
Products  
Ginger tea 
Peppermint tea 
Camomile tea 
Lemon tea  
Green tea  
Fennel tea 
Redbush tea  
Nettle tea  
Lady’s mantle tea 
Milk thistle  
Valerian  
St. John’s wort 
Ginseng  
Dandelion 
Raspberry leaf 
tea  
Cranberry juice 
Echinacea 
tablets  
Cinnamon tablets 
 
229 
 
40 
53 
36 
28 
23 
8 
11 
1 
1 
1 
2 
1 
1 
1 
1 
 
1 
4 
 
1 
 
Natural 
Products  
Ginger capsules, 
powder or tea. 
Peppermint tea 
Camomile tea 
Lemon tea  
Green tea  
Senna tea  
Fennel tea  
Redbush tea  
Nettle tea  
Jasmine tea 
Dandelion 
Cranberry juice 
Echinacea 
tablets  
Cinnamon tablets 
Garlic tablets  
Evening primrose 
oil 
 
 
356 
 
72 
 
96 
70 
26 
31 
1 
11 
23 
3 
5 
1 
2 
2 
 
1 
3 
1 
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Table 14 Frequency of use of complementary and alternative medicines 
(CAM) before and in early pregnancy (continued) 
Before 
pregnancy 
n Early  
Pregnancy 
n 
 
Garlic tablets  
Evening primrose 
oil 
Multivitamins and 
mineral tablets 
and syrup. 
 
Mind-Body 
medicine   
Yoga  
Acupuncture 
Reflexology 
 
 
 
Manipulative 
and body-based 
practices  
Massage 
Osteopathy 
Chiropractic 
therapy 
 
Other CAM 
practices  
Chinese 
medicine 
Homeopathic 
remedies 
Aromatherapy 
Alexander 
technique 
Pilates  
 
 
2 
4 
 
9 
 
 
 
58 
 
29 
26 
3 
 
 
 
28 
 
 
23 
3 
2 
 
 
21 
 
3 
 
11 
 
5 
1 
 
1 
 
Multivitamins and 
mineral tablets 
and syrup. 
 
 
 
 
Mind-Body 
medicine  
Yoga  
Acupuncture 
Acupressure 
bands  
Reflexology 
 
Manipulative 
and body-based 
practices  
Massage 
Osteopathy 
Chiropractic 
therapy 
 
Other CAM 
practices  
Chinese 
medicine 
Homeopathic 
remedies 
Aromatherapy 
Alexander 
technique  
Pilates 
 
8 
 
 
 
 
 
 
44 
 
20 
20 
3 
 
1 
 
16 
 
 
13 
2 
1 
 
 
27 
 
2 
 
16 
 
7 
1 
 
1 
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2.6.2.3 Associations between participants’ characteristics and medicine 
or recreational substance use in early pregnancy 
Univariate analyses were carried out with chi-square test to determine the 
associations between participants’ characteristics and the use of medicine or 
recreational substance in the first trimester and p < 0.1 was considered 
significant. The selected variables were then tested in multivariate analyses 
with logistic regression and p < 0.05 was considered significant. 
Compared to non-users, prescription medicine users were more likely to: 
 be university-educated,  
 have been pregnant at least once before.  
In the multivariate analysis, education (AOR 1.895; 95%CI 1.134 - 3.168) 
and gravidity (AOR 1.565; 95%CI 1.032 - 2.372) remained significantly 
associated with prescription medicine use in early pregnancy. 
When compared to non-users, over-the-counter medicine users were more 
likely to:  
 be in the age group of 31 - 40 years,  
 be whites,  
 be university-educated, 
 have been pregnant at least once before,   
 have given birth at least once before, 
 have consumed tea. 
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Multivariate analysis showed that parity (AOR 1.740; 95%CI 1.153 – 2.628), 
tea consumption (AOR 1.779; 95%CI 1.190 – 2.661), age and ethnic origin 
were significantly associated with over-the-counter medicine use. Relative to 
those in the age group of 31 – 40 years, over-the-counter medicine use was 
less likely in women between 21 – 30 years old (AOR 0.482; 95%CI 0.293 – 
0.793). Furthermore, relative to whites, women of black origin (AOR 0.394; 
95%CI 0.184 – 0.845) or Asians (AOR 0.247; 95%CI 0.094 – 0.652) were 
less likely to report over-the-counter medicine use. 
In comparison to non-users, complementary and alternative medicine users 
were more likely to:  
 be between 31 and 40 years old,  
 be whites,  
 be university-educated,  
 have never given birth, and 
 have not consumed coffee.  
In the multivariate analysis, education (AOR 1.947; 95%CI 1.200 – 3.161) 
and age remained significantly associated with complementary and 
alternative medicine use. Relative to those in the age group of 31 – 40 years, 
complementary and alternative medicine use was less likely in women 
between 21 – 30 years old (AOR 0.539; 95%CI 0.355 – 0.819).    
Compared to non-users, women who have taken alcohol were more likely to: 
 be in the age group of 31- 40 years, 
 be whites,  
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 be university-educated,  
 have been pregnant at least once before, 
 have given birth at least once before, 
 have consumed tea.  
Multivariate analysis indicated that tea consumption (AOR 2.522; 95%CI 
1.438 – 4.424) and age remained significantly associated with alcohol 
consumption. Relative to those in the age group of 31 – 40 years, alcohol 
consumption was less likely in women between 21 – 30 years old (AOR 
0.300; 95%CI 0.133 – 0.674). 
Compared to non-smokers, cigarette smokers were more likely to:  
 be younger (between 21 and 30 years old),  
 have education which is below the university level, 
 have consumed coffee, and  
 have not taken cola drinks.  
Multivariate analysis demonstrated that coffee consumption (AOR 2.947; 
95%CI 1.031 – 8.423) and education (AOR 0.081; 95%CI 0.021 – 0.317) 
remained significantly associated with cigarette smoking. 
Users of cannabis were more likely to be older (> 30 years) compared to 
non-users. 
All other characteristics did not differ significantly between users and non-
users of the medicines or substances in pregnancy (Appendices 3 and 4). 
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2.6.2.4 Safety Knowledge and Medicine Preferences 
In terms of information on the safety of medicines and recreational 
substances in pregnancy, it was observed that 37.0% of the participants felt 
they had little or no information about prescription medicines, 36.2% believed 
they had little or no information about over-the-counter medicines and 57.1% 
reported having little or no information about complementary and alternative 
medicines. In contrast, 94.6% of the women felt they had enough information 
about licit substances while 80.0% thought they had enough information 
about the safety of illicit substances in pregnancy (Figure 6). 
 
 Figure 6 Reported safety information about medicines and substances in pregnancy 
       *POM = Prescription medicines; OTC = Over-the-counter medicines; CAM = Complementary and alternative medicines 
 
When all the study participants were asked to compare the safety of CAM to 
conventional medicines, 12.3% felt CAM is safer, 27% thought both CAM 
and conventional medicines are equally safe, 15.9% felt CAM is less safe 
while 44.8% felt they did not know about the safety of CAM compared to 
conventional medicines (Figure 7). Furthermore, in treating a new medical 
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condition, 17.1% of the participants would choose CAM rather than 
conventional medicines as their most preferred therapy. 
 
 
       Figure 7 Comparison of the safety of CAM to conventional medicines 
 
2.6.2.5 Sources of information on medicine and recreational substance 
use in pregnancy 
As illustrated in Figure 8, the GP (72.0%) and the internet (51.1%) were 
commonly chosen by participants as their sources for further information on 
medicine or recreational substance use in pregnancy. 
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Figure 8 Potential sources of information on medicines or substances in pregnancy 
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2.6.3 Prospective cohort study (N = 455) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                          Figure 9 The data collection process 
 
 
Pregnant women recruited in the 
first trimester                                 
N = 455 
80.2% Consented to follow up       
n = 365 
 
Second trimester interviews              
n = 267 
Lost to 
follow up 
n = 98 
 
 
Lost to 
follow up 
n = 36 
 
 
Third trimester interviews (cohort 
with 3 complete interviews)                           
n = 231 
Pregnancy outcomes of all 
participants (N = 455) retrieved 
from the medical records 
Missing records       
n = 103 
Twins excluded        
n = 8 
Total number of records available 
for review                                        
n = 344 
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2.6.3.1 Characteristics of the cohort 
As illustrated in Figure 9, 455 women were recruited in the first trimester out 
of which 365 (80.2%) consented to be followed up in the other trimesters. 
Two hundred and sixty-seven participants were interviewed in the second 
trimester. In the third trimester, 231 interviews were carried out (19 women 
were interviewed within 1 week postpartum); all others were lost to follow-up. 
Therefore, the number of participants who completed the 3 interviews was 
231. The characteristics of the cohort are similar to those described in 
section 2.6.2.1 (the cross-sectional study) because they were from the same 
population. 
2.6.3.2 Prevalence of medicine and recreational substance use before 
and during pregnancy 
As shown in Table 15, prescription medicine use was 30.8% in the 3 months 
before pregnancy and this decreased to 9.5% in the third trimester (after 
excluding multivitamins and mineral supplements). Over-the-counter 
medicines which had a prevalence of 52.7% before pregnancy decreased to 
25.1% in the second trimester but increased to 40.3% in the third trimester 
(after excluding multivitamins and mineral supplements). The proportion of 
complementary and alternative medicine users was 32.7% prior to 
pregnancy and this increased to 49.8% in the third trimester. There was a 
statistically significant difference in the prevalence of use of prescription, 
over-the-counter, and complementary and alternative medicines in the first, 
second and third trimesters (p < 0.0001). 
For the cohort with complete interviews (n = 231), the proportion of 
participants who have used prescription, over-the-counter and 
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complementary and alternative medicines in at least one trimester were 
32.5%, 50.2% and 57.1% respectively.   
Alcohol and cigarette had prevalence of 69.2% and 13.2% before pregnancy 
respectively. These reduced to 11.4% and 2.4% in the first trimester but 
increased slightly in the second and third trimesters for alcohol and cigarette 
respectively. During pregnancy, the average units of alcohol consumed per 
week was 1.5 and the average number of cigarette sticks which was smoked 
per day was seven. There was a statistically significant difference in the 
exposures to alcohol and cigarette in the first, second and third trimesters (p 
< 0.0001). A reduction in the percentages of participants who admitted to the 
use of illicit substances in pregnancy was found compared to before 
pregnancy. The prevalence of use of alcohol, cigarette and illicit substances 
in at least one trimester of the cohort with complete interviews were 16.0%, 
3.5% and 0.9% respectively.
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Table 15 Reported use of medicines and recreational substances before and during pregnancy, by trimesters 
Medicine/Substance Before Pregnancy 
 
n = 455 
During Pregnancy 
(by trimesters) 
1st (n = 455) 
 
 
2nd (n = 267)   
 
 
3rd (n = 231) 
 
 
At least one 
trimester (n = 231) 
 
 
Prescription 
medicines 
 
Over-the-counter 
medicines 
 
Complementary and 
alternative medicines 
 
Alcohol 
 
Cigarette 
 
Illicit substances 
 
n (%) 
140 (30.8) 
 
 
240 (52.7) 
 
 
149 (32.7) 
 
 
315 (69.2) 
 
60 (13.2) 
 
10 (2.2) 
 
n (%) 
122 (26.8) 
 
 
126 (27.7) 
 
 
202 (44.4) 
 
 
52 (11.4) 
 
11 (2.4) 
 
2 (0.4) 
 
n (%) 
29 (10.9) 
 
 
67 (25.1) 
 
 
122 (45.7) 
 
 
33 (12.4) 
 
7 (2.6) 
 
1 (0.4) 
 
n (%) 
22 (9.5) 
 
 
93 (40.3) 
 
 
115 (49.8) 
 
 
33 (14.3) 
 
7 (3.0) 
 
1 (0.4) 
 
n (%) 
75 (32.5) 
 
 
116 (50.2) 
 
 
132 (57.1) 
 
 
37 (16.0) 
 
8 (3.5) 
 
2 (0.9) 
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2.6.3.3 Neonatal characteristics and Pregnancy outcomes 
Out of the 455 participants, 103 medical records were missing due to 
transferred care by the mother to another hospital (n = 65), and unavailable 
electronic records (n = 38). Eight sets of twins were excluded to avoid bias in 
the results (section 2.5.3.2). This left a total of 344 medical records for review 
(Figure 9). 
Fifty-eight point four percent (58.4%) of the neonates were females while 
41.6% were males. The gestational age of the neonates was 39.47 ± 2.39 
weeks (mean ± SD) and 50.6% were between 35.01 and 40.00 weeks old at 
birth. More than half of them had birth weights between 2.51 and 3.50 
kilogrammes (mean ± SD = 3.35 ± 0.56 kg). Their recorded head 
circumference was 34.28 ± 1.63 centimetres and about three-quarters of 
them had measurements between 30.01 and 35.00 cm. The birth length was 
51.90 ± 3.46 centimetres and over 50% had lengths which were greater than 
50cm. The mean APGAR (Appearance, Pulse, Grimace, Acitivity, 
Respiration) scores at 1, 5 and 10 minutes were 8.6, 9.7 and 10 respectively.  
Twenty-six out of 341 babies (7.6%) were preterm (delivery from 28 up to 37 
completed weeks of gestation) while 5.3% (18/341) had low birth weight 
(birth weight < 2.50kg).  
The proportion of neonates with documented congenital anomalies was 3.8% 
(13/344). Left positional talipes, situs inversus totalis, hypospadias, bilateral 
positional talipes, clinodactyly and vaginal fistula without anal opening were 
documented. 
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Forty-four out of 344 neonates (12.8%) were admitted to the neonatal unit for 
conditions such as systemic infection, hypoglycaemia, hypothermia, 
tachypnoea, bradycardia, respiratory distress syndrome, preterm delivery, 
low birth weight, and jaundice requiring phototherapy.  
Fifty-two out of 344 babies (15.1%) had other problems like difficulty in the 
establishment of feeding, grunting at birth, baby vomiting and mild jaundice. 
One case of termination of pregnancy due to foetal defect and another of 
miscarriage were included in this group. These results are presented in 
Table 16. 
 
Table 16 Neonatal characteristics and Pregnancy outcomes 
Characteristic n (%) 
 
Sex, n = 341 
Female 
Male 
 
Gestational age (weeks), n = 344 
≤ 25.00 
25.01 – 30.00 
30.01 – 35.00 
35.01 – 40.00 
40.01 – 45.00 
 
Birth weight (kg), n = 341 
≤ 1.50 
1.51 – 2.50 
2.51 – 3.50 
3.51 – 4.50 
4.51 – 5.50 
 
Head circumference (cm), n = 325 
≤ 30.00 
30.01 – 35.00 
35.01 – 40.00 
 
 
 
199 (58.4) 
142 (41.6) 
 
 
3 (0.9) 
1 (0.3) 
10 (2.9) 
174 (50.6) 
156 (45.3) 
 
 
3 (0.9) 
15 (4.4) 
188 (55.1) 
131 (38.4) 
4 (1.2) 
 
 
5 (1.5) 
247 (76.0) 
73 (22.5) 
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Table 16 Neonatal characteristics and Pregnancy outcomes (continued) 
Characteristic n (%) 
 
Length (cm), n = 309 
≤ 45.00 
45.01 – 50.00 
50.01 – 55.00 
55.01 – 60.00 
60.01 – 65.00 
 
APGAR at 1 minute, n = 341 
1 
2 – 4 
5 – 7 
8 – 10 
 
APGAR at 5 minutes, n = 338 
7 
8 – 9 
10 
 
APGAR at 10 minutes, n = 194 
9 
10 
 
Preterm birth, n = 341 
No 
Yes 
 
Low birth weight, n = 341 
No 
Yes 
 
Congenital anomaly, n = 344 
No 
Yes 
 
Admission to NNU, n = 344 
No 
Yes 
 
Other problems, n = 344 
No 
Yes 
 
 
 
12 (3.9) 
84 (27.2) 
166 (53.7) 
45 (14.6) 
2 (0.6) 
 
 
1 (0.3) 
5 (1.5) 
23 (6.7) 
312 (91.5) 
 
 
1 (0.3) 
95 (28.1) 
242 (71.6) 
 
 
9 (4.6) 
185 (95.4) 
 
 
315 (92.4) 
26 (7.6) 
 
 
323 (94.7) 
18 (5.3) 
 
 
331 (96.2) 
13 (3.8) 
 
 
300 (87.2) 
44 (12.8) 
 
 
292 (84.9) 
52 (15.1) 
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2.6.3.4 Associations between use of medicines and recreational 
substances during pregnancy and the pregnancy outcomes 
Univariate analyses were carried out with chi-square test to determine the 
associations between use of medicines and recreational substances and the 
pregnancy outcomes and p < 0.1 was considered significant. Missing data 
were left as such and not inputted. 
2.6.3.4.1 First trimester cohort (N = 455) 
Congenital anomaly 
The univariate analysis showed that compared to those without congenital 
anomalies, mothers of babies with congenital anomalies were more likely to 
have used (in the first trimester of pregnancy): 
 POM + CAM + Alcohol  
 CAM + Cigarette  
Low birth weight 
Compared to those without low birth weight babies, mothers of babies with 
low birth weights were more likely to: 
 be Asians or ‘Other’ ethnic origin 
 be pregnant for the first time 
 have used prescription medicines 
Preterm birth 
Compared to those without preterm babies, mothers of preterm babies were 
more likely to have used prescription medicines in early pregnancy. 
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Admission to NNU 
Compared to babies not admitted to NNU, mothers whose babies were 
admitted were more likely to be younger (age between ≤ 20 and 30 years). 
Other Problems 
Compared to babies who did not have ‘other problems’, mothers whose 
babies had ‘other problems’ were more likely to have: 
 had previous obstetric problems, 
 consumed tea, 
 smoked cigarettes, and 
 have not consumed coffee 
All other variables did not differ significantly between mothers who had the 
pregnancy outcomes of interest and those who did not (Appendix 5). 
2.6.3.4.2 Cohort with complete interviews (N = 231) 
Congenital anomaly 
The univariate analysis showed that compared to those without congenital 
anomalies, mothers of babies with congenital anomalies were more likely to 
have used (during at least one trimester of pregnancy): 
 OTC 
 OTC + CAM 
 POM + OTC + CAM 
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Preterm birth 
Compared to those without preterm babies, mothers of preterm babies were 
more likely to: 
 be younger (between ≤ 20 and 30 years), 
 be of Black origin, Asians or ‘Other’ ethnic group 
 have education which is below university level, 
 have consumed cola drinks, and 
 did not have healthy children previously. 
Low birth weight 
Compared to those without low birth weight babies, mothers of babies with 
low birth weights were more likely to be: 
 younger (between ≤ 20 and 30 years) 
 Asians 
Admission to NNU 
Compared to babies not admitted to NNU, mothers whose babies were 
admitted were more likely to have used: 
 OTC + Cigarette 
 OTC + CAM + Cigarette 
 CAM + Cigarette, and  
 have not used CAM + Alcohol 
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Other Problems 
Compared to babies who did not have ‘other problems’, mothers whose 
babies had ‘other problems’ were more likely to have: 
 had previous obstetric problems, 
 used POM + OTC, 
 used POM + OTC + Cigarette, 
 smoked cigarettes, and 
 have not consumed coffee. 
All other variables did not differ significantly between mothers who had the 
pregnancy outcomes of interest and those who did not (Appendix 6). 
2.7 Discussion 
In this study, the information on medicine and recreational substance use in 
pregnancy were collected by interviewing participants with a structured 
questionnaire. The data collected included prescription medicines, over-the-
counter medicines, complementary and alternative medicines as well as 
recreational substances (licit and illicit substances). The study was 
conducted in two phases: a cross-sectional study and a prospective cohort 
study. 
In the cross-sectional study which was carried out at University College 
London and St. Thomas’ Hospitals, the use of medicines and recreational 
substances were investigated in the 3 months prior to and in the first 
trimester of pregnancy. It also assessed the characteristics associated with 
medicine or recreational substance use as well as pregnant women’s safety 
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knowledge. The prospective cohort study was carried out only at University 
College London Hospital and it further explored medicine and recreational 
substance use in the second and third trimesters and the associations with 
pregnancy outcomes. 
2.7.1 Cross-sectional study 
The prevalence of use of prescription and over-the-counter medicines in the 
first trimester amongst the 560 participants was found to be 27.7% and 
25.5% respectively (after excluding multivitamins and mineral supplements). 
The proportion of women exposed to complementary and alternative 
medicines was 40.5%, 11.4% took alcohol, 3.0% smoked cigarettes while 
0.4% consumed cannabis. There is however a challenge in making 
comprehensive comparison of these findings with other studies because of 
the differences in study designs, sample sizes and the specific medicines or 
recreational substances studied. Previous reports have also showed that 
medicine or recreational substance use during pregnancy differs between 
countries and even varies in the same country over time (Zhu et al., 2010). 
Some prior studies have reported higher prevalence of prenatal use of 
medicines and recreational substances and this may be because such 
studies reported the exposure throughout pregnancy; or in the case of 
prescription and over-the-counter medicines, multivitamins and mineral 
supplements were included in the figures. 
There are no comparable UK studies for the prevalence of prescription, over-
the-counter, complementary and alternative medicines as well as alcohol use 
in the first trimester which employed the same methods as the current study. 
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A similar study carried out in the US by Buitendijk and Bracken (1991) in 
which pregnant women were interviewed about their medicine use in the first 
trimester reported a prevalence of 27.3%. Two other prior studies with the 
same methodology reported higher prevalence of exposure to prescription 
medicines in the first trimester. A Norwegian study by Nordeng et al. (2001) 
reported a slightly higher prevalence of 29%. This could be due to the fact 
that pregnant women were recruited in early second trimester and 
interviewed about prescription medicine use in the first trimester, thus the 
subjects could have reported some medicine exposures which do not reflect 
first trimester use. An Irish study by Cleary et al. (2010) also reported a 
higher prevalence of 39.2% and this could be because of the geographical 
differences in prescription medicine use between the Republic of Ireland and 
the UK. Furthermore, the present study found that prescription medicine 
users were more likely to be university-educated and have been pregnant at 
least once before. 
With respect to over-the-counter medicines, a similar study was carried out in 
the Republic of Ireland by Cleary et al. (2010). The authors found a 
prevalence of 19.5% whereas in the current study, 25.5% of the women were 
exposed to over-the-counter medicines in the first trimester. The lower 
prevalence reported by the previous research could be because the sample 
size of participants was higher (n = 61 252) than that of the present study (n 
= 560). Two other previous studies which employed same method as the 
current study demonstrated much lower prevalence of 5% (Li et al., 2003) 
and a much higher prevalence of 54.9% (Buitendijk and Bracken, 1991). Li 
and colleagues (2003) in their US study reported a prevalence of 5% 
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because the authors focused on NSAIDs (Non-steroidal anti-inflammatory 
drugs), aspirin and paracetamol. Another US research (Buitendijk and 
Bracken, 1991) reported that 54.9% of their study participants were exposed 
to over-the-counter medicines. This is higher than the present study and 
could be explained by international variations in the medicines which are 
available over-the-counter. It was also discovered that users of over-the-
counter medicines in the current study were more likely to be in the age 
group of 31 – 40 years, whites, have had one or more previous children and 
have consumed tea.  
Regarding the use of complementary and alternative medicine in early 
pregnancy, the Irish study by Cleary et al. (2010) reported a 0.58% 
prevalence of use of herbal medicines and supplements. This very low 
prevalence in comparison to the current study (40.5%) may be due to the 
fact that only herbals were assessed while the present study assessed all 
categories of complementary and alternative medicines including herbals. 
Moreover, the authors did not document the type of herbal products 
reportedly used by respondents. The discrepancy could also be explained by 
the differences in culture of the pregnant populations of the UK and the 
Republic of Ireland. In addition, the current study found that complementary 
and alternative medicine users were more likely to be between 31 and 40 
years and university-educated. 
In the case of alcohol consumption in early pregnancy, a US work by 
Harrison and Sidebottom (2009) reported a prevalence of 5.6%. The low 
prevalence compared to the present study of 11.4% could be due to the fact 
that in the previous study, data collection was carried out as part of a 
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federally-funded ‘Healthy Start Initiative’ which aimed to reduce infant 
mortality and other poor birth outcomes. Hence, it is possible that the 
pregnant women were aware of this initiative and its objectives. The 
comparatively low prevalence is therefore suggestive that some participants 
may have failed to disclose alcohol consumption in the first trimester in order 
not to feel guilty. Another reason for the low prevalence of alcohol use could 
be because the study sample was quite young, with more than two-thirds of 
the respondents being ≤ 24 years old. In the current study, users of alcohol 
were more likely to be in the age group of 31-40 years and have consumed 
tea. 
Internationally, there are no comparable studies for the prevalence of 
cigarette smoking and illicit substance use in early pregnancy which 
employed the same methods as the current study. In the US research by 
Hayes et al. (2002), which used medical record review as the data collection 
method, it was reported that 42% of the women smoked cigarettes in early 
pregnancy. In comparison, the present study found that 3.0% (17/560) of 
participants had smoked cigarettes. It is important to note that the previous 
study was carried out on a predominantly low-income, Caucasians in a rural 
area with most of the participants (70.3%) being less than 26 years old. This 
in addition to the data collection method employed, might have accounted for 
the differences in the prevalence of cigarette smoking in the first trimester 
between the two countries. Furthermore, the study was carried out over a 
decade ago and there could have been increased awareness amongst 
pregnant women of the risks associated with cigarette smoking during 
pregnancy which could help reduce consumption. In the present study, the 
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women who smoked were more likely to have lower education (below 
university level) and more likely to have consumed coffee. 
As regards illicit substance use in the first trimester, in a UK study by 
Fergusson et al. (2002), participants filled self-completed postal 
questionnaires in the second trimester about their substance use and it was 
discovered that 2.3% of the women had consumed cannabis in pregnancy. 
The reported prevalence of the only illicit substance found in the present 
study- cannabis- was very low (0.4%) because only 2 out of 560 women 
disclosed prenatal use. The much lower prevalence in the present study 
could be due either to recall problems or the decision by the participants not 
to admit use because of the face-to-face data collection method used. 
Therefore, the prevalence of exposure may have been under-estimated. The 
under-reporting of illicit substances by pregnant women is, however not 
surprising, and has been previously described in some studies (Hingson et 
al., 1986; Day and Richardson, 1991; Pegues et al., 1994; Lester et al., 
2001; Pichini et al., 2005; Lozano et al., 2007). Women’s reluctance to admit 
the use of illicit substances may also be due to shame, guilt, and fear of 
having their children taken away from them into care (Koren et al., 2002). 
A notable result of the current study which was not previously assessed in 
prior researches is the safety knowledge of expectant mothers about 
medicine and recreational substance use in the antenatal period. It was 
discovered that although a high proportion of the women felt they had 
enough information on the safety of recreational substances (licit and illicit), a 
substantial number of them believed they had little or no information about 
the safety of medicines (prescription, over-the-counter and complementary 
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and alternative medicines) in pregnancy. Thus, the belief that they had 
insufficient safety knowledge about medicines could influence their decisions 
positively or negatively when considering prenatal use of these agents.  
2.7.2 Prospective cohort study 
This study describes medicine and recreational substance use before 
pregnancy, and in the first, second and third trimesters of pregnancy as well 
as the pregnancy outcomes in a cohort of women. It is the first UK study to 
prospectively examine exposures to all medicines and recreational 
substances across all trimesters using a structured interview approach and 
this helped to reduce the effect of recall bias on prevalence estimates. 
Prescription medicine use was 30.8% in the 3 months before pregnancy and 
this decreased to 9.5% in the third trimester. Over-the-counter medicines 
which had a prevalence of 52.7% before pregnancy, decreased to 25.1% in 
the second trimester but increased to 40.3% in the third trimester. The 
proportion of complementary and alternative medicine users was 32.7% prior 
to pregnancy and this increased to 49.8% in the third trimester. 
Alcohol and cigarette had prevalence of 69.2% and 13.2% before pregnancy 
respectively. These reduced to 11.4% and 2.4% in the first trimester but 
increased slightly in the second and third trimesters for alcohol and cigarette 
respectively. A reduction in the percentages of participants who admitted to 
the use of illicit substances in pregnancy was found compared to before 
pregnancy (Table 15).  
With regard to the pregnancy outcomes, concomitant use of complementary 
and alternative medicines with cigarette in the first trimester was univariably 
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associated with an increased risk of congenital anomaly in the baby (p = 
0.001). The use of complementary and alternative medicines jointly with 
over-the-counter medicines in at least one trimester was also univariably 
associated with a higher risk of congenital anomaly in the baby (p = 0.001). 
Comparable results on concomitant use of these agents and associations 
with pregnancy outcomes were not found in previous international studies. 
However, due to the limited sample size of the cohort, logistic regression 
could not be carried out to control for potential confounders. Hence, the 
results should be regarded as preliminary and further investigation is 
necessary. 
2.7.3 Strengths and Limitations 
The findings from this study need to be viewed in the context of some 
limitations. The sample size of the cohort was limited, thus the statistical 
analyses examined the effects of medicines and recreational substances on 
pregnancy outcomes univariably using the chi-square test; confounders were 
not controlled for. Furthermore, the analysis of the effects of complementary 
and alternative medicines on pregnancy outcomes was not stratified into 
ingested or physical therapies. 
Despite these limitations, the study approach has reduced the effect of poor 
recall or recall bias on prevalence estimates as previous work suggest that 
women interviewed post-natally have poorer recall of antenatal information 
than women interviewed antenatally (Bryant et al., 1989), hence a major 
strength of the current study is the fact that women were interviewed in the 
antenatal period to ascertain medicine and recreational substance exposure. 
Additionally, the exposure information about medicines and recreational 
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substances was prospective in relation to the pregnancy outcomes, thus it is 
unlikely that ascertainment was dependent on the outcome, which is the 
case in retrospective studies (Cleary et al., 2010). Therefore, the accuracy of 
the data was enhanced. 
Interviewing participants with a questionnaire also allowed participants to ask 
clarifying questions and helped to avoid missing variables, thereby 
enhancing more complete answers. Furthermore, interviewing participants 
directly also helped to gather information on complementary and alternative 
medicines which are not usually documented in databases. 
2.8 Conclusions 
This study indicates that the use of medicines (prescription, over-the-counter, 
complementary and alternative medicines) was reportedly more common 
than recreational substances (licit and illicit) during pregnancy. Furthermore, 
the study could not show an association between the medicines and 
recreational substances used during pregnancy and increased risk of 
congenital anomalies in the baby. However, a considerable number of the 
participants believed they had little or no information about the safety of 
medicines in pregnancy. In addition to the risks associated with foetal 
exposure to medicines and recreational substances, there are risks 
associated with women’s inadequate or lack of information regarding safety. 
Therefore, an area for further research which has emerged from this study is 
that of women’s beliefs about the use of medicines and recreational 
substances during pregnancy. This issue provides the implications for the 
second part of this thesis. The next two chapters investigate the health 
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beliefs, attitudes and knowledge of expectant mothers with respect to 
medicine and recreational substance use during pregnancy.
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3.1 Introduction 
The beliefs and attitudes of expectant mothers influence whether or not they 
will use medicines and their conformation to healthy behaviours (Rosenblatt, 
1998). Health beliefs are defined as “the personal convictions that influence 
health behaviours” (Anderson et al., 2002) and individuals’ health beliefs and 
risk perceptions are significant predictors of health-related behaviours 
(Brown and Morley, 2007; Kaptein et al., 2007). An attitude is “a relatively 
enduring organisation of beliefs, feelings, and behavioural tendencies 
towards socially significant objects, groups, events or symbols” (Hogg and 
Vaughan, 2005). 
Pregnant women are of special interest in terms of medicine and recreational 
substance use. Studies have found evidence on the importance of beliefs 
and attitudes in determining whether or not pregnant women perform 
recommended health actions, such as folic acid intake (Tinsley, 1993; 
Haslam et al., 2003). The beliefs of pregnant women can also influence their 
decision on whether to use a medicine or not, especially when considering 
over-the-counter or complementary and alternative medicines.  
In the case of prescribed medicines, a woman’s beliefs or attitudes may 
affect adherence to the doctor’s prescription (Nordeng et al., 2010b). Some 
studies have shown that most expectant mothers have an unrealistic fear of 
medicines (Koren et al., 1989; Sanz et al., 2001; Einarson, 2007; Nordeng et 
al., 2010b), and that wrong perception of risk can affect health behaviour 
(Koren and Pastuszak 1990; Baggley et al., 2004). This is because a woman 
may perceive the risk of taking a medicine during pregnancy to be higher 
than the actual risk and as a result may compromise her health or that of the 
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unborn child by discontinuing needed medicines or terminating a pregnancy 
(Koren et al., 1989; Sanz et al., 2001; Einarson, 2007). This issue is 
especially important for many medicines which are used in the treatment of 
medical conditions such as hypertension, which if left untreated, may be 
more harmful than the prescribed medicine to both the mother and foetus. 
Therefore, there could be serious health consequences if the expectant 
mothers’ attitudes affect adherence to needed medicines in a negative way 
(Nordeng et al., 2010a).  
Other studies have documented the role of beliefs in behaviours of medical 
concern such as prenatal smoking (Lawson 1994; Haslam and Lawrence 
2004). It has also been reported that women have differing attitudes about 
the risk associated with drinking alcohol and this influenced their 
consumption during pregnancy (Raymond et al., 2009). This is because 
information about the potentially harmful effects of alcohol during pregnancy 
does not necessarily equate to understanding while information and 
knowledge may not be associated with pregnant women’s attitudes toward 
drinking (Kesmodel and Kesmodel 2002). 
Given the foregoing, it is important to recognise and understand the common 
health beliefs, attitudes and knowledge in this population and to identify the 
gaps in the international literatures. 
3.2 Aim 
To conduct a narrative literature review on the health beliefs, attitudes and 
knowledge of pregnant women with respect to medicine (prescription, over-
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the-counter and complementary and alternative medicines) and recreational 
substance (licit and illicit) use in pregnancy. 
3.3 Methods 
3.3.1 Databases 
The databases that were searched for articles which focus on health beliefs, 
attitudes and knowledge about medicine and recreational substance use in 
pregnancy are: PubMed (1950 to October 2012), EMBASE (1980 to 2012 
Week 46), International Pharmaceutical Abstracts (1970 to October 2012) 
and CINAHL Plus (1937 to November 2012). In addition to these, the 
reference lists of the relevant articles were searched for other relevant 
publications. This search was carried out again in August 2013 but no new 
relevant article was found. 
3.3.2 Search strategy and terms 
Prescription drugs OR prescription medicines OR prescription medications 
OR over-the-counter drugs OR over-the-counter medicines OR over-the-
counter medications OR herbal medicines OR herbal products OR herbal 
remedies OR herbal therapy OR herbal preparations OR complementary 
medicines OR complementary therapy OR alternative medicines OR 
alternative therapy OR traditional medicines OR traditional remedies OR 
phytotherapy OR phytomedicines OR botanicals OR botanical products OR 
alcohol OR ethanol OR cigarette OR tobacco OR cigar OR licit drugs OR 
illicit drugs OR illegal drugs OR recreational drugs OR social drugs OR drugs 
of abuse OR substance use OR substance abuse OR substance misuse 
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AND 
Pregnant OR pregnancy OR pregnant woman OR pregnant women OR 
gestation OR gestational OR prenatal OR antenatal OR maternal 
AND 
Health belief OR health beliefs OR health practice OR health practices OR 
health value OR health values OR health behaviour OR health behaviours 
OR health norm OR health norms OR health culture OR health cultures OR 
health attitude OR health attitudes OR health tradition OR health traditions 
OR health view OR health views OR health opinion OR health opinions OR 
health perception OR health perceptions OR health conviction OR health 
convictions OR health idea OR health ideas OR health action OR health 
actions OR health activity OR health activities OR health knowledge OR 
health information 
3.3.3 Inclusion criteria 
Original studies (qualitative and quantitative) written in English language 
reporting health beliefs, attitudes and knowledge about the use of medicines 
and recreational substances in pregnancy were included. Of interest in this 
review are prescription medicines, over-the-counter medicines, 
complementary and alternative medicines and recreational substances (licit 
and illicit substances). 
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Figure 10 Review flow chart 
 
3.4 Results 
The electronic search produced 1303 articles – 638 from PubMed, 185 from 
EMBASE, 478 from CINAHL plus and 2 from International Pharmaceutical 
Abstracts. A total of 35 articles reporting 27 quantitative and 8 qualitative 
studies met the inclusion criteria (Table 17). However, there are disparities 
Articles retrieved and imported into EndNote      
(n = 1,303)                     
Removal of duplicates         
(n = 129)  
Irrelevant articles excluded      
(n = 1105) 
Article titles and abstracts 
screened for relevance        
(n = 1174) 
Full text articles assessed for 
eligibility (n = 69) 
Articles included in the review 
(n = 35) 
Reference lists of included 
articles reviewed (n = 0) 
Total number of articles included in the literature 
review (n = 35)  
34 articles excluded 
Reviews (n = 2)        
Prevalence studies (n = 13) 
RCTs (n = 3)                      
Non-English articles (n = 9)  
Others e.g. commentaries, 
research letters, editorial 
reports, short communications, 
etc (n = 7)  
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amongst the articles because of the differences in data collection methods, 
study objectives, sample sizes and study participants (pregnant or 
postpartum women). The studies also focused on different medicines and 
recreational substances of interest – Complementary and alternative 
medicines (n = 7), Alcohol (n = 17), Tobacco (n = 14), Illicit substances (n = 
1), Over-the-counter medicines (n = 5), and Prescription medicines (n = 2). 
Some of the articles studied more than one medicine or recreational 
substance. The papers were from Ghana (n = 1), Dominican republic (n = 1), 
United States (n = 5), United Kingdom (n = 5), Lebanon (n = 1), Zambia and 
Democratic Republic of Congo (n = 1), Ireland (n = 1), Japan (n = 1), South 
Africa (n = 1), Canada (n = 1), Nigeria (n = 1), Australia (n = 2), Brazil (n = 1), 
Turkey (n = 1), Denmark (n = 1), Korea (n = 1), Papua New Guinea (n = 1), 
Czech Republic (n = 1), Italy (n = 1), France (n = 2), Finland (n = 1), 
Honduras (n = 1), Norway (n = 2) and Israel (n = 1).  
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Table 17 Articles included in the review 
 
 
 
Author Year Country Objectives Medicine/Substance studied Major findings
Theoretical framework Data collection Sample size Study participants
Baric and MacArthur 1977 United Kingdom
Develop a method of measuring social 
expectations (norms) and to find out 
how far pregnant women conform in 
their behaviour to the norms None
Quantitative 
(Interview with 
questionnaire) n  = 243
Pregnant and 
postpartum women
Cigarette, alcohol and over-the-
counter medication
                                                                                   
39% of the women thought that a pregnant 
woman was not expected to smoke at all 
while 40% thought that pregnant women 
were expected to reduce the number of 
cigarettes smoked. Fifty one percent (51%) 
of the women felt pregnant women should 
reduce their drinking or to drink only small 
amounts of alcohol; 8% felt they were 
expected to stop taking alcohol completely; 
7% believed that there was a beneficial 
effect in drinking stout during pregnancy. 
Seventy-five percent (75%) thought that a 
pregnant woman should not take any 
medicines without first consulting a doctor. 
Barbour 1990 USA
Explore the drinking behaviours of 
pregnant women and factors influencing 
the behaviours None
Qualitative 
(Interview) n  = 20 Pregnant women Alcohol
                                                                                   
19 of the women knew about the dangers 
of alcohol in pregnancy; many of them 
believed that wine or beer is not as bad as 
other forms of alcohol and that alcohol can 
only cause problems in early pregnancy; 
they also believed that it is dangerous to 
the foetus only if large amounts are 
consumed.
Methods Population characteristics
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Table 17 Articles included in the review (continued) 
 
 
Butters and Howie 1990 United Kingdom
Assess the attitudes and knowledge 
among pregnant women of the effects 
of commonly used drugs, cigarette and 
alcohol on the foetus None
Quantitative (Self-
administered 
questionnaire) n  = 514 Postpartum women
Precription and Over-the-counter 
medicines, Cigarette and Alcohol
                                                                                   
85% of the women recognised that the 
foetus is most at risk of being harmed by 
drugs during the first 3 months of 
pregnancy; 83% felt it was safest not to 
smoke any cigarettes at all during 
pregnancy; 88% were aware of the 
adverse effects of smoking on foetal 
growth; 55% thought that alcohol should be 
avoided during pregnancy while 28% 
considered it safe to consume one drink a 
week. 51% thought that drinking alcohol in 
pregnancy could result in growth 
retardation and 66% thought it could cause 
foetal abnormalities. 49% said they would 
take an antibiotic prescribed by the doctor 
while 48% said they would not. 16% would 
avoid taking any form of analgesia during 
pregnancy.  
Daly et al 1992 Ireland
Establish the level of alcohol and 
cigarette consumption and the level of 
knowledge of potential adverse effects None
Quantitative 
(Interview with 
questionnaire) n  = 100 Postpartum women Alcohol and Cigarette
                                                                                   
58% of the women were aware of the 
harmful effects of alcohol during 
pregnancy; 93% were aware of the harmful 
effects of smoking during pregnancy. 
Dow-Clarke et al 1994 Canada
Assess the health behaviours of 
pregnant women None
Quantitative 
(Questionnaire) n  = 173 Pregnant women
Over-the-counter medications 
and alcohol
                                                                                   
92.4% of the women agreed with the 
statement that non-prescription 
medications should be avoided during 
pregnancy. In terms of alcohol, 43.4% 
agreed with the statement that it is okay to 
drink occasionally during pregnancy while 
48% disagreed with this statement. 
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Table 17 Articles included in the review (continued) 
 
Lawson 1994 USA
                                                         
Examine the role of cigarette smoking in 
the lives of pregnant adolescents None
Qualitative (In-
depth interview) n  = 20
Pregnant 
adolescents Cigarette
                                                                                   
The respondents believed that cigarette 
smoking controlled body weight and that 
cessation consistently produced marked 
weight gain. They also believed that 
cigarette smoking would assure having a 
smaller baby which would result in a 
shorter labour and less painful delivery.  
Lelong et al 1995 France
Investigate the attitudes and behaviour 
of pregnant women towards tobacco 
and alcohol consumption None
Quantitative 
(Interview with a 
structured 
questionnaire) n  = 176
Pregnant and 
postpartum women Alcohol and Tobacco
                                                                             
Most women were aware that alcohol and 
tobacco could be harmful to their babies 
but heavy drinkers recognised the 
influence of alcohol in pregnancy less often 
than the others. Sixty percent (60%) of the 
women thought that two drinks per day 
was a reasonable level of consumption 
during pregnancy.
Steyn et al 1997 South Africa
                                                         
Estimate exposure to active and 
passive smoking of pregnant women 
and to determine their knowledge and 
behaviour about smoking during 
pregnancy None
Quantitative (Self-
administered 
questionnaire) n  = 394 Pregnant women Tobacco
88.8% of the women believed that smoking 
is bad for the mother's health; 92.1% 
believed that smoking is bad for the unborn 
baby's health.
Kaskutas 2000 USA
Examine pregnant women's drinking 
during pregnancy and their beliefs about 
the risks None
Qualitative 
(Interview) n  = 321 Pregnant women Alcohol
                                                                                   
17% of the women believed that there is a 
point in pregnancy when it is too late to 
reduce one's drinking. In terms of 
comparative safety, 26% of beer drinkers 
said beer is safer; 31% of wine drinkers felt 
wine is safer; 26% of wine cooler drinkers 
said wine cooler is safer.
Kesmodel and 
Kesmodel 2002 Denmark
Assess the attitudes toward and beliefs 
and knowledge of pregnant women 
about drinking during pregnancy None
Quantitative 
(Interview with 
questionnaire) n  = 439 Pregnant women Alcohol
                                                                                   
76% of the women considered some 
alcohol intake during pregnancy to be 
acceptable, mostly on a weekly basis; 85% 
believed that binge drinking was potentially 
harmful to the foetus. 
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Table 17 Articles included in the review (continued) 
 
 
 
Chaaya et al 2004 Lebanon
Assess pregnant women's knowledge 
of the chemical contents and harmful 
effects of cigarettes and argileh, their 
attitudes towards smoking and their 
smoking habits before and during 
pregnancy None
Quantitative 
(Interview with a 
questionnaire) n  = 864 Pregnant women Cigarette
                                                                                   
68.7% of the pregnant women were aware 
that cigarette contains addictive 
substances; 69% knew it contains 
carcinogens; 78.4% knew it affects the 
foetus; 76.8% knew that cigarette affects 
the newborn 
Gaffney and Smith 2004 Australia
Examine women's views towards the 
use of complementary and alternative 
medicines (CAM) during pregnancy None
Quantitative 
(Interview with 
questionnaire) n  = 220 Pregnant women
Complementary and alternative 
medicines
                                                                                   
Majority of the women considered the use 
of CAM to be safe during pregnancy. 
36.4% agreed with the statement "I believe 
complementary therapy to be more 
effective for my problem than conventional 
medicine"; 50% agreed with the statement 
"I feel that complementary treatment is a 
more natural form of healing than 
conventional medicine"; 52.3% agreed with 
the statement "I believe that CAM enables 
me to take a more active part in 
maintaining my health"; 11.4% agreed with 
the statement "I have a more equal 
relationship with my complementary 
practitioner than with my doctor"; 61.4% 
agreed with the statement "I value the 
emphasis on treating the whole person".
Garcias and Schuler-
Faccini 2004 Brazil
Investigate the beliefs of mothers 
regarding risk factors associated with 
congenital abnormalities None
Quantitative 
(Interview with 
questionnaire) n  = 3219 Postpartum women Tobacco and Alcohol
                                                                                   
88.4% of the women believed that tobacco 
smoking can cause congenital defects; 
88.8% believed that alcohol consumption 
can cause congenital abnormalities.
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Table 17 Articles included in the review (continued) 
 
Griffiths et al 2005 United Kingdom
Assess pregnant women's knowledge 
of foetal and maternal risk of smoking 
and to determine the motivators for 
smoking cessation None
Quantitative 
(Interview with a 
questionnaire) n  = 145 Pregnant women Tobacco
                                                                                   
92% of the women were aware that 
smoking can cause lung cancer; 76% 
knew it can cause myocardial infarction; 
50% knew it can cause miscarriage; 34% 
were aware it can cause ante-partum 
haemorrhage; 44% knew it can cause 
decreased birth weight; 33% knew it can 
cause slower cognitive development; 38% 
were aware it can lead to cot death. 
Kralikova et al 2005 Czech Republic
Investigate information about smoking 
impact on pregnancy None
Quantitative 
(Structured 
interview) n  = 265 Postpartum women Cigarette
                                                                                   
Most of the women had insufficient 
information about the impact of smoking on 
the baby.
Nordeng and Havnen 2005 Norway
Investigate the impact of socio-
demographic factors, knowledge and 
attitude on the use of herbal drugs in 
pregnancy None
Quantitative 
(Interview with a 
structured 
questionnaire) n  = 400 Postpartum women Herbal medicines
                                                             
62.3% of the women agreed that herbal 
drugs generally give less adverse effects 
than conventional drugs; 57% expressed 
that herbal drugs can be used by pregnant 
women; 40.8% believed that pregnant 
women should preferably use herbal drugs 
than other drugs and 56.5% agreed that 
pregnant women should not use herbal 
drugs without the consent of the physician
Chang et al 2006 USA
Assess the knowledge of pregnant 
women about alcohol use None
Quantitative (Self-
completed 
questionnaire) n  = 254 Pregnant women Alcohol
                                                                                   
79.9% of the women were correct that 
there is no universally safe level of prenatal 
alcohol use; 94% were correct that alcohol 
exposure may have negative effects 
throughout pregnancy.
Milla et al 2007 Honduras
Determine the knowledge, attitudes, and 
practices related to folic acid and birth 
defects among postpartum women None
Quantitative 
(Interview with 
questionnaire) n  = 2619 Postpartum women
Over-the-counter medicine - 
Folic acid
                                                                                   
37.6% of the women were aware that folic 
acid helped to avoid birth defects and was 
good for the growth and development of 
the baby; 24.1% felt folic acid was a 
vitamin or was related to anaemia or iron; 
7.8% thought folic acid was good for health 
in general.
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Table 17 Articles included in the review (continued) 
 
 
Lapi et al 2008 Italy
Explore pregnant women's use, 
attitudes, knowledge and beliefs of 
complementary and alternative drugs None
Quantitative 
(Interview with 
semi-structured 
questionnaire) n  = 172 Pregnant women
Complementary and alternative 
drugs
                                                                                   
52% of the women were convinced that 
complementary and alternative drugs are 
safer than conventional medications while 
62.7% considered them as having equal 
efficacy as conventional drugs.
Yamamoto et al 2008 Japan
Examine alcohol consumption and 
abstention among pregnant women None
Quantitative (Self-
administered 
questionnaire) n  = 14 239 Pregnant women Alcohol
72.8% of the women had knowledge 
regarding the risks of alcohol consumption 
during pregnancy
Fakeye et al 2009 Nigeria
Determine the attitude and use of herbal 
medicines among pregnant women None
Quantitative 
(Structured 
questionnaire) n  = 595 Pregnant women Herbal medicines
                                                             
33.4% of the participants felt herbal 
medicines were safe; 81% believed in the 
efficacy of herbal medicines
Holst et al 2009 United Kingdom
Determine the motivations for the use of 
herbal medicine during pregnancy None
Qualitative 
(Focus group 
discussion) n  = 6 Pregnant women Herbal medicines
                                                                             
The women were aware of the fact that 
nothing is absolutely safe but they believed 
that herbs are safer than pharmaceuticals. 
They also knew that interactions of herbals 
with pharmaceuticals could occur. 
Karcaaltincaba et al 2009 Turkey
                                                         
Investigate the level of knowledge about 
the effects of cigarette smoking and 
status before and during pregnancy None
Quantitative 
(Interview with a 
questionnaire) n  = 1020 Pregnant women Cigarette
97.5% of the women knew smoking was 
harmful; 62.5% were aware of at least 
three hazardous effects.
Raymond et al 2009 United Kingdom
Explore pregnant women's attitudes 
towards drinking alcohol in pregnancy 
and their attitudes towards sources of 
information about drinking in pregnancy None
Qualitative 
(Telephone 
interview) n  = 20 Pregnant women Alcohol
Most women considered that there were 
risks involved with drinking during 
pregnancy.
Senn et al 2009
Papua New 
Guinea
Investigate the habits of betel nut 
chewing and possible impact on 
pregnancy None
Quantitative 
(Semi-structured 
questionnaire) n  = 310 Pregnant women
Recreational substance - Betel 
nut
80% of the women perceived no risk in 
using betel nut during pregnancy for the 
foetus.
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Table 17 Articles included in the review (continued) 
 
Bercaw et al 2010 USA
Investigate the use of herbs, vitamins, 
over-the-counter and prescription 
medications among Hispanic women  None
Quantitative (Self-
administered 
questionnaire) n  = 485 Postpartum women Herbs and vitamins
                                                                                   
22% of the women believed that herbs and 
vitamins are safer to use than prescription 
medication; 20% believed that herbs are 
better at treating medical problems than 
prescription medication; 50% agreed that 
they would use herbs if given information 
about these by a doctor. 
Chomba et al 2010
Zambia and 
Democratic 
Republic of 
Congo
                                                         
Assess pregnant women's knowledge, 
attitudes and behaviours towards 
tobacco use and secondhand smoke 
exposure, and exposure to advertising 
for and against tobacco products None
Quantitative 
(Face-to-face 
survey) n  = 1756 Pregnant women Tobacco
86.5% thought cigarette smoking during 
pregnancy can harm the baby; 96.8% felt 
cigarette smoking can harm a woman's 
health 
Nordeng et al 2010 Norway
Investigate pregnant women's beliefs 
about medication and the factors that 
determine those beliefs None
Quantitative (Self-
completed 
structured 
questionnaire on 
the internet) n  = 866 Pregnant women
Prescription medications and 
herbal remedies
                                                                                   
87.4% agreed with the statement that they 
were more cautious about using 
medications when they are pregnant; 
12.1% agreed that natural remedies can 
generally be used by pregnant women; 
22.9% agreed that natural remedies are 
safer than conventional medicines; 13.2% 
agreed that pregnant women should 
preferably use natural remedies during 
pregnancy and 69.6% believed that 
pregnant women should not use natural 
remedies without the consent of a doctor
Toutain 2010 France
Determine what the women in France 
say about alcohol abstinence during 
pregnancy None
Qualitative 
(Internet 
discussion) n  = 42 Pregnant women Alcohol
                                                               
80% mentioned alcohol abstinence; 20% 
talked about the consequences of drinking 
on the unborn babies. However, the 
concept of abstinence tends to be 
misunderstood because for most of them, 
abstinence was not perceived as "not 
drinking at all" while little is known about 
the consequences of alcohol consumption 
for the unborn babies  
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Table 17 Articles included in the review (continued) 
 
Kim and Park 2011 Korea
                                                         
Investigate prenatal alcohol 
consumption and knowledge of alcohol 
risks and foetal alcohol syndrome 
among Korean women None
Quantitative (Self-
completed 
questionnaire) n  = 221 Postpartum women Alcohol
The knowledge level regarding alcohol 
risks and foetal alcohol syndrome among 
participants was poor.
Senecky et al 2011 Israel
                                                         
Evaluate the awareness and knowledge 
of women regarding alcohol 
consumption during pregnancy; 
determine how many women received 
information about alcohol consumption 
from medical professionals; and to 
evaluate the drinking habits of the 
women during pregnancy None
Quantitative 
(Questionnaire) n  = 3815 Postpartum women Alcohol
71.6% claimed that women should not 
consume alcohol at all during pregnancy; 
21.4% thought it was permissible if limited 
to 2 drinks per week
Torres et al  2011
Dominican 
Republic
Assess the attitudes, beliefs, 
perceptions, and practices regarding 
tobacco use and exposure among 
pregnant women None
Quantitative 
(Interview with 
questionnaire) n  = 192 Pregnant women Tobacco
                                                                                   
97% believed women who smoke can 
harm their health; 98% believed pregnant 
women who smoke can harm their unborn 
baby's health; 33% believed tobacco use 
could cause general illness; 15% believed 
it could cause cancer and 1% believed it 
can lead to death.  
Adusi-Poku et al 2012 Ghana
                                                         
Determine the the magnitude of drinking 
and to assess the general knowledge 
about the effects of alcohol in 
pregnancy None
Quantitative 
(Structured 
questionnaire) n  = 397 Pregnant women Alcohol
78% of the women said alcohol could be 
harmful.
Jones and Telenta 2012 Australia
                                                         
Explore attitudes towards alcohol 
consumption during pregnancy None
Qualitative (Semi-
structured 
interview) n  = 12 Pregnant women Alcohol
                                                                                   
All the women believed there were no 
benefits to drinking alcohol while pregnant 
and that not drinking was the best option. 
Majority of them expressed a lack of 
knowledge of the actual risks of alcohol 
consumption on the foetus.
Leppo 2012 Finland
Investigate the perception of pregnant 
women about the risks involved in 
prenatal illicit drug use.  None
Qualitative (Semi-
structured 
interview) n  = 14
Pregnant and 
postpartum women Illicit drug - Buprenorphine
                                                                                   
The women were not primarily concerned 
about the health risks of illicit drugs; their 
greatest fears were giving birth to a child 
with withdrawal symptoms; they did not 
see abstaining from drugs as a risk-free 
option. 
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3.4.1 Data collection methods employed by the studies 
Out of the 35 articles included in this review, 27 were quantitative while 8 
were qualitative studies.  
In the 27 quantitative studies, participants were either interviewed with a 
questionnaire or self-administered the questionnaires. Only Nordeng et al. 
(2010a) employed self-administered internet questionnaire (Table 18). The 
quantitative studies consist of 2 articles on prescription medicines (Butters 
and Howie, 1990; Nordeng et al., 2010a), 5 on over-the-counter medicines 
(Baric and MacArthur, 1977; Butters and Howie, 1990; Dow-Clarke et al., 
1994; Milla et al., 2007; Bercaw et al., 2010), 6 on complementary and 
alternative medicines (Gaffney and Smith, 2004; Nordeng and Havnen, 
2005; Lapi et al., 2008; Fakeye et al., 2009; Bercaw et al., 2010; Nordeng et 
al., 2010a), 12 on alcohol (Baric and MacArthur, 1977; Butters and Howie, 
1990; Daly et al., 1992; Dow-Clarke et al., 1994; Lelong et al., 1995; 
Kesmodel and Kesmodel, 2002; Garcias and Schuler-Faccini, 2004; Chang 
et al., 2006; Yamamoto et al., 2008; Kim and Park, 2011; Senecky et al., 
2011; Adusi-Poku et al., 2012) and 13 papers on tobacco (Baric and 
MacArthur, 1977; Butters and Howie, 1990; Daly et al., 1992; Lelong et al., 
1995; Steyn et al., 1997; Chaaya et al., 2004; Garcias and Schuler-Faccini, 
2004; Griffiths et al., 2005; Kralikova et al., 2005; Karcaaltincaba et al., 2009; 
Senn et al., 2009; Chomba et al., 2010; Torres et al., 2011). 
The different approaches employed by the 8 qualitative studies were focus 
group discussion, face-to-face individual interview, telephone interview and 
internet discussion (Table 19). The studies reported on complementary and 
alternative medicines (Holst et al., 2009b), tobacco (Lawson, 1994), illicit 
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substance (Leppo, 2012) and alcohol (Barbour, 1990; Kaskutas, 2000; 
Raymond et al., 2009; Toutain, 2010; Jones and Telenta, 2012). There were 
no qualitative studies on prescription and over-the-counter medicines. 
Majority of the reviewed articles assessed only health beliefs and attitudes 
(e.g Leppo, 2012), or only knowledge (e.g Kim and Park, 2011) while only 6 
papers (Barbour, 1990; Butters and Howie, 1990; Lelong et al., 1995; Milla et 
al., 2007; Holst et al., 2009b; Jones and Telenta, 2012) studied all the factors 
of interest - health beliefs, attitudes and knowledge (Table 20). These 6 
articles were made up of 3 quantitative and 3 qualitative studies and reported 
on alcohol (n = 3), tobacco (n = 1), prescription medicine (n = 1), over-the-
counter medicine (n = 1) and complementary and alternative medicine (n = 
1). 
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Table 18 Studies which employed quantitative data collection methods 
 
Author Year Country Objectives Medicine/Substance studied Major findings
Theoretical framework Data collection Sample size Study participants
Baric and MacArthur 1977 United Kingdom
Develop a method of measuring social 
expectations (norms) and to find out 
how far pregnant women conform in 
their behaviour to the norms None
Quantitative 
(Interview with 
questionnaire) n  = 243
Pregnant and 
postpartum women
Cigarette, alcohol and over-the-
counter medication
                                                                                   
39% of the women thought that a pregnant 
woman was not expected to smoke at all 
while 40% thought that pregnant women 
were expected to reduce the number of 
cigarettes smoked. Fifty one percent (51%) 
of the women felt pregnant women should 
reduce their drinking or to drink only small 
amounts of alcohol; 8% felt they were 
expected to stop taking alcohol completely; 
7% believed that there was a beneficial 
effect in drinking stout during pregnancy. 
Seventy-five percent (75%) thought that a 
pregnant woman should not take any 
medicines without first consulting a doctor. 
Butters and Howie 1990 United Kingdom
Assess the attitudes and knowledge 
among pregnant women of the effects 
of commonly used drugs, cigarette and 
alcohol on the foetus None
Quantitative (Self-
administered 
questionnaire) n  = 514 Postpartum women
Precription and Over-the-counter 
medicines, Cigarette and Alcohol
                                                                                   
85% of the women recognised that the 
foetus is most at risk of being harmed by 
drugs during the first 3 months of 
pregnancy; 83% felt it was safest not to 
smoke any cigarettes at all during 
pregnancy; 88% were aware of the 
adverse effects of smoking on foetal 
growth; 55% thought that alcohol should be 
avoided during pregnancy while 28% 
considered it safe to consume one drink a 
week. 51% thought that drinking alcohol in 
pregnancy could result in growth 
retardation and 66% thought it could cause 
foetal abnormalities. 49% said they would 
take an antibiotic prescribed by the doctor 
while 48% said they would not. 16% would 
avoid taking any form of analgesia during 
pregnancy.  
Methods Population characteristics
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Table 18 Studies which employed quantitative data collection methods (continued) 
 
 
Daly et al 1992 Ireland
Establish the level of alcohol and 
cigarette consumption and the level of 
knowledge of potential adverse effects None
Quantitative 
(Interview with 
questionnaire) n  = 100 Postpartum women Alcohol and Cigarette
                                                                                   
58% of the women were aware of the 
harmful effects of alcohol during 
pregnancy; 93% were aware of the harmful 
effects of smoking during pregnancy. 
Dow-Clarke et al 1994 Canada
Assess the health behaviours of 
pregnant women None
Quantitative 
(Questionnaire) n  = 173 Pregnant women
Over-the-counter medications 
and alcohol
                                                                                   
92.4% of the women agreed with the 
statement that non-prescription 
medications should be avoided during 
pregnancy. In terms of alcohol, 43.4% 
agreed with the statement that it is okay to 
drink occasionally during pregnancy while 
48% disagreed with this statement. 
Lelong et al 1995 France
Investigate the attitudes and behaviour 
of pregnant women towards tobacco 
and alcohol consumption None
Quantitative 
(Interview with a 
structured 
questionnaire) n  = 176
Pregnant and 
postpartum women Alcohol and Tobacco
                                                                             
Most women were aware that alcohol and 
tobacco could be harmful to their babies 
but heavy drinkers recognised the 
influence of alcohol in pregnancy less often 
than the others. Sixty percent (60%) of the 
women thought that two drinks per day 
was a reasonable level of consumption 
during pregnancy.
Steyn et al 1997 South Africa
                                                         
Estimate exposure to active and 
passive smoking of pregnant women 
and to determine their knowledge and 
behaviour about smoking during 
pregnancy None
Quantitative (Self-
administered 
questionnaire) n  = 394 Pregnant women Tobacco
88.8% of the women believed that smoking 
is bad for the mother's health; 92.1% 
believed that smoking is bad for the unborn 
baby's health.
Kesmodel and 
Kesmodel 2002 Denmark
Assess the attitudes toward and beliefs 
and knowledge of pregnant women 
about drinking during pregnancy None
Quantitative 
(Interview with 
questionnaire) n  = 439 Pregnant women Alcohol
                                                                                   
76% of the women considered some 
alcohol intake during pregnancy to be 
acceptable, mostly on a weekly basis; 85% 
believed that binge drinking was potentially 
harmful to the foetus. 
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Table 18 Studies which employed quantitative data collection methods (continued) 
 
 
Gaffney and Smith 2004 Australia
Examine women's views towards the 
use of complementary and alternative 
medicines (CAM) during pregnancy None
Quantitative 
(Interview with 
questionnaire) n  = 220 Pregnant women
Complementary and alternative 
medicines
                                                                                   
Majority of the women considered the use 
of CAM to be safe during pregnancy. 
36.4% agreed with the statement "I believe 
complementary therapy to be more 
effective for my problem than conventional 
medicine"; 50% agreed with the statement 
"I feel that complementary treatment is a 
more natural form of healing than 
conventional medicine"; 52.3% agreed with 
the statement "I believe that CAM enables 
me to take a more active part in 
maintaining my health"; 11.4% agreed with 
the statement "I have a more equal 
relationship with my complementary 
practitioner than with my doctor"; 61.4% 
agreed with the statement "I value the 
emphasis on treating the whole person".
Garcias and Schuler-
Faccini 2004 Brazil
Investigate the beliefs of mothers 
regarding risk factors associated with 
congenital abnormalities None
Quantitative 
(Interview with 
questionnaire) n  = 3219 Postpartum women Tobacco and Alcohol
                                                                                   
88.4% of the women believed that tobacco 
smoking can cause congenital defects; 
88.8% believed that alcohol consumption 
can cause congenital abnormalities.
Chaaya et al 2004 Lebanon
Assess pregnant women's knowledge 
of the chemical contents and harmful 
effects of cigarettes and argileh, their 
attitudes towards smoking and their 
smoking habits before and during 
pregnancy None
Quantitative 
(Interview with a 
questionnaire) n  = 864 Pregnant women Cigarette
                                                                                   
68.7% of the pregnant women were aware 
that cigarette contains addictive 
substances; 69% knew it contains 
carcinogens; 78.4% knew it affects the 
foetus; 76.8% knew that cigarette affects 
the newborn 
Kralikova et al 2005 Czech Republic
Investigate information about smoking 
impact on pregnancy None
Quantitative 
(Structured 
interview) n  = 265 Postpartum women Cigarette
                                                                                   
Most of the women had insufficient 
information about the impact of smoking on 
the baby.
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Table 18 Studies which employed quantitative data collection methods (continued) 
 
Nordeng and Havnen 2005 Norway
Investigate the impact of socio-
demographic factors, knowledge and 
attitude on the use of herbal drugs in 
pregnancy None
Quantitative 
(Interview with a 
structured 
questionnaire) n  = 400 Postpartum women Herbal medicines
                                                             
62.3% of the women agreed that herbal 
drugs generally give less adverse effects 
than conventional drugs; 57% expressed 
that herbal drugs can be used by pregnant 
women; 40.8% believed that pregnant 
women should preferably use herbal drugs 
than other drugs and 56.5% agreed that 
pregnant women should not use herbal 
drugs without the consent of the physician
Griffiths et al 2005 United Kingdom
Assess pregnant women's knowledge 
of foetal and maternal risk of smoking 
and to determine the motivators for 
smoking cessation None
Quantitative 
(Interview with a 
questionnaire) n  = 145 Pregnant women Tobacco
                                                                                   
92% of the women were aware that 
smoking can cause lung cancer; 76% 
knew it can cause myocardial infarction; 
50% knew it can cause miscarriage; 34% 
were aware it can cause ante-partum 
haemorrhage; 44% knew it can cause 
decreased birth weight; 33% knew it can 
cause slower cognitive development; 38% 
were aware it can lead to cot death. 
Chang et al 2006 USA
Assess the knowledge of pregnant 
women about alcohol use None
Quantitative (Self-
completed 
questionnaire) n  = 254 Pregnant women Alcohol
                                                                                   
79.9% of the women were correct that 
there is no universally safe level of prenatal 
alcohol use; 94% were correct that alcohol 
exposure may have negative effects 
throughout pregnancy.
Milla et al 2007 Honduras
Determine the knowledge, attitudes, and 
practices related to folic acid and birth 
defects among postpartum women None
Quantitative 
(Interview with 
questionnaire) n  = 2619 Postpartum women
Over-the-counter medicine - 
Folic acid
                                                                                   
37.6% of the women were aware that folic 
acid helped to avoid birth defects and was 
good for the growth and development of 
the baby; 24.1% felt folic acid was a 
vitamin or was related to anaemia or iron; 
7.8% thought folic acid was good for health 
in general.
Yamamoto et al 2008 Japan
Examine alcohol consumption and 
abstention among pregnant women None
Quantitative (Self-
administered 
questionnaire) n  = 14 239 Pregnant women Alcohol
72.8% of the women had knowledge 
regarding the risks of alcohol consumption 
during pregnancy
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Table 18 Studies which employed quantitative data collection methods (continued) 
 
Lapi et al 2008 Italy
Explore pregnant women's use, 
attitudes, knowledge and beliefs of 
complementary and alternative drugs None
Quantitative 
(Interview with 
semi-structured 
questionnaire) n  = 172 Pregnant women
Complementary and alternative 
drugs
                                                                                   
52% of the women were convinced that 
complementary and alternative drugs are 
safer than conventional medications while 
62.7% considered them as having equal 
efficacy as conventional drugs.
Fakeye et al 2009 Nigeria
Determine the attitude and use of herbal 
medicines among pregnant women None
Quantitative 
(Structured 
questionnaire) n  = 595 Pregnant women Herbal medicines
                                                             
33.4% of the participants felt herbal 
medicines were safe; 81% believed in the 
efficacy of herbal medicines
Senn et al 2009
Papua New 
Guinea
Investigate the habits of betel nut 
chewing and possible impact on 
pregnancy None
Quantitative 
(Semi-structured 
questionnaire) n  = 310 Pregnant women
Recreational substance - Betel 
nut
80% of the women perceived no risk in 
using betel nut during pregnancy for the 
foetus.
Karcaaltincaba et al 2009 Turkey
                                                         
Investigate the level of knowledge about 
the effects of cigarette smoking and 
status before and during pregnancy None
Quantitative 
(Interview with a 
questionnaire) n  = 1020 Pregnant women Cigarette
97.5% of the women knew smoking was 
harmful; 62.5% were aware of at least 
three hazardous effects.
Nordeng et al 2010 Norway
Investigate pregnant women's beliefs 
about medication and the factors that 
determine those beliefs None
Quantitative (Self-
completed 
structured 
questionnaire on 
the internet) n  = 866 Pregnant women
Prescription medications and 
herbal remedies
                                                                                   
87.4% agreed with the statement that they 
were more cautious about using 
medications when they are pregnant; 
12.1% agreed that natural remedies can 
generally be used by pregnant women; 
22.9% agreed that natural remedies are 
safer than conventional medicines; 13.2% 
agreed that pregnant women should 
preferably use natural remedies during 
pregnancy and 69.6% believed that 
pregnant women should not use natural 
remedies without the consent of a doctor
Bercaw et al 2010 USA
Investigate the use of herbs, vitamins, 
over-the-counter and prescription 
medications among Hispanic women  None
Quantitative (Self-
administered 
questionnaire) n  = 485 Postpartum women Herbs and vitamins
                                                                                   
22% of the women believed that herbs and 
vitamins are safer to use than prescription 
medication; 20% believed that herbs are 
better at treating medical problems than 
prescription medication; 50% agreed that 
they would use herbs if given information 
about these by a doctor. 
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Table 18 Studies which employed quantitative data collection methods (continued) 
 
 
Chomba et al 2010
Zambia and 
Democratic 
Republic of 
Congo
                                                         
Assess pregnant women's knowledge, 
attitudes and behaviours towards 
tobacco use and secondhand smoke 
exposure, and exposure to advertising 
for and against tobacco products None
Quantitative 
(Face-to-face 
survey) n  = 1756 Pregnant women Tobacco
86.5% thought cigarette smoking during 
pregnancy can harm the baby; 96.8% felt 
cigarette smoking can harm a woman's 
health 
Kim and Park 2011 Korea
                                                         
Investigate prenatal alcohol 
consumption and knowledge of alcohol 
risks and foetal alcohol syndrome 
among Korean women None
Quantitative (Self-
completed 
questionnaire) n  = 221 Postpartum women Alcohol
The knowledge level regarding alcohol 
risks and foetal alcohol syndrome among 
participants was poor.
Senecky et al 2011 Israel
                                                         
Evaluate the awareness and knowledge 
of women regarding alcohol 
consumption during pregnancy; 
determine how many women received 
information about alcohol consumption 
from medical professionals; and to 
evaluate the drinking habits of the 
women during pregnancy None
Quantitative 
(Questionnaire) n  = 3815 Postpartum women Alcohol
71.6% claimed that women should not 
consume alcohol at all during pregnancy; 
21.4% thought it was permissible if limited 
to 2 drinks per week
Torres et al  2011
Dominican 
Republic
Assess the attitudes, beliefs, 
perceptions, and practices regarding 
tobacco use and exposure among 
pregnant women None
Quantitative 
(Interview with 
questionnaire) n  = 192 Pregnant women Tobacco
                                                                                   
97% believed women who smoke can 
harm their health; 98% believed pregnant 
women who smoke can harm their unborn 
baby's health; 33% believed tobacco use 
could cause general illness; 15% believed 
it could cause cancer and 1% believed it 
can lead to death.  
Adusi-Poku et al 2012 Ghana
                                                         
Determine the the magnitude of drinking 
and to assess the general knowledge 
about the effects of alcohol in 
pregnancy None
Quantitative 
(Structured 
questionnaire) n  = 397 Pregnant women Alcohol
78% of the women said alcohol could be 
harmful.
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Table 19 Studies which employed qualitative data collection methods 
 
 
Author Year Country Objectives Medicine/Substance studied Major findings
Theoretical framework Data collection Sample size Study participants
Barbour 1990 USA
Explore the drinking behaviours of 
pregnant women and factors influencing 
the behaviours None
Qualitative 
(Interview) n  = 20 Pregnant women Alcohol
                                                                                   
19 of the women knew about the dangers 
of alcohol in pregnancy; many of them 
believed that wine or beer is not as bad as 
other forms of alcohol and that alcohol can 
only cause problems in early pregnancy; 
they also believed that it is dangerous to 
the foetus only if large amounts are 
consumed.
Lawson 1994 USA
                                                         
Examine the role of cigarette smoking in 
the lives of pregnant adolescents None
Qualitative (In-
depth interview) n  = 20
Pregnant 
adolescents Cigarette
                                                                                   
The respondents believed that cigarette 
smoking controlled body weight and that 
cessation consistently produced marked 
weight gain. They also believed that 
cigarette smoking would assure having a 
smaller baby which would result in a 
shorter labour and less painful delivery.  
Kaskutas 2000 USA
Examine pregnant women's drinking 
during pregnancy and their beliefs about 
the risks None
Qualitative 
(Interview) n  = 321 Pregnant women Alcohol
                                                                                   
17% of the women believed that there is a 
point in pregnancy when it is too late to 
reduce one's drinking. In terms of 
comparative safety, 26% of beer drinkers 
said beer is safer; 31% of wine drinkers felt 
wine is safer; 26% of wine cooler drinkers 
said wine cooler is safer.
Holst et al 2009 United Kingdom
Determine the motivations for the use of 
herbal medicine during pregnancy None
Qualitative 
(Focus group 
discussion) n  = 6 Pregnant women Herbal medicines
                                                                             
The women were aware of the fact that 
nothing is absolutely safe but they believed 
that herbs are safer than pharmaceuticals. 
They also knew that interactions of herbals 
with pharmaceuticals could occur. 
Methods Population characteristics
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Table 19 Studies which employed qualitative data collection methods (continued) 
 
 
 
Raymond et al 2009 United Kingdom
Explore pregnant women's attitudes 
towards drinking alcohol in pregnancy 
and their attitudes towards sources of 
information about drinking in pregnancy None
Qualitative 
(Telephone 
interview) n  = 20 Pregnant women Alcohol
Most women considered that there were 
risks involved with drinking during 
pregnancy.
Toutain 2010 France
Determine what the women in France 
say about alcohol abstinence during 
pregnancy None
Qualitative 
(Internet 
discussion) n  = 42 Pregnant women Alcohol
                                                               
80% mentioned alcohol abstinence; 20% 
talked about the consequences of drinking 
on the unborn babies. However, the 
concept of abstinence tends to be 
misunderstood because for most of them, 
abstinence was not perceived as "not 
drinking at all" while little is known about 
the consequences of alcohol consumption 
for the unborn babies  
Jones and Telenta 2012 Australia
                                                         
Explore attitudes towards alcohol 
consumption during pregnancy None
Qualitative (Semi-
structured 
interview) n  = 12 Pregnant women Alcohol
                                                                                   
All the women believed there were no 
benefits to drinking alcohol while pregnant 
and that not drinking was the best option. 
Majority of them expressed a lack of 
knowledge of the actual risks of alcohol 
consumption on the foetus.
Leppo 2012 Finland
Investigate the perception of pregnant 
women about the risks involved in 
prenatal illicit drug use.  None
Qualitative (Semi-
structured 
interview) n  = 14
Pregnant and 
postpartum women Illicit drug - Buprenorphine
                                                                                   
The women were not primarily concerned 
about the health risks of illicit drugs; their 
greatest fears were giving birth to a child 
with withdrawal symptoms; they did not 
see abstaining from drugs as a risk-free 
option. 
Chapter 3 
 
176 
 
Table 20 Studies which reported on health beliefs, attitudes and knowledge 
 
 
 
Author Year Country Objectives Medicine/Substance studied Major findings
Theoretical framework Data collection Sample size Study participants
Barbour 1990 USA
Explore the drinking behaviours of 
pregnant women and factors influencing 
the behaviours None
Qualitative 
(Interview) n  = 20 Pregnant women Alcohol
                                                                                   
19 of the women knew about the dangers 
of alcohol in pregnancy; many of them 
believed that wine or beer is not as bad as 
other forms of alcohol and that alcohol can 
only cause problems in early pregnancy; 
they also believed that it is dangerous to 
the foetus only if large amounts are 
consumed.
Butters and Howie 1990 United Kingdom
Assess the attitudes and knowledge 
among pregnant women of the effects 
of commonly used drugs, cigarette and 
alcohol on the foetus None
Quantitative (Self-
administered 
questionnaire) n  = 514 Postpartum women
Precription and Over-the-counter 
medicines, Cigarette and Alcohol
                                                                                   
85% of the women recognised that the 
foetus is most at risk of being harmed by 
drugs during the first 3 months of 
pregnancy; 83% felt it was safest not to 
smoke any cigarettes at all during 
pregnancy; 88% were aware of the 
adverse effects of smoking on foetal 
growth; 55% thought that alcohol should be 
avoided during pregnancy while 28% 
considered it safe to consume one drink a 
week. 51% thought that drinking alcohol in 
pregnancy could result in growth 
retardation and 66% thought it could cause 
foetal abnormalities. 49% said they would 
take an antibiotic prescribed by the doctor 
while 48% said they would not. 16% would 
avoid taking any form of analgesia during 
pregnancy.  
Methods Population characteristics
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Table 20 Studies which reported on health beliefs, attitudes and knowledge (continued) 
 
 
Lelong et al 1995 France
Investigate the attitudes and behaviour 
of pregnant women towards tobacco 
and alcohol consumption None
Quantitative 
(Interview with a 
structured 
questionnaire) n  = 176
Pregnant and 
postpartum women Alcohol and Tobacco
                                                                             
Most women were aware that alcohol and 
tobacco could be harmful to their babies 
but heavy drinkers recognised the 
influence of alcohol in pregnancy less often 
than the others. Sixty percent (60%) of the 
women thought that two drinks per day 
was a reasonable level of consumption 
during pregnancy.
Milla et al 2007 Honduras
Determine the knowledge, attitudes, and 
practices related to folic acid and birth 
defects among postpartum women None
Quantitative 
(Interview with 
questionnaire) n  = 2619 Postpartum women
Over-the-counter medicine - 
Folic acid
                                                                                   
37.6% of the women were aware that folic 
acid helped to avoid birth defects and was 
good for the growth and development of 
the baby; 24.1% felt folic acid was a 
vitamin or was related to anaemia or iron; 
7.8% thought folic acid was good for health 
in general.
Holst et al 2009 United Kingdom
Determine the motivations for the use of 
herbal medicine during pregnancy None
Qualitative 
(Focus group 
discussion) n  = 6 Pregnant women Herbal medicines
                                                                             
The women were aware of the fact that 
nothing is absolutely safe but they believed 
that herbs are safer than pharmaceuticals. 
They also knew that interactions of herbals 
with pharmaceuticals could occur. 
Jones and Telenta 2012 Australia
                                                         
Explore attitudes towards alcohol 
consumption during pregnancy None
Qualitative (Semi-
structured 
interview) n  = 12 Pregnant women Alcohol
                                                                                   
All the women believed there were no 
benefits to drinking alcohol while pregnant 
and that not drinking was the best option. 
Majority of them expressed a lack of 
knowledge of the actual risks of alcohol 
consumption on the foetus.
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3.4.2 Themes identified 
The themes identified in the reviewed articles are presented under 2 major 
headings – ‘Health beliefs and attitudes’ and ‘Knowledge’. 
3.4.2.1 Prescription medicines 
3.4.2.1.1 Health beliefs and attitudes 
 Being restrictive or careful about use. This theme was identified in 
2 studies. In a Norwegian study by Nordeng et al. (2010a), 87.4% of 
the 866 participants believed that pregnant women should be more 
restrictive regarding use of medications during pregnancy. Forty-eight 
percent (48%) of 514 postpartum women from the UK article by 
Butters and Howie (1990) stated that they would not take an antibiotic 
prescribed by the doctor. 
3.4.2.1.2 Knowledge 
 Trimester of risk. Only one study reported on the knowledge of 
women about prescription medicine use during pregnancy. Butters 
and Howie (1990) in a UK study of 514 postpartum women found that 
85% of the participants recognised the first 3 months of pregnancy as 
the period when the foetus is most at risk of being harmed by 
medicines. 
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3.4.2.2 Over-the-counter medicines 
3.4.2.2.1 Health beliefs and attitudes 
 Being restrictive or careful about use. This theme was also noted 
in 3 studies. Baric and MacArthur (1977) reported that 75% of 243 
participants thought that a pregnant woman should not take any 
medicines without first consulting a doctor; 92.4% of a sample of 173 
pregnant women agreed with the statement that medications should 
be avoided during pregnancy (Dow-Clarke et al., 1994) while in a UK 
study of 514 postpartum women, 16% stated that they would avoid 
taking any form of analgesia during pregnancy (Butters and Howie, 
1990). 
 Benefits of vitamins. The attitudes of women about the benefits of 
vitamins were highlighted in 2 articles. Milla et al. (2007) indicated that 
24.1% of the 2619 respondents felt folic acid was a vitamin or was 
related to anaemia or iron while 7.8% of the women thought folic acid 
was good for health in general. This finding is not far removed from 
the report by Bercaw et al. (2010) in which 22% of the 485 postpartum 
responders expressed beliefs that vitamins are safe to use. 
3.4.2.2.2 Knowledge 
 Benefits of vitamins. The Honduran study by Milla et al. (2007) also 
found that 37.6% of the participants were aware that folic acid helped 
to avoid birth defects and was good for the growth and development 
of the baby. 
 
Chapter 3 
 
180 
 
3.4.2.3 Complementary and alternative medicines 
3.4.2.3.1 Health beliefs and attitudes 
 Efficacy. Four studies described women’s beliefs about the efficacy of 
complementary and alternative medicines with or without comparison 
to conventional medicines. The study by Fakeye et al. (2009) in 
Nigeria found that 81% of the 595 pregnant women believed in the 
efficacy of herbal medicines. In Australia, another study with 220 
respondents revealed that 36.4% of them believed complementary 
and alternative medicines to be more effective than conventional 
medicines (Gaffney and Smith, 2004). In a sample of 485 postpartum 
women in the USA, Bercaw et al. (2010) discovered that 20% of the 
women believed that herbs are better at treating medical problems 
than prescription medication. Lapi et al. (2008) however indicated that 
62.7% of the 172 participants considered complementary and 
alternative medicines as having equal efficacy as conventional drugs. 
 Safety. The beliefs and attitudes of pregnant women about the safety 
of complementary and alternative medicines were reported by 7 
papers – 1 qualitative and 6 quantitative. Fakeye et al. (2009) 
demonstrated that 33.4% felt herbal medicines were safe. Gaffney 
and Smith (2004) reported that majority of the pregnant respondents 
considered the use of complementary and alternative medicines to be 
safe during pregnancy and 50% of them felt that complementary 
treatment is a more natural form of healing than conventional 
medicine. Bercaw et al. (2010) indicated that 22% of the participants 
believed that herbs are safer to use than prescription medication. In a 
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qualitative study- focus group discussion of 6 participants in the UK - 
Holst et al. (2009b) reported that the pregnant women believed that 
herbs are safer than pharmaceuticals. Lapi et al. (2008) indicated that 
52% of the pregnant women were convinced that complementary and 
alternative medicines are safer than conventional medications. In a 
study of 400 postpartum women in Norway, Nordeng and Havnen 
(2005) reported that 62.3% of the women agreed that herbal drugs 
generally give less adverse effects than conventional drugs and 57% 
of them agreed that herbal drugs can be used by pregnant women. In 
addition, 40.8% of the respondents believed that pregnant women 
should preferably use herbal drugs than other drugs. Furthermore, in 
the article by Nordeng et al. (2010a), 22.9% of the 866 pregnant 
women agreed that natural remedies are safer than conventional 
medicines; about 12% of them agreed that herbal medicines can 
generally be used by pregnant women; and about 13% of the study 
participants agreed that pregnant women should preferably use herbal 
remedies during pregnancy. 
 Seeking advice/consent from the doctor. Three articles indicated 
the attitudes of women about seeking advice before using 
complementary and alternative medicines during pregnancy. Bercaw 
et al. (2010) reported that half of the study respondents agreed that 
they would use herbs if given information about it by a doctor. 
Nordeng and Havnen (2005) noted that 56.5% of the subjects agreed 
that pregnant women should not use herbal drugs without the consent 
of the physician. Nordeng et al. (2010a) also reported that 69.6% of 
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the study participants believed that pregnant women should not use 
herbal remedies without the consent of the doctor. 
 Holistic approach and participation in maintaining health. Gaffney 
and Smith (2004) demonstrated that 61.4% of the subjects said they 
valued the emphasis on treating the whole person which is the usual 
approach of complementary practitioners; 52.3% believed that 
complementary and alternative medicines enable them to take a more 
active part in maintaining their health and 11.4% of them agreed that 
they have a more equal relationship with their complementary 
practitioner than with their doctor. 
3.4.2.3.2 Knowledge 
 Safety issues and drug interactions. Holst et al. (2009b) 
demonstrated that the 6 pregnant women who participated in a focus 
group discussion were aware of the fact that nothing is absolutely safe 
in pregnancy. They also knew that interactions of herbals with 
pharmaceuticals could occur. 
3.4.2.4 Illicit substance (Buprenorphine) 
3.4.2.4.1 Health beliefs and attitudes 
 Health risks to mother and baby. In a Finnish study by Leppo 
(2012), it was reported that the women were not primarily concerned 
about the health risks to themselves of illicit drugs but their greatest 
fears were giving birth to a child with withdrawal symptoms. They also 
did not see abstaining from drugs as a risk-free option. 
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3.4.2.5 Tobacco 
3.4.2.5.1 Health beliefs and attitudes 
 Health risks to mother and baby. Four articles reported on women’s 
beliefs about the health risks of tobacco use on themselves and the 
developing child. A South African study (Steyn et al., 1997) reported 
that in a sample of 394 pregnant women, 88.8% of them believed that 
smoking is bad for the mother’s health while 92.1% believed that 
smoking is bad for the unborn baby’s health. Similarly, the article by 
Torres et al. (2011) reported that 97% of the 192 pregnant participants 
believed women who smoke can harm their health, 98% believed 
pregnant women who smoke can harm their unborn baby’s health, 
33% believed tobacco use can cause general illness, 15% believed it 
can cause cancer and 1% believed it can lead to death. Garcias and 
Schuler-Faccini (2004) in their Brazilian work on 3219 postpartum 
respondents also reported that 88.4% of them believed that tobacco 
smoking can cause congenital defects. In the study by Chomba et al. 
(2010), 86.5% of the 1756 pregnant women thought cigarette smoking 
during pregnancy can harm the baby while 96.8% felt cigarette 
smoking can harm a woman’s health. 
 Reduction or no intake. Two studies documented women’s attitudes 
to smoking during pregnancy. Baric and MacArthur (1977), in a 
quantitative work on 243 participants reported that 39% of them 
thought that a pregnant woman was not expected to smoke at all 
while 40% thought that pregnant women were expected to reduce the 
number of cigarettes smoked. Similarly, Butters and Howie (1990) in 
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their UK quantitative work on 514 postpartum participants showed that 
83% of them felt it was safest not to smoke any cigarettes at all during 
pregnancy.  
 Benefits of smoking. In an in-depth interview of 20 pregnant 
adolescents conducted in the USA by Lawson (1994), the 
respondents believed that cigarette smoking controlled body weight 
and that cessation consistently produced marked weight gain. They 
also believed that cigarette smoking would assure having a smaller 
baby which would result in a shorter labour and less painful delivery. 
3.4.2.5.2 Knowledge 
 Awareness of health risks to the baby. Six articles demonstrated 
the awareness of the women about the risks of smoking during 
pregnancy on the foetus. In a quantitative research conducted on 176 
pregnant and postpartum women in France (Lelong et al., 1995), most 
of the women were aware that tobacco could be harmful to the baby. 
A similar Turkish study by Karcaaltincaba et al. (2009) also reported 
that 97.5% of the 1020 participants knew smoking was harmful while 
62.5% were aware of at least three hazardous effects. The study of 
864 pregnant women in Lebanon (Chaaya et al., 2004) reported that 
78.4% of the respondents knew that cigarette affects the foetus, 
76.8% knew that cigarette affects the newborn, 68.7% were aware 
that cigarette contains addictive substances while 69% knew it 
contains carcinogens. An Irish study conducted by Daly et al. (1992) 
demonstrated that 93 of the 100 postpartum women were aware of 
the harmful effects of smoking during pregnancy. In a UK study by 
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Butters and Howie (1990), 88% of the participants were aware of the 
adverse effects of smoking on foetal growth. In terms of the specific 
health hazards associated with smoking, Griffiths et al. (2005) carried 
out a study in the UK with 145 pregnant women. The authors reported 
that 92% of the participants were aware that smoking can cause lung 
cancer, 76% knew it can cause myocardial infarction, 50% knew it can 
cause miscarriage, 34% were aware it can cause ante-partum 
haemorrhage, 44% knew it can cause decreased birth weight, 33% 
knew it can cause slower cognitive development while 38% of the 
women were aware it can lead to cot death. 
 Insufficient information about health risks to the baby. In 2 
articles, the authors reported that women had insufficient or no 
information about the risks of tobacco use on the developing baby. 
The article by Kralikova et al. (2005) which was a research carried out 
in Czech Republic reported that most of the 265 postpartum women 
had insufficient information about the impact of smoking on the baby. 
Similarly, a quantitative research of 310 pregnant women in Papua 
New Guinea (Senn et al., 2009) demonstrated that 80% of the women 
perceived no risk to the foetus in using betel nut (‘smokeless’ tobacco) 
during pregnancy. 
3.4.2.6 Alcohol 
3.4.2.6.1 Health beliefs and attitudes 
 Health risks to the baby. Three articles highlighted expectant 
mothers’ beliefs about the risks of alcohol consumption on the foetus. 
Butters and Howie (1990) showed that 51% of the participants thought 
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that drinking alcohol in pregnancy could result in growth retardation 
and 66% thought it could cause foetal abnormalities. In a Brazilian 
study by Garcias and Schuler-Faccini (2004) in which 3219 
postpartum women were interviewed with a questionnaire, 88.8% of 
them believed that alcohol consumption can cause congenital 
abnormalities. It was also reported by Raymond et al. (2009) in a 
qualitative study of 20 pregnant women conducted in the UK that most 
of the participants considered that there were risks involved with 
drinking during pregnancy.  
 Quantity and period associated with risks. This was reported in 2 
papers. In a sample of 20 pregnant women recruited for a qualitative 
study in the USA by Barbour (1990), many of the women believed that 
alcohol can only cause problems in early pregnancy. They also 
believed that alcohol is dangerous to the foetus only if large amounts 
are consumed. Kesmodel and Kesmodel (2002) indicated that 85% of 
the subjects believed that binge drinking was potentially harmful to the 
foetus. 
 Comparative safety of alcohol types. Women’s comparison of the 
safety of alcohol types were documented in 2 studies. In a qualitative 
interview with 321 pregnant women in the USA by Kaskutas (2000), it 
was reported that 26% of beer drinkers said beer is safer, 31% of wine 
drinkers felt wine is safer and 26% of wine cooler drinkers said wine 
cooler is safer than other kinds of alcohol. Barbour (1990) also found 
that many of the women believed that wine or beer is not as bad as 
other forms of alcohol. 
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 Reduction or no intake. Seven papers demonstrated the attitudes of 
pregnant women to alcohol consumption during pregnancy. Senecky 
et al. (2011), in an Israeli study of 3815 postpartum women showed 
that 71.6% of the respondents felt that women should not consume 
alcohol at all during pregnancy while 21.4% thought it was permissible 
if limited to 2 drinks per week. In a French study by Lelong et al. 
(1995), 60% of the participants (n = 176) thought that 2 drinks per day 
was a reasonable level of consumption during pregnancy. A Canadian 
study by Dow-Clarke et al. (1994) recruited 173 pregnant women and 
discovered that 43.4% of the respondents agreed with the statement 
that it is okay to drink occasionally during pregnancy. Butters and 
Howie (1990) reported that 55% of the 514 participants thought that 
alcohol should be avoided during pregnancy while 28% considered it 
safe to consume one drink a week. Baric and MacArthur (1977) 
reported that 51% of the 243 participants in their UK study felt that 
pregnant women are expected to reduce their drinking or to drink only 
small amounts of alcohol while 8% felt they were expected to stop 
taking alcohol completely. A Danish work by Kesmodel and Kesmodel 
(2002) on 439 pregnant women revealed that 76% of them considered 
some alcohol intake during pregnancy to be acceptable on a weekly 
basis. All the women (n = 12) in a qualitative interview by Jones and 
Telenta (2012) in Australia believed there were no benefits to drinking 
alcohol while pregnant and that not drinking was the best option. 
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 Beneficial effects of drinking. Baric and MacArthur (1977) reported 
that 7% of the participants believed that there was a beneficial effect 
in drinking stout during pregnancy.  
3.4.2.6.2 Knowledge 
 Awareness of health risks to the baby.  Six articles described the 
knowledge of women about the risks of taking alcohol during 
pregnancy on the baby. In a French study by Lelong et al. (1995), 
most of the 176 participants were aware that alcohol can be harmful to 
the baby but heavy drinkers recognised the influence of alcohol in 
pregnancy less often than the others. A large questionnaire study of 
14,239 pregnant women was carried out in Japan by Yamamoto et al. 
(2008). This study reported that 72.8% of the women had knowledge 
regarding the risks of alcohol consumption during pregnancy. Chang 
et al. (2006) reported that 79.9% of the subjects were aware that there 
is no universally safe level of prenatal alcohol use while 94% knew 
that alcohol exposure may have negative effects throughout 
pregnancy. In the USA, Barbour (1990) employed a qualitative 
approach to interview 20 pregnant and discovered that 19 of them 
knew about the dangers of alcohol in pregnancy. Daly et al. (1992) in 
their Irish study documented that 58 of the 100 postpartum 
respondents were aware of the harmful effects of alcohol during 
pregnancy. In a Ghanaian study by Adusi-Poku et al. (2012), 78% of 
the 397 sample of pregnant women said alcohol could be harmful. 
 Insufficient information about health risks to the baby. This theme 
was identified in 3 papers. In France, Toutain (2010) carried out a 
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qualitative research in form of internet discussion with 42 pregnant 
women and discovered that the concept of abstinence tends to be 
misunderstood by the women. For most of them, abstinence was not 
perceived as “not drinking at all”. Also, little is known about the 
consequences of alcohol consumption for the unborn babies. Majority 
of the pregnant women in an article by Jones and Telenta (2012) 
expressed lack of knowledge of the actual risks of alcohol 
consumption on the foetus. Similarly, a Korean work by Kim and Park 
(2011) on 221 postpartum women investigated the knowledge of 
participants about alcohol risks. It was discovered that the knowledge 
level regarding alcohol risks and foetal alcohol syndrome among 
participants was poor. 
 
3.5 Discussion 
3.5.1 Methodological issues 
In designing appropriate intervention strategies as well as effective 
implementation which is targeted at promoting healthy behaviours in 
pregnancy, the importance of recognising and understanding the common 
beliefs, attitudes and knowledge of women about medicine and recreational 
substance use cannot be over-emphasised.  
The articles included in this review represent different quantitative and 
qualitative approaches for investigating the health beliefs, attitudes and 
knowledge of expectant mothers regarding medicines and recreational 
substance use in pregnancy. It is noteworthy that the papers are from 
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different parts of the world; health care beliefs and practices are diverse, 
complex and differ across ethnic, cultural and social boundaries. Culture has 
some influence on perceptions of health and diseases while antenatal 
services and policies also differ between countries. Furthermore, there is 
heterogeneity amongst articles due to differences in study objectives, sample 
sizes, data collection methods (quantitative or qualitative), study participants 
(pregnant or postpartum women) and the medicines or recreational 
substances studied. A major cause of heterogeneity is the data collection 
methods employed by the papers. Therefore, the findings should be 
interpreted with caution. 
In the quantitative studies, participants were either interviewed with a 
questionnaire or self-administered the questionnaires. Only one of the 
reviewed articles employed self-administered internet questionnaire. Self-
administered questionnaires are thought to be less prone to influences on 
response patterns (Cartwright, 1988). However, the study objectives, the 
introductory letter and the questionnaire lay-out all have some influence on 
the response (Lyberg and Kasprzyk, 1991). On the other hand, interviewing 
participants with a questionnaire allow each participant to ask clarifying 
questions, thus enhancing more complete answers (Nordeng and Havnen 
2005). The internet questionnaire is an efficient way of collecting population-
based data as it helps to reduce the risk for sampling bias but its limitation is 
that not all households have access to the internet and it is likely that those 
who will participate in the study will have a higher education than the general 
population of pregnant women (Nordeng et al., 2010a). 
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Generally, quantitative studies are based on responses to questions which 
participants might not be able to expand on. Also, the data collection 
instruments – questionnaires - used by the different studies might vary; there 
could have been inconsistencies in the questions asked and how they were 
framed. Furthermore, it is not possible to assess all aspects of beliefs, 
attitudes and knowledge with the use of questionnaire as some other aspects 
cannot be covered due to the choice of statements in the questionnaire 
(Nordeng et al., 2010a). 
The different approaches to the qualitative method of data collection 
employed by the articles were focus group discussion, face-to-face individual 
interview, telephone interview and internet discussion. Focus groups can 
stimulate discussion through group dynamics; the interaction within the group 
provides a social context in which participants can develop their ideas 
(Krueger, 1994; Pletsch and Johnson, 1996). However people may also feel 
uncomfortable about disclosing or expressing their views on sensitive issues 
with complete strangers (Krueger, 1994; Van der Kooi and Theobald, 2006). 
Face-to-face individual interviews have the advantage of eliciting non-verbal 
information (Raymond et al., 2009); its disadvantage is that it is expensive 
and has the potential of producing interviewer effects in terms of producing 
responses that depend partly on how the interviewer looks, poses the 
questions, and expresses his or her body language (Bradburn and Sudman, 
1979). Telephone interviews are usually less expensive than face-to-face 
interviews (Frey, 1989); and interviewer effects are expected to be lower 
than in face-to-face interviews (Nybo Andersen and Olsen, 2002). It has 
been reported that women are more open in an anonymous telephone 
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interview compared to face-to-face interview at an unfamiliar location 
(Raymond et al., 2009). However, the absence of face-to-face contact with 
the interviewer might have some influence on participant’s responses 
(Kormendi and Noordhoek, 1989). An internet discussion was carried out in 
one study. As stated earlier under the internet questionnaire, the limitation of 
this data collection method is that the participants are more likely to be more 
educated than the general pregnant population (Nordeng et al., 2010a). 
Additionally, none of the qualitative articles employed a theoretical 
framework in the studies. 
3.5.2 Major Findings 
Some of the articles in this review studied more than one medicine or 
recreational substance; 31 of the reports were on alcohol and tobacco, few 
articles studied prescription, over-the-counter and complementary and 
alternative medicines while only one article reported the beliefs and attitudes 
of pregnant women about an illicit substance. 
The 2 studies on prescription medicines revealed that women’s health beliefs 
and attitudes were more of being restrictive or careful about medicine use 
during pregnancy. The first trimester was also noted by women to be the 
period when the foetus is most at risk of being harmed by medicines.  
The articles on over-the-counter medicines also showed that women’s health 
beliefs and attitudes were more of being careful or restrictive about use of 
such medicines during pregnancy. The studies also found that women knew 
and believed that vitamins were good for the growth and development of the 
baby, helped to avoid birth defects, and were safe to use.  
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Most of the articles on complementary and alternative medicines 
demonstrated that women believed in the safety and efficacy of the 
therapies. They however felt it is better to seek the consent or advice of the 
doctor before using the therapies. One article further indicated that women 
were aware that interactions of herbals with conventional medicines could 
occur while another study reported women’s positive attitude about the 
holistic approach and active participation in maintaining health which 
complementary and alternative medicines offer them. 
With regard to alcohol, most of the studies demonstrated that women 
believed that abstinence or reduction in intake during pregnancy were the 
safe options. The participants were also aware and believed in the health 
risks of alcohol consumption during pregnancy on the unborn baby. A few 
other articles reported that: women believed that consumption of alcohol in 
early pregnancy and binge drinking can be potentially harmful to the foetus; 
wine or beer were safer than other types of alcohol; there are beneficial 
effects of drinking in pregnancy; and that women had insufficient information 
about the health risks of consumption on the unborn child. 
Most of the studies on tobacco similarly showed that women were aware and 
believed in the health risks of consumption during pregnancy on the foetus 
and the mother. Two of the articles also reported that women believed that 
abstinence or reduction in intake during pregnancy were the safe options. In 
contrast to these findings, a study on pregnant adolescents discovered their 
beliefs on the benefits of smoking in pregnancy with regard to body weight 
control, having a smaller baby, shorter duration of labour, and less painful 
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delivery. Two other papers reported women’s insufficient knowledge about 
the risks of tobacco use during pregnancy on the developing baby. 
The only study on illicit substance reported that the women were not 
primarily concerned about the health risks to themselves of illicit substances 
but their greatest fears were giving birth to a child with withdrawal symptoms; 
they also did not see abstaining from drugs as a risk-free option. 
3.6 Implications for this thesis 
This review has provided information on the common health beliefs, attitudes 
and knowledge of women about medicine and recreational substance use 
during pregnancy. However, some gaps have been identified in the 
international literatures. 
First, most of the published studies are quantitative (section 3.4.1), and little 
is known about women’s in-depth beliefs, attitudes and knowledge about 
medicine and recreational substance use and the impact of these factors on 
health behaviours in pregnancy. Thus, qualitative approach is necessary in 
future studies since this possess a great value in sensitively exploring 
perceptions, experiences and understanding of issues in different contexts 
(Van der Kooi and Theobald, 2006). 
Second, in the identified articles which employed qualitative data collection 
methods, there is lack of theoretical research processes in the studies as 
none of them employed a theoretical framework. Therefore, another aspect 
which needs to be developed is the use of a theoretical framework which 
takes into account the context of the lives of the expectant mothers. Such a 
theoretical framework enables researchers to look at issues or problems 
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from different angles while focusing their attention on the different parts of 
the data. It also provides a framework for data analysis and may contribute to 
the designing of intervention strategies in order to improve maternal and 
foetal outcomes (Reeves et al., 2008). Accordingly, future qualitative studies 
which will employ theoretical frameworks are important to enrich the 
understanding of these factors in pregnancy and how women contextualise 
issues.  
Third, only 6 papers studied all the factors of interest – health beliefs, 
attitudes and knowledge (Table 20) out of which 3 were published in the last 
decade. Therefore, current studies which aim to link health beliefs and 
attitudes to knowledge are necessary in order to determine the impact of 
knowledge on the other factors and to define and explain relationships. For 
example, Leppo (2012) investigated the perceptions of pregnant women 
about the risks involved in prenatal illicit substance use. The author found as 
part of the results that ‘the women did not see abstaining from drugs as a 
risk-free option’. An assessment of the women’s knowledge on the subject 
matter would have provided the researcher with additional information on 
why the participants held such a belief. 
Fourth, majority of the studies (n = 32) were carried out both on subjects that 
used and did not use medicines or recreational substances while only 3 
studies were conducted only on those that used medicines and recreational 
substances (Lawson, 1994; Holst et al., 2009b; Leppo, 2012). It is therefore 
possible that in those 32 studies, users and non-users will have different 
beliefs or attitudes depending on their level of knowledge. Future qualitative 
studies which would aim for women who have used medicines or 
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recreational substances are especially important to determine their 
perceptions about what they have used. Results from such studies can help 
to better clarify relationships between factors while also informing the 
provision of evidence-based counselling about use of medicines and 
recreational substances in the antenatal period.  
Fifth, it is important to note that fewer number of articles reported on 
prescription medicines (n = 2), over-the-counter medicines (n = 5) and 
complementary and alternative medicines (n = 7) compared to recreational 
substances (n = 32). However, studies have reported that some pregnant 
women have medical conditions which require pharmacological treatment 
and that avoidance of medicine use can be impractical in such situations 
(Andrade et al., 2004; Bakker et al., 2006). Since people’s health beliefs, 
attitudes and knowledge have significant impacts on health behaviours, 
findings from future qualitative work on medicine use in pregnancy can 
provide a greater insight into the types of health behaviour changes which 
occur as a result of pregnancy and the reasons for such changes. 
Finally, in the last two decades, only 3 United Kingdom studies were 
identified in this review. Griffiths et al. (2005) was a quantitative study of 
women’s knowledge of the risk of tobacco in pregnancy; Holst et al. (2009b) 
reported a focus group discussion of six women about their beliefs and 
knowledge of herbals in pregnancy; while Raymond et al. (2009) qualitatively 
explored women’s attitudes towards alcohol consumption during pregnancy 
(Table 21). These imply that further work on this topic is especially 
necessary. 
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Table 21 Studies carried out within the United Kingdom in the past two decades 
 
 
 
Author Year Country Objectives Medicine/Substance studied Major findings
Theoretical framework Data collection Sample size Study participants
Griffiths et al 2005 United Kingdom
Assess pregnant women's 
knowledge of foetal and 
maternal risk of smoking and 
to determine the motivators 
for smoking cessation None
Quantitative 
(Interview with a 
questionnaire) n  = 145 Pregnant women Tobacco
                                                                                   
92% of the women were aware that 
smoking can cause lung cancer; 76% 
knew it can cause myocardial 
infarction; 50% knew it can cause 
miscarriage; 34% were aware it can 
cause ante-partum haemorrhage; 44% 
knew it can cause decreased birth 
weight; 33% knew it can cause slower 
cognitive development; 38% were 
aware it can lead to cot death. 
Holst et al 2009 United Kingdom
Determine the motivations for 
the use of herbal medicine 
during pregnancy None
Qualitative 
(Focus group 
discussion) n  = 6 Pregnant women Herbal medicines
                                                                             
The women were aware of the fact that 
nothing is absolutely safe but they 
believed that herbs are safer than 
pharmaceuticals. They also knew that 
interactions of herbals with 
pharmaceuticals could occur. 
Raymond et al 2009 United Kingdom
Explore pregnant women's 
attitudes towards drinking 
alcohol in pregnancy and their 
attitudes towards sources of 
information about drinking in 
pregnancy None
Qualitative 
(Telephone 
interview) n  = 20 Pregnant women Alcohol
Most women considered that there 
were risks involved with drinking during 
pregnancy.
Methods Population characteristics
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3.7 Summary 
This narrative review provides researchers and healthcare professionals with 
the common health beliefs, attitudes and knowledge about medicine and 
recreational substance use in the pregnant population. However, the 
published articles on this topic are mainly quantitative studies, hence there is 
scarcity of information on women’s in-depth beliefs, attitudes and knowledge 
about medicine and recreational substance use during pregnancy and the 
effects of these on health behaviours. 
The review therefore underscores the fact that a comprehensive 
understanding of these factors and their relationships is necessary and can 
better be provided by employing qualitative approach (which incorporates a 
theoretical framework) in data collection. Findings from such qualitative 
studies would also help to complement and broaden the results of the 
existing quantitative studies. This additional knowledge would be invaluable 
to women’s health researchers and those involved in maternity care services. 
Thus chapter 4 of this thesis investigates the health beliefs of pregnant 
women using a qualitative data collection method. 
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CHAPTER 4 - A QUALITATIVE STUDY ON THE HEALTH BELIEFS OF 
PREGNANT WOMEN 
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4.1 Introduction 
The health-related activities that pregnant women engage in and the extent 
to which they follow treatment regimens are related to their beliefs or 
perceptions (Heaman et al., 2004). 
Since the thalidomide tragedy, standard medical advice has been that no 
medicines are safe to use during pregnancy (Baggley, 2004). Healthcare 
professionals still advise pregnant women to avoid medicines unless if it is 
extremely necessary. Because most pregnant women will do everything 
possible to have a normal and healthy baby, they are most likely to heed this 
advice. (Baggley, 2004). 
The claims that complementary therapies are natural and safe may appeal to 
pregnant women who are often concerned about their unborn baby’s 
wellbeing (Nordeng and Havnen 2005). It has been proposed that users of 
these modalities hold a particular set of values and beliefs which may have 
contributed to their reasons for choosing them (Easthope, 1993). 
As regards recreational substances, contact with the health care system 
increases the likelihood that pregnant women will change their habits to 
protect the developing child (Chaaya et al., 2004). However, it has been 
pointed out that expectant mothers’ behaviour will in any case be made 
according to risk perception and available information from health personnel, 
media, friends and family which are evaluated against previous experience 
(Kesmodel and Kesmodel 2002).  
Understanding health beliefs has emerged as an important concept in 
developing behavioural change programmes since the 1980s, although few 
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studies have been undertaken to explore these issues in the pregnant 
population. (Nutbeam and Harris, 2004).  
Thus, it is crucial to determine the health beliefs of expectant mothers about 
medicine and recreational substance use during pregnancy as the findings 
can provide a basis for development of relevant clinical interventions in order 
to promote maternal and foetal health. 
4.2 Aim 
To investigate the beliefs of pregnant women about their health as well as 
medicine and recreational substance use in pregnancy. 
4.3 Research questions 
1. What are the perceptions of pregnant women about their health in 
pregnancy? 
2. What are the perceptions of pregnant women about their unborn baby’s 
health? 
3. How do maternal characteristics influence perceptions of health of the 
mother and unborn baby? 
4. How do pregnant women’s perceptions influence medicine or recreational 
substance use during pregnancy? 
4.4 Research Ethics 
An amendment of the protocol for the quantitative study was made to include 
the qualitative interviews as part of the follow up of the women in the third 
trimester. This was submitted to the South East London REC 3 (Research 
Ethics Committee 3). Approval was obtained and the qualitative study was 
carried out only with participants from University College London Hospital. 
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The R and D (Research and Development) approval was obtained from the 
hospital before participants were interviewed. 
 
4.5 Methods 
4.5.1 Phenomenological approach 
A phenomenological approach was employed in this study. This approach 
describes the meaning for individuals of their lived experiences of a concept 
or a phenomenon. As such the study is powerful for understanding subjective 
experience, the features of the phenomenon as well as gaining insights into 
people’s motivations and actions. It would be important to understand these 
experiences of individuals in order to develop practices and policies or to 
inform, support or challenge policy and action (Lester, 1999; Creswell, 2007). 
Knowing some common experiences can be valuable for groups such as 
therapists, teachers, health personnel, and policymakers. Hence, 
phenomenology is popular in the social and health sciences, nursing, 
psychology and education (Creswell, 2007). 
To this end, qualitative researchers identify a phenomenon of interest to 
study - an “object” of human experience (van Manen, 1990). This human 
experience may be phenomena such as insomnia, anger, grief, 
professionalism, what it means to be underweight, or what it means to be a 
wrestler. Data are then collected from the individuals who have experienced 
the phenomenon. Often data collection in phenomenological studies consists 
of in-depth interviews and multiple interviews with participants. A variety of 
other methods can also be used, including conversations, participant 
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observation, action research, focus meetings, discussions and analysis of 
personal texts and representing it from the perspective of the research 
participants (Creswell, 2007). 
Polkinghorne (1989) recommends that researchers interview from 5 to 25 
carefully chosen individuals who have all experienced the phenomenon in 
question, so that the researcher, in the end, can forge a common 
understanding. After data collection, the researcher develops a composite 
description of the essence of the experience for all of the individuals. This 
description consists of “what” they experienced and “how” they experienced 
it (Moustakas, 1994). Phenomenology is not only a description, but it is also 
seen as an interpretive process in which the researcher makes an 
interpretation (i.e., the researcher “mediates” between different meanings) of 
the meaning of the lived experiences (van Manen, 1990). 
This is in contrast to the grounded theory approach which moves beyond 
description and interpretation to generate or discover a theory, an abstract 
analytical schema of a process, action or interaction (Strauss and Corbin, 
1998).   
4.5.2 Justification for choosing the Health Belief Model as the 
theoretical framework 
In section 3.6 of chapter 3, it was suggested that qualitative research which 
incorporates a theoretical framework is the most suitable method of 
collecting data about the perceptions, beliefs and attitudes of expectant 
mothers.  
Qualitative research focuses on how people interpret their experiences and 
how they use those interpretations to guide their way of life. It is “the most 
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appropriate method of gathering data when the purpose of the research is to 
expose beliefs, perceptions, attitudes, and opinions that are otherwise 
hidden in people’s minds” (Ritchie, 2001). Thus, interviews make it possible 
for respondents to use their own words to describe their views and beliefs 
and this helps achieve a better and broader understanding of such beliefs 
and views. It is generally believed that interviews can capture perceptions in 
ways that a questionnaire cannot (Rich and Ginsburg, 1999).  
Furthermore the use of theories in qualitative research is important in patient 
care and health policy because it enables researchers to gain insights into 
the processes which occur latently, develop the knowledge of the underlying 
principles to such processes, and to translate and present such to the 
stakeholders. The use of theories in qualitative research is therefore 
immediate, insightful, and applicable in practice (Reeves et al., 2008). There 
are many theories and models which can be used to assess health beliefs, 
but the most commonly used are summarised below. 
 Theory of Planned Behaviour (TPB) is a behavioural prediction 
theory which represents a social-psychological approach to 
understanding and predicting the determinants of health-behaviour 
(Montano et al., 1997). It suggests that performance of a given 
behaviour is a function of both the intentions and perceived 
behavioural control (Jones et al., 2009). There are several limitations 
of the TPB, which include that it does not account for other variables 
that affect behavioural intention and motivation, such as fear, threat, 
mood, or past experience. It also does not take into account 
environmental or economic factors that may influence a person's 
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intention to perform a behaviour. Furthermore, the majority of TPB 
research has focused on the prediction of behavioural intention rather 
than on the behaviour itself. Unfortunately, because the correlation 
between behaviour and intention is not particularly impressive, 
research on attitudes and behaviours is often dismissed (Redding et 
al., 2000). 
 The Transtheoretical Model (TTM) or Stages of change model is a 
model of intentional behaviour change (Redding et al., 2000). The 
model has informed the development of numerous interventions to 
facilitate health-related behaviour change in the past two decades and 
is considered by many to be the dominant model of health behaviour 
change (Armitage, 2009). The model describes five stages of a 
person’s readiness to change an unhealthy behaviour – Pre-
contemplation, Contemplation, Preparation, Action and Maintenance. 
(Jones et al., 2009). One of the limitations of the model is that it 
assumes that individuals make coherent and logical plans in their 
decision-making process when this is not always true. The theory also 
ignores the socio-economic context in which change occurs. 
 Social Cognitive Theory (SCT) emphasizes what people think and 
its effect on their behaviour (Perry et al., 1990; Baranowski et al., 
1997). The theory goes well beyond individual factors in health 
behaviour change to include environmental and social factors. In fact, 
this theory may be the most comprehensive model of human 
behaviour yet proposed. The concept of SCT states that there is a 
continuous, dynamic interaction between the individual, the 
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environment, and behaviour. Thus, a change in one of these factors 
impacts on the other two (Redding et al., 2000). As the theory involves 
numerous key concepts and can be broad-reaching, its major 
shortcoming is that it can be difficult to operationalise in entirety. 
 The Health Belief Model (HBM) is derived from behavioural and 
psychological theory. It was developed in the 1950s by social 
psychologists at the United States Public Health Services to help 
identify, explain and predict public attitudes and behaviour around 
health issues (Rosenstock, 1974; Janz and Becker, 1984). The model 
describes a person’s health behaviour as an expression of health 
beliefs and is the most commonly used theory in health education and 
health promotion (Glanz et al., 2002; National Cancer Institute, 2003). 
It also provides a way to understanding and predicting how people will 
behave in relation to their health and how they will comply with 
treatment regimens. Since its development, the HBM has been 
employed in a variety of public health settings over the years. The 
model’s ability to explain and predict variety of health-related 
behaviours has been validated across various domains and among 
wide range populations (Janz and Becker 1984; Carpenter, 2010), of 
which three broad areas can be identified: 1. Preventive health 
behaviours, which include health-promoting (e.g. diet, exercise) and 
health-risk (e.g. smoking) behaviours as well as vaccination and 
contraceptive practices; 2. Sick role behaviours, which refer to 
compliance with treatment regimens; and 3. Clinic use, which includes 
physician visits for a variety of reasons (Conner and Norman, 1996). 
Chapter 4 
 
207 
 
The model has also been used in designing many successful health 
interventions (Arik and Boeijen, 2009; Kharrazi, 2009). 
The HBM was therefore chosen as the theoretical framework for this study 
because it is the most appropriate for the research aim and objectives. The 
main constructs of the model are Perceived Susceptibility, Perceived 
Severity, Perceived Benefits and Perceived Barriers (Rosenstock, 1974). 
Each of these perceptions, individually or in combination, can be used to 
explain health behaviour. More recently, other constructs have been added 
to the HBM; thus the model has been expanded to include Modifying 
Factors, Cues to Action and Self-Efficacy. 
Perceived Susceptibility/Risk/Vulnerability. Personal risk or susceptibility 
is a powerful perception which helps in prompting people to adopt healthier 
behaviours. The greater the perceived risk, the greater the likelihood of 
engaging in behaviours to decrease risk (Rosenstock, 1974). 
Perceived Severity/Seriousness. The construct of perceived severity is an 
individual’s belief about the seriousness or severity of a disease or condition. 
While the perception of severity is often based on medical information or 
knowledge, it may also come from beliefs a person has about the difficulties 
a disease would create or the effects it would have on his or her life in 
general (Rosenstock, 1974). When the perception of susceptibility is 
combined with severity, it results in perceived threat (Stretcher and 
Rosenstock, 1997). 
Perceived Benefits. This is a person’s opinion of the value or usefulness of 
a new behaviour in decreasing the risk of developing a disease. People tend 
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to adopt healthier behaviours when they believe the new behaviour will 
decrease their chances of developing a disease (Rosenstock, 1974). 
Perceived Barriers. This construct of the HBM addresses the issue of 
perceived barriers to change. It is an individual’s own evaluation of the 
obstacles in the way of him or her adopting a new behaviour. Of all the 
constructs, perceived barriers are the most significant in determining 
behaviour change (Janz and Becker, 1984). In order for a new behaviour to 
be adopted, a person needs to believe the benefits of the new behaviour 
outweigh the consequences of continuing the old behaviour (Centres for 
Disease Control and Prevention, 2004). This enables barriers to be 
overcome and the new behaviour to be adopted. 
Modifying Factors/Variables. The four major constructs of perception are 
modified by other variables, such as age, culture or ethnicity, educational 
status, occupation, past experiences and motivation. These are individual 
characteristics that influence personal perceptions (Rosenstock, 1974). 
Cues to Action. In addition to the four beliefs or perceptions and modifying 
factors, the HBM suggests that behaviour is also influenced by cues to 
action. Cues to action are events, people or things that move people to 
change their behaviour. Examples include illness of a family member, media 
reports (Graham, 2002), mass media campaigns, advice from others, 
reminder postcards from healthcare provider, or health warning labels on a 
product (Ali, 2002).          
Self-Efficacy. In 1988, self-efficacy was added to the HBM (Rosenstock et 
al., 1988). It is the belief in one’s own ability to do something. People 
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generally do not try to do something new unless they think they can do it. If 
someone believes a new behaviour is useful (perceived benefit), but does 
not think he or she is capable of doing it, chances are that it will not be tried 
(Bandura, 1977). 
It is worth pointing out some strengths and limitations of the HBM. The main 
strength of the model is its use of simplified health-related constructs that 
make it easy to implement, apply, and test (Conner, 2010). The HBM has 
provided a useful theoretical framework for assessing the cognitive 
determinants of a wide range of behaviours for over three decades. It has 
focused researchers’ and healthcare professionals’ attention on variables 
that are prerequisites for health behaviour. Thus, it provides a useful 
checklist of issues that need to be addressed and has formed a basis for 
many practical interventions across a range of behaviours (Jones et al., 
1987). However, a limitation of the HBM is that it does not take into account 
social or environmental factors which can influence health behaviour. The 
model also did not expressly spell out the relationships between the 
variables and there are no clear rules for combining the formulated variables 
(Sheeran and Abraham, 1996; Armitage and Conner, 2000). However, this 
limitation can also be viewed as strength, because lack of strict rules of 
combination offers flexibility that makes the HBM adaptable and applicable to 
many health behaviour and population groups (Orji et al., 2012). 
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4.5.3 Data Collection 
Semi-structured telephone interviews were carried out using an interview 
guide (Appendix 8). The development of the interview guide was informed by 
knowledge acquired from the literature review from this PhD project 
(Rosenstock, 1974; Janz and Becker, 1984; Rosenstock et al., 1988; Tiedje 
et al., 1992). The researcher received formal training courses on ‘Qualitative 
Research, Interviews and Analysis’ as well as coaching from Professor 
Felicity Smith of the Department of Practice and Policy who is an expert in 
qualitative research. The format of the interview guide was carefully planned 
such that the first set of questions was non-threatening and easy to answer. 
A semi-structured approach was chosen because it ensured that participants 
remained focused on the topic while also enabling them to expand on their 
views. Furthermore, the interviews were conducted on telephone because it 
was more feasible than in the hospital setting where there could be 
distractions and lack of privacy. Moreover, telephone method was more 
convenient and created lesser burden on participants, allowing them to 
express themselves openly in their usual and familiar environment. 
A pilot study was carried out with 3 postpartum women and the interview 
guide was revised based on their responses and with further inputs from 
Professor Smith. The pilot data was not included in the final analysis. 
 
4.5.4 Sample size and recruitment 
The purposive sampling technique, also called judgment sampling, is the 
deliberate choice of participants due to the qualities they possess. It is a non-
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random or non-probability technique that does not need underlying theories 
or a set number of participants. Simply put, the researcher decides what 
needs to be known and sets out to find people who can and are willing to 
provide the information by virtue of knowledge or experience (Bernard 2002; 
Lewis and Sheppard 2006). In contrast, random or probability sampling is 
recommended whenever possible as a means of participant selection 
because randomisation reduces biases and allows for the extension of 
results to the entire sampling population. Results may also be applied 
beyond the community studied (Tongco, 2007). However, random sampling 
is not always feasible, and not always efficient. A high dispersion of samples 
may induce higher costs for a researcher (Alexiades, 1996; Bernard, 2002). 
Purposive sampling is not free from bias. However when used appropriately, 
is more efficient than random sampling in practical field circumstances 
(Bernard, 2002) because the random participants may not be as 
knowledgeable and observant as an informed participant. This method is 
especially useful when there are not enough funds and other resources. 
Purposive sampling can be more realistic than randomisation in terms of 
efficiency, time, effort and cost needed in finding participants (Topp et al. 
2004; Tongco, 2007). The inherent bias of the method contributes to its 
efficiency, and the method stays reliable and robust even when tested 
against random probability sampling (Bernard, 2002; Lewis and Sheppard, 
2006). Hence, data collected from purposive sampling may still be valid for 
certain studies. There is no cap on how many participants should make up a 
purposive sample, as long as the needed information is obtained (Bernard, 
2002). Seidler (1974) studied different sample sizes of participants selected 
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purposively and found that at least five participants were needed for the data 
to be reliable. 
In this qualitative study, a purposive sampling technique was employed in 
order to get the information-rich cases (Malterud, 2001). A purposive sample 
of consecutive women in the third trimester who have used at least 2 types of 
medicines (prescription, over-the-counter, complementary and alternative 
medicines) with or without recreational substances during pregnancy and 
verbally consented to be interviewed was chosen. Twenty-two potential 
participants were approached for the interview but 2 of them declined due to 
other commitments and therefore 20 participants were recruited because it 
was more feasible within the available time frame of the project. 
After explaining the purpose of the study and assuring confidentiality and 
anonymity, permission was obtained from each participant to record the 
interview. 
The researcher (Mariam Wahab), who had been trained in interview 
techniques, had met all the women at the antenatal clinic during their first 
trimester scan while conducting the first part of her research. Her contact 
with them at the time of the interview was the third time hence she had 
already created a friendly and informal atmosphere prior to the interview 
which allowed the participants to speak and express their thoughts freely. 
After each interview, the researcher listened to the audio recording and 
made her interview summaries before carrying out another interview. All the 
interviews were carried out by the researcher and each lasted between 24 
and 35 minutes. The interviews were carried out from October 2012 to 
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January 2013 and the interviewees were not rewarded for their participation 
in the study. The demographic characteristics of the subjects had been 
collected during the first part of the project (the quantitative study).  
All the interviews were audio-recorded and verbatim transcription was done 
by a paid transcriber. The transcripts were checked against the audio 
records by the researcher before coding and analysis. 
 
4.5.5 Data analysis 
Two interviews were coded independently by 2 researchers (Mariam Wahab 
and Dr. Chi Huynh who recently completed his PhD at the Centre for 
Paediatric Pharmacy Research and who also carried out a qualitative study 
as part of his PhD research). The initial coding frameworks by the 
researchers were compared and the discrepancies resolved in order to arrive 
at a single expanded one which was used to code the other interviews by 
Mariam Wahab (Appendix 9). Coding was carried out with the computerised 
qualitative data analysis package Nvivo 10 but the framework analysis was 
carried out manually (outside the Nvivo software).  
The coding framework was used to develop the themes which were then 
used in answering the research questions. During this stage of the 
framework analysis, credibility of the results was ensured by having the 2 
researchers (Mariam Wahab and Dr. Chi Huynh) carry out the analysis. The 
development of 3 themes, the interpretations made of the themes and the 
associations between the themes were carried out and a consensus was 
reached after discussions by the 2 researchers. 
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4.6 Results 
4.6.1 Participants’ characteristics 
The mean age of the pregnant women was 32.7 years (the age range was 
between 26 and 41 years) and half of them were primigravida. Majority of the 
participants were whites (n = 14) and university-educated (n = 17). They 
were between 28 and 39 weeks pregnant at the time of interview (mean 
gestational age: 36.3 weeks). In the context of the Health Belief Model, the 
participant’s characteristics are regarded as part of the modifying factors. 
These are shown in Table 22.  
 
Table 22 Participants’ characteristics 
 
 
Participant ID Age (years) Ethnic origin Education Gravidity Gestational age (weeks)
P1 30 White University 2 28
P2 30 African University 2 35
P3 37 White University 3 35
P4 33 White University 3 37
P5 34 White University 1 39
P6 34 White University 1 36
P7 35 White University 2 37
P8 29 Black other Vocational 2 35
P9 34 White University 1 38
P10 35 Mixed University 1 38
P11 30 African University 1 39
P12 33 African University 1 37
P13 34 White University 2 35
P14 29 White University 1 35
P15 41 White University 1 36
P16 26 White Secondary 3 36
P17 37 White University 3 36
P18 34 White University 1 38
P19 30 White Secondary 5 37
P20 29 African University 1 39
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4.6.2 Medicines and recreational substances used during pregnancy 
All the women used over-the-counter medicines the most common of which 
was vitamin supplements; 12 of them were exposed to prescription 
medicines, 19 used complementary and alternative medicines, 6 consumed 
alcohol, one of them smoked cigarettes and another one consumed cannabis 
(Table 23). 
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Table 23 Medicines and recreational substances used by participants during pregnancy 
 
 
 
Participant ID Prescription medicines Over-the-counter medicines Complementary and alternative medicines Recreational substances
P1 Metoclopramide Multivitamins, Rennie Redbush, Peppermint Alcohol
P2 N/A Multivitamins Homeopathy (Oscillococcinum), Cranberry N/A
P3 N/A Multivitamins Raspberry leaf tea Alcohol, Cannabis
P4 Amoxicillin Multivitamins Redbush, Camomile, Massage N/A
P5 N/A Multivitamins Acupuncture, Yoga, fennel, liquorice, peppermint teas N/A
P6 Metoclopramide Multivitamins Ginger, Raspberry leaf N/A
P7 Paracetamol Multivitamins Homeopathy (Lutenium, Sepia, Nux vomica) N/A
P8 N/A Multivitamins Ginger, Peppermint, Redbush Alcohol
P9 Cephalexin, Amoxiclav Multivitamins Massage, Yoga N/A
P10 N/A Multivitamins, Paracetamol Raspberry leaf, Yoga N/A
P11 Zineryt, Iron tablets Multivitamins Massage N/A
P12 Paracetamol, Gaviscon, Iron tablets Multivitamins Mint tea N/A
P13 Co-dydramol, Amoxicillin, Fluconazole Multivitamins, Ranitidine Mint tea, Yoga Alcohol
P14 Iron tablets Folic acid Acupuncture, Ginger, Camomile, Raspberry leaf N/A
P15 N/A Folic acid, Vitamin D, Iron tablets Raspberry leaf Alcohol
P16 Metformin Multivitamins Reflexology Cigarette
P17 N/A Multivitamins Homeopathy(Melissa), Lemon and Ginger, Acupuncture Alcohol
P18 N/A Multivitamins, Folic acid 5mg Acupuncture, Yoga, Nettle tea N/A
P19 Metformin, Insulin, Iron tablets, Canesten pessaries Multivitamins N/A N/A
P20 Solpadol, Iron tablets Multivitamins Redbush N/A
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4.6.3 Themes 
The seventeen themes identified are presented in Table 24 below alongside 
the theoretical constructs. Other themes which came up but could not be 
fitted into the model are also included in the last part of the table.  
Table 24 Theoretical constructs and the themes identified 
Theoretical constructs Themes 
Perceived Severity 
 
 
 
Perceived Risk 
 
 
 
 
 
 
Perceived Benefits 
 
 
 
 
 
 
 
Perceived Barriers 
 
 
 
Cues to action 
 
 
 
Self-efficacy 
 
Other themes 
Lifestyle changes 
Mother’s health 
Unborn baby’s health 
 
Risks of non-adherence (prescription, 
over-the-counter) 
Risks of using complementary and 
alternatives 
Risks of using recreational 
substances 
 
Adherence to medicines 
(prescription, over-the-counter) 
Effectiveness of medicines 
(prescription, over-the-counter, 
complementary and alternatives) 
Perceived benefits of alcohol 
consumption 
 
Barriers to non-adherence 
(prescription, over-the-counter) 
 
 
Information 
Trust in conventional or 
complementary practitioners 
 
Difficulty to stop cigarette smoking 
 
Experiences of medicine use 
(prescription, over-the-counter) 
Communication with healthcare 
professionals (complementary and 
alternative medicines, alcohol) 
Recommending complementary and 
alternative medicines 
Friends or family consumption of 
substances 
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4.6.4 Lifestyle changes 
When asked how often they think about their health in pregnancy, 15 of the 
women said they do think of their health ‘quite often’ while others said the 
thought of their health comes to them ‘sometimes’. All the women talked 
about lifestyle changes related to health and wellbeing such as exercise, 
energy levels and posture as well as taking healthy diets. They reported 
eating balanced diets to support their health and the developing child in 
pregnancy while avoiding what may be harmful to them. In addition, three of 
them commented on how their medical condition – diabetes - had influenced 
what they consumed during pregnancy. 
“Urm mostly if I’m doing the right things for the baby to be healthy, if 
I’m getting enough exercise. I do a lot of walking…” (P6) 
“… I try and eat healthily and not take anything that I think will be 
harmful. I’ve tried to eat more healthily and drink more water…” (P10) 
“… so, yes I am trying to cut down on all my sugars and certain foods 
so I am always thinking about that” (P16) 
One participant communicated her thoughts during and beyond the antenatal 
period. She said: 
“Well everything I would say like what I should eat, if I am eating the 
right things, and obviously other things as well, how am I going to be 
after pregnancy, with a lot of weight?… I’m reading books about how 
to care about my baby when she is born…” (P14) 
As a follow up to the previous theme, participants were asked if they were 
concerned about 2 issues- their health and that of the unborn baby’s health. 
4.6.5 Mother’s health 
Nine women expressed different concerns about their health in pregnancy. 
These concerns were about medical conditions or symptoms of such medical 
conditions- high blood pressure, low-lying placenta, diabetes, spotting or 
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bleeding, positive fibronectin test, ‘rare blood type’, pain due to fibroid and 
fatigue. Four of the nine women expressed concerns about adequate water 
intake, vitamin and mineral supplements, and weight gain. 
“Yes the problems are diabetes and because I have a rare blood type 
as well. I have antibodies in my blood…” (P19) 
“I worry about getting enough vitamins erm and water” (P1) 
Other participants reported not having concerns about their health and 
despite the fact that one of these women was diabetic, she did not express 
any concern. She noted: 
“Not really because I go up to the hospital often because of the 
diabetes and I am having more regular scans as well so I am being 
well looked after” (P16) 
 
4.6.5.1 The influence of maternal characteristics on the perceptions of 
mother’s health 
Gravidity appeared to be the factor which determined women’s expression of 
concerns about their health. Most of those who had concerns (6/9) have 
been pregnant at least once before so they already had some experience of 
the pregnancy phase. The other 3 women were primigravida who had some 
issues in early pregnancy which might have given rise to their concerns. 
They talked about spotting, low blood iron and pain due to fibroid: 
“…at the beginning of my third month in pregnancy I was spotting and 
erm I went to the hospital for emergency scan and some tests and 
they said everything is OK. But it disappeared after, it was maybe 
because I was working a lot that it happens...” (P10) 
“There was only one thing, my iron was low and then they sent me 
another letter saying that I have to have another blood test and the 
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nurse who took the blood, she said if something very bad they will call 
me…” (P14) 
“…my biggest headache is the [fibroid] pain. I think about it a lot, you 
know, but in reality I can’t do anything about it now because of the 
baby… it’s the pregnancy that made it come out, you know it’s my first 
time and before the pregnancy, it wasn’t disturbing me. I have to go 
and look after it after the pregnancy” (P20) 
Most of the women (7/11) who did not report concerns about their health 
were primigravida. The other 4 women have been pregnant at least once 
before, and their close relationship with and confidence in the healthcare 
professionals might have boosted their confidence or allayed their fears: 
“…he [doctor] is a friend, so I just told him I’m having this problem 
[nausea] and he said: ‘oh just use this one and that one’ and that’s it. 
It’s as if your brother was a doctor as well and just told you when 
you’re at home having dinner: ‘oh well just use this one…” (P7)  
“…my dad is a doctor and I took his advice as well” (P13) 
 
4.6.6 Unborn baby’s health 
Eight of the women had concerns about unborn baby’s health as regards 
preterm delivery and complications which could arise from their medical 
conditions:  
“… but urm I’m still worried about like having a preterm baby, I mean if 
I have it now I’m 28 weeks, it should be fine but it’s not ideal still…” 
(P1) 
“Yes because I am diabetic and they said that she might (pauses) 
because they said that she might have to go into neonatal and she 
might have breathing problems so yes I am concerned about that” 
(P19) 
However, a participant had a different kind of concern which was related to 
her food intake in early pregnancy. 
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“Yes, I do worry that I didn’t do enough in the start of pregnancy… you 
know, I just could have eaten more healthily at the beginning” (P18) 
Twelve participants reportedly did not have any concerns about their unborn 
babies’ health for reasons which were related to their confidence in the 
healthcare professionals, ultra sound scan and test results, as well as the 
reassurance from foetal movements. 
“… I think the baby is fairly regularly monitored as well, there is 
certainly nothing medically that we think would cause any concern” 
(P5) 
“… every time I go for scan, they tell me my baby is OK, it’s fine. I 
don’t have any, any erm red flags about the baby at all in all the tests 
I’ve done. All the tests are always normal so I don’t have any 
concerns at all” (P20) 
“… she seems OK and she is moving more today so she is OK” (P14) 
4.6.6.1 The influence of maternal characteristics on perceptions of 
unborn baby’s health 
Women who had concerns about their unborn baby’s health were similar in 
characteristics to those who did not express concerns. However, 3 women’s 
concerns were especially noted to be related to previous experience of an 
adverse pregnancy outcome and their medical condition. One woman talked 
about preterm delivery while the other 2 women’s concerns were about 
diabetes. Since the 3 women had been pregnant at least once before, 
gravidity might have played a role in their perceptions. They explained their 
worries: 
“I think that my last baby was very healthy even though I didn’t carry 
him full term. Urm and I think with this baby as well is very healthy… I 
had 2 scares in this pregnancy, one was for the blood so I went to get 
that checked out but I was fine urm they said there was nothing 
wrong. They tested me for urm platelets and for caffeine and they said 
it was fine and then erm I had another scare because they did this 
(pauses) it is quite a new test. The test was for, was called fibronectin, 
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which is the protein that you release before you go into labour and I 
tested positive for it so I had a bit of a scare and then I went back and 
did another test and I tested negative for it. So I don’t know why 
maybe the test was wrong or just you know (pauses) but urm I’m still 
worried about like having a preterm baby…” (P1)  
“I do yes. I am worried that she might end up having diabetes or that 
she would end up being (pauses) I was told that with the diabetes the 
baby could end up being quite big so I am worried about that…” (P16) 
“Yes, because I am diabetic and they said that she might (pauses) 
because they said that she might have to go into neonatal and she 
might have breathing problems so yes I am concerned about that” 
(P19) 
 
4.6.7 Prescription medicines 
Twelve participants were prescribed medicines at different stages of 
pregnancy and some of them took more than one medicine.  
4.6.7.1 Information 
Without exception, all the women received information about one or more of 
their medicines from health professionals - GP, midwife or pharmacist. The 
information was mainly about safety of the medicines in pregnancy.  
“… whether it was safe for me to take it for the baby and whether it 
was going to be necessary for me to take it and whether I could look 
at the balance between not knowing what it could do to the baby and 
me needing to get better...” (P13) 
“I asked whether it was safe to take in pregnancy and they [the GP] 
said yes” (P4)  
 
Some of the women also got the information about the safety of their 
medicines from the internet, product leaflets and books although those who 
claimed to have read the product leaflets could not recall the information 
contained in it except for one subject who experienced a side effect when 
using metoclopramide and then went to read up the leaflet. She recounted: 
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“... I got a bit of insomnia so I then got a bit nervous so I thought oh 
let’s just read up on the drug so I read the leaflet which seemed quite 
intense erm I can’t remember all now but it was like it can cause 
insomnia and this and that and like all these quite serious conditions 
and don’t take with this and don’t take with that as they word…” (P1) 
She also went further to get more information about metoclopramide from the 
internet. She discovered a study which linked the use of metoclopramide to 
preterm birth and a perceived threat of having another premature child 
(based on the experience of her first child being premature) made her stop 
using the medicine: 
“…so I researched it online and urm I found (pauses) it was a small 
study but it said that it was linked to preterm birth so I switched off and 
I stopped taking it for 2 weeks because my first child, a boy was 
preterm. Urm and then during that stage urm I had, like I’ve got friends 
who are midwives and doctors and they were all saying: ‘don’t listen to 
the internet and you know, it would be fine and everyone has learnt 
their lessons from thalidomide’ and erm so I went back into the 
research and I saw that for the one study that I found, it was only done 
in 175 women and there was another study that was done in 75,000 
women erm and that showed no link to premature birth so that made 
me feel better…” 
The perceived threat of weight loss from her untreated morning sickness 
made her to seek help and to continue the use of metoclopramide: 
“… urm and because I was so sick at the time urm I had to move in 
with my in-laws… I couldn’t actually look after my son [first child] and 
urm and I couldn’t keep any food down either, I couldn’t keep water 
down as well, I mean I could throw up like 5 times a day. So urm so I 
decided that the risk probably wasn’t as great as I thought it was and I 
went back on it. I did have erm 2 other drugs my friend, basically erm 
it was prescribed by one doctor a shot of erm Valoid [cyclizine], just a 
one-off injection and I even became sicker, bad decision! I think I was 
sicker because my body had already gone down, I had lost weight, 
you know. Then I was also given Valoid suppository and that was 
before I went back on metoclopramide. Again I went back on 
metoclopramide because I’ve done more research…” (P1) 
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4.6.7.2 Trust in healthcare professionals 
Some of the women also talked about their trust in the healthcare 
professionals they consulted: 
“… the diabetic nurse, she was really helpful yes when I first came for 
my visit and I got a printout from her because she was very nice and 
she told me how to use it and what it does… (P19) 
“… I am being well looked after… I was just advised by the midwife 
about it and that I have to take it twice a day” (P16) 
 
4.6.7.3 Effectiveness of medicines 
Effectiveness of the medicines was the main theme which emerged from 
asking the women about the benefits of using their medicines. Except one of 
the participants, all the women verbalised that all their medicines were 
effective for the indications they were prescribed for: 
“… it works and each time I stop using it I notice that that yes I have 
stopped using it because I have acne come back. Since I have been 
using it, it’s worked, the lotion works...” (P11) 
“Well the amoxicillin was excellent and it cleared the mastitis 
immediately and that was very good” (P13) 
 
4.6.7.4 Experiences of medicine use 
Most of the participants commented that the medicines were ‘fine’ when they 
were asked their experiences of use although a few of them reported some 
side effects. They remarked: 
“It was fine. I managed to remember and I didn’t have any bad side 
effects, well I didn’t have any side effects so it was fine. I was happy 
with the experience…” (P4) 
“… the only thing is it [iron tablets] causes constipation which I have 
sometimes experienced” (P11) 
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Yet one woman did not have any experience to report. She simply 
responded:  
“Erm nothing really” (P14) 
 
4.6.7.5 Adherence to medicines 
When participants were asked how they take their medicines, they reported 
taking them as prescribed. However, when probed further about their 
experiences of use or thoughts on missed doses, it was discovered that 
some of them did not adhere to their prescribed medicines. 
Eight of them reportedly adhered to one or more of their regimens. They took 
antibiotics, anti-diabetics, anti-emetics, iron preparations and Canesten 
pessaries.  
“Well I think it’s quite important to take all the doses when you’re 
taking antibiotics. So I think it’s quite an important thing to do... I know 
you’re meant to take the whole course of antibiotics or it might not be 
so effective next time if you don’t finish the course…” (P4, took 
amoxicillin) 
“… I am very strict on taking my medicines” (P19, used metformin, 
insulin and Canesten pessaries) 
 
4.6.7.6 Risks of non-adherence to medicines 
With the exception of two women who declared not having information on the 
risks of not using their medicines, most of the participants considered that 
their health or medical condition could get worse if the medicines were not 
taken. For example, one woman who was prescribed antibiotics noted: 
“Well no one told me but I suppose, from what I understood, is that the 
infection gets worse and worse and it won’t go away by itself…” (P9) 
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Apart from worsening health or medical condition, a respondent expressed 
concerns about inadequate care for herself and family which can result from 
not taking her metoclopramide for the pregnancy-related vomiting. She 
commented: 
“… urm and then the other risk I think of not taking it is erm it wasn’t 
about the baby but it was about my son [first child] because I was so ill 
that I couldn’t look after him. Urm and I fall asleep in the house and I 
wake up, finding him, you know, erm upstairs having put all the caps 
on, having you know, urm put lights on and stuffs and climbing things. 
Because I was so nauseous from the inset I just didn’t know where 
he’s been and what danger he could have got in I mean, just running 
around. And I couldn’t even cook for him properly because any 
cooking makes me feel sick so I struggle to feed him and he suffered 
as well, me suffering as well and the baby suffering. So for all those 
reasons, I just made up my mind that it’s just better to go on the drug 
even though I’d rather not take it but erm it just made sense” (P1) 
 
4.6.7.7 The influence of maternal perceptions on prescription medicine 
use 
In the group of women who reported adherence to medicines, it was 
discovered that the reasons for their adherence were due to the fact that 
either they perceived the severity of their medical conditions to be high, or 
their perception of the risks of non-adherence was high or they had trust in 
the healthcare professional whom they had contact with at the time of 
starting the medicines. They explained: 
 
“… before pregnancy I know that I used to have low blood even as a 
spinster, you know, so if I, you know, maybe I would have started 
taking it earlier before maybe it would have prevented erm, you know, 
it would have helped me a little bit than this late stage when I couldn’t 
control (pauses), you know, because all those times I was feeling 
tired, I was still managing it and when I complained they said take 
enough rest, because even at that, the rest was not the issue until if I 
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now sit in a place that is airtight or pressured, I don’t feel good any 
more… Umm, yeah I think I’ve been stable with the ferrous, yeah I’ve 
actually been stable because what was happening to me before that I 
was erm actually fainting, you know. In as much as they said it was 
normal but my own was becoming a concern because it was like 
every now and then so I went to, I talked to the GP, I went for a test 
and discovered that I had a low blood haemoglobin count… I was, you 
know, any (pauses), if I stay in a place that is erm airtight, yeah I 
would just lose consciousness and then I was unnecessarily fatigued, 
you know, yeah” (P12, took iron tablets) 
“… I was so sick that if I didn’t (pauses) so even I take it 3 times a 
day, I would start feeling ill about an hour, an hour and a half before I 
take my second dose of metoclopramide, so erm I couldn’t do without 
it” (P6, took metoclopramide) 
“… the diabetic nurse, she was really helpful yes when I first came for 
my visit and I got a printout from her because she was very nice and 
she told me how to use it and what it does… (P19, used metformin 
and insulin) 
 
Conversely, other women admitted non-adherence to the physician’s 
prescriptions for different reasons. 
 Perceived barriers (forgetfulness and side effects experience),  
 Lack of risk perception which can result from non-adherence,  
 A low perceived severity of the medical condition, and 
 Lack of trust in the healthcare professional were found to explain the 
participants’ behaviours. 
As regards the barriers to adherence, one woman commented on her 
forgetfulness: 
“Oh, I might have forgotten maybe once or twice erm but I just did the 
best that I could…” (P9, took cephalexin and amoxiclav) 
Another woman, despite expressing that her greatest concern was the pain 
due to fibroid, recounted how her experience of the side effects of solpadol 
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affected her adherence:  
“… so when I started taking it [solpadol], because of the codeine you 
know codeine has side effect, I was having constipation, I would be 
constipated, occasionally I would throw up. So erm I started disliking 
the medicine because of the side effects because when I take it 
sometimes I would start feeling uncomfortable so I only take it when 
necessary… it makes me feel drowsy too” (P20) 
 
A participant demonstrated her lack of risk perception which can result from 
non-adherence to iron tablets by saying: 
“I don’t know exactly the risks” (P14) 
One woman who perceived the severity of anaemia to be low remarked: 
“Well I’m supposed to be taking it one twice a day, but I take it one 
most of the days because from my own knowledge anyway I don’t 
think I needed to be so compliant with it because my iron is not that 
low because after the second test my iron was at borderline again and 
I do take other fruits, things that are rich in iron… it’s not only the 
tablet that increases your iron, other things can increase your iron 
levels…” (P11, took iron tablets) 
As regards the issue of lack of trust in the healthcare professional, one 
woman recalled being prescribed 1g paracetamol 6 hourly for cold and high 
temperature by the GP. She however chose to reduce the dosage herself 
because according to her, 1g of paracetamol was ‘too high’. 
“… when I had a high temperature, I wanted to make sure and I think 
I’m a bit more cautious than the recommendation, even here in the UK 
actually because I think the dose [of paracetamol] is too high… erm 
well I know what the practice is in my country [France], I thought that 
in pregnancy it was recommended to use paracetamol as well in my 
country but the dose is lower… what I’m doing is I’m just trying to use 
the maximum dose recommended which is the French one which is 
about half of the UK one…” (P7, took paracetamol) 
There was also an interesting case of a woman who was not convinced that 
she had been diagnosed correctly. She complained to the GP of blood in her 
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urine and was given a prescription for amoxicillin which she reportedly did 
not use but chose an alternative therapy. The lack of trust in her GP and a 
low perception of severity of her medical condition could be the reason for 
her behaviour. She reflected on her experience: 
“… and he [the GP] asked me if I was familiar with urinary infection 
and stuff and I said no, I never had any, and when I was given the 
amoxicillin prescription, I even went to the pharmacy to pick the box 
because I thought ok the doctor said: ‘take your course and after one 
week when you finish the course you come back again and we do a 
test to see’. So I took the box [of amoxicillin] home and I decided to 
drink my cranberry juice because I know it has a good impact erm on 
the urinary erm system and I was drinking almost 2 litres per day and 
after one week when I did the exam, nothing was found! … if I had a 
real infection I think I would have taken the antibiotics. My problem 
with the decision of my doctor was the fact that he asked me about 
the symptoms I didn’t have any symptoms of infection, I did not have 
any burning while urinating. He asked me all of these things: ‘do you 
have any fever? Are you feeling any pain during urination?’ I said no 
but the fact that I had some blood samples few times erm blood in the 
urine few times prompted him, you know because he said: ‘oh it can 
be kidney infection’ … so because of that I wasn’t convinced, I didn’t 
take the medicine because I wasn’t convinced by it! …but it might be 
that the sample he used to make a decision was more concentrated 
because I wasn’t taking enough fluid then, who knows?...” (P2) 
It was also noted that one participant who disclosed 2 medical conditions- 
diabetes and anaemia- perceived the severity of diabetes to be greater than 
anaemia and this affected how she took her medicines. She reported 
adherence to anti-diabetics but not to iron tablets. As regards the iron tablets, 
she noted: 
“A few weeks ago they did a blood test when I had a regular check-up, 
the regular midwife appointments and the blood test results came 
back and the midwife said that I was under the required level. I don’t 
remember what my iron count is, and that I should take iron tablets 
because I was a bit anaemic” (P19) 
But she further expressed the fact that she was not too worried about 
missing her doses of iron tablets: 
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“… I’m not too worried though about forgetting, I just take it the next 
day when I remember…” (P19) 
 
4.6.8 Over-the-counter medicines 
The most frequently used over-the-counter medicine was folic acid (either 
singly or in combination with other vitamins) and all the women reportedly 
took vitamin supplements. 
4.6.8.1 Information 
Eight participants received recommendations on the importance of taking 
vitamin supplements during pregnancy by the GP or midwife. Others either 
took a self-decision to use it or were advised by friends or family members. 
They noted: 
“… it was recommended to me to take folic acid by the midwife…” 
(P17) 
“No one, no one recommended it. Erm I was in Sainsbury’s and I saw 
it but I was checking it because I didn’t want to buy any erm vitamins 
for mum that didn’t have calcium, I wanted calcium in it and that one 
had calcium so that made my decision” (P1) 
“… it was a friend that told me about vitamin D and the Pregnacare” 
(P12) 
 
 
4.6.8.2 Effectiveness of vitamins 
Although the participants recognised that vitamins are supplements which 
play a crucial role in the development of the baby and health of the mother, 
almost half of them reported that they were unsure of the effectiveness of the 
vitamins. They commented: 
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“Urm honestly, I don’t know, they didn’t change anything. I don’t know 
whether they are doing something internally but I am not finding or 
feeling anything in particular. I am just taking them because I just feel 
that they are good and I needed to take them, not that I am seeing 
any change or something. But I don’t know whether they are doing 
anything in the body” (P12) 
“I haven’t noticed anything, I’m assuming that I’m not supposed to 
necessarily notice. I’m just hoping that it’s been beneficial to the baby” 
(P15) 
 
4.6.8.3 Experiences of vitamin use 
Reflecting upon their experiences, most of the women reported that it was 
‘fine’ or ‘good’ and without side effects: 
“Yes, absolutely fine. It’s nothing really. I just take it with a meal every 
day and I just know I am getting my extra vitamins” (P16) 
“… I haven’t had any bad effects from it, so it’s okay so far” (P6) 
 
4.6.8.4 Adherence to vitamins 
Only 8 out of the 20 participants admitted taking their vitamin supplements as 
recommended. Typical responses were: 
“Every day, one every day… I just take it in the evenings after I’ve had 
my dinner every day… I leave it on the table so I can see it every day” 
(P10) 
“… I mean I’m used to taking the pill everyday so it’s not that hard to 
remember to take it” (P6) 
 
4.6.8.5 Risks of non-adherence to vitamins 
Inadequate nutrition and development of the baby was noted by 9 
participants as the risks of not using the vitamins. Specifically, they 
mentioned spinal defects, cleft lip and rickets. 
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“Erm folic acid lack can cause spina bifida something or which is like a 
curvature of the spine if the baby doesn’t have enough folic acid… 
and the other thing that it can cause is cleft lip urm from a lack of folic 
acid although I’ve not heard of how actually they are, I don’t know. 
Everyone tells you take folic acid when you are pregnant or trying…” 
(P1) 
“… the vitamin D I know helps the baby’s bones to develop well so 
deficiency can cause (pauses) rickets, yeah rickets” (P2) 
Other participants admitted not knowing the risks associated with non-
adherence to vitamins during pregnancy or that they do not believe in any 
risk as long as the mother takes healthy diets: 
“… I don’t know if whether you have taken it or not (pauses), whether 
if you don’t take it, the baby will not grow well, I don’t know” (P12) 
“No there isn’t [any risk]. I think it would be fine not to take it as long 
as you have a decent diet” (P19) 
 
4.6.8.6 The influence of maternal perceptions on vitamin use 
The main influences on adherence to vitamins were perceived barriers (such 
as forgetfulness) and the lack of perceived risks of non-adherence. 
Half of the women reported being forgetful about their supplements or 
running out of medicines. Reasons given by others for non-adherence 
included sickness, big size of the tablet, they were ‘not good at taking 
medicines’, or that the vitamin was ‘just a supplement’. These were the 
barriers to adherence to the vitamins. In the words of the participants: 
“Yes, I sometimes forget but I don’t think it’s a big deal, it’s just a 
supplement, it’s not essential. If I miss it a day then I’ll miss it a day 
and I’ll carry on…” (P3) 
“It’s meant to be every day but I don’t take it [Pregnacare] every day 
maybe I only take it like once or twice a week… Well I don’t take it 
regularly because it’s too big if not I should be taking it regularly” 
(P20) 
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“… I wasn’t very good at taking the medicine [vitamins]. I’m meant to 
be taking them every day and I would say at one point during the 
pregnancy from about 5 months when I stopped being sick, I took it for 
about a month and a half almost every day but then I’ve sort of 
stopped taking it now… I didn’t mean to stop, I just erm ran out of it 
and haven’t bothered to go and get more [laughs]. (P1) 
Furthermore, it was observed that most of the participants did not consider or 
believed in the risks which can result from non-adherence to vitamin 
recommendations: 
“I don’t know what the risks are for not taking them, I’m sure there are 
many women out there who don’t take any vitamins at all and their 
children are absolutely fine… I try to remember to eat nice and 
healthily so you get the same goodness” (P8) 
“Well I don’t believe that there will be any serious risk because I 
believe that erm well all those things anyway are things that you get 
from food, that’s what I believe, so if I eat well then I shouldn’t worry. If 
you eat fruits, I eat a lot of fruits, you shouldn’t be bothered about all 
those things” (P11) 
 
There was however one woman who reported good adherence to her 5mg 
folic acid in early pregnancy but when she switched to Pregnacare in the 
second trimester, she became forgetful, developed the perception that it was 
an ‘ordinary supplement’ and complained of tablet size. Her adherence to 
5mg folic acid was because she perceived the risk of having a baby with cleft 
lip and palate to be high since she also had a cleft lip and palate at birth. This 
woman might have learnt that folic acid intake is most essential in the first 
trimester when the developing baby needs it to grow the neural tube that will 
eventually form the spine and nervous system. She recalled: 
“Erm, I used the folic acid 5mg every day up until about 20 weeks or 
18 weeks, something like that… it was recommended to me by 
genetic health screening that I had done a couple of years beforehand 
because I was born with cleft lip and palate so the consultant who saw 
me said that at the point of trying to get pregnant plus up to whenever 
they can exclude cleft lip, which is about 16 weeks, I need to be taking 
5mg of folic acid… so once that finished, I just switched to 
Pregnacare, the usual one” (P18) 
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4.6.9 Complementary and alternative medicines (CAM) 
Nineteen out of the 20 respondents have used at least one form of CAM 
therapy for some conditions during pregnancy. These are shown in Table 25 
below. 
4.6.9.1 Information  
Most of the women reported that their friends or family members 
recommended one or more of the CAM to them. Others got information 
about the CAM from the internet, product leaflets, CAM practitioners or 
midwives.  
“Well because I was having some nausea, first trimester related and 
one of my friends is basically a doctor and he knows how to prescribe 
homeopathic remedies… he did have training as well for homeopathic 
remedies so he told me to use those ones” (P7) 
“Well, erm I know that ginger is good for sickness… the acupuncture, 
once I did the research I’d read that it could be successful so erm I 
thought I would try it… it was my own choice and I sought out the 
information. I went to find the information, yes” (P17) 
 
4.6.9.2 Communication with healthcare professionals 
Most of the women did not discuss the use of CAM with their GP or midwife 
because they felt it was not necessary or important to talk about it. They 
noted: 
“Well, I didn’t feel there was any need for a discussion on it…” (P2) 
“I didn’t think it was that important so I didn’t say anything” (P4) 
Yet one woman remarked that the consultation time was too short to give 
room for such a discussion: 
“Well erm because when I see my midwife it lasts for 5 minutes and 
there is no discussion really… that’s the only reason” (P7) 
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A few other women discussed the use of one or more CAM with either the 
GP or midwife to which the healthcare professionals commented ‘good’ or 
‘fine’. They recalled: 
“I also mentioned it [raspberry leaf] to the midwife and she said yes, 
that’s fine…” (P10)  
“Yes but they [midwife] actually asked me if I do it [yoga] very often 
and I said I just do it only periodically here and there so she [midwife] 
said: ‘that’s fine, just keeps you going’…” (P13) 
 
Table 25 CAM therapies and the reported indications for use 
CAM modality Indications/Reasons for use 
Cranberry juice Urinary tract infection 
Redbush tea Health and wellbeing, antioxidant, 
caffeine-free/alternative to caffeine 
Camomile tea Stomach pains, alternative to caffeine 
Fennel tea Alternative to caffeine, hydration, 
carminative, indigestion 
Liquorice Alternative to caffeine, hydration, 
carminative, indigestion 
Peppermint tea Alternative to caffeine, hydration, 
carminative, indigestion, nausea and 
vomiting  
Ginger tea Nausea and vomiting, stomach pains, 
hydration 
Nettle tea To boost iron levels in the body 
Raspberry leaf tea To prepare the uterine muscles for 
labour, to induce labour 
Acupuncture Nausea and vomiting, health and 
wellbeing, indigestion, preparation for 
birth, to induce labour 
Yoga Indigestion, preparation for birth, 
health and wellbeing, to help with 
labour, for socialising  
Massage Wellbeing, back ache 
Reflexology Wellbeing, to help with labour 
Homeopathy Flu, nausea and vomiting 
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4.6.9.3 The influence of maternal perceptions on CAM use  
The main influences on CAM use was the women’s perception of ‘no risks’ 
as well as perceived effectiveness and trust in CAM practitioners. Moreover, 
most of these women will recommend the CAM they have used to other 
pregnant women and this is a demonstration of their belief in the CAM. 
4.6.9.3.1 Risks of using CAM 
When asked what they knew about the risks of using CAM during pregnancy, 
all of them verbalised that the therapies were natural, and without risks or 
‘not harmful’. One woman for example who had used a homeopathic remedy 
in early pregnancy for flu commented: 
“… so I am just trying to keep myself on the safe side and erm, erm 
because I have been using that homeopathic remedy erm before 
being pregnant anyway and the fact that it’s all natural just reassured 
me…” (P2) 
Some other women gave similar comments: 
“… also I know through experience that herbal teas certainly do you 
no harm” (P5) 
“… it’s very safe and very good, very beneficial and it’s got to be 
pregnancy yoga, not normal, other types of yoga are not beneficial” 
(P9) 
 
4.6.9.3.2 Effectiveness of CAM 
In terms of effectiveness, most of the women declared that the CAM used 
was effective for the different indications: 
“... so in my first trimester I had erm, erm really bad morning sickness 
and erm and so I was erm researching on how I can stop being so 
sick and I read that acupuncture helps so I started having acupuncture 
and erm I am still having it because it is really helpful. I feel much 
better for it… well it’s all about a belief isn’t it? It’s whether you believe 
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that it works or not I suppose, isn’t it? But erm I believe that it 
definitely helped with my morning sickness” (P14) 
“… the peppermint tea was to aid digestion in terms of, you know, it 
would go down when I was sick if I sipped some peppermint teas into 
what doesn’t agree with me, so I would have it every now and then… 
the peppermint tea was also helpful especially with the sickness” (P1) 
In four other instances, the women felt their therapies were not as effective 
as they wanted it to be. One woman remarked: 
“… oh I don’t know somebody said that it [mint tea] was good for your 
digestion. Occasionally if I’ve eaten too much like in a restaurant I 
would drink some mint tea afterwards… but it’s probably not 
effective…” (P13) 
Three women said they were uncertain about the effectiveness of raspberry 
leaf tea which was used to ‘prepare the uterine muscles for labour’. One of 
them noted: 
“I don’t really know… I haven’t really noticed any change to be honest 
but I figured I might as well” (P6) 
 
4.6.9.3.3 Trust in CAM practitioners 
The trust in the practitioners whom the women consulted also came up as a 
theme. They expressed their confidence in the services received as well as 
the honesty of the professionals: 
“I trust her because you know homeopathy (pauses) a lot of people 
practice it more like erm from a commercial point of view. I really trust 
her because she is also a pharmacist and when you have things that 
erm you know she feels that homeopathy wouldn’t help, she tells 
you…” (P2) 
“… I have researched it and I knew she is specialised in working with 
some people (pauses), she is a professional and as long as the 
professionals knew what they were doing erm, which she did 
anyway…” (P17) 
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One participant even went as far as disclosing what she intends to do if she 
goes past her estimated date of delivery. She said: 
 “The only thing that I’m planning to do is if I go overdue I don’t really 
want to be induced along the methods that are suggested medically, 
I’d like to do it homoeopathically. So erm I don’t really want to be 
induced and that’s why I’m taking the raspberry leaf for my uterus 
muscles… Well, the reason I don’t want an induced labour is because 
it increases the risk of a caesarean section and I really, really don’t 
want to have a caesarean section… if it [normal contractions] doesn’t 
come then I’d rather use a homeopathic method of inducing labour 
than I would use a traditional method… In the homeopathic method, 
you have a consultation with a homeopath for about half an hour, 45 
minutes and then they ask you questions about yourself, your health, 
everything and erm then they suggest a form of homeopathic remedy 
that can induce the child. A friend of mine had this done and it worked 
for her really well, although she did panicked a little bit when it 
happened anyway. I’d rather trust that than I would be induced in 
another way…” (P15) 
 
4.6.9.3.4 Recommending CAM 
A higher proportion of the participants said they would recommend one or 
more of their CAM therapies to another pregnant woman. Some of them 
said: 
“Yes I would recommend all of them…” (P5) 
“Yes I would… well like I said the person I went to see, she was also 
very good, it was a very good consultation as well so it [acupuncture] 
was a positive experience” (P18) 
Some women admitted that they will not recommend one or more of the 
CAM they have used to another pregnant woman due to perceived 
ineffectiveness or because they felt therapy needs to be individualised:  
“… No because the raspberry leaf tea is not doing anything” (P10) 
“No I wouldn’t because I’m not a doctor so I wouldn’t say, I would say 
well really you should go and see your doctor who is specialising in 
that and erm then she will be able to find something for you but I 
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wouldn’t say to you use this and that really because I think also it’s 
very different depending on people as well, so no…” (P7) 
 
Yet, a few other participants said they were not sure they would recommend 
to another pregnant woman: 
“Maybe, probably. I’m not sure…” (P3) 
“The ginger I am not quite sure about…” (P14) 
4.6.10 Alcohol 
4.6.10.1 Information 
Only six participants disclosed taking 1 or 2 units of alcohol per week. The 
women spoke about friends and family, internet, media, pregnancy book and 
health professionals- GP and midwife- as their sources of information on 
alcohol in pregnancy. The main information reported was about the 
perception that occasional intake of alcohol during pregnancy was 
permissible. 
4.6.10.2 Communication with healthcare professionals 
When asked whether there were discussions about alcohol in pregnancy with 
healthcare professionals, all replied in the affirmative although 4 women did 
not disclose consumption. They remarked: 
“… they ask you whether you smoke and I said, ‘no’, and they ask you 
whether you drink and I said, ‘no’. I think I don’t look very naive so I 
don’t think they feel that I need to be told” (P13) 
“They asked me if I was smoking and drinking and I said ‘no’. So they 
obviously didn’t see me as a case to worry about so, not really. No I’m 
not smoking and I don’t even know if (pauses) I have the occasional 
glass of wine but a maximum of two a week though I haven’t really 
mentioned it but I haven’t been told (pauses), I haven’t really been told 
that you shouldn’t really be drinking” (P15) 
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The 2 other subjects however reported that they received ‘positive’ feedback 
during their discussion with healthcare professionals: 
“… I told the midwife I have alcohol every now and then and they are 
like: ‘oh that’s fine’…” (P1) 
“… from talking to doctors, midwives and everything they’ve said after 
the first trimester, it’s not necessarily going to be harmful to the 
baby…” (P8) 
 
4.6.10.3 The influence of maternal perceptions on alcohol consumption  
In this group of women, there was perception of some benefits in drinking. 
This perception, alongside their low perceived risk of drinking as well as the 
influence of friends or family consumption seemed to explain their behaviour. 
4.6.10.3.1 Perceived benefits of consumption 
The reasons given by the women for drinking alcohol were because they 
liked it and it is relaxing: 
“I enjoy it. I like the taste…” (P13) 
“… a glass of wine every now and then I think is relaxing and the 
actual effects of the alcohol could sometimes outweigh the effects of 
the scotch and alkanol in it [laughs]…” (P1) 
 
4.6.10.3.2 Risks of alcohol consumption 
All the six women believed that one or two units of alcohol per week as a 
reasonable level of consumption in pregnancy. In their words: 
“… I believe that in moderation it’s absolutely fine… I have like 2 
glasses of wine per week …but erm yeah, I am not erm I don’t really 
lecture on it though like I think erm as a mum, you sort of feel what’s 
good and you feel what’s not good for you, your body would crave 
certain things and if it’s not good, your body would not want to take it. 
And sometimes even when I told you I’ve had some cider at one time 
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erm I started drinking it, I felt a bit sick and I couldn’t finish a glass of 
it. So that’s it...” (P1)  
“… I’ve read quite a lot since I’ve been pregnant so that’s backed up 
by stuff that I’ve read as well. And erm the NHS pregnancy book 
actually allows you to drink a glass or 2 small units of wine twice a 
week” (P15) 
When probed further about the risks of alcohol intake during pregnancy, 
most of the women seemed to ignore answering it by expressing the 
common belief that small intake of alcohol would not adversely affect the 
unborn baby. They verbalised their perceptions: 
“Erm well, I don’t believe that there is any harm to the baby from the 
occasional glass of wine, that’s what I know” (P13) 
“My mum drank, not like heavily through her pregnancies with my 
sister and I but she would have a drink and my partner’s mum would 
have a drink and in fact most of my parents’ friends and my uncles 
and aunties and stuff they said they had all drunk and we are all 
perfectly fine. In fact some of my cousins are highly intelligent people, 
so yes there can be risks but I think they are few and far between” 
(P8) 
Additionally, 2 women admitted the fact that alcohol can actually have 
adverse effects on the baby only if large amounts are consumed: 
“…Well I do know if you drink too much, you can cause quite a lot of 
extensive damage to the baby… probably brain development and 
things like that as well, there can be problems with that” (P8) 
“… because I’ve been having a glass of wine occasionally I don’t 
really see that as really, really bad. Obviously alcohol in excess is a 
very, very bad thing for the body… it’s bad, yes, it’s toxin isn’t it? 
Basically, if you’re putting toxins into your body the toxins are also 
going to be transferred to your baby …” (P15) 
Two women also tried to justify that alcohol consumption was still ‘better’ 
than smoking during pregnancy: 
“…I don’t smoke anyway, I’m paranoid about smoking now or being 
around any kind of smoke because I don’t want preterm again. Urm 
and I know smoking limits the amount of oxygen in the blood for the 
baby” (P1) 
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“I know that when you smoke the oxygen levels that are getting to 
your baby are lowered… I see smoking as the worst thing possible” 
(P15) 
 
4.6.10.3.3 Friends or family consumption 
All the participants had friends or family members who consume alcohol and 
they reported being influenced by them. One of the women even explained 
how she could not resist drinking because her partner and other family 
members drink: 
“He [partner] does… it’s like quite difficult, especially when your 
partner drinks and you’ve got other people drinking around you and 
loads around you and you are not doing anything, it’s quite hard not to 
but, like my partner’s mum, my mum, my dad…” (P8) 
 
“… then I also have cider when I’m out with friends and on some 
weekends when we socialise” (P1) 
 
4.6.11 Cigarette 
The only subject interviewed about cigarette said she reduced her intake to 4 
or 5 sticks per day and that her partner also smokes. Despite acknowledging 
the risks to the foetus, she verbalised her lack of self-efficacy- she found it 
difficult to stop smoking: 
“… it’s obviously bad for baby because of all the carbon monoxide that 
would be in my system and she would be taking it in… it is best for my 
baby to stop obviously but it is very hard. I’ve been smoking for a long 
time” (P16) 
She further demonstrated the lack of self-efficacy to stop smoking when she 
was referred to a stop smoking clinic and was given nicotine patches. She 
used the patches for about a month and stopped because of perceived 
ineffectiveness. She noted: 
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“… I used them [nicotine patches] for maybe a month or so… they 
didn’t really work. It didn’t really work for me anyway, I was still 
craving” (P16) 
 
4.6.12 Cannabis 
Only one participant was interviewed about cannabis. She claimed to have 
reduced her consumption during pregnancy to once a month and her partner 
also consumes the substance. When asked about the information on 
cannabis in pregnancy, the participant simply said she is an ‘informed’ 
person who does not consume much. She felt that healthcare professionals 
target people who consume large amounts:  
“… I’m an informed person and I do know the limits. Then also 
because I don’t consume that much, they don’t question you that 
much I think. I imagine they target people that are consuming large 
amounts” (P3) 
However, despite claiming to be an ‘informed’ person, the participant 
reported not knowing much about the risks of taking cannabis in pregnancy. 
Table 26 summarises the theoretical constructs which could be used to 
predict or explain participants’ behaviour with regard to medicine and 
recreational substance use during pregnancy. 
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Table 26 Summary table of results 
Medicine/Substance Predictors of behaviour 
 
Prescription medicines 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Over-the-counter medicines 
(Vitamins) 
 
 
 
 
Complementary and alternative 
medicines 
 
 
Alcohol 
 
 
 
Cigarette 
 
 
 
Cannabis 
 
Adherence: 
High perceived severity of medical 
condition  
High perceived risks of non-
adherence 
Trust in healthcare professional  
 
Non-adherence: 
Perceived barriers (forgetfulness 
and side effects experience) 
Lack of trust in healthcare 
professional 
Low perceived severity of medical 
condition 
Lack of perceived risks of non-
adherence 
 
Non-adherence: 
Perceived barriers (forgetfulness)  
Lack of perceived risks of non-
adherence  
 
 
Perceived effectiveness 
Lack of perceived risks of therapies  
Trust in CAM practitioner 
 
Low perceived risks of consumption  
Perceived benefits  
Friends or family consumption 
 
Low perceived risks of smoking 
Lack of self-efficacy 
Friends or family consumption 
 
Lack of perceived risks of 
consumption 
Friends or family consumption 
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4.7 Discussion 
A broader understanding of women’s health beliefs and perceptions of 
medicine and recreational substance use during pregnancy is necessary 
such that medical services can be tailored appropriately for them. In this 
qualitative study, the beliefs of expectant mothers about their health as well 
as medicine and recreational substance use in pregnancy were investigated 
using the Health Belief Model as the framework. 
It is however challenging to compare the findings of the present study with 
previous work due to the differences in study objectives and data collection 
methods. Furthermore, there are no comparative data available as regards 
the qualitative assessment of the beliefs of pregnant women using the Health 
Belief Model, hence this is the first of its kind. 
All the participants in the present study reported lifestyle modifications as 
regards diet, exercise and avoidance of harmful substances. Almost half of 
the participants expressed concerns about their health in terms of adequate 
vitamin and water intake as well as medical conditions such as high blood 
pressure and diabetes. Most of the women who had concerns about their 
health have been pregnant at least once before. The women who reported 
concerns about their unborn baby’s health were either those who had prior 
experience of an adverse pregnancy outcome and thus worried about the 
outcome of the current pregnancy, or those who had medical conditions 
which they feared might affect the unborn baby. These data highlight the 
knowledge of the women about the importance of lifestyle changes during 
pregnancy. 
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An important theme of adherence came up with respect to prescription 
medicines and vitamin use during pregnancy. Adherence to medicines is 
defined as the extent to which the patient’s action matches the agreed 
recommendations. Non-adherence may limit the benefits of medicines, 
resulting in lack of improvement, or deterioration in health (NICE guideline, 
2009).  
The present study found that a high perception of the severity of a medical 
condition, trust in the healthcare professional, a high perception of the risks 
which can result from not taking medicines, and perceived barriers such as 
forgetfulness and side-effects experience were the predictors of adherence 
to prescribed medicines amongst pregnant women. 
The current study also indicated that perception of the risks which can result 
from not taking vitamins and perceived barriers such as forgetfulness were 
the predictors of adherence to vitamin recommendations. Women who were 
forgetful to take their vitamins, those who were not aware of the risks or who 
believed there were no risks associated with non-adherence tended not to 
take their vitamin supplements as recommended. The reason for the latter 
perception could be because vitamins were used for preventive purposes as 
some of them pointed out that they were uncertain about the effectiveness of 
the supplements.  
With regard to complementary and alternative medicine (CAM) use, the 
present study found that trust in CAM practitioners whom the women 
consulted and the confidence in the CAM services received influenced 
women’s use of the therapies. Most of the participants will recommend the 
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CAM they have used to other pregnant women. Furthermore, all the 
respondents in this study felt the CAM they have used had no risks in 
pregnancy. A possible explanation for this perception may be that women 
are aware of the potential teratogenic effects of some medicines and 
therefore take responsibility for their health and the unborn baby’s health. 
This corroborates the finding by Gaffney and Smith (2004) which 
demonstrated that majority of the 220 study participants believed the use of 
CAM to be safe during pregnancy. Most of the women in the current study 
also believed in the effectiveness of the CAM they have used and this is in 
keeping with the research by Fakeye and colleagues (2009) which showed 
that 81% of the 595 participants believed in the efficacy of herbal medicines. 
The present study found that the participants who took alcohol had low 
perceived risks of consumption on the baby since they believed that 
consuming a few units of alcohol during pregnancy was reasonable and that 
only large amounts can harm the developing foetus. This finding is not far 
removed from the results of past studies on alcohol consumption in 
pregnancy (Baric and MacArthur, 1977; Barbour, 1990; Lelong et al., 1995; 
Kesmodel and Kesmodel 2002; Toutain 2010; Kim and Park 2011; Jones 
and Telenta 2012). Furthermore, it was observed that some women in the 
present study compared alcohol intake favourably to smoking during 
pregnancy. This is not unexpected as research suggests that people 
compare themselves with counterparts who engage in other unhealthy 
behaviours and by so doing, one can appear more advantaged than others 
(Lawson, 1994). All the participants also perceived the benefits of relaxation 
and enjoyment from alcohol consumption during pregnancy. This finding 
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lends support to the work of Raymond et al. (2009) which reported that 
pregnant women described alcohol consumption as being beneficial with 
regard to stress relief and relaxation. The current study also found that the 
participants who consumed alcohol reported having family members or 
friends with whom they drank. This is consistent with a prior study- Senecky 
et al. (2011) noted that there was a direct relationship between pregnant 
woman’s drinking habits and those of her spouse or partner. 
The only participant in this study who admitted smoking during pregnancy 
had a low perceived risk of smoking on the developing child. Despite her 
referral to the stop smoking clinic where she was given nicotine patches, this 
participant lacked the self-efficacy to stop. According to her, she found it 
difficult to stop because she had been smoking for years and that the 
nicotine patches were not effective since she was still craving for cigarettes 
while using it. Additionally, she reported that her partner also smokes and 
this could also influence her to smoke as previous research found that 
women who smoked during pregnancy lived in homes with significantly more 
smokers than in the homes of non-smoking women (Steyn et al., 1997). 
The only participant who disclosed cannabis use claimed to be an informed 
person but expressed lack of knowledge of the risks of consumption during 
pregnancy. However, an explanation for this participant’s attitude is that she 
probably declared not knowing the risks of cannabis on the unborn baby in 
order to justify her unhealthy behaviour. 
Another important finding from the present study was about the sources of 
information on medicine and recreational substance use in pregnancy. The 
internet is one of the fastest-growing sources of information on a wide range 
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of health-related issues, including pregnancy (Lagan et al., 2006). However, 
women find a lot of conflicting information on the internet which are often not 
evidence-based (De Santis et al., 2010). Even the evidence-based studies 
require being a professional in the field to be able to discern and apply the 
results. The widespread use of this source was demonstrated by a 
participant in the present study whose fear of the safety of her medicine 
seemed to be confirmed by the results of a study which she read online. 
Therefore, the role of healthcare professionals as a source of evidence-
based information on medicine and recreational substance use during 
pregnancy cannot be over-emphasized. Moreover, trust in the healthcare 
professional was observed as one of the factors which influenced the use of 
prescription medicines during pregnancy. 
4.8 Strengths and Limitations 
Some limitations need to be considered when interpreting the results from 
this study. The validated tools which are used for smoking and alcohol intake 
were not incorporated in the interview guide design. The analysis of 
prescription medicines was not classified into medicines for acute or chronic 
conditions, and data saturation was not achieved with the medicines and 
recreational substances studied. Furthermore, qualitative research is based 
on interpretation which necessarily requires input from researchers 
(Wulandari and Whelan, 2011), hence it is possible that the researcher’s 
personal experience as a pharmacist and mother may have influenced the 
interpretation of the data. However, the likelihood of this is low as a male 
researcher who is single was involved in developing the coding framework 
and the interpretative processes of the themes and this helped to establish 
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the confirmability of the results. This study was conducted in a central 
London teaching hospital with participants who were mainly whites and 
university-educated. The use of a purposive sample and the voluntary nature 
of participation in the study also meant that the study sample may differ from 
the general population in their beliefs or perceptions about medicine or 
recreational substance use during pregnancy. Hence the results may not be 
transferable to other populations.  
However, despite the fact that the study sample limits transferability of the 
results to a broader population, the women’s concepts, beliefs, perceptions 
and ideas about prenatal use of medicines and recreational substances were 
insightful and provided important information which will be useful for 
healthcare professionals and researchers. The other strengths of this study 
lie in the data collection method employed. The semi-structured interview 
method provided the rigour needed to ensure that perceptions related to the 
research questions were explored while allowing flexibility for the participants 
to bring up other issues which were important to them but not covered by the 
interview guide. The interviewer had been following up the women from their 
first trimester, hence participants were confident discussing with her. The 
telephone interviews were also fixed at convenient times for the 
interviewees, therefore enabling them to communicate openly with the 
interviewer. The sampling procedure, data collection and analysis were 
appropriately explained in order to establish the trustworthiness of the 
results. 
 
Chapter 4 
 
251 
 
4.9 Conclusions 
This study demonstrates that expectant mothers choose to take 
responsibility for their health and the unborn child’s health. In making 
decisions about medicine use in the antenatal period therefore, expectant 
mothers consider many factors including the severity of a medical condition 
for which the medicine is indicated, the risks of non-adherence to the 
medicine as well as the anxiety about the risks of medicines on the 
developing foetus. With regard to prenatal use of recreational substances, a 
low or lack of risk perception could be used to explain the unhealthy 
behaviour. Most of the women in this study needed more information about 
the benefits or risks of prenatal use of medicines or recreational substances. 
Although knowledge alone does not guarantee compliance with healthy 
behaviours, it does allow women to make informed choices. Healthcare 
professionals should make every effort to protect the health of pregnant 
women and the unborn babies through the provision of appropriate evidence-
based counselling which is guided by women’s perceptions. 
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5.1 Introduction 
The vulnerability of the foetus to the adverse effects of medicines and 
recreational substances during pregnancy attracts huge attention from 
researchers and healthcare professionals because of the highly publicised 
incidents such as thalidomide and diethylstilboestrol experiences.  
The inclusion of pregnant women in clinical trials to test the teratogenic 
properties of medicines is not possible due ethical reasons. Yet, expectant 
mothers do have chronic and acute medical conditions which may require 
medicines. Therefore, epidemiological approaches to risk evaluation are of 
major importance in order to improve the evidence base for using medicines 
in pregnancy. It has also been proposed that most pregnant women are 
sensitive to the risks of medicines for the unborn baby (Baric and MacArthur 
1977); and that little is known about women’s health beliefs about medicines 
and recreational substances in pregnancy (Heaman et al., 2004).  
Although the volume of literature on the use of medicines and recreational 
substances in pregnancy has been growing, there remain concerns about 
the limitations of previous researches. A literature review of epidemiological 
studies discovered that there is limited data on the full extent of prenatal 
medicine (prescription, over-the-counter, and complementary and alternative 
medicines) and recreational substance (licit and illicit substances) use and 
their effects on pregnancy outcomes (section 1.2.6.4). The international 
literatures also demonstrate that there is scarcity of information on pregnant 
women’s in-depth beliefs about their health and medicine and recreational 
substance use (section 3.6). Thus, the overall aim of this thesis was to 
investigate medicine and recreational substance use in pregnancy. The 
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objectives were to determine medicine and recreational substance use 
during pregnancy (first, second and third trimesters) as well as the 
pregnancy outcomes; and to qualitatively assess the health beliefs of the 
same antenatal population of London using the Health Belief Model as the 
framework. In this chapter, a discussion of the main findings described in this 
thesis will be presented along with the implications, recommendation for 
future research, and conclusions. 
5.2 Main findings 
5.2.1 Medicine and recreational substance use in pregnancy 
There are no comparable UK studies for the prevalence of prescription, over-
the-counter, complementary and alternative medicines as well as alcohol use 
in the first trimester which employed the same methods as the current study. 
Internationally, there are no comparable studies for the prevalence of 
cigarette smoking and illicit substance use in early pregnancy which used the 
same methods as the current study.  
The use of medicines in this antenatal population is reportedly more common 
than recreational substances. Participants who used medicines or alcohol 
were more likely to be university-educated or in the age range of 31 – 40 
years while users of cigarette were more likely to have education which is 
below the university level. 
The results obtained from assessing the safety knowledge of the mothers 
demonstrated that although a high proportion of the women felt they had 
enough information about the safety of recreational substances, a substantial 
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number of them believed they had little or no information about the safety of 
medicines in pregnancy (section 2.6.2.4). 
With regard to the pregnancy outcomes, concomitant use of complementary 
and alternative medicines with cigarette in the first trimester was univariably 
associated with an increased risk of congenital anomaly in the baby (p = 
0.001). The use of complementary and alternative medicines jointly with 
over-the-counter medicines in at least one trimester was also univariably 
associated with a higher risk of congenital anomaly in the baby (p = 0.001). 
Comparable results on concomitant use of these agents and associations 
with pregnancy outcomes were not found in previous international studies. 
However, due to the limited sample size of the cohort, logistic regression 
could not be carried out to control for potential confounders. Hence, the 
results should be regarded as preliminary and further investigation is 
necessary. 
5.2.2 Qualitative study on health beliefs 
There are no comparative data available internationally as regards the 
qualitative assessment of the health beliefs of pregnant women using the 
Health Belief Model. The findings from this study showed that all the 
participants in the qualitative study reported lifestyle modifications as regards 
diet, exercise and avoidance of harmful substances. Almost half of the 
participants expressed concerns about their health in terms of adequate 
vitamin and water intake as well as medical conditions such as high blood 
pressure and diabetes. Most of the women who had concerns about their 
health have been pregnant at least once before. The women who reported 
concerns about their unborn baby’s health were either those who had prior 
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experience of an adverse pregnancy outcome and thus worried about the 
outcome of the current pregnancy, or those who had medical conditions 
which they feared might affect the unborn baby. 
The findings indicated that a high perception of the severity of a medical 
condition, perceived barriers such as forgetfulness, trust in the health care 
professional and a high perception of the risks which can result from not 
taking medicines were observed to explain the behaviour of women as 
regards adherence to prescribed medicines. Women who perceived the 
severity of their medical condition (for instance diabetes) to be high, those 
who trusted the information and services received from healthcare 
professionals or those who perceived a risk from not using their medicines 
were more likely to adhere to their prescribed medicines. 
Folic acid and other vitamins were the main over-the-counter medicines 
described in this part of the thesis. Participants who perceived barriers such 
as forgetfulness to take the vitamins, those who were not aware of the risks 
or who believed there were no risks associated with non-adherence were 
more likely not to take their supplements as recommended. 
The results about complementary and alternative medicines (CAM) 
demonstrated that all the participants believed that the therapies constitute 
no risk to the unborn child. Most of them also believed in the effectiveness of 
CAM as well as trusted the CAM practitioner which they consulted. 
The participants who took recreational substances- alcohol, cigarette or 
cannabis- perceived little or no risks of consumption on the developing 
foetus. It was discovered that most of the women in this study needed more 
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information about the benefits or risks of prenatal use of medicines or 
recreational substances. 
Another important finding from this study is the trust in healthcare 
professionals which influenced the use of prescription medicines during 
pregnancy. This confirms that healthcare professionals play a pivotal role in 
providing evidence-based information about the prenatal use of these 
agents. 
Overall, this study is suggestive that the Health Belief Model is a useful 
model for explaining and predicting health-related behaviours in the pregnant 
population. However, as pointed out by the critics of the model, friends or 
family consumption of recreational substances (alcohol, cigarette or 
cannabis) which came up as a predictor for use, is an environmental 
influence on health behaviour which the model did not consider in its 
constructs.  
5.3 Implications for practice and policy 
The findings presented in this thesis have some implications for healthcare 
professionals caring for pregnant women and for policy makers.  
First, healthcare professionals have a role in educating reproductive age 
women about the safety of medicines as well as counselling against 
unnecessary exposures to over-the-counter and complementary and 
alternative medicines which can pose a risk to the foetus. Furthermore, 
because of the potential for herbals to interact with conventional medicines 
(McLay et al., 2012), routine screening and counselling about herbals and 
other CAM modalities should become part of antenatal visits.  
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Second, policy makers also need to ensure that there is proper and efficient 
documentation of the safety of complementary and alternative medicines in 
pregnancy. 
Third, it has been suggested that there is an erroneous assumption by 
healthcare professionals that women are aware of the foetal risks of 
substance use during pregnancy and therefore do not need to be educated 
about it (Griffiths et al., 2005). Thus, it is necessary for health care providers 
to provide appropriate advice for pregnant women at risk for using 
recreational substances, on the benefits of quitting since the negative 
outcomes caused by these agents are preventable. 
Fourth, non-adherence to prescribed or recommended medicines may 
represent a loss to patients, the healthcare system and society (NICE 
guideline, 2009). This is because some prescribed or recommended 
medicines can help in preventing birth defects or other adverse pregnancy 
outcomes. Hence, healthcare professionals need to appropriately advise 
pregnant women about the benefits of adherence to prescribed or 
recommended medicines during pregnancy. 
Lastly, healthcare professionals need to take the time to find out about health 
beliefs of women and to adopt a sensitive and non-judgemental approach 
when enquiring about medicine or recreational substance use during 
pregnancy in order to earn the trust of their patients. The perspectives, 
beliefs, concerns and experiences of expectant mothers should be taken 
seriously during counselling because it could make the communication of 
benefits and risks in healthcare settings more effective. Furthermore, there 
could be more productive discussions which can serve as an avenue for 
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passing other relevant messages across to the women. This will enable the 
women to make informed decisions which can help in minimising risks. 
 
5.4 Further work 
First, further research is necessary as regards the effects of concomitant use 
of medicines and recreational substances during pregnancy on pregnancy 
outcomes. Such studies would need to be of larger sample sizes, and also 
consider the dose and duration of exposures to these agents. The studies 
would also need to statistically control for potential confounders including 
maternal medical conditions or illnesses during pregnancy and exposure to 
environmental toxins and chemicals as these may also adversely affect 
pregnancy outcomes. 
Second, congenital anomalies may go undetected clinically until some years 
after birth such as in the case of diethylstilboestrol. Therefore, a follow-up of 
children who have been exposed to medicines and recreational substances 
in pregnancy will be necessary in order to detect the long term effects of 
such exposures. 
Third, in this thesis, recreational substance use was assessed by self-report, 
and future investigation could involve the use of biochemical verification in 
which other methods such as blood, urine, breathe or meconium analyses 
may be used to assess exposure status. These objective screening methods 
could add more information to self-report use of recreational substances. 
Fourth, as demonstrated in this thesis, the field of risk or safety perception 
and communication is important. Thus, it would also be interesting to 
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investigate how information on safety, risk and benefits of pregnancy 
exposures to medicines and recreational substances is provided to expectant 
mothers by midwives and other healthcare professionals. 
Lastly, further research is also needed to explore the relationship between 
health beliefs and health behaviours over the course of pregnancy. Hence, 
longitudinal research would be helpful in examining the associations between 
women’s intentions to improve health behaviour and actual behavioural 
change. In this regard, it may be necessary to develop an assessment tool 
with which healthcare professionals can identify individual health beliefs early 
in pregnancy. Consequently, relevant clinical interventions can be developed 
in order to safeguard maternal and foetal health. 
5.5 Conclusions 
The work described in this thesis investigated the epidemiology and health 
beliefs of medicine and recreational substance use during pregnancy in 
London, UK. 
This thesis is an original contribution to knowledge as it is the first study to 
qualitatively assess the health beliefs in an antenatal population using a 
theoretical framework. It is also the first study to report the effects of 
concomitant use of medicines and recreational substances on pregnancy 
outcomes. It is the first UK study to prospectively examine exposures to all 
medicines and recreational substances during the course of pregnancy using 
a structured interview approach. Furthermore, it is the first UK study to 
assess the safety knowledge of pregnant women about medicines and 
recreational substances. 
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The key findings in this thesis are summarised below: 
 The use of medicines in this antenatal population is reportedly more 
common than recreational substances. 
 Women who used medicines or alcohol were more likely to be 
university-educated or in the age range of 31 – 40 years while users 
of cigarette were more likely to have education which is below the 
university level. 
 The thesis was not powered (in terms of sample size) to demonstrate 
an association between the medicines and recreational substances 
used during pregnancy and increased risk of congenital anomalies in 
the baby. 
 Pregnant women choose to take responsibility for their health and the 
unborn child’s health. 
 Pregnant women’s adherence to medicines could be explained by 
women’s perception of the severity of a medical condition for which 
the medicine is indicated, risks of non-adherence to the medicine as 
well as the anxiety about the risks of the medicine on the developing 
foetus. In the case of recreational substance use, a low risk 
perception could be used to explain women’s behaviour. 
 Most of the participants needed more information about the benefits or 
risks of medicines and recreational substances in pregnancy. 
 Healthcare professionals are most suited to provide appropriate 
evidence-based information to pregnant women. 
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 The Health Belief Model is a promising framework which health 
agencies, healthcare professionals and researchers can adopt in 
assessing health beliefs. 
In conclusion, the findings from this thesis provide essential insights for those 
providing maternity care as it demonstrated that prenatal use of medicines 
and recreational substances is crucial, not only because of the potential risks 
to the unborn child, but because of the benefits to the mother and baby 
which some medicines provide during pregnancy. It has therefore improved 
the evidence base on the subject matter and it is an important contribution to 
the effective healthcare of pregnant women as well as the protection of 
maternal and foetal health. 
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UCL INSTITUTE OF CHILD HEALTH 
 
Patient Information Sheet v.2              June 2010 
 
A multi-centre, cross-sectional surveillance study to estimate the prevalence 
of prescription, over-the-counter, ‘recreational’ and complementary drug use 
in early pregnancy in an ethnically diverse inner-city population in the UK.  
 
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you. One of our team will go through the information sheet with you and 
answer any questions you have. Ask us if there is anything that is not clear. 
It is up to you to decide to join the study. We will describe the study and go through 
this information sheet. If you agree to take part, we will then ask you to sign a 
consent form. You are free to withdraw at any time, without giving a reason. This 
would not affect the standard of care you receive. 
We are interested in what prescription medication and other substances women in 
early pregnancy use. If you agree to take part we will ask you to complete a 
questionnaire based interview with one of our research team lasting approximately 
15 minutes. This interview will be conducted in the antenatal unit after you have 
attended for your routine ultrasound scan.  
We cannot promise the study will help you but the information we get from this study 
will be of help to doctors, pharmacists, midwives, scientists and pregnant women in 
the future. 
All information which is collected about you during the course of the research will be 
kept strictly confidential, and any information about you which leaves the hospital 
will have your name and address removed so that you cannot be recognised. Your 
GP will not be informed, unless specifically requested by you.  
A written report of the findings will be sent to your registered address at the 
conclusion of the study. 
If you withdraw from the study, we will destroy your questionnaire, but we will need 
to use the data collected up to your withdrawal. 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers who will do their best to answer your questions or the head 
of the study Dr Alastair Sutcliffe, Senior Lecturer in Child Health at the UCL 
Institute of Child Health on 020 7905 2190. 
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UCL INSTITUTE OF CHILD HEALTH 
 
 
 
 
Centre Number:  
 
Study Number:  
 
Patient Identification Number:  
 
 
CONSENT FORM  
 
A multi-centre, cross-sectional surveillance study to estimate the prevalence 
of prescription, over-the-counter, ‘recreational’ and complementary drug use 
in early pregnancy in an ethnically diverse inner-city population in the UK.  
 
Name of Researcher:  Dr Alastair Sutcliffe, Senior Lecturer in Child Health, UCL 
 
 
 
1. I confirm that I have read and understand the information sheet dated June 2010 
(version 2) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights being 
affected.  
 
3. I understand that relevant sections of my medical notes and data collected during 
the study, may be looked at by individuals of the research team, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records.  
 
4. I agree to take part in the above study.  
 
 
 
_________________________________________________________________________________ 
Name of Patient     Date    Signature  
 
_________________________________________________________________________________ 
Name of Person taking consent   Date    Signature  
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UCL INSTITUTE OF CHILD HEALTH 
 
 
Medication Use in Pregnancy Questionnaire v.2 
 
Demographic data  
1. Age ________________ 
 
2. Ethnic Origin   
1 White   5 Indian  9 Other ________________________ 
2 African   6 Pakistani 
3 Black Caribbean  7 Bangladeshi 
4 Black Other  8 Chinese 
 
Pregnancy data 
3. Date of last menstrual period  ___________________ 
4. How many times have you been pregnant?  _____________________ 
5. Have you experienced problems before in pregnancy? (e.g. 
miscarriage/termination) YES/NO 
If YES please describe  ___________________________ 
6. Have you previously given birth?  YES/NO 
If YES were your previous children fit and healthy?  __________________________ 
 
Lifestyle data 
7. How many cups of coffee/tea/cola do you now drink per day? _________________ 
Before pregnancy?  __________________________ 
8. How much alcohol do you now drink per week? ______________units  
Before pregnancy?____________________________ 
(1 unit = 1/2 pint beer or cider/1 glass wine/ 1 measure of spirit) 
9. If you smoke how many cigarettes/cigars do you smoke per day? ______________ 
Before pregnancy?_______________________________ 
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Medicines Data 
10. a. Are you taking any PRESCRIPTION medicines now or have done during your 
pregnancy so far?  YES/NO 
If YES please describe (under ‘Frequency’ if Regular give duration/ if When required 
give times/month) 
 
Name of Medicine Frequency/When Indication 
   
   
   
   
 
b. Were you taking any prescription medicines before pregnancy?  YES/NO 
If YES please describe (including oral contraceptives/morning after pill) 
 
Name of Medicine Frequency/When Indication 
   
   
   
   
 
11. a. Are you taking any OVER-THE-COUNTER medicines now or have done 
during your pregnancy so far?  YES/NO 
If YES please describe (including multi-vitamins) 
 
Name of Medicine Frequency/When Indication 
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b. Were you taking any over-the-counter medicines before pregnancy?  YES/NO 
If YES please describe. 
 
Name of Medicine Frequency/When Indication 
   
   
   
   
 
12. a. Are you taking any ALTERNATIVE or TRADITIONAL remedies now or have 
done during your pregnancy so far?  YES/NO 
If YES please describe. (Homeopathic or flower remedies/Aromatherapy massage 
oils/Herbal or homeopathic from a practitioner) 
 
Name of Therapy Frequency/When Indication 
   
   
   
   
 
b. Were you taking any alternative or traditional remedies before pregnancy?  
YES/NO 
If YES please describe. 
 
Name of Therapy Frequency/When Indication 
   
   
   
   
 
13. a. Do you use RECREATIONAL drugs now or have done during your 
pregnancy so far?  YES/NO 
  
298 
 
If YES please describe (marijuana, cannabis, cocaine, crack, LSD, amphetamine, 
ecstasy, heroin). 
 
Name of Drug Frequency/When Indication 
   
   
   
   
 
b. Have you been taking any recreational drugs before pregnancy? YES/NO 
If YES please describe. 
 
Name of Drug Frequency/When Indication 
   
   
   
   
 
14. If you need more information on medicine/drug use in pregnancy, where would 
you go?  
1 GP   4 Literature  7 Other __________________________________ 
2 Clinic  5 Internet 
3 Pharmacist  6 Friends/family 
 
15. Have you been taking folic acid during your pregnancy?  YES/NO 
 
 
Thank you for completing the questionnaire. All responses are strictly 
confidential. 
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Appendix 2 – Patient information sheet, Consent form and 
Questionnaires (Final versions) 
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UCL INSTITUTE OF CHILD HEALTH 
 
Patient Information Sheet v.3              April 2011 
 
A multi-centre longitudinal study to estimate the prevalence of prescription, 
over-the-counter, ‘recreational’ and complementary drug use in pregnancy 
and the pregnancy outcomes in an ethnically diverse inner-city population in 
the UK.  
 
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you. One of our team will go through the information sheet with you and 
answer any questions you have. Ask us if there is anything that is not clear. 
It is up to you to decide to join the study. We will describe the study and go through 
this information sheet. If you agree to take part, we will then ask you to sign a 
consent form. You are free to withdraw at any time, without giving a reason. This 
would not affect the standard of care you receive. 
We are interested in what prescription medication and other substances women use 
during pregnancy. If you agree to take part we will ask you to complete a 
questionnaire based interview with one of our research team lasting approximately 
15 minutes. This interview will be conducted in the antenatal unit after you have 
attended for your routine ultrasound scan. We would also want to know the 
medicines you are taking in your second and third trimesters by telephoning you. 
We will request your phone number and agree on a convenient time to call at the 
end of your first interview. The phone call will take about 6 minutes. 
We cannot promise the study will help you but the information we get from this study 
will be of help to doctors, pharmacists, midwives, scientists and pregnant women in 
the future. 
All information which is collected about you during the course of the research will be 
kept strictly confidential, and any information about you which leaves the hospital 
will have your name and address removed so that you cannot be recognised. Your 
GP will not be informed, unless specifically requested by you.  
A written report of the findings will be sent to your registered address at the 
conclusion of the study. 
If you withdraw from the study, we will destroy your questionnaire, but we will need 
to use the data collected up to your withdrawal. 
 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers who will do their best to answer your questions or the head 
of the study Dr Alastair Sutcliffe, Senior Lecturer in Child Health at the UCL 
Institute of Child Health on 020 7905 2190. 
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UCL INSTITUTE OF CHILD HEALTH 
 
 
 
 
Centre Number:  
 
Study Number:  
 
Patient Identification Number:  
 
 
CONSENT FORM  
 
A multi-centre longitudinal study to estimate the prevalence of prescription, over-
the-counter, ‘recreational’ and complementary drug use in pregnancy and the 
pregnancy outcomes in an ethnically diverse inner-city population in the UK.  
 
Name of Researcher:  Dr Alastair Sutcliffe, Senior Lecturer in Child Health, UCL 
 
 
 
1. I confirm that I have read and understand the information sheet dated April 2011 
(version 3) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights being 
affected.  
 
3. I understand that relevant sections of my medical notes and data collected during 
the study, may be looked at by individuals of the research team, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records.  
 
4. I agree to take part in the above study.  
 
 
_________________________________________________________________________________ 
Name of Patient      Date   Signature        Phone number/Time to call  
     
 
_________________________________________________________________________________ 
Name of Person taking consent   Date    Signature  
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UCL INSTITUTE OF CHILD HEALTH 
 
 
Medication Use in Pregnancy Questionnaire v.3 (Questionnaire for the first 
trimester interview) 
 
Thank you for agreeing to take part in this study. All responses are strictly 
confidential. 
 
Demographic data  
1. Age ________________ 
 
2. Ethnic Origin   
1 White   5 Indian  9 Other ______________________ 
2 African   6 Pakistani 
3 Black Caribbean  7 Bangladeshi 
4 Black Other  8 Chinese 
 
3. Educational status 
1 Secondary      5 Other  
2 Vocational  
3 University (first degree) 
4 University (post-graduate) 
 
Pregnancy data 
4. Date of last menstrual period  ___________________ 
5. How many times have you been pregnant?  _____________________ 
6. Have you experienced problems before in pregnancy? (e.g. 
miscarriage/termination) YES/NO 
If YES please describe  ___________________________ 
7. Have you previously given birth?  YES/NO 
If YES were your previous children fit and healthy?  __________________________ 
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Lifestyle data 
8. How many cups of coffee/tea/cola do you now drink per day? _________________ 
Before pregnancy?  __________________________ 
9. How much alcohol do you now drink per week? ______________units  
Before pregnancy?____________________________ 
(1 unit = 1/2 pint beer or cider/1 glass wine/ 1 measure of spirit) 
10. If you smoke, how many cigarettes/cigars do you now smoke per day? ______ 
Before pregnancy?_______________________________ 
 
Medicines Data 
11. a. Are you taking any PRESCRIPTION medicines now or have done during your 
pregnancy so far?  YES/NO 
If YES please describe (under ‘Frequency’ if Regular give duration/ if When required 
give times/month). 
Name of Medicine Frequency/When Indication 
   
   
   
   
 
b. In terms of information on the safety of prescription medicines in pregnancy, do 
you feel you have 
1. Enough information 2. Little information  3. No information? 
 
c. Were you taking any prescription medicines before pregnancy?  YES/NO 
If YES please describe. (including oral contraceptives/morning after pill) 
Name of Medicine Frequency/When Indication 
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12. a. Are you taking any OVER-THE-COUNTER medicines now or have done 
during your pregnancy so far?  YES/NO 
If YES please describe. (including multi-vitamins) 
Name of Medicine Frequency/When Indication 
   
   
   
   
 
b. In terms of information on the safety of over-the-counter medicines in pregnancy, 
do you feel you have 
1. Enough information 2. Little information  3. No information? 
 
c. Were you taking any over-the-counter medicines before pregnancy?  YES/NO 
If YES please describe. 
Name of Medicine Frequency/When Indication 
   
   
   
   
 
13. a. Are you taking any ALTERNATIVE or TRADITIONAL remedies now or have 
done during your pregnancy so far?  YES/NO 
If YES please describe. (Homeopathic or flower remedies/Aromatherapy massage 
oils/Herbal or homeopathic from a practitioner) 
 
Name of Therapy Frequency/When Indication 
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b. In terms of information on the safety of alternative or traditional remedies in 
pregnancy, do you feel you have 
1. Enough information 2. Little information  3. No information? 
 
c. What do you think about the safety of alternative or traditional remedies 
compared with conventional medicines? 
1. Safer   2. Equally safe   3. Less safe    4. Don’t know   
 
d. Were you taking any alternative or traditional remedies before pregnancy?  
YES/NO 
If YES please describe. 
Name of Therapy Frequency/When Indication 
   
   
   
   
 
14. a. Do you use RECREATIONAL drugs now or have done during your 
pregnancy so far?  YES/NO 
If YES please describe (marijuana, cannabis, cocaine, crack, LSD, amphetamine, 
ecstasy, heroin). 
Name of Drug Frequency/When Indication 
   
   
   
   
 
b. In terms of information on the safety of recreational drugs in pregnancy, do you 
feel you have 
1. Enough information 2. Little information  3. No information? 
 
c. In terms of information on the safety of cigarette and alcohol in pregnancy, do you 
feel you have 
1. Enough information 2. Little information  3. No information? 
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d. Have you been taking any recreational drugs before pregnancy? YES/NO 
If YES please describe. 
Name of Drug Frequency/When Indication 
   
   
   
   
 
15. Have you been taking folic acid during your pregnancy?  YES/NO 
 
16. If you were told you have a new medical condition, rank in order which of these 
types of medicines would you prefer to take? (1 = most preferred, 3 = least 
preferred) 
Prescription medicines Over-the-counter medicines  Traditional or alternative 
remedies 
17. If you need more information on medicine/drug use in pregnancy, where would 
you go? 
1 GP    4 Literature (e.g. books) 7 Other _______________  
2 Clinic (midwife/consultant)  5 Internet 
3 Pharmacist    6 Friends/family 
 
 
 
Thank you for completing the questionnaire. 
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UCL INSTITUTE OF CHILD HEALTH 
 
 
Medication Use in Pregnancy Questionnaire v.3 (Questionnaire for the second 
and third trimester interviews) 
 
Thank you for agreeing to take part in this study. All responses are strictly 
confidential. 
 
 
Lifestyle data 
1. How many cups of coffee/tea/cola do you now drink per day? _________________ 
2. How much alcohol do you now drink per week? ______________units  
 (1 unit = 1/2 pint beer or cider/1 glass wine/ 1 measure of spirit) 
3. If you smoke, how many cigarettes/cigars do you now smoke per day? ______ 
 
Medicines Data 
4. You were/were not taking any PRESCRIPTION medicines the last time, has that 
changed? Are there any new medicines?  YES/NO 
If YES please describe (under ‘Frequency’ if Regular give duration/ if When required 
give times/month). 
Name of Medicine Frequency/When Indication 
   
   
   
   
 
 
5. You were/were not taking any OVER-THE-COUNTER medicines the last time, 
has that changed? Are there any new medicines?  YES/NO 
If YES please describe. (including multi-vitamins) 
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Name of Medicine Frequency/When Indication 
   
   
   
   
 
6. You were/were not taking any ALTERNATIVE or TRADITIONAL remedies the 
last time, has that changed? Are there any new medicines/remedies?  YES/NO 
If YES please describe. (Homeopathic or flower remedies/Aromatherapy massage 
oils/Herbal or homeopathic from a practitioner) 
Name of Therapy Frequency/When Indication 
   
   
   
   
 
7. You were/were not taking any RECREATIONAL drugs the last time, has that 
changed? Are there any drugs you are taking now?  YES/NO 
If YES please describe (marijuana, cannabis, cocaine, crack, LSD, amphetamine, 
ecstasy, heroin). 
Name of Drug Frequency/When Indication 
   
   
   
   
 
 
 
Thank you. 
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Appendix 3 – Univariate associations between participants’ 
characteristics and medicine or substance use in early pregnancy 
(Cross-sectional study, N = 560) 
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Univariate associations between participants’ characteristics and 
prescription medicine use in early pregnancy 
Characteristic Users 
(n = 155) 
Non-users 
(n = 405) 
p value 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational 
status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous 
obstetric 
problems 
Yes  
No 
 
Parity 
   0 
≥ 1 
 
Previous 
healthy 
child(ren) 
Yes 
No 
 
Lifestyle 
variables (early 
pregnancy) 
Coffee 
Yes 
n (%) 
 
1 (0.6) 
53 (34.2) 
90 (58.1) 
11 (7.1) 
 
 
103 (66.5) 
21 (13.5) 
12 (7.7) 
19 (12.3) 
 
 
 
30 (19.4) 
 
125 (80.6) 
 
 
 
48 (31.0) 
107 (69.0) 
 
 
 
 
59 (55.1) 
48 (44.9) 
 
 
78 (50.3) 
77 (49.7) 
 
 
 
 
72 (93.5) 
5 (6.5) 
 
 
 
 
 
42 (27.1) 
n (%) 
 
11 (2.7) 
141 (34.8) 
239 (59.0) 
14 (3.5) 
 
 
271 (66.9) 
47 (11.6) 
39 (9.6) 
48 (11.9) 
 
 
 
115 (28.4) 
 
290 (71.6) 
 
 
 
163 (40.2) 
242 (59.8) 
 
 
 
 
119 (49.2) 
123 (50.8) 
 
 
221 (54.6) 
184 (45.4) 
 
 
 
 
178 (96.7) 
6 (3.3) 
 
 
 
 
 
130 (32.1) 
 
0.133 
 
 
 
 
 
0.848 
 
 
 
 
 
0.029 
 
 
 
 
 
 
0.043 
 
 
 
 
0.304 
 
 
 
 
0.368 
 
 
 
 
0.236 
 
 
 
 
 
 
 
0.251 
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No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
113 (72.9) 
 
 
71 (45.8) 
84 (54.2) 
 
 
23 (14.8) 
132 (85.2) 
275 (67.9) 
 
 
177 (43.7) 
228 (56.3) 
 
 
43 (10.6) 
362 (89.4) 
 
 
0.654 
 
 
 
0.166 
 
 
 
 
Univariate associations between participants’ characteristics and over-
the-counter medicine use in early pregnancy 
Characteristic Users 
(n = 143) 
Non-users 
(n = 417) 
p value 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational 
status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous 
obstetric 
problems 
Yes 
No 
 
n (%) 
 
3 (2.1) 
29 (20.3) 
107 (74.8) 
4 (2.8) 
 
 
112 (78.3) 
10 (7.0) 
5 (3.5) 
16 (11.2) 
 
 
 
25 (17.5) 
 
118 (82.5) 
 
 
 
45 (31.5) 
98 (68.5) 
 
 
 
 
48 (49.0) 
50 (51.0) 
 
n (%) 
 
9 (2.2) 
165 (39.6) 
222 (53.2) 
21 (5.0) 
 
 
262 (62.8) 
58 (13.9) 
46 (11.0) 
51 (12.2) 
 
 
 
120 (28.8) 
 
297 (71.2) 
 
 
 
166 (39.8) 
251 (60.2) 
 
 
 
 
130 (51.8) 
121 (48.2) 
 
 
<0.0001 
 
 
 
 
 
0.002 
 
 
 
 
 
 
0.008 
 
 
 
 
 
0.076 
 
 
 
 
 
0.637 
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Parity 
   0 
≥ 1 
 
Previous 
healthy 
child(ren) 
Yes 
No 
 
Lifestyle 
variables (early 
pregnancy) 
Coffee 
Yes 
No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
 
63 (44.1) 
80 (55.9) 
 
 
 
 
75 (93.8) 
5 (6.3) 
 
 
 
 
 
50 (35.0) 
93 (65.0) 
 
 
78 (54.5) 
65 (45.5) 
 
 
20 (14.0) 
123 (86.0) 
 
236 (56.6) 
181 (43.4) 
 
 
 
 
175 (96.7) 
6 (3.3) 
 
 
 
 
 
122 (29.3) 
295 (70.7) 
 
 
170 (40.8) 
247 (59.2) 
 
 
46 (11.0) 
371 (89.0) 
0.009 
 
 
 
 
 
0.277 
 
 
 
 
 
 
0.202 
 
 
 
0.004 
 
 
 
0.344 
 
 
 
 
Univariate associations between participants’ characteristics and 
complementary and alternative medicine use in early pregnancy 
Characteristic Users 
(n = 227) 
Non-users 
(n = 333) 
p value 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
 
 
n (%) 
 
1 (0.4) 
54 (23.8) 
157 (69.2) 
15 (6.6) 
 
 
168 (74.0) 
15 (6.6) 
14 (6.2) 
30 (13.2) 
 
 
 
n (%) 
 
11 (3.3) 
140 (42.0) 
172 (51.7) 
10 (3.0) 
 
 
206 (61.9) 
53 (15.9) 
37 (11.1) 
37 (11.1) 
 
 
 
 
<0.0001 
 
 
 
 
 
0.001 
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Educational 
status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous 
obstetric 
problems 
Yes 
No 
 
Parity 
   0 
≥ 1 
 
Previous 
healthy 
child(ren) 
Yes 
No 
 
Lifestyle 
variables (early 
pregnancy) 
Coffee 
Yes 
No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
 
 
33 (14.5) 
 
194 (85.5) 
 
 
 
91 (40.1) 
136 (59.9) 
 
 
 
 
75 (55.1) 
61 (44.9) 
 
 
131 (57.7) 
96 (42.3) 
 
 
 
 
91 (94.8) 
5 (5.2) 
 
 
 
 
 
82 (36.1) 
145 (63.9) 
 
 
105 (46.3) 
122 (53.7) 
 
 
24 (10.6) 
203 (89.4) 
 
 
 
112 (33.6) 
 
221 (66.4) 
 
 
 
120 (36.0) 
213 (64.0) 
 
 
 
 
103 (48.4) 
110 (51.6) 
 
 
168 (50.5) 
165 (49.5) 
 
 
 
 
159 (96.4) 
6 (3.6) 
 
 
 
 
 
90 (27.0) 
243 (73.0) 
 
 
143 (42.9) 
190 (57.1) 
 
 
42 (12.6) 
291 (87.4) 
<0.0001 
 
 
 
 
 
 
0.331 
 
 
 
 
0.216 
 
 
 
 
0.091 
 
 
 
 
 
0.542 
 
 
 
 
 
 
0.022 
 
 
 
0.438 
 
 
 
0.462 
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Univariate associations between participants’ characteristics and 
alcohol consumption in early pregnancy 
Characteristic Users 
(n = 64) 
Non-users 
(n = 496) 
p value 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational 
status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous 
obstetric 
problems 
Yes 
No 
 
Parity 
   0 
≥ 1 
 
Previous 
healthy 
child(ren) 
Yes 
No 
 
Lifestyle 
variables (early 
pregnancy) 
Coffee 
Yes 
n (%) 
 
0 (0.0) 
8 (12.5) 
55 (85.9) 
1 (1.6) 
 
 
51 (79.7) 
4 (6.3) 
2 (3.1) 
7 (10.9) 
 
 
 
7 (10.9) 
 
57 (89.1) 
 
 
 
18 (28.1) 
46 (71.9) 
 
 
 
 
24 (52.2) 
22 (47.8) 
 
 
27 (42.2) 
37 (57.8) 
 
 
 
 
36 (97.3) 
1 (2.7) 
 
 
 
 
 
25 (39.1) 
n (%) 
 
12 (2.4) 
186 (37.5) 
274 (55.2) 
24 (4.8) 
 
 
323 (65.1) 
64 (12.9) 
49 (9.9) 
60 (12.1) 
 
 
 
138 (27.8) 
 
358 (72.2) 
 
 
 
193 (38.9) 
303 (61.1) 
 
 
 
 
154 (50.8) 
149 (49.2) 
 
 
272 (54.8) 
224 (45.2) 
 
 
 
 
214 (95.5) 
10 (4.5) 
 
 
 
 
 
147 (29.6) 
 
<0.0001 
 
 
 
 
 
0.080 
 
 
 
 
 
 
0.004 
 
 
 
 
 
0.094 
 
 
 
 
0.865 
 
 
 
 
0.056 
 
 
 
 
 
0.621 
 
 
 
 
 
 
0.124 
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No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
39 (60.9) 
 
 
41 (64.1) 
23 (35.9) 
 
 
8 (12.5) 
56 (87.5) 
349 (70.4) 
 
 
207 (41.7) 
289 (58.3) 
 
 
58 (11.7) 
438 (88.3) 
 
 
0.001 
 
 
 
0.851 
 
 
 
 
Univariate associations between participants’ characteristics and 
cigarette smoking in early pregnancy 
Characteristic Users 
(n = 17) 
Non-users 
(n = 543) 
p value 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational 
status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous 
obstetric 
problems 
Yes 
No 
 
n (%) 
 
2 (11.8) 
9 (52.9) 
4 (23.5) 
2 (11.8) 
 
 
12 (70.6) 
2 (11.8) 
1 (5.9) 
2 (11.8) 
 
 
 
14 (82.4) 
 
3 (17.6) 
 
 
 
4 (23.5) 
13 (76.5) 
 
 
 
 
9 (69.2) 
4 (30.8) 
 
n (%) 
 
10 (1.8) 
185 (34.1) 
325 (59.9) 
23 (4.2) 
 
 
362 (66.7) 
66 (12.2) 
50 (9.2) 
65 (12.0) 
 
 
 
131 (24.1) 
 
412 (75.9) 
 
 
 
207 (38.1) 
336 (61.9) 
 
 
 
 
169 (50.3) 
167 (49.7) 
 
 
0.002 
 
 
 
 
 
0.971 
 
 
 
 
 
 
<0.0001 
 
 
 
 
 
0.221 
 
 
 
 
 
0.180 
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Parity 
   0 
≥ 1 
 
Previous 
healthy 
child(ren) 
Yes 
No 
 
Lifestyle 
variables (early 
pregnancy) 
Coffee 
Yes 
No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
 
8 (47.1) 
9 (52.9) 
 
 
 
 
9 (100.0) 
0 (0.0) 
 
 
 
 
 
9 (52.9) 
8 (47.1) 
 
 
7 (41.2) 
10 (58.8) 
 
 
7 (41.2) 
10 (58.8) 
 
291 (53.6) 
252 (46.4) 
 
 
 
 
241 (95.6) 
11 (4.4) 
 
 
 
 
 
163 (30.0) 
380 (70.0) 
 
 
241 (44.4) 
302 (55.6) 
 
 
59 (10.9) 
484 (89.1) 
0.595 
 
 
 
 
 
0.522 
 
 
 
 
 
 
0.044 
 
 
 
0.793 
 
 
 
<0.0001 
 
 
 
Univariate associations between participants’ characteristics and 
cannabis use in early pregnancy 
Characteristic Users 
(n = 2) 
Non-users 
(n = 558) 
p value 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
 
 
n (%) 
 
0 (0.0) 
0 (0.0) 
1 (50.0) 
1 (50.0) 
 
 
1 (50.0) 
0 (0.0) 
0 (0.0) 
1 (50.0) 
 
 
 
n (%) 
 
12 (2.2) 
194 (34.8) 
328 (58.8) 
24 (4.3) 
 
 
373 (66.8) 
68 (12.2) 
51 (9.1) 
66 (11.8) 
 
 
 
 
0.018 
 
 
 
 
 
0.401 
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Educational 
status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous 
obstetric 
problems 
Yes 
No 
 
Parity 
   0 
≥ 1 
 
Previous 
healthy 
child(ren) 
Yes 
No 
 
Lifestyle 
variables (early 
pregnancy) 
Coffee 
Yes 
No 
 
Tea 
Yes 
No 
 
Cola 
Yes 
No 
 
 
0 (0.0) 
 
2 (100.0) 
 
 
 
0 (0.0) 
2 (100.0) 
 
 
 
 
2 (100.0) 
0 (0.0) 
 
 
1 (50.0) 
1 (50.0) 
 
 
 
 
1 (100.0) 
0 (0.0) 
 
 
 
 
 
0 (0.0) 
2 (100.0) 
 
 
2 (100.0) 
0 (0.0) 
 
 
0 (0.0) 
2 (100.0) 
 
 
145 (26.0) 
 
413 (74.0) 
 
 
 
211 (37.8) 
347 (62.2) 
 
 
 
 
176 (50.7) 
171 (49.3) 
 
 
298 (53.4) 
260 (46.6) 
 
 
 
 
249 (95.8) 
11 (4.2) 
 
 
 
 
 
172 (30.8) 
386 (69.2) 
 
 
246 (44.1) 
312 (55.9) 
 
 
66 (11.8) 
492 (88.2) 
 
0.402 
 
 
 
 
 
0.271 
 
 
 
 
 
0.164 
 
 
 
0.923 
 
 
 
 
 
0.834 
 
 
 
 
 
 
0.346 
 
 
 
0.112 
 
 
 
0.605 
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Appendix 4 – Multivariate analyses with Logistic regression (Cross-
sectional study, N = 560) 
Variable Adjusted OR 95% CI Significance 
 
Prescription 
medicinesa 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Over-the-counter 
medicinesb 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Parity 
   0 
≥ 1 
 
Tea 
No 
Yes 
 
Complementary 
and alternative 
medicinesc 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
 
 
 
 
 
Ref 
 
1.895 
 
 
 
Ref 
1.565 
 
 
 
 
 
1.617 
0.482 
Ref 
0.378 
 
 
Ref 
0.394 
0.247 
0.758 
 
 
Ref 
1.740 
 
 
Ref 
1.779 
 
 
 
 
 
 
0.211 
0.539 
Ref 
 
 
 
 
 
Ref 
 
1.134 - 3.168 
 
 
 
Ref 
1.032 - 2.372 
 
 
 
 
 
0.358 – 7.308 
0.293 – 0.793 
Ref 
0.124 – 1.153 
 
 
Ref 
0.184 – 0.845 
0.094 – 0.652 
0.405 – 1.419 
 
 
Ref 
1.153 – 2.628 
 
 
Ref 
1.190 – 2.661 
 
 
 
 
 
 
0.025 – 1.757 
0.355 – 0.819 
Ref 
 
 
 
 
 
Ref 
 
0.015 
 
 
 
Ref 
0.035 
 
 
 
 
 
0.532 
0.004 
Ref 
0.087 
 
 
Ref 
0.017 
0.005 
0.386 
 
 
Ref 
0.008 
 
 
Ref 
0.005 
 
 
 
 
 
 
0.150 
0.004 
Ref 
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41 – 50 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Alcohold 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Tea 
No 
Yes 
 
Cigarettee 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Coffee 
No 
Yes 
1.515 
 
 
Ref 
 
1.947 
 
 
 
 
 
0.000 
0.300 
Ref 
0.199 
 
 
Ref 
2.522 
 
 
 
 
Ref 
 
0.081 
 
 
 
Ref 
2.947 
0.653 – 3.517 
 
 
Ref 
 
1.200 – 3.161 
 
 
 
 
 
0.000 – . 
0.133 – 0.674 
Ref 
0.026 – 1.530 
 
 
Ref 
1.438 – 4.424 
 
 
 
 
Ref 
 
0.021 – 0.317 
 
 
 
Ref 
1.031 – 8.423 
0.334 
 
 
Ref 
 
0.007 
 
 
 
 
 
0.999 
0.004 
Ref 
0.121 
 
 
Ref 
0.001 
 
 
 
 
Ref 
 
<0.0001 
 
 
 
Ref 
0.044 
 
aOdds ratio adjusted for age, ethnic origin, education and gravidity.  
bOdds ratio adjusted for age, ethnic origin, education, parity and tea 
consumption.   
cOdds ratio adjusted for age, ethnic origin, education, parity and coffee 
consumption. 
dOdds ratio adjusted for age, ethnic origin, education, parity and tea 
consumption. 
eOdds ratio adjusted for age, education, and coffee consumption. 
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Appendix 5 – Univariate associations between use of medicines and 
recreational substances in the first trimester and the pregnancy 
outcomes (First trimester cohort, N = 455) 
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Prevalence of concomitant use of medicines and recreational 
substances in the first trimester (N = 455) 
Medicine/Substance Prevalence of use (%) 
 
POM + OTC 
 
POM + CAM 
 
OTC + CAM 
 
POM + OTC + CAM 
 
Alcohol + Cigarette 
 
POM + Alcohol 
 
POM + Cigarette 
 
POM + OTC + Alcohol 
 
POM + OTC + Cigarette 
 
POM + CAM + Alcohol 
 
POM + CAM + Cigarette 
 
OTC + Alcohol 
 
OTC + Cigarette 
 
OTC + CAM + Alcohol 
 
OTC + CAM + Cigarette 
 
CAM + Alcohol 
 
CAM + Cigarette 
 
POM + OTC + CAM + Alcohol 
 
POM + OTC + CAM + Cigarette 
 
8.1 
 
11.9 
 
14.3 
 
4.0 
 
0.0 
 
2.0 
 
0.4 
 
0.7 
 
0.0 
 
0.9 
 
0.0 
 
4.8 
 
0.0 
 
2.6 
 
0.0 
 
5.9 
 
0.9 
 
0.4 
 
0.0 
 
*POM = Prescription medicines; OTC = Over-the-counter medicines; CAM = Complementary 
and alternative medicines 
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Univariate associations between use of medicines and recreational 
substances in the first trimester and congenital anomaly 
 
 
Variable 
Congenital 
anomaly 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
10 (3.0) 
98 (29.6) 
210 (63.4) 
13 (3.9) 
 
 
236 (71.3) 
25 (7.6) 
29 (8.8) 
41 (12.4) 
 
 
77 (23.3) 
 
254 (76.7) 
 
 
 
123 (37.2) 
208 (62.8) 
 
 
 
94 (45.2) 
114 (54.8) 
 
 
184 (55.6) 
147 (44.4) 
 
 
 
8 (5.4) 
139 (94.6) 
 
 
237 (71.6) 
94 (28.4) 
 
 
181 (54.7) 
n (%) 
 
 
0 (0.0) 
5 (38.5) 
7 (53.8) 
1 (7.7) 
 
 
11 (84.6) 
1 (7.7) 
0 (0.0) 
1 (7.7) 
 
 
4 (30.8) 
 
9 (69.2) 
 
 
 
5 (38.5) 
8 (61.5) 
 
 
 
5 (62.5) 
3 (37.5) 
 
 
6 (46.2) 
7 (53.8) 
 
 
 
1 (14.3) 
6 (85.7) 
 
 
9 (69.2) 
4 (30.8) 
 
 
6 (46.2) 
 
 
0.720 
 
 
 
 
 
0.643 
 
 
 
 
 
0.532 
 
 
 
 
 
0.924 
 
 
 
 
0.335 
 
 
 
0.502 
 
 
 
 
0.330 
 
 
 
0.853 
 
 
 
0.545 
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Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
150 (45.3) 
 
 
290 (87.6) 
41 (12.4) 
 
 
243 (73.4) 
88 (26.6) 
 
 
235 (71.0) 
96 (29.0) 
 
 
187 (56.5) 
144 (43.5) 
 
 
289 (87.3) 
42 (12.7) 
 
 
324 (97.9) 
7 (2.1) 
 
 
304 (91.8) 
27 (8.2) 
 
 
294 (88.8) 
37 (11.2) 
 
 
286 (86.4) 
45 (13.6) 
 
 
320 (96.7) 
11 (3.3) 
 
 
325 (98.2) 
6 (1.8) 
 
 
329 (99.4) 
2 (0.6) 
 
7 (53.8) 
 
 
12 (92.3) 
1 (7.7) 
 
 
8 (61.5) 
5 (38.5) 
 
 
9 (69.2) 
4 (30.8) 
 
 
6 (46.2) 
7 (53.8) 
 
 
12 (92.3) 
1 (7.7) 
 
 
12 (92.3) 
1 (7.7) 
 
 
11 (84.6) 
2 (15.4) 
 
 
10 (76.9) 
3 (23.1) 
 
 
10 (76.9) 
3 (23.1) 
 
 
12 (92.3) 
1 (7.7) 
 
 
12 (92.3) 
1 (7.7) 
 
 
13 (100.0) 
0 (0.0) 
 
 
 
0.612 
 
 
 
0.344 
 
 
 
0.891 
 
 
 
0.461 
 
 
 
0.593 
 
 
 
0.191 
 
 
 
0.358 
 
 
 
0.189 
 
 
 
0.333 
 
 
 
0.400 
 
 
 
0.141 
 
 
 
0.779 
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POM+OTC+Alcohol 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM 
+ Alcohol 
No 
Yes 
 
 
328 (99.1) 
3 (0.9) 
 
 
328 (99.1) 
3 (0.9) 
 
 
312 (94.3) 
19 (5.7) 
 
 
321 (97.0) 
10 (3.0) 
 
 
309 (93.4) 
22 (6.6) 
 
 
330 (99.7) 
1 (0.3) 
 
 
 
329 (99.4) 
2 (0.6) 
 
 
13 (100.0) 
0 (0.0) 
 
 
12 (92.3) 
1 (7.7) 
 
 
13 (100.0) 
0 (0.0) 
 
 
13 (100.0) 
0 (0.0) 
 
 
12 (92.3) 
1 (7.7) 
 
 
12 (92.3) 
1 (7.7) 
 
 
 
13 (100.0) 
0 (0.0) 
 
0.730 
 
 
 
0.025 
 
 
 
0.374 
 
 
 
0.525 
 
 
 
0.882 
 
 
 
0.001 
 
 
 
 
0.779 
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Univariate associations between use of medicines and recreational 
substances in the first trimester and low birth weight 
 
 
Variable 
Low birth 
weight 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
8 (2.5) 
94 (29.1) 
207 (64.1) 
14 (4.3) 
 
 
235 (72.8) 
26 (8.0) 
23 (7.1) 
39 (12.1) 
 
 
74 (22.9) 
 
249 (77.1) 
 
 
 
117 (36.2) 
206 (63.8) 
 
 
 
95 (46.1) 
111 (53.9) 
 
 
175 (54.2) 
148 (45.8) 
 
 
 
9 (6.1) 
139 (93.9) 
 
 
229 (70.9) 
94 (29.1) 
 
 
175 (54.2) 
n (%) 
 
 
1 (5.6) 
8 (44.4) 
9 (50.0) 
0 (0.0) 
 
 
9 (50.0) 
0 (0.0) 
6 (33.3) 
3 (16.7) 
 
 
5 (27.8) 
 
13 (72.2) 
 
 
 
10 (55.6) 
8 (44.4) 
 
 
 
4 (50.0) 
4 (50.0) 
 
 
13 (72.2) 
5 (27.8) 
 
 
 
0 (0.0) 
5 (100.0) 
 
 
14 (77.8) 
4 (22.2) 
 
 
11 (61.1) 
 
 
0.352 
 
 
 
 
 
0.001 
 
 
 
 
 
0.634 
 
 
 
 
 
0.099 
 
 
 
 
0.829 
 
 
 
0.134 
 
 
 
 
0.570 
 
 
 
0.530 
 
 
 
0.565 
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Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
148 (45.8) 
 
 
285 (88.2) 
38 (11.8) 
 
 
239 (74.0) 
84 (26.0) 
 
 
228 (70.6) 
95 (29.4) 
 
 
180 (55.7) 
143 (44.3) 
 
 
281 (87.0) 
42 (13.0) 
 
 
315 (97.5) 
8 (2.5) 
 
 
296 (91.6) 
27 (8.4) 
 
 
286 (88.5) 
37 (11.5) 
 
 
278 (86.1) 
45 (13.9) 
 
 
312 (96.6) 
11 (3.4) 
 
 
316 (97.8) 
7 (2.2) 
 
 
321 (99.4) 
2 (0.6) 
 
7 (38.9) 
 
 
15 (83.3) 
3 (16.7) 
 
 
10 (55.6) 
8 (44.4) 
 
 
14 (77.8) 
4 (22.2) 
 
 
10 (55.6) 
8 (44.4) 
 
 
17 (94.4) 
1 (5.6) 
 
 
18 (100.0) 
0 (0.0) 
 
 
17 (94.4) 
1 (5.6) 
 
 
15 (83.3) 
3 (16.7) 
 
 
15 (83.3) 
3 (16.7) 
 
 
17 (94.4) 
1 (5.6) 
 
 
18 (100.0) 
0 (0.0) 
 
 
18 (100.0) 
0 (0.0) 
 
 
 
0.534 
 
 
 
0.086 
 
 
 
0.513 
 
 
 
0.989 
 
 
 
0.354 
 
 
 
0.499 
 
 
 
0.673 
 
 
 
0.504 
 
 
 
0.745 
 
 
 
0.630 
 
 
 
0.528 
 
 
 
0.738 
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POM+OTC+Alcohol 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM 
+ Alcohol 
No 
Yes 
 
 
320 (99.1) 
3 (0.9) 
 
 
319 (98.8) 
4 (1.2) 
 
 
304 (94.1) 
19 (5.9) 
 
 
313 (96.9) 
10 (3.1) 
 
 
300 (92.9) 
23 (7.1) 
 
 
321 (99.4) 
2 (0.6) 
 
 
 
321 (99.4) 
2 (0.6) 
 
 
18 (100.0) 
0 (0.0) 
 
 
18 (100.0) 
0 (0.0) 
 
 
18 (100.0) 
0 (0.0) 
 
 
18 (100.0) 
0 (0.0) 
 
 
18 (100.0) 
0 (0.0) 
 
 
18 (100.0) 
0 (0.0) 
 
 
 
18 (100.0) 
0 (0.0) 
 
0.681 
 
 
 
0.635 
 
 
 
0.290 
 
 
 
0.449 
 
 
 
0.241 
 
 
 
0.738 
 
 
 
 
0.738 
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Univariate associations between use of medicines and recreational 
substances in the first trimester and preterm birth 
 
 
Variable 
Preterm birth 
 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
8 (2.5) 
90 (28.6) 
203 (64.4) 
14 (4.4) 
 
 
229 (72.7) 
24 (7.6) 
24 (7.6) 
38 (12.1) 
 
 
70 (22.2) 
 
245 (77.8) 
 
 
 
117 (37.1) 
198 (62.9) 
 
 
 
89 (44.9) 
109 (55.1) 
 
 
175 (55.6) 
140 (44.4) 
 
 
 
7 (5.0) 
133 (95.0) 
 
 
223 (70.8) 
92 (29.2) 
 
 
169 (53.7) 
n (%) 
 
 
1 (3.8) 
12 (46.2) 
13 (50.0) 
0 (0.0) 
 
 
15 (57.7) 
2 (7.7) 
5 (19.2) 
4 (15.4) 
 
 
9 (34.6) 
 
17 (65.4) 
 
 
 
10 (38.5) 
16 (61.5) 
 
 
 
10 (62.5) 
6 (37.5) 
 
 
13 (50.0) 
13 (50.0) 
 
 
 
2 (15.4) 
11 (84.6) 
 
 
20 (76.9) 
6 (23.1) 
 
 
17 (65.4) 
 
 
0.205 
 
 
 
 
 
0.189 
 
 
 
 
 
0.150 
 
 
 
 
 
0.894 
 
 
 
 
0.176 
 
 
 
0.584 
 
 
 
 
0.128 
 
 
 
0.507 
 
 
 
0.248 
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Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
146 (46.3) 
 
 
278 (88.3) 
37 (11.7) 
 
 
234 (74.3) 
81 (25.7) 
 
 
222 (70.5) 
93 (29.5) 
 
 
176 (55.9) 
139 (44.1) 
 
 
273 (86.7) 
42 (13.3) 
 
 
307 (97.5) 
8 (2.5) 
 
 
289 (91.7) 
26 (8.3) 
 
 
279 (88.6) 
36 (11.4) 
 
 
271 (86.0) 
44 (14.0) 
 
 
304 (96.5) 
11 (3.5) 
 
 
308 (97.8) 
7 (2.2) 
 
 
313 (99.4) 
2 (0.6) 
 
9 (34.6) 
 
 
22 (84.6) 
4 (15.4) 
 
 
15 (57.7) 
11 (42.3) 
 
 
20 (76.9) 
6 (23.1) 
 
 
14 (53.8) 
12 (46.2) 
 
 
25 (96.2) 
1 (3.8) 
 
 
26 (100.0) 
0 (0.0) 
 
 
24 (92.3) 
2 (7.7) 
 
 
22 (84.6) 
4 (15.4) 
 
 
22 (84.6) 
4 (15.4) 
 
 
25 (96.2) 
1 (3.8) 
 
 
26 (100.0) 
0 (0.0) 
 
 
26 (100.0) 
0 (0.0) 
 
 
 
0.584 
 
 
 
0.067 
 
 
 
0.486 
 
 
 
0.841 
 
 
 
0.161 
 
 
 
0.411 
 
 
 
0.920 
 
 
 
0.547 
 
 
 
0.842 
 
 
 
0.925 
 
 
 
0.442 
 
 
 
0.684 
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POM+OTC+Alcohol 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM 
+ Alcohol 
No 
Yes 
 
 
312 (99.0) 
3 (1.0) 
 
 
311 (98.7) 
4 (1.3) 
 
 
296 (94.0) 
19 (6.0) 
 
 
305 (96.8) 
10 (3.2) 
 
 
292 (92.7) 
23 (7.3) 
 
 
313 (99.4) 
2 (0.6) 
 
 
 
313 (99.4) 
2 (0.6) 
 
 
26 (100.0) 
0 (0.0) 
 
 
26 (100.0) 
0 (0.0) 
 
 
26 (100.0) 
0 (0.0) 
 
 
26 (100.0) 
0 (0.0) 
 
 
26 (100.0) 
0 (0.0) 
 
 
26 (100.0) 
0 (0.0) 
 
 
 
26 (100.0) 
0 (0.0) 
 
0.617 
 
 
 
0.563 
 
 
 
0.197 
 
 
 
0.356 
 
 
 
0.154 
 
 
 
0.684 
 
 
 
 
0.684 
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Univariate associations between use of medicines and recreational 
substances in the first trimester and admission to NNU 
 
 
Variable 
Admission to 
NNU 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
7 (2.3) 
85 (28.3) 
194 (64.7) 
14 (4.7) 
 
 
219 (73.0) 
24 (8.0) 
23 (7.7) 
34 (11.3) 
 
 
68 (22.7) 
 
232 (77.3) 
 
 
 
109 (36.3) 
191 (63.7) 
 
 
 
84 (44.0) 
107 (56.0) 
 
 
165 (55.0) 
135 (45.0) 
 
 
 
7 (5.2) 
128 (94.8) 
 
 
215 (71.7) 
85 (28.3) 
 
 
158 (52.7) 
n (%) 
 
 
3 (6.8) 
18 (40.9) 
23 (52.3) 
0 (0.0) 
 
 
28 (63.6) 
2 (4.5) 
6 (13.6) 
8 (18.2) 
 
 
13 (29.5) 
 
31 (70.5) 
 
 
 
19 (43.2) 
25 (56.8) 
 
 
 
15 (60.0) 
10 (40.0) 
 
 
25 (56.8) 
19 (43.2) 
 
 
 
2 (10.5) 
17 (89.5) 
 
 
31 (70.5) 
13 (29.5) 
 
 
29 (65.9) 
 
 
0.053 
 
 
 
 
 
0.244 
 
 
 
 
 
0.315 
 
 
 
 
 
0.380 
 
 
 
 
0.131 
 
 
 
0.821 
 
 
 
 
0.353 
 
 
 
0.868 
 
 
 
0.100 
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Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
142 (47.3) 
 
 
261 (87.0) 
39 (13.0) 
 
 
218 (72.7) 
82 (27.3) 
 
 
211 (70.3) 
89 (29.7) 
 
 
169 (56.3) 
131 (43.7) 
 
 
261 (87.0) 
39 (13.0) 
 
 
292 (97.3) 
8 (2.7) 
 
 
274 (91.3) 
26 (8.7) 
 
 
264 (88.0) 
36 (12.0) 
 
 
259 (86.3) 
41 (13.7) 
 
 
290 (96.7) 
10 (3.3) 
 
 
294 (98.0) 
6 (2.0) 
 
 
298 (99.3) 
2 (0.7) 
 
15 (34.1) 
 
 
41 (93.2) 
3 (6.8) 
 
 
33 (75.0) 
11 (25.0) 
 
 
33 (75.0) 
11 (25.0) 
 
 
24 (54.5) 
20 (45.5) 
 
 
40 (90.9) 
4 (9.1) 
 
 
44 (100.0) 
0 (0.0) 
 
 
41 (93.2) 
3 (6.8) 
 
 
40 (90.9) 
4 (9.1) 
 
 
37 (84.1) 
7 (15.9) 
 
 
42 (95.5) 
2 (4.5) 
 
 
43 (97.7) 
1 (2.3) 
 
 
44 (100.0) 
0 (0.0) 
 
 
 
0.242 
 
 
 
0.745 
 
 
 
0.524 
 
 
 
0.823 
 
 
 
0.464 
 
 
 
0.273 
 
 
 
0.680 
 
 
 
0.574 
 
 
 
0.689 
 
 
 
0.682 
 
 
 
0.905 
 
 
 
0.587 
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POM+OTC+Alcohol 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM 
+ Alcohol 
No 
Yes 
 
 
297 (99.0) 
3 (1.0) 
 
 
296 (98.7) 
4 (1.3) 
 
 
282 (94.0) 
18 (6.0) 
 
 
290 (96.7) 
10 (3.3) 
 
 
278 (92.7) 
22 (7.3) 
 
 
298 (99.3) 
2 (0.7) 
 
 
 
298 (99.3) 
2 (0.7) 
 
 
44 (100.0) 
0 (0.0) 
 
 
44 (100.0) 
0 (0.0) 
 
 
43 (97.7) 
1 (2.3) 
 
 
44 (100.0) 
0 (0.0) 
 
 
43 (97.7) 
1 (2.3) 
 
 
44 (100.0) 
0 (0.0) 
 
 
 
44 (100.0) 
0 (0.0) 
 
0.505 
 
 
 
0.441 
 
 
 
0.312 
 
 
 
0.219 
 
 
 
0.209 
 
 
 
0.587 
 
 
 
 
0.587 
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Univariate associations between use of medicines and recreational 
substances in the first trimester and other problems 
 
 
Variable 
Other problems 
 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
6 (2.1) 
89 (30.5) 
184 (63.0) 
13 (4.5) 
 
 
208 (71.2) 
20 (6.8) 
27 (9.2) 
37 (12.7) 
 
 
68 (23.3) 
 
224 (76.7) 
 
 
 
110 (37.7) 
182 (62.3) 
 
 
 
94 (51.6) 
88 (48.4) 
 
 
157 (53.8) 
135 (46.2) 
 
 
 
9 (6.7) 
126 (93.3) 
 
 
200 (68.5) 
92 (31.5) 
 
 
165 (56.5) 
n (%) 
 
 
4 (7.7) 
14 (26.9) 
33 (63.5) 
1 (1.9) 
 
 
39 (75.0) 
6 (11.5) 
2 (3.8) 
5 (9.6) 
 
 
13 (25.0) 
 
39 (75.0) 
 
 
 
18 (34.6) 
34 (65.4) 
 
 
 
5 (14.7) 
29 (85.3) 
 
 
33 (63.5) 
19 (36.5) 
 
 
 
0 (0.0) 
19 (100.0) 
 
 
46 (88.5) 
6 (11.5) 
 
 
22 (42.3) 
 
 
0.127 
 
 
 
 
 
0.357 
 
 
 
 
 
0.789 
 
 
 
 
 
0.674 
 
 
 
 
<0.0001 
 
 
 
0.195 
 
 
 
 
0.246 
 
 
 
0.003 
 
 
 
0.058 
 
  
335 
 
Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
127 (43.5) 
 
 
258 (88.4) 
34 (11.6) 
 
 
215 (73.6) 
77 (26.4) 
 
 
209 (71.6) 
83 (28.4) 
 
 
162 (55.5) 
130 (44.5) 
 
 
255 (87.3) 
37 (12.7) 
 
 
287 (98.3) 
5 (1.7) 
 
 
269 (92.1) 
23 (7.9) 
 
 
259 (88.7) 
33 (11.3) 
 
 
252 (86.3) 
40 (13.7) 
 
 
282 (96.6) 
10 (3.4) 
 
 
287 (98.3) 
5 (1.7) 
 
 
291 (99.7) 
1 (0.3) 
 
30 (57.7) 
 
 
44 (84.6) 
8 (15.4) 
 
 
36 (69.2) 
16 (30.8) 
 
 
35 (67.3) 
17 (32.7) 
 
 
31 (59.6) 
21 (40.4) 
 
 
46 (88.5) 
6 (11.5) 
 
 
49 (94.2) 
3 (5.8) 
 
 
46 (88.5) 
6 (11.5) 
 
 
45 (86.5) 
7 (13.5) 
 
 
44 (84.6) 
8 (15.4) 
 
 
50 (96.2) 
2 (3.8) 
 
 
50 (96.2) 
2 (3.8) 
 
 
51 (98.1) 
1 (1.9) 
 
 
 
0.448 
 
 
 
0.510 
 
 
 
0.532 
 
 
 
0.580 
 
 
 
0.820 
 
 
 
0.074 
 
 
 
0.381 
 
 
 
0.654 
 
 
 
0.746 
 
 
 
0.879 
 
 
 
0.315 
 
 
 
0.167 
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POM+OTC+Alcohol 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM 
+ Alcohol 
No 
Yes 
 
 
290 (99.3) 
2 (0.7) 
 
 
288 (98.6) 
4 (1.4) 
 
 
276 (94.5) 
16 (5.5) 
 
 
283 (96.9) 
9 (3.1) 
 
 
271 (92.8) 
21 (7.2) 
 
 
290 (99.3) 
2 (0.7) 
 
 
 
290 (99.3) 
2 (0.7) 
 
 
51 (98.1) 
1 (1.9) 
 
 
52 (100.0) 
0 (0.0) 
 
 
49 (94.2) 
3 (5.8) 
 
 
51 (98.1) 
1 (1.9) 
 
 
50 (96.2) 
2 (3.8) 
 
 
52 (100.0) 
0 (0.0) 
 
 
 
52 (100.0) 
0 (0.0) 
 
0.376 
 
 
 
0.396 
 
 
 
0.933 
 
 
 
0.647 
 
 
 
0.374 
 
 
 
0.549 
 
 
 
 
0.549 
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Appendix 6 – Univariate associations between use of medicines and 
recreational substances in at least one trimester and the pregnancy 
outcomes (Cohort with complete interviews, N = 231) 
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Prevalence of concomitant use of medicines and recreational 
substances in at least one trimester (N = 231) 
Medicine/Substance Prevalence of use (%) 
 
POM + OTC 
 
POM + CAM 
 
OTC + CAM 
 
POM + OTC + CAM 
 
Alcohol + Cigarette 
 
POM + Alcohol 
 
POM + Cigarette 
 
POM + OTC + Alcohol 
 
POM + OTC + Cigarette 
 
POM + CAM + Alcohol 
 
POM + CAM + Cigarette 
 
OTC + Alcohol 
 
OTC + Cigarette 
 
OTC + CAM + Alcohol 
 
OTC + CAM + Cigarette 
 
CAM + Alcohol 
 
CAM + Cigarette 
 
POM + OTC + CAM + Alcohol 
 
POM + OTC + CAM + Cigarette 
 
15.6 
 
16.9 
 
30.3 
 
8.7 
 
0.0 
 
3.5 
 
0.9 
 
2.2 
 
0.4 
 
1.7 
 
0.0 
 
10.4 
 
1.3 
 
6.9 
 
0.9 
 
10.0 
 
0.9 
 
1.3 
 
0.0 
 
*POM = Prescription medicines; OTC = Over-the-counter medicines; CAM = Complementary 
and alternative medicines 
 
  
339 
 
Univariate associations between use of medicines and recreational 
substances in at least one trimester and congenital anomaly 
 
 
Variable 
Congenital 
anomaly 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
6 (3.0) 
55 (27.8) 
127 (64.1) 
10 (5.1) 
 
 
145 (73.2) 
13 (6.6) 
17 (8.6) 
23 (11.6) 
 
 
42 (21.2) 
 
156 (78.8) 
 
 
 
76 (38.4) 
122 (61.6) 
 
 
 
51 (41.8) 
71 (58.2) 
 
 
113 (57.1) 
85 (42.9) 
 
 
 
6 (7.1) 
79 (92.9) 
 
 
142 (71.7) 
56 (28.3) 
 
 
85 (42.9) 
n (%) 
 
 
0 (0.0) 
3 (42.9) 
4 (57.1) 
0 (0.0) 
 
 
6 (85.7) 
1 (14.3) 
0 (0.0) 
0 (0.0) 
 
 
1 (14.3) 
 
6 (85.7) 
 
 
 
1 (14.3) 
6 (85.7) 
 
 
 
3 (50.0) 
3 (50.0) 
 
 
2 (28.6) 
5 (71.4) 
 
 
 
1 (20.0) 
4 (80.0) 
 
 
4 (57.1) 
3 (42.9) 
 
 
5 (71.4) 
 
 
0.762 
 
 
 
 
 
0.542 
 
 
 
 
 
0.658 
 
 
 
 
 
0.196 
 
 
 
 
0.691 
 
 
 
0.135 
 
 
 
 
0.294 
 
 
 
0.403 
 
 
 
0.135 
 
  
340 
 
Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
113 (57.1) 
 
 
170 (85.9) 
28 (14.1) 
 
 
135 (68.2) 
63 (31.8) 
 
 
101 (51.0) 
97 (49.0) 
 
 
90 (45.5) 
108 (54.5) 
 
 
166 (83.8) 
32 (16.2) 
 
 
192 (97.0) 
6 (3.0) 
 
 
169 (85.4) 
29 (14.6) 
 
 
167 (84.3) 
31 (15.7) 
 
 
145 (73.2) 
53 (26.8) 
 
 
184 (92.9) 
14 (7.1) 
 
 
191 (96.5) 
7 (3.5) 
 
 
196 (99.0) 
2 (1.0) 
 
2 (28.6) 
 
 
6 (85.7) 
1 (14.3) 
 
 
4 (57.1) 
3 (42.9) 
 
 
0 (0.0) 
7 (100.0) 
 
 
3 (42.9) 
4 (57.1) 
 
 
6 (85.7) 
1 (14.3) 
 
 
7 (100.0) 
0 (0.0) 
 
 
5 (71.4) 
2 (28.6) 
 
 
5 (71.4) 
2 (28.6) 
 
 
1 (14.3) 
6 (85.7) 
 
 
5 (71.4) 
2 (28.6) 
 
 
7 (100.0) 
0 (0.0) 
 
 
7 (100.0) 
0 (0.0) 
 
 
 
0.991 
 
 
 
0.539 
 
 
 
0.008 
 
 
 
0.892 
 
 
 
0.894 
 
 
 
0.640 
 
 
 
0.312 
 
 
 
0.361 
 
 
 
0.001 
 
 
 
0.037 
 
 
 
0.613 
 
 
 
0.789 
 
 
 
  
341 
 
 
POM+OTC+Alcohol 
No 
Yes 
 
POM+OTC+Cigarette 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+Cigarette 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
OTC+CAM+Cigarette 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM + 
Alcohol 
No 
Yes 
 
 
194 (98.0) 
4 (2.0) 
 
 
197 (99.5) 
1 (0.5) 
 
 
195 (98.5) 
3 (1.5) 
 
 
177 (89.4) 
21 (10.6) 
 
 
196 (99.0) 
2 (1.0) 
 
 
185 (93.4) 
13 (6.6) 
 
 
197 (99.5) 
1 (0.5) 
 
 
179 (90.4) 
19 (9.6) 
 
 
197 (99.5) 
1 (0.5) 
 
 
 
196 (99.0) 
2 (1.0) 
 
 
7 (100.0) 
0 (0.0) 
 
 
7 (100.0) 
0 (0.0) 
 
 
7 (100.0) 
0 (0.0) 
 
 
6 (85.7) 
1 (14.3) 
 
 
7 (100.0) 
0 (0.0) 
 
 
6 (85.7) 
1 (14.3) 
 
 
7 (100.0) 
0 (0.0) 
 
 
6 (85.7) 
1 (14.3) 
 
 
7 (100.0) 
0 (0.0) 
 
 
 
7 (100.0) 
0 (0.0) 
 
0.704 
 
 
 
0.850 
 
 
 
0.743 
 
 
 
0.757 
 
 
 
0.789 
 
 
 
0.426 
 
 
 
0.850 
 
 
 
0.681 
 
 
 
0.850 
 
 
 
 
0.789 
 
 
 
 
  
342 
 
Univariate associations between use of medicines and recreational 
substances in at least one trimester and preterm birth 
 
 
Variable 
Preterm birth 
 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
4 (2.1) 
50 (26.5) 
125 (66.1) 
10 (5.3) 
 
 
142 (75.1) 
13 (6.9) 
13 (6.9) 
21 (11.1) 
 
 
36 (19.0) 
 
153 (81.0) 
 
 
 
70 (37.0) 
119 (63.0) 
 
 
 
49 (41.2) 
70 (58.8) 
 
 
107 (56.6) 
82 (43.4) 
 
 
 
5 (6.1) 
77 (93.9) 
 
 
133 (70.4) 
56 (29.6) 
 
 
83 (43.9) 
n (%) 
 
 
1 (7.1) 
8 (57.1) 
5 (35.7) 
0 (0.0) 
 
 
7 (50.0) 
1 (7.1) 
4 (28.6) 
2 (14.3) 
 
 
6 (42.9) 
 
8 (57.1) 
 
 
 
6 (42.9) 
8 (57.1) 
 
 
 
5 (62.5) 
3 (37.5) 
 
 
7 (50.0) 
7 (50.0) 
 
 
 
2 (28.6) 
5 (71.4) 
 
 
11 (78.6) 
3 (21.4) 
 
 
6 (42.9) 
 
 
0.041 
 
 
 
 
 
0.036 
 
 
 
 
 
0.034 
 
 
 
 
 
0.664 
 
 
 
 
0.238 
 
 
 
0.630 
 
 
 
 
0.034 
 
 
 
0.514 
 
 
 
0.939 
 
  
343 
 
Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
106 (56.1) 
 
 
165 (87.3) 
24 (12.7) 
 
 
131 (69.3) 
58 (30.7) 
 
 
92 (48.7) 
97 (51.3) 
 
 
83 (43.9) 
106 (56.1) 
 
 
158 (83.6) 
31 (16.4) 
 
 
183 (96.8) 
6 (3.2) 
 
 
160 (84.7) 
29 (15.3) 
 
 
159 (84.1) 
30 (15.9) 
 
 
134 (70.9) 
55 (29.1) 
 
 
173 (91.5) 
16 (8.5) 
 
 
183 (96.8) 
6 (3.2) 
 
 
187 (98.9) 
2 (1.1) 
 
8 (57.1) 
 
 
9 (64.3) 
5 (35.7) 
 
 
7 (50.0) 
7 (50.0) 
 
 
10 (71.4) 
4 (28.6) 
 
 
8 (57.1) 
6 (42.9) 
 
 
12 (85.7) 
2 (14.3) 
 
 
14 (100.0) 
0 (0.0) 
 
 
13 (92.9) 
1 (7.1) 
 
 
11 (78.6) 
3 (21.4) 
 
 
12 (85.7) 
2 (14.3) 
 
 
14 (100.0) 
0 (0.0) 
 
 
13 (92.9) 
1 (7.1) 
 
 
14 (100.0) 
0 (0.0) 
 
 
 
0.018 
 
 
 
0.135 
 
 
 
0.100 
 
 
 
0.337 
 
 
 
0.836 
 
 
 
0.499 
 
 
 
0.404 
 
 
 
0.587 
 
 
 
0.234 
 
 
 
0.257 
 
 
 
0.432 
 
 
 
0.699 
 
 
 
  
344 
 
 
POM+OTC+Alcohol 
No 
Yes 
 
POM+OTC+Cigarette 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+Cigarette 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
OTC+CAM+Cigarette 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM + 
Alcohol 
No 
Yes 
 
 
185 (97.9) 
4 (2.1) 
 
 
188 (99.5) 
1 (0.5) 
 
 
186 (98.4) 
3 (1.6) 
 
 
167 (88.4) 
22 (11.6) 
 
 
187 (98.9) 
2 (1.1) 
 
 
175 (92.6) 
14 (7.4) 
 
 
188 (99.5) 
1 (0.5) 
 
 
169 (89.4) 
20 (10.6) 
 
 
188 (99.5) 
1 (0.5) 
 
 
 
187 (98.9) 
2 (1.1) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
14 (100.0) 
0 (0.0) 
 
 
 
14 (100.0) 
0 (0.0) 
 
0.582 
 
 
 
0.785 
 
 
 
0.635 
 
 
 
0.176 
 
 
 
0.699 
 
 
 
0.291 
 
 
 
0.785 
 
 
 
0.200 
 
 
 
0.785 
 
 
 
 
0.699 
 
 
 
 
  
345 
 
Univariate associations between use of medicines and recreational 
substances in at least one trimester and low birth weight 
 
 
Variable 
Low birth 
weight 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
4 (2.1) 
52 (26.9) 
127 (65.8) 
10 (5.2) 
 
 
145 (75.1) 
14 (7.3) 
12 (6.2) 
22 (11.4) 
 
 
38 (19.7) 
 
155 (80.3) 
 
 
 
70 (36.3) 
123 (63.7) 
 
 
 
52 (42.3) 
71 (57.7) 
 
 
106 (54.9) 
87 (45.1) 
 
 
 
7 (8.0) 
80 (92.0) 
 
 
136 (70.5) 
57 (29.5) 
 
 
85 (44.0) 
n (%) 
 
 
1 (10.0) 
6 (60.0) 
3 (30.0) 
0 (0.0) 
 
 
4 (40.0) 
0 (0.0) 
5 (50.0) 
1 (10.0) 
 
 
4 (40.0) 
 
6 (60.0) 
 
 
 
6 (60.0) 
4 (40.0) 
 
 
 
2 (50.0) 
2 (50.0) 
 
 
8 (80.0) 
2 (20.0) 
 
 
 
0 (0.0) 
2 (100.0) 
 
 
8 (80.0) 
2 (20.0) 
 
 
4 (40.0) 
 
 
0.037 
 
 
 
 
 
<0.0001 
 
 
 
 
 
0.122 
 
 
 
 
 
0.131 
 
 
 
 
0.758 
 
 
 
0.119 
 
 
 
 
0.676 
 
 
 
0.517 
 
 
 
0.802 
 
  
346 
 
Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
108 (56.0) 
 
 
166 (86.0) 
27 (14.0) 
 
 
132 (68.4) 
61 (31.6) 
 
 
95 (49.2) 
98 (50.8) 
 
 
85 (44.0) 
108 (56.0) 
 
 
162 (83.9) 
31 (16.1) 
 
 
187 (96.9) 
6 (3.1) 
 
 
164 (85.0) 
29 (15.0) 
 
 
162 (83.9) 
31 (16.1) 
 
 
138 (71.5) 
55 (28.5) 
 
 
178 (92.2) 
15 (7.8) 
 
 
187 (96.9) 
6 (3.1) 
 
 
191 (99.0) 
2 (1.0) 
 
6 (60.0) 
 
 
8 (80.0) 
2 (20.0) 
 
 
6 (60.0) 
4 (40.0) 
 
 
7 (70.0) 
3 (30.0) 
 
 
6 (60.0) 
4 (40.0) 
 
 
8 (80.0) 
2 (20.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
9 (90.0) 
1 (10.0) 
 
 
8 (80.0) 
2 (20.0) 
 
 
8 (80.0) 
2 (20.0) 
 
 
9 (90.0) 
1 (10.0) 
 
 
9 (90.0) 
1 (10.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
 
0.596 
 
 
 
0.579 
 
 
 
0.200 
 
 
 
0.322 
 
 
 
0.742 
 
 
 
0.571 
 
 
 
0.662 
 
 
 
0.742 
 
 
 
0.560 
 
 
 
0.799 
 
 
 
0.244 
 
 
 
0.746 
 
 
 
  
347 
 
 
POM+OTC+Alcohol 
No 
Yes 
 
POM+OTC+Cigarette 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+Cigarette 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
OTC+CAM+Cigarette 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM + 
Alcohol 
No 
Yes 
 
 
189 (97.9) 
4 (2.1) 
 
 
192 (99.5) 
1 (0.5) 
 
 
190 (98.4) 
3 (1.6) 
 
 
171 (88.6) 
22 (11.4) 
 
 
191 (99.0) 
2 (1.0) 
 
 
179 (92.7) 
14 (7.3) 
 
 
192 (99.5) 
1 (0.5) 
 
 
173 (89.6) 
20 (10.4) 
 
 
192 (99.5) 
1 (0.5) 
 
 
 
191 (99.0) 
2 (1.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
10 (100.0) 
0 (0.0) 
 
 
 
10 (100.0) 
0 (0.0) 
 
0.646 
 
 
 
0.819 
 
 
 
0.691 
 
 
 
0.258 
 
 
 
0.746 
 
 
 
0.377 
 
 
 
0.819 
 
 
 
0.284 
 
 
 
0.819 
 
 
 
 
0.746 
 
 
 
 
  
348 
 
Univariate associations between use of medicines and recreational 
substances in at least one trimester and admission to NNU 
 
 
Variable 
Admission to 
NNU 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
4 (2.2) 
50 (27.6) 
117 (64.6) 
10 (5.5) 
 
 
137 (75.7) 
12 (6.6) 
13 (7.2) 
19 (10.5) 
 
 
36 (19.9) 
 
145 (80.1) 
 
 
 
65 (35.9) 
116 (64.1) 
 
 
 
48 (41.4) 
68 (58.6) 
 
 
99 (54.7) 
82 (45.3) 
 
 
 
7 (8.5) 
75 (91.5) 
 
 
128 (70.7) 
53 (29.3) 
 
 
78 (43.1) 
n (%) 
 
 
2 (8.3) 
8 (33.3) 
14 (58.3) 
0 (0.0) 
 
 
14 (58.3) 
2 (8.3) 
4 (16.7) 
4 (16.7) 
 
 
7 (29.2) 
 
17 (70.8) 
 
 
 
12 (50.0) 
12 (50.0) 
 
 
 
6 (50.0) 
6 (50.0) 
 
 
16 (66.7) 
8 (33.3) 
 
 
 
0 (0.0) 
8 (100.0) 
 
 
18 (75.0) 
6 (25.0) 
 
 
12 (50.0) 
 
 
0.220 
 
 
 
 
 
0.264 
 
 
 
 
 
0.294 
 
 
 
 
 
0.181 
 
 
 
 
0.565 
 
 
 
0.267 
 
 
 
 
0.389 
 
 
 
0.663 
 
 
 
0.522 
 
  
349 
 
Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
103 (56.9) 
 
 
155 (85.6) 
26 (14.4) 
 
 
120 (66.3) 
61 (33.7) 
 
 
89 (49.2) 
92 (50.8) 
 
 
83 (45.9) 
98 (54.1) 
 
 
151 (83.4) 
30 (16.6) 
 
 
176 (97.2) 
5 (2.8) 
 
 
151 (83.4) 
30 (16.6) 
 
 
151 (83.4) 
30 (16.6) 
 
 
131 (72.4) 
50 (27.6) 
 
 
166 (91.7) 
15 (8.3) 
 
 
175 (96.7) 
6 (3.3) 
 
 
179 (98.9) 
2 (1.1) 
 
12 (50.0) 
 
 
21 (87.5) 
3 (12.5) 
 
 
19 (79.2) 
5 (20.8) 
 
 
14 (58.3) 
10 (41.7) 
 
 
10 (41.7) 
14 (58.3) 
 
 
21 (87.5) 
3 (12.5) 
 
 
23 (95.8) 
1 (4.2) 
 
 
23 (95.8) 
1 (4.2) 
 
 
21 (87.5) 
3 (12.5) 
 
 
17 (70.8) 
7 (29.2) 
 
 
23 (95.8) 
1 (4.2) 
 
 
23 (95.8) 
1 (4.2) 
 
 
24 (100.0) 
0 (0.0) 
 
 
 
0.805 
 
 
 
0.205 
 
 
 
0.399 
 
 
 
0.698 
 
 
 
0.610 
 
 
 
0.701 
 
 
 
0.111 
 
 
 
0.610 
 
 
 
0.874 
 
 
 
0.479 
 
 
 
0.829 
 
 
 
0.605 
 
 
 
  
350 
 
 
POM+OTC+Alcohol 
No 
Yes 
 
POM+OTC+Cigarette 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+Cigarette 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
OTC+CAM+Cigarette 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM + 
Alcohol 
No 
Yes 
 
 
177 (97.8) 
4 (2.2) 
 
 
180 (99.4) 
1 (0.6) 
 
 
178 (98.3) 
3 (1.7) 
 
 
160 (88.4) 
21 (11.6) 
 
 
180 (99.4) 
1 (0.6) 
 
 
167 (92.3) 
14 (7.7) 
 
 
181 (100.0) 
0 (0.0) 
 
 
161 (89.0) 
20 (11.0) 
 
 
181 (100.0) 
0 (0.0) 
 
 
 
179 (98.9) 
2 (1.1) 
 
 
24 (100.0) 
0 (0.0) 
 
 
24 (100.0) 
0 (0.0) 
 
 
24 (100.0) 
0 (0.0) 
 
 
23 (95.8) 
1 (4.2) 
 
 
23 (95.8) 
1 (4.2) 
 
 
24 (100.0) 
0 (0.0) 
 
 
23 (95.8) 
1 (4.2) 
 
 
24 (100.0) 
0 (0.0) 
 
 
23 (95.8) 
1 (4.2) 
 
 
 
24 (100.0) 
0 (0.0) 
 
0.462 
 
 
 
0.715 
 
 
 
0.525 
 
 
 
0.269 
 
 
 
0.091 
 
 
 
0.158 
 
 
 
0.006 
 
 
 
0.086 
 
 
 
0.006 
 
 
 
 
0.605 
 
 
 
 
  
351 
 
Univariate associations between use of medicines and recreational 
substances in at least one trimester and other problems 
 
 
Variable 
Other problems 
 
No 
 
 
Yes 
 
 
p value 
 
 
Age (years) 
≤ 20 
21 – 30 
31 – 40 
41 – 50 
 
Ethnic Origin 
White 
Black origin 
Asian 
Other 
 
Educational status 
Below university 
qualification 
University 
qualification 
 
Gravidity 
   1 
≥ 2 
 
Previous obstetric 
problems 
No 
Yes 
 
Parity 
   0 
≥ 1 
 
Previous healthy 
child(ren) 
No 
Yes 
 
Coffee 
No 
Yes 
 
Tea 
No 
n (%) 
 
 
4 (2.3) 
48 (27.9) 
111 (64.5) 
9 (5.2) 
 
 
124 (72.1) 
12 (7.0) 
15 (8.7) 
21 (12.2) 
 
 
37 (21.5) 
 
135 (78.5) 
 
 
 
64 (37.2) 
108 (62.8) 
 
 
 
51 (47.2) 
57 (52.8) 
 
 
94 (54.7) 
78 (45.3) 
 
 
 
7 (9.0) 
71 (91.0) 
 
 
118 (68.6) 
54 (31.4) 
 
 
79 (45.9) 
n (%) 
 
 
2 (6.1) 
10 (30.3) 
20 (60.6) 
1 (3.0) 
 
 
27 (81.8) 
2 (6.1) 
2 (6.1) 
2 (6.1) 
 
 
6 (18.2) 
 
27 (81.8) 
 
 
 
13 (39.4) 
20 (60.6) 
 
 
 
3 (15.0) 
17 (85.0) 
 
 
21 (63.6) 
12 (36.4) 
 
 
 
0 (0.0) 
12 (100.0) 
 
 
28 (84.8) 
5 (15.2) 
 
 
11 (33.3) 
 
 
0.633 
 
 
 
 
 
0.669 
 
 
 
 
 
0.667 
 
 
 
 
 
0.812 
 
 
 
 
0.007 
 
 
 
0.341 
 
 
 
 
0.280 
 
 
 
0.059 
 
 
 
0.182 
 
  
352 
 
Yes 
 
Cola 
No 
Yes 
 
POM 
No 
Yes 
 
OTC 
No 
Yes 
 
CAM 
No 
Yes 
 
Alcohol 
No 
Yes 
 
Cigarette 
No 
Yes 
 
POM + OTC 
No 
Yes 
 
POM + CAM 
No 
Yes 
 
OTC + CAM 
No 
Yes 
 
POM+OTC+CAM 
No 
Yes 
 
POM + Alcohol 
No 
Yes 
 
POM + Cigarette 
No 
Yes 
 
93 (54.1) 
 
 
146 (84.9) 
26 (15.1) 
 
 
120 (69.8) 
52 (30.2) 
 
 
84 (48.8) 
88 (51.2) 
 
 
75 (43.6) 
97 (56.4) 
 
 
144 (83.7) 
28 (16.3) 
 
 
169 (98.3) 
3 (1.7) 
 
 
150 (87.2) 
22 (12.8) 
 
 
145 (84.3) 
27 (15.7) 
 
 
124 (72.1) 
48 (27.9) 
 
 
160 (93.0) 
12 (7.0) 
 
 
167 (97.1) 
5 (2.9) 
 
 
171 (99.4) 
1 (0.6) 
 
22 (66.7) 
 
 
30 (90.9) 
3 (9.1) 
 
 
19 (57.6) 
14 (42.4) 
 
 
19 (57.6) 
14 (42.4) 
 
 
18 (54.5) 
15 (45.5) 
 
 
28 (84.8) 
5 (15.2) 
 
 
30 (90.9) 
3 (9.1) 
 
 
24 (72.7) 
9 (27.3) 
 
 
27 (81.8) 
6 (18.2) 
 
 
24 (72.7) 
9 (27.3) 
 
 
29 (87.9) 
4 (12.1) 
 
 
31 (93.9) 
2 (6.1) 
 
 
32 (97.0) 
1 (3.0) 
 
 
 
0.363 
 
 
 
0.170 
 
 
 
0.358 
 
 
 
0.248 
 
 
 
0.872 
 
 
 
0.022 
 
 
 
0.033 
 
 
 
0.722 
 
 
 
0.941 
 
 
 
0.313 
 
 
 
0.361 
 
 
 
0.190 
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POM+OTC+Alcohol 
No 
Yes 
 
POM+OTC+Cigarette 
No 
Yes 
 
POM+CAM+Alcohol 
No 
Yes 
 
OTC + Alcohol 
No 
Yes 
 
OTC+Cigarette 
No 
Yes 
 
OTC+CAM+Alcohol 
No 
Yes 
 
OTC+CAM+Cigarette 
No 
Yes 
 
CAM + Alcohol 
No 
Yes 
 
CAM + Cigarette 
No 
Yes 
 
POM + OTC + CAM + 
Alcohol 
No 
Yes 
 
 
169 (98.3) 
3 (1.7) 
 
 
172 (100.0) 
0 (0.0) 
 
 
169 (98.3) 
3 (1.7) 
 
 
153 (89.0) 
19 (11.0) 
 
 
171 (99.4) 
1 (0.6) 
 
 
160 (93.0) 
12 (7.0) 
 
 
171 (99.4) 
1 (0.6) 
 
 
154 (89.5) 
18 (10.5) 
 
 
171 (99.4) 
1 (0.6) 
 
 
 
170 (98.8) 
2 (1.2) 
 
 
32 (97.0) 
1 (3.0) 
 
 
32 (97.0) 
1 (3.0) 
 
 
33 (100.0) 
0 (0.0) 
 
 
30 (90.9) 
3 (9.1) 
 
 
32 (97.0) 
1 (3.0) 
 
 
31 (93.9) 
2 (6.1) 
 
 
33 (100.0) 
0 (0.0) 
 
 
31 (93.9) 
2 (6.1) 
 
 
33 (100.0) 
0 (0.0) 
 
 
 
33 (100.0) 
0 (0.0) 
 
0.625 
 
 
 
0.022 
 
 
 
0.445 
 
 
 
0.740 
 
 
 
0.190 
 
 
 
0.848 
 
 
 
0.661 
 
 
 
0.435 
 
 
 
0.661 
 
 
 
 
0.534 
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Appendix 7 – Comparison of first, second and third trimester use of 
medicines or recreational substances using the chi-square test 
Medicine/Substance Trimesters (p 
values) 
1st and 2nd 
 
 
2nd and 3rd 
 
 
1st and 3rd 
 
Prescription 
medicines 
 
Over-the-counter 
medicines 
 
Complementary and 
alternative medicines 
 
Alcohol 
 
Cigarette 
 
 
<0.0001 
 
 
<0.0001 
 
 
<0.0001 
 
 
<0.0001 
 
<0.0001 
 
<0.0001 
 
 
<0.0001 
 
 
<0.0001 
 
 
<0.0001 
 
<0.0001 
 
<0.0001 
 
 
<0.0001 
 
 
<0.0001 
 
 
<0.0001 
 
<0.0001 
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Appendix 8 – Interview guide for the qualitative study (Final version) 
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UCL INSTITUTE OF CHILD HEALTH 
 
 
INTERVIEW GUIDE 
Preamble: I am the research pharmacist at the hospital. Following your participation 
in the first part of our study on Medicine and recreational substance use in 
pregnancy, I would like to carry out a 30-minute interview with you. The purpose of 
this interview is to find out your beliefs and views on the use of medicines and 
recreational substances during pregnancy. We would also be grateful if you could 
share your experiences of the medicines or substances you have used. 
All responses are confidential and anonymous. 
 
 
General Questions 
1. How often do you think about your health in pregnancy? 
(What are the things you think about?) 
 
2. Do you have any concerns about your health?  
 
3. Do you have any concerns about the health of your unborn baby? 
 
 
 
Prescription medicines 
 
1. As regards your medicines, can you tell me what you know about 
them? 
(Safety information; sources of information e.g. GP, midwife/consultant, 
pharmacist, books, internet, friends/family, other sources; other 
discussions/advice received with the medicines from doctor/midwife/other 
health professional; anything else…) 
 
2. How do you take your medicines?  
(The dose, frequency and duration of use) 
 
3. Do you remember how it was prescribed? 
 
4. Can you tell me what your experience has been as regards taking your 
regular medicines every day? 
(Your thoughts on missed doses) 
  
5. What do you know about the benefits of taking these medicines during 
pregnancy? 
 
6. What do you know about the risks of not taking these medicines during 
pregnancy? 
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Over-the-counter medicines 
1. As regards your over-the-counter medications, can you tell me what 
you know about them? 
(Safety information; sources of information e.g. GP, midwife/consultant, 
pharmacist, books, internet, friends/family, other sources; other 
discussions/advice received with the medicines from doctor/midwife/other 
health professional; anything else…) 
 
2. How do you take the medicines?  
(The dose, frequency and duration of use) 
 
3. Do you remember how it was recommended? 
 
4. Can you tell me what your experience has been as regards taking your 
regular medicines every day? 
(Your thoughts on missed doses) 
5.  What do you know about the benefits of taking these medicines during 
pregnancy? 
6. What do you know about the risks of not taking these medicines during 
pregnancy? 
   
 
 
Complementary and Alternative Medicines (CAM) 
1. You mentioned in the questionnaire that you are using CAM, can you 
tell me more about it? 
(Why you decided to use it; the source e.g. therapist/practitioner, 
friends/family, internet, other sources; safety information; other 
discussions/advice received with the CAM; anything else…) 
 
2. What do you know about the benefits of taking the CAM during 
pregnancy?  
 
3. What do you know about the risks of taking the CAM during 
pregnancy? 
 
4. Have you spoken to your midwife/doctor about your CAM use? 
(Midwife/doctor’s comments) 
 
5. Based on your experience, will you recommend the CAM to another 
pregnant woman? 
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Recreational Substances (cigarette, alcohol and cannabis) 
1. In the questionnaire, you talked about using 
cigarette/alcohol/cannabis, can you tell me more about your reasons 
for using it in pregnancy? 
(Frequency of use during pregnancy; does the partner/spouse or 
friends/family drink or smoke?) 
  
2. Can you tell me the information you have about the 
cigarette/alcohol/cannabis? 
(Safety information; belief in safety limits; sources of information e.g. GP, 
midwife/consultant, pharmacist, books, internet, friends/family, other 
sources; other discussions/advice received from doctor/midwife/other health 
professional; anything else…) 
 
3. What do you know about the risks of taking cigarette/alcohol/cannabis 
during pregnancy? 
 
4. Are you interested in stopping cigarette/alcohol/cannabis during your 
pregnancy? 
(Have you tried stopping? What are the things you feel you can do to help 
you stop?) 
 
 
Do you have any other thoughts or experiences about the use of medicines and 
substances in pregnancy that you would like to share? 
 
Thank you very much for your time. 
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Appendix 9 – The coding framework for the qualitative study 
Main Codes Sub codes 
1. Thinking of health 1.1 Quite often/All the time 
1.2 Sometimes 
2. Concerns/worries about 
health 
2.1 Yes 
2.1.1 High blood pressure 
2.1.2 Enough vitamins/minerals 
2.1.3 Enough water 
2.1.4 Bleeding/Spotting 
2.1.5 Positive fibronectin test 
2.1.6 Low-lying placenta 
2.1.7 Diabetes 
2.1.8 Rare blood type 
2.1.9 Fibroid pain, contractions 
2.1.10 Fatigue 
2.1.11 Weight gain 
 
2.2 No concerns 
  
3. Concerns about unborn 
baby’s health 
3.1 Yes 
3.1.1 Preterm delivery 
3.1.2 Neonatal complications 
3.1.3 Baby’s heart beat/breathing 
problems 
3.1.4 Large abdominal 
circumference 
3.1.5 Food intake 
 
3.2 No concerns 
3.2.1 Regular check-ups 
3.2.2 Low risk 
3.2.3 Scan and test results 
3.2.4 Foetal movements 
 
4. Prescription medicines 4.1 Sources of information 
4.1.1 GP 
4.1.2 Midwife 
4.1.3 Pharmacist 
4.1.4 Internet 
4.1.5 Product leaflets 
4.1.6 Books 
 
4.2 Adherence issues 
4.2.1 Medicine taken or used as 
prescribed 
4.2.2 Thoughts on missed doses 
4.2.2.1 On and off the 
medicine/medicine used 
anytime 
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4.2.2.2 Non-adherence due to 
lack of conviction about 
diagnosis 
4.2.2.3 Non-adherence due to 
high dosage perception 
4.2.2.4 Non-adherence due to 
side effects 
4.2.2.5 Non-adherence due to 
forgetfulness 
4.2.2.6 Non-adherence due to 
perception that iron is not 
low 
4.2.2.7 Supplementing with 
fruits 
 
4.3 Experiences of medicine use 
4.3.1 Fine 
4.3.2 Side effects experience 
4.3.3 None 
 
4.4 Benefits of using medicine 
4.4.1 Control of nausea 
4.4.2 Gets rid of UTI 
4.4.3 Lowering blood sugar 
4.4.4 Boosting iron or blood level 
4.4.5 Relieves aches and pains 
4.4.6 Controls heartburn and 
indigestion 
4.4.7 Gets rid of infections 
4.4.8 No information on benefits 
 
4.5 Risks of not using medicine 
4.5.1 Dehydration 
4.5.2 Inadequate vitamins 
4.5.3 Inadequate care for self 
and family 
4.5.4 Symptoms would not 
improve or infection gets 
worse 
4.5.5 Blood sugar getting high 
4.5.6 Activity levels becoming 
affected 
4.5.7 Low blood level or fainting 
4.5.8 No information on risks 
 
5. Over-the-counter medicines 
(Vitamins) 
5.1 Recommended 
5.1.1 By Midwife 
5.1.2 By GP 
5.1.3 Friends/Family 
5.1.4 Self-decision 
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5.1.5 Other sources of 
information (Internet, 
product leaflets) 
 
5.2 Adherence issues 
5.2.1 Vitamins taken as 
recommended 
5.2.2 Thoughts on missed doses 
5.2.2.1 Non-adherence to 
forgetfulness 
5.2.2.2 Non-adherence due to 
sickness 
5.2.2.3 Not good at taking 
medicines 
5.2.2.4 Running out of medicine 
5.2.2.5 Big tablets 
5.2.2.6 Just a supplement 
 
5.3 Experiences of vitamin use 
5.3.1 Fine/Good 
5.3.2 No bad effects 
5.3.3 None 
  
5.4 Benefits of using vitamins 
5.4.1 Supplements food  
5.4.2 Feeling healthier/better  
5.4.3 Good for baby development 
5.4.4 Not sure of the effects 
  
5.5 Risks of not using vitamins 
5.5.1 Spina bifida/spinal defects 
5.5.2 Cleft lip 
5.5.3 Inadequate calcium and 
vitamins for baby 
5.5.4 Rickets 
5.5.5 Inadequate development of 
the baby 
5.5.6 Don’t know the risks 
5.5.7 Don’t believe in risks 
 
6. Complementary and 
alternative medicines (CAM)  
6.1 Recommended 
6.1.1 By Friends/Family 
6.1.2 By midwife 
6.1.3 By CAM practitioner 
6.1.4 Other sources of 
information (Internet, 
product leaflets) 
 
6.2 Indications/Reasons for use 
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6.3 Benefits of using CAM 
6.3.1 Yes 
6.3.2 No 
6.3.3 Not sure/Uncertain 
 
6.4 Risks of using CAM 
6.4.1 Natural 
6.4.2 No risks 
6.4.3 Not harmful/dangerous 
 
6.5 Discussion with healthcare 
professionals 
6.5.1 Yes 
6.5.2 No because it was not 
important 
6.5.3 No because of time 
constraints 
 
6.6 Recommending CAM 
6.6.1 Yes 
6.6.2 No 
6.6.3 Not sure 
   
7. Alcohol 7.1 Taking 1-2 units per week 
7.2 Liking for alcohol 
7.3 It is relaxing 
7.4 Friends/family consumption 
7.5 Small intake (1-2 units) won’t 
hurt baby 
7.6 Large amount can hurt baby 
7.7 Fine in moderation 
7.8 Paranoid about smoking 
7.9 Smoking is worse 
 
7.10 Sources of information 
7.10.1 Healthcare professionals 
7.10.2 Friends/Family 
7.10.3 Internet 
7.10.4 Media 
7.10.5 Pregnancy book 
 
7.11 Discussion with 
healthcare professionals 
7.11.1 Yes but did not admit 
consumption 
7.11.2 Yes and admitted 
consumption 
 
8. Cigarette 8.1 Smoking for long 
8.2 Finding it hard to stop 
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8.3 Cut down in pregnancy 
8.4 Referral to stop smoking clinic 
8.5 Use of nicotine patches 
8.6 Ineffectiveness of patches 
8.7 Risk to the baby 
8.8 Partner’s consumption 
  
9. Cannabis 9.1 Consumed once a month 
9.2 Reduced intake in pregnancy  
9.3 For creative inspiration 
9.4 Does not consume much 
9.5 Partner’s consumption 
9.6 No knowledge of risks 
 
10. Other thoughts/experiences 10.1 Trust in healthcare 
professionals 
10.2 Trust in CAM 
practitioners 
10.3 Preference for 
homeopathic labour induction 
10.4 Researching for 
information about medicines 
10.5 Seeking medical advice 
10.6 Eating healthily and on 
time 
10.7 Taking things in 
moderation is fine 
 
 
 
